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Human-pathogenic fungi constitute a serious problem in medical health care due to the
increasing number of immunocompromised patients and are associated with high mortality
rates. The immune system – a highly complex system – provides an arsenal of effector
mechanisms that protect the healthy status of the host. However, various causes may
intimidate the protective function of the immune system, which allows invading microbes
to cause severe infections. The research on host-pathogen interactions between human-
pathogenic fungi and the immune system is essential for the development of new diagnostic
and therapeutic approaches. In this thesis, these host-pathogen interactions have been
investigated according to the concept of systems biology. Based on an experimental
data basis, virtual infection modelling has been applied, in order to decipher the driving
forces during the innate immune response against the fungal pathogens Candida albicans,
Candida glabrata and Aspergillus fumigatus.
The opportunistic pathogens C. albicans and C. glabrata are commensals in the
microbiota of large fractions of the world population. Typically, they colonize skin and
mucosal surfaces and do not cause infections in healthy individuals. However, under
immunocompromised conditions they can become pathogenic and can cause superficial
as well as systemic infections due to pathogen translocation into the bloodstream. In
a previous study, a whole-blood infection assay with C. albicans has been established
in order to investigate the innate immune response against this fungus. Based on the
measured data, a state-based model (SBM) was developed that quantifies innate immune
reaction rates. In this thesis, a bottom-up modelling approach, which incorporates an
extended version of the previously developed SBM and its spatial counterpart – an
agent-based model (ABM) was developed. The ABM enabled prediction of immune cell
migration parameters, which are not directly accessible in experiment. In order to keep
computational costs within limits, the ABM takes advantage of estimated immune reaction
rates from the SBM. This bottom-up modelling approach was used to address various
research questions regarding the host-pathogen interaction in whole-blood infection assays
with C. albicans and C. glabrata. In another study, the SBM was used for hypothesis
testing of an immune evasion mechanism that could not be elucidated until now and was
observerd in whole-blood infection assays. Furthermore, we simulated neutropenia and
immune dysregulation and found that the infection outcome during impaired neutrophil
migration resembles the infection outcome during neutropenia. Thus, we hypothesize
that an improved neutrophil activity might recover the infection outcome in neutropenic
patients to that of non-neutropenic individuals. We addressed this hypothesis using the
bottom-up modelling approach, where we first determined immune reaction rates and
migration parameters under healthy immune conditions. Subsequently, we simulated
virtual neutropenic patients and investigated the infection outcome with C. albicans and
C. glabrata. Eventually, we simulated an in silico cytokine treatment that enhanced
phagocytic activity and migration of the remaining neutrophils, which indeed could
successfully clear the fungal infections in the neutropenic patients and was more efficient
for C. glabrata.
Contrary, to Candida spp., A. fumigatus naturally does not colonize humans, but
occurs in soil. Its conidia are distributed via the air and every human individual inhales
several hundreds up to thousands of them every day. Their small size allows the conidia to
reach the alveoli in the lower respiratory tract, where they immediately face host immune
responses, which efficiently clear the lung from the conidia in healthy hosts. However,
if the immune system is compromised conidia are not eliminated before onset of the
germination, leading to severe pulmonary infections. In this thesis, two publications focus
on the host-pathogen interaction between the innate immune response and A. fumigatus.
In a first publication, evolutionary game theory on graphs was applied that simulated
different stages of this immune response in response to the fungus. To this end, a
sequence of interaction situations, called games, was simulated, including the complement
system, alveolar macrophages and neutrophils. This approach enabled to investigate
the key parameters of the biological system and revealed the different roles of alveolar
macrophages under various infection doses. In a second publication, we adapted a
previously developed realistic to-scale hybrid ABM of a human alveolus to the murine
system. This model included migration of alveolar macrophages as well as chemokine
secretion and diffusion. Using the human and murine virtual alveoli, a comparative
analysis of the early infection process during experimental A. fumigatus infection in
mice and physiological A. fumigatus infection in humans was performed with regard to
differences in their lung morphology and infection doses.
In this thesis, virtual infection modelling was applied to investigate host-pathogen
interactions between the innate immune response and the human-pathogenic fungi
C. albicans, C. glabrata and A. fumigatus. Different individual-based modelling techniques
have been applied to investigate the driving forces in the immune response against the
aforementioned pathogens and to generate relevant hypotheses. These hypotheses need to
be addressed in future experimental studies starting the cycle of systems biology anew.
Zusammenfassung
Human-pathogene Pilze stellen aufgrund der zunehmenden Anzahl von immungeschwäch-
ten Patienten ein zunehmendes Problem im Gesundheitswesen dar und sind mit hohen
Sterblichkeitsraten assoziiert. Das menschliche Immunsystem – ein hochkomplexes System
– stellt ein Arsenal an Effektormechanismen bereit, die den gesunden Zustand des Wirts
schützen. Vielfältige Ursachen können jedoch diese schützende Funktion des Immunsys-
tems beeinträchtigen, was es eindringenden Mikroben erlaubt, schwere Infektionen zu
verursachen. Die Forschung an Wirt-Pathogen-Interaktionen zwischen humanpathogenen
Pilzen und dem Immunsystem ist essentiell für die Entwicklung neuer diagnostischer und
therapeutischer Verfahren. In dieser Arbeit wurden diese Wirt-Pathogen-Interaktionen
entsprechend des Konzepts der Systembiologie, untersucht. Basierend auf experimentel-
len Daten wurden virtuelle Infektionsmodelle entwickelt, um die treibenden Kräfte der
angeborenen Immunantwort gegen die pilzlichen Erreger C. albicans, C. glabrata und
A. fumigatus zu entschlüsseln.
Die opportunistischen Pilze C. albicans und C. glabrata kommen in der Mikrobiota
großer Teile der Weltbevölkerung als Kommensal vor. Typischerweise kolonisieren sie Haut
und Schleimhäute, verursachen aber bei gesunden Menschen keine Infektionen. In immun-
geschwächten Patienten können sie jedoch krankheitserregend werden und oberflächliche
sowie systemische Infektionen, durch das Eindringen in die Blutbahn, verursachen. In
einer vorangegangenen Studie wurde ein Vollblut-Infektionsassay mit C. albicans eta-
bliert, um die angeborene Immunantwort gegen diesen Pilz zu untersuchen. Basierend
auf den gemessenen Daten wurde ein zustandsbasiertes Modell (SBM) entwickelt, das
Immunreaktionsraten des angeborenen Immunsystems quantifiziert. In dieser Arbeit
wurde ein Bottom-up-Modellierungsansatz entwickelt, welcher eine erweiterte Version
des zuvor entwickelten SBM sowie dessen räumliches Pendant – ein agentenbasiertes
Modell (ABM) – beinhaltet. Das ABM erlaubt die Vorhersage von Migrationsparametern
von Immunzellen, welche nicht direkt experimentell zugänglich sind. Um die Rechen-
kosten in Grenzen zu halten, nutzt das ABM die geschätzten Immunreaktionsraten aus
dem SBM. Dieser Bottom-up-Modellierungsansatz wurde verwendet, um verschiedene
Forschungsfragen bezüglich der Wirt-Pathogen-Interaktion in Vollblut-Infektionsassays
mit C. albicans und C. glabrata zu behandeln. In einer weiteren Studie wurde der SBM
zur Hypothesenprüfung eines Immunevasionsmechanismus verwendet, der in Vollblut-
Infektionsassays beobachtet wurde und bis heute nicht aufgeklärt werden konnte. Darüber
hinaus haben wir Neutropenie und die Dysregulation des Immunsystems simuliert und
festgestellt, dass der Infektionsausgang während der gestörten Neutrophilenmigration
dem Infektionsausgang unter Neutropenie ähnelt. Daher vermuten wir, dass eine verbes-
serte Neutrophilen-Aktivität den Infektionsausgang bei neutropenischen Patienten auf
das von nicht-neutropenischen Individuen zurückführen könnte. Wir haben diese Hypo-
these mithilfe des Bottom-up-Modellierungsansatzes untersucht, bei dem wir zunächst
die Immunreaktionsraten und Migrationsparameter unter gesunden Immunbedingun-
gen bestimmt haben. Anschließend simulierten wir virtuelle neutropenische Patienten
und untersuchten den Infektionsausgang mit C. albicans und C. glabrata. Schließlich
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simulierten wir eine in silico Zytokin-Behandlung, die die phagozytische Aktivität und
Migration der verbleibenden Neutrophilen verbesserte, was tatsächlich die Pilzinfektionen
in neutropenischen Patienten beseitigen konnte und für C. glabrata effizienter war.
Im Gegensatz zu Candida Spezies werden Menschen nicht von A. fumigatus Konidien
kolonisiert, welche vorwiegend im Erdreich vorkommen. Die über die Luft verbreiteten
Konidien werden von jedem Menschen jeden Tag hundert- bis tausendfach eingeatmet.
Ihre kleine Größe erlaubt ein Vordringen bis in die Lungenbläschen in den unteren
Atemwegen, wo sie sofort mit der Immunantwort des Wirts konforntiert werden, wel-
che in gesunden Menschen die Konidien in der Lunge effizient eliminiert. Wenn das
Immunsystem geschwächt ist, werden die Konidien jedoch nicht rechtzeitig beseitigt und
können auskeimen, was zu schweren Infektionen der Lunge führen kann. Teil dieser Dis-
sertation sind zwei Veröffentlichungen, die die Wirt-Pathogen-Interaktion zwischen dem
angeborenen Immunsystem und A. fumigatus untersuchen. In der ersten Veröffentlichung
wurde evolutionäre Spieltheorie genutzt, um mehrere Stadien dieser Immunantwort zu
simulieren. Dazu wurde eine Sequenz aus mehreren Spielen, d.h. Interaktionen zwischen
Komponenten des Immunsystems, wie dem Komplementsystem, alveolaren Makrophagen
und Neutrophilen, simuliert. Dies erlaubte die Untersuchung der Schlüsselparameter des
biologischen Systems und klärte die unterschiedlichen Rollen alveolarer Makrophagen
unter verschiedenen Infektionsdosen auf. In einer zweiten Publikation haben wir ein zuvor
entwickeltes, realistisches, skalengerechtes, hybrides ABM eines menschlichen Lungen-
bläschens für das Maussystem angepasst. Dieses Modell umfasst die Migration alveolarer
Makrophagen sowie die Sekretion und Diffusion von Chemokinen. Unter Nutzung der
virtuellen Lungenbläschen für Mensch und Maus haben wir eine vergleichende Analyse
des frühen Infektionsprozesses während experimenteller A. fumigatus Infektion in Mäusen
und physiologischer A. fumigatus Infektion in Menschen durchgeführt. Dabei haben wir
insbesondere die verschiedenen Lungenmorphologien sowie Infektionsdosen betrachtet.
In dieser Dissertation wurden virtuelle Infektionsmodelle erstellt, um Wirt-Pathogen-
Interaktionen zwischen dem angeborenem Immunsystem und den humanen Pilzerregern
C. albicans, C. glabrata und A. fumigatus zu erforschen. Verschiedene individuenbasierte
Modellierungstechniken wurden angewandt, um die treibenden Kräfte in der Immun-
antwort gegen die zuvor genannten Erreger zu ermitteln und relevante Hypothesen zu
generieren. Zukünftige experimentelle Untersuchungen dieser Hypothesen werden den
Kreislauf der Systembiologie von Neuem starten.
Abbreviations
Biological
ABPA allergic bronchopulmonary aspergillosis
AEC alveolar epithelial cells
CNPA chronic necrotizing pulmonary aspergillosis
CPA chronic pulmonary aspergillosis
CR3 complement receptor 3
DNA deoxyribonucleic acid
FACS fluorescence-activated cell sorting
FHL-1 factor-H-like protein 1
G-CSF granulocyte colony-stimulating factor
GM-CSF granulocyte-macrophage colony-stimulating factor
HIV human immunodeficiency virus
IFNγ interferon γ
IL-8 interleukin 8
NETs neutrophil extracellular traps
NK cells natural killer cells
PAMPs pathogen associated molecular patterns
PIDs primary immune disorders
Pra1 pH-regulated antigen 1
PRRs pattern recognition receptors
RNA ribonucleic acid
ROS reactive oxygen species
Saps secreted aspartyl proteases
SCID severe combined immunodeficiency






CGT classical game theory
CPM cellular Potts model
EGT evolutionary game theory
GT game theory
hABM hybrid agent-based model
IBM individual-based model
LSE least squares error
ODE ordinary differential equation
PDE partial differential equation
RSS residual sum of squares
SBM state-based model
SDE stochastic differential equation




3Humankind tried to classify living organisms into kingdoms ever since. From Aristotle
to the mid of the 20th century living organisms on earth were grouped into plants and
animals. However, with increasing knowledge about biology this concept turned out to
be not sufficient to describe the huge variety of living organisms. In the past, several
proposals for the classification of organisms into groups have been made on the basis of
different criteria. For example, in 1866 Ernst Haeckel proposed a three-kingdom system
that incorporated not only plants and animals but also the kingdom of protista that
contained microscopic organisms. Further research revealed a much more complex picture
of the phylogeny of life on earth. New technologies and further research on the molecular
level, especially DNA-Sequencing allowed for an increasingly better classification of the
kingdoms of live. Nowadays, a five- or six-kingdom system is widely accepted. The five
kingdom system includes animalia, plantae, fungi, protista and monera, while the six
kingdom system further separates monera into archea and eubacteria. This emphasizes
the importance of fungi for life on earth, as they constitute a separate kingdom of
life. Fungi are eukaryotic organisms that occupy all habitats on earth in air, soil and
water in all climate zones, as they are highly adaptable and can cope with extreme
environmental conditions [1]. Currently, over 21,000 different fungal species are described
in "The Dictionary of the fungi" by Ainsworth and Bisby [2]. However, there exist several
estimates on the total number of fungal species that range between 712,000 [3] up to
5.1 million [4]. Furthermore, some species have mutualistic, commensalistic or parasitic
relationships with other organisms like plants, insects and vertebrates.
The research on fungi is, among other issues, driven by economical, ecological, phar-
maceutical and medical interests. Some fungal species constitute a major problem in
agriculture where they are responsible for vast harvest losses [5]. However, other species
like white-rot fungi are used as bioremediators as they are able to degrade for example
heavy metals, dyes, pesticides, herbicides, plastic and thereby help in counteracting
environmental pollution [6]. Furthermore, some fungal species like A. fumigatus, C. al-
bicans, C. glabrata, Pseudomonas aeruginosa and many others are opportunistic or
pathogenic to human individuals. Due to the increasing number of immunocompromised
patients, fungal infections, ranging from superficial up to systemic infections, are an
increasing problem in medical health care [7, 8]. Besides these problems caused by some
species, fungi yield also an enormous potential in their secondary metabolites to find
new natural products that might be useful in different fields of applications, such as
antibiotics, immunosuppressants, angiogenesis inhibitors, anti-osteoporosis agents and
anti-migraine [9].
The subject of research of the present thesis is the host-pathogen interaction of the
human innate immune system with the fungal pathogens C. albicans, C. glabrata and
A. fumigatus, which was investigated using a systems biology approach. The concept of
systems biology describes an iterative cycle between wet-lab studies, i.e. experiments
performed in laboratories, and computational data analysis, modelling and simulation.
The work on which this thesis is build upon was conducted within a transregional
Collaborative Research Center (CRC/Transregio 124) funded by the Deutsche Forschungs-
gemeinschaft (DFG), called FungiNet. This transregional project is a collaborative work
of experts on fungal pathogens in the two cities Jena and Würzburg. It aims at un-
derstanding the cause and process of fungal infections of the two major fugal human
pathogens A. fumigatus and C. albicans. Special focus is placed on virulence factors of
the fungal pathogens, the immune response as well as host-pathogen interactions. Of
4particular note is the complementary work of experimental and theoretical groups that
collaborate according to the cycle of systems biology. These investigations drive the
development of new diagnostic and therapeutic methods with regard to fungal infections.
In the first chapter of the introduction human-pathogenic fungi will be introduced,
with special emphasis on the species C. albicans, C. glabrata and A. fumigatus. The
second chapter focuses on the human immune system with regard to the innate immune
response against these human-pathogenic fungi. Eventually, the third chapter introduces
the concept of systems biology and gives an overview about computational modelling
and parameter estimation methods, that are of relevance for this thesis.
1. Human-pathogenic fungi
– an underestimated threat –
Besides bacteria and viruses, fungi constitute a major threat to the health of the human
body [10]. It is estimated that there are around 600 human-pathogenic fungi that infect
mucosa, skin, hair, nails and cause allergies [11]. Most people face benign superficial
fungal infections during their life-time that are usually easy to treat [7].
On the contrary, millions of people worldwide per year acquire invasive fungal infections,
which are often diagnosed too late, treated not appropriately and come along with high
mortality rates up to 50% [7]. The number of invasive fungal infections increased
during the last years due to the increased use of immunosuppressive and invasive medical
interventions worldwide [12]. These possibly lethal infections occur mainly in patients with
a compromised or suppressed immune system. For example, HIV patients, neutropenic
patients, patients that underwent anti-cancer chemotherapy or patients that receive
immunosuppressive therapy due to an organ transplantation are at high risk for invasive
fungal infections [12].
The most prevalent invasive fungal infections are aspergillosis, mainly caused by
A. fumigatus, candidiasis, mainly caused by C. albicans and cryptococcosis, mainly caused
by Cryptococcus neoformans. However, there are many other fungal species that cause
invasive fungal infections as well [7]. The focus of this thesis mainly laid on Candida
blood stream infection and Aspergillus lung infection. Therefore, this chapter introduces
morphology, life cycle and the occurrence in the human body of the human-pathogenic
fungi C. albicans, C. glabrata and A. fumigatus. Furthermore, associated diseases and
the course of infection of these pathogens will be part of this chapter.
1.1. The human commensals Candida albicans and Candida glabrata
The cell number of the human body is estimated on 3.72 · 1013 cells [13]. About the same
number of microbial cells colonise skin and mucosal surfaces forming the ’normal flora’ –
the so called microbiota [14]. The human microbiota contains an enormous diversity of
microbial species, with fungal species among them [15].
A common fungal commensal that colonizes over 75% of all humans is C. albicans [16].
However, the genus Candida comprises approximately 150 different species [16], of which
more than 17 are opportunistic pathogens to humans and colonize skin and mucosal
surfaces of a large fraction of the world population [17, 18]. Over the last 15 years cases
of non-albicans candidiasis increased 2 to 10-fold [19, 20], where in European countries,
the USA and Australia, C. glabrata was the second most prevalent isolate. However,
C. albicans is still the main cause of invasive candida blood stream infections [17, 21].
Therefore, the main focus with regard to candidiasis in this thesis is on the two species
C. albicans and C. glabrata.





Figure 1.: Morphology of C. albicans and C. glabrata. Upper panel shows different morphological
stages of C. albicans , which can be in the yeast form (A), in the hyphal form (B) [22]
or form pseudo-hyphae (C) [23]. The lower panel shows electron microscopy images of
C. albicans (A) and C. glabrata biofilms [24]. Images were taken from Sudbery (2011),
Sudbery et al. (2004) and Vila and Rozental (2012).
1.1.1. Morphology and occurrence in the human body
As Candida spp. are part of the human microbiota, they are present on skin and mucosal
surfaces, like the oral cavity, the gastrointestinal or the urogenital tract. Despite the fact
that C. albicans and C. glabrata belong to the same genus, they feature some fundamental
differences. For instance, C. albicans is a polymorphic fungus, while C. glabrata is
exclusively present in the typical yeast form also called blastoconidia [25, 26]. The
different morphologies that C. albicans can exhibit, feature different functionalities and
occur under different conditions. Furthermore, the morphological changes of C. albicans
contribute also to the virulence of this species.
Under healthy immune conditions C. albicans stays in its benign commensal form,
where it is present in its typical round-to-oval yeast form (see Figure 1 (A)) [16]. If the
immune system is weakened, C. albicans is able to germinate and form elongated cells with
parallel cell walls, which are called true hyphae (see Figure 1 (B)). Usually in infections
yeast and true hyphae are found [16, 27, 28]. While hyphae are invasive, yeast cells are
usually involved in the dissemination during invasive bloodstream infections [28]. The
morphology of C. albicans cells depends on various factors, such as the pH, temperature,
CO2 level and the contact to serum or specific medium. Besides yeast and hyphal
forms, this fungus can also exhibit other morphologies, such as pseudohyphae, which are
elongated ellipsoid cells with constrictions at the septa (see Figure 1 (C)).
Although C. glabrata exhibits the yeast form and is not polymorphic, it nevertheless
can also undergo the switch from the commensal to the pathogenic state. To date the
exact mechanisms of C. glabrata invasion is not fully understood. However, C. glabrata
is also able to invade the human body by the production of tissue-damaging enzymes,
such as proteases, phospholipases, and hemolysins, and thereby causes bloodstream
infections [18, 25, 29].
Furthermore, Candida spp. have the ability to form biofilms on epithelial cells as well
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as on various materials (see Figure 1 (D,E)) [30, 31]. Biofilm formation of C. albicans is
a major problem in health care, since it comes along with resistance against antifungals
and host-immune responses and is responsible for a major fraction of nosocomial fungal
infections [9, 32–34]. Particularly, biofilm formation on catheters as used in hospitals
pose a major risk factor for bloodstream infections, since they allow Candida spp. to
enter the blood stream.
Taken together, C. albicans and C. glabrata feature a large variety of virulence factors,
which make them successful pathogens. These virulence factors include for example
the yeast-to-hyphae transition, the adhesion to host epithelia, biofilm formation, the
adaptation to different nutrient sources, the production of hydrolytic enzymes and immune
evasion mechanisms [34].
1.1.2. Course of infection and associated diseases
Superficial infections with both pathogens arise on mucosal surfaces that are colonized
by these fungi. First, the fungal cells attach to epithelial cells. In the case of C. albicans,
germination and hyphae formation is initiated, which allows penetration of the tissue
and invasion. C. glabrata is also able to invade the tissue, though without morphological
changes. Superficial Canidia infections can be acute, recurrent or chronic. The most
common diseases are pseudomembranous candidiasis, also known as thrush and vulvovagi-
nal candidiasis. Oral thrush often occurs in patients with acute leukaemia undergoing
chemotherapy as well as HIV patients [35]. Moreover, vulvovaginal candidiasis can be
acute or recurrent and affects up to 75% of all women in child-bearing age [36].
Invasive candidiasis is the fourth most common cause of bloodstream infections in
intensive care units with 250 000 cases per year and mortality rates of 40% [37]. Risk
factors are extremes of age, central vascular catheters, recent abdominal surgeries and
broad-spectrum antibiotic therapy [37]. Fungal cells can enter the blood stream through
catheters or due to a disturbed integrity of the intestinal epithelial barrier [37–39].
Surgeries or medical treatments may cause leakages or a higher permeability in the
intestinal epithelium allowing fungal cells to invade the blood stream. Furthermore,
patients suffering from sepsis in immunoparalysis are predisposed for candidemia [37, 39]
but also patients suffering from candidemia may develop sepsis. Furthermore, Candida
blood stream infections may lead to deep-seated infections in organs and other sites, such
as bones, muscles, joints, the central nervous system, liver and kidney [37]. Typical drugs
applied in invasive candidiasis are fluconacole, caspofungin and variconacole [18, 37].
1.2. The airborne fungus Aspergillus fumigatus
The genus Aspergillus comprises approximately 200 different species, of which about 20
species are pathogenic for humans [40, 41]. Among these 20 species A. fumigatus is the
most prevalent isolate causing invasive fungal infections [41, 42]. A. fumigatus is an
airborne saprophytic mould that naturally occurs in soil, where it recycles carbon and
nitrogen sources by decaying organic material [40, 41, 43].
1.2.1. Morphology, life cycle and course of infection
Naturally, A. fumigatus does not colonize human individuals. However, since its spores,
also called conidia, are distributed over the air, every human individual inhales several
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thousand of these spores every day [43]. Due to their small size of about 2− 3µm they
are able to overcome several filter mechanism of the respiratory tract and enter the
lung alveoli in the lower respiratory tract. Typically, this poses no problem in healthy
people as the immune system can efficiently clear the conidia from the lung. However, in
immunocompromised patients this clearance may not work properly and A. fumigatus can
become infectious. During its life cycle A. fumigatus undergoes morphological changes
that are associated with different properties in their virulence, like cell wall composition
as well as metabolic and reproductive activity [42].
Figure 2.: Life cycle of A. fumigatus: (A) Conidia with a size of about 2− 3µm in diameter. In
contact to water and nutrients conidia begin to swell (B) and germinate (C), which leads
to hyphae formation (D). In contact to air, A. fumigatus forms conidiophores (E) that in
turn produce asexual conidia, which has the potential to spread the fungus. This figure is
adapted from Dagenais and Keller (2009), Margalit and Kavanagh (2015) and Shapiro
et al. (2011).
The spherical conidia of A. fumigatus (see Fig. 2 (A)) are ubiquitous and are, due to
their hydrophobic surface, predestined to be distributed via the air. This hydrophobic
surface is composed of a rodlet layer on the outer layer of the fungal cell wall, which
shields the underlying polysaccharides and thereby makes the conidia immunologically
inert [46]. The metabolic activity of conidia is very low, i. e. they are in a resting state,
where they require only little nutrients and water, but also are not able to grow or
replicate. When the conidia are exposed to water and nutrients they begin to swell and
germinate (see Fig. 2 (B,C)) [45, 47]. A physiological temperature of 37◦C provides
optimal growth conditions and therefore attributes to the virulence of A. fumigatus.
Swelling and germination involve an increase in size causing the burst of the rodlet layer,
which leads to the uncovering of the underlying polysaccharides, that can be bound by
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receptors of innate immune cells. Furthermore, swelling and germination is followed
by hyphae formation (see Fig. 2 (D)). Hyphae are elongated cells that constitute an
important virulence factor of A. fumigatus, since hyphae are able to break epithelial
barriers. This further leads to invasion and dissemination in the body. Furthermore,
A. fumigatus is able to form biofilms, where hyphae are embedded in an extracellular
matrix [43, 48]. Changes in the cell wall composition of the different morphologies trigger
distinct immune reactions [46, 49].
1.2.2. Associated diseases
Pulmonary aspergillosis can occur in various clinical cases and can be distinguished in
three different groups, which are chronic, asthmatic and invasive aspergillosis [43, 44].
The most lethal examples for chronic aspergilloses are chronic pulmonary aspergillosis
(CPA) or chronic necrotizing pulmonary aspergillosis (CNPA). Here, fungal growth
occurs within damaged tissue or cavities in the lung that are for example caused by
tuberculosis or sarcoidosis [42]. This often leads to the formation of aspergilloma, also
known as “fungal balls”, in the lung [43]. The most common allergic aspergillosis
is allergic bronchopulmonary aspergillosis (ABPA), where fungal allergens provoke an
inflammatory response but no fungal growth takes place [42, 43]. ABPA often occurs
in asthmatic and cystic fibrosis patients. Immunocompromised patients that retrieve
immuno-suppressive drugs like in hematopoetic stem cell or solid organ transplantation,
as well as chemotherapy or AIDS patients are at high risk for invasive aspergillosis. This
disease develops very fast and is associated with mycelial growth and invasion in the lung
leading to high mortality rates.

2. Host-pathogen interactions
– an arms race –
When infectious microbes enter the human body they are immediately combated by the
immune system. However, pathogens try to evade or counteract host immune mechanisms.
This chapter introduces general aspects of the human immune system and host-pathogen
interactions of the innate immune system and the human-pathogenic fungi C. albicans,
C. glabrata and A. fumigatus.
2.1. The human immune system
During evolution a sophisticated and highly efficient system – the immune system – has
developed, in order to combat possible threats by invading microbes and thus secure the
health of our body. The immune system comprises various mechanisms on humoral and
cellular scales that are strongly regulated and interwoven. In general, one can distinguish
two major parts of the immune system, that complement and regulate each other: the
innate and the adaptive immune system [50].
The innate immune system
The innate or in-born immune system provides an immediate active defence upon
encounter of cues that intimidate the healthy status of an individual. Its defence
mechanisms range from physical barriers, like the skin and mucosa, via the humoral
response of cytokines and the complement system up to the cellular response of phagocytes
and antigen-presenting cells [51].
The complement system is the fist line of defence of the immune system against
foreign cells as well as altered host cells and is activated within seconds [52, 53]. It
comprises three different pathways – the classical pathway, the lectin pathway and
the alternative pathway – that work as a cascade and converge in a common terminal
pathway [52–57]. The complement system comprises approximately 30 to 40 soluble and
surface-expressed molecules [58, 59], where most of them are inactive precursors that
become enzymatically active upon cleavage and can work in a self-amplified fashion [53,
54]. These molecules opsonize pathogens and create an inflammatory milieu that guides
cellular components of the immune system. The central component along the cascade of
the complement system is C3, an inactive precursor. The activation of all three pathways
ultimately leads to cleavage of C3 into C3a, an inflammatory mediator, and C3b, an
opsonin that covalently binds to cell membranes and tags cells for phagocytosis. Moreover,
the complement system can also actively destroy microbial invaders by formation of the
membrane attack complex that causes perforation of the cell membrane leading to death
of the pathogen [52, 55]. In order to prevent opsonization of host cells regulatory proteins,
such as factor H, provide self from non-self discrimination mechanisms [57].
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Phagocytes comprise three major cell types that contribute to the innate immune
system: monocytes, granulocytes and dendritic cells [52]. Granulocytes consist of three
different cell types – neutrophils, eosinophils and basophils – where neutrophils make up
over 70% of all blood leukocytes [60]. While the main task of monocytes and neutrophils
in humans is their phagocytic activity, dendritic cells are antigen-presenting cells, i. e.
they phagocytose and digest detected pathogens or altered host cells and present the cell
fragments on their surface in order to activate adaptive immune responses. Monocytes are
phagocytes that are present in the blood circulation. They can enter various tissues and
differentiate into tissue specific macrophages and stay their as resident immune cells that
are often the first immune cells to encounter invading pathogens. Upon inflammatory
signals, produced by the complement system and resident macrophages, neutrophils are
recruited from the blood stream to the site of infection [52]. They provide an arsenal
of defence mechanisms against pathogens, such as phagocytosis and the formation of
a cytotoxic milieu due to the secretion of antimicrobial peptides and the production
of reactive oxygen species (ROS). Furthermore, as a final act of defence neutrophils
can commit an altruistic suicide, where they release their deoxyribonucleic acid (DNA)
content and form neutrophil extracellular traps (NETs), in order to trap the fungus [61, 62].
The recognition of pathogens by phagocytes is realized by so called pattern recognition
receptors (PRRs), which bind to pathogen associated molecular patterns (PAMPs), specific
molecules that are present on microbial surfaces [63, 64]. PRRs can activate signalling
cascades that orchestrate the immune response through transcriptional responses, like the
production of pro-inflammatory cytokines, and the increase of phagocytic activities. The
binding of pathogens by receptors of professional phagocytes leads to engulfment of the
pathogen into the phagosome. Eventually, lysosomes fuse with the phagosome, forming
the phagolysosome, which leads to acidification and thereby killing of the pathogen [52].
The adaptive immune system
Often innate immune reactions initiate adaptive immune responses by building up an
inflammatory milieu. Since the adaptive immune response is not subject of this thesis this
section will only give a brief overview of the most important components of the adaptive
immune system. Similar to the innate immune system the adaptive immune system
comprises cellular and humoral components. While the innate immune system acts within
seconds, minutes and hours, the onset of the adaptive immune system may take several
days or weeks [52]. Additionally, it provides highly pathogen-specific immunologic effector
mechanisms and includes an immunologic memory [65]. Lymphocytes constitute the most
important cellular components of the adaptive immune system. They include T and B
lymphocytes [65], which intensely interact with dendritic cells in the lymph nodes, where
they maturate and develop highly specialised receptors against detected pathogens. After
maturation B cells can develop into plasma cells that produce antibodies [65]. These
antibodies, also called immunoglobulins, are Y-shaped proteins that bind specific to
antigens – characteristic pathogenic molecules [66]. The opsonization of pathogens with
antibodies tags them for recognition by phagocytes, is able to directly neutralize them
and, thus, prevents invasion and activates the complement system [52, 66]. Furthermore,
memory B cells allow for a faster production of antibodies upon repeated pathogen
encounter. Thereby, B cells mediate the humoral adaptive immune response [65].
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Disorders and Dysregulation of the Immune System
The immune system involves highly complex and interwoven mechanisms that in most
cases successfully protect the human body against external and internal threats. However,
this protective property might be impaired due to various disorders that can affect
different components of the immune system. Such disorders can be classified into primary
and secondary immune deficiencies. While, primary immune disorders (PIDs) are in-born
and therefore have a genetic origin, secondary disorders are acquired during life [67, 68].
Examples for PIDs are severe combined immunodeficiency (SCID), where T cells and
in some forms also B cells are completely missing, and X-linked agammaglobulinemia
(XLA), the most common form of antibody deficiency, where the process of B cell
maturation is disturbed and no functional antibodies are produced [67, 69]. Secondary
immune deficiencies are much more common than PIDs and can have various causes,
such as extremes of age, malnutrition, infectious agents, drugs, metabolic diseases and
environmental conditions [68]. Drug-related immune deficiencies can be caused by
corticosteroids and immunosuppressive drugs that are for example used in hematopoetic
stem cell transplantations, solid organ transplantations and anti-cancer chemotherapy.
Furthermore, the human immunodeficiency virus (HIV) is the most prominent example
for secondary immune diseases caused by infectious agents [68]
Furthermore, severe infections with bacterial, viral and fungal pathogens can lead to
dysregulation of the host immune response, which can result in life-threatening organ
dysfunction, referred to as sepsis [70, 71].
The condition of neutropenia, i.e. a reduced absolute neutrophil count, constitutes
a major risk factor for candidiasis and aspergillosis and can arise due to congenital
impairments, such as severe congenital neutropenia (SCN) [72]. However, most cases
of neutropenia are acquired and constituted by diverse causes, such as autoimmune
disorders, where antibodies attack neutrophils in blood, anti-cancer chemotherapy [73],
leukemia, alcoholism as well as nutrition deficiencies. Infections like hepatitis A, B,
C as well as HIV/AIDS, but also sepsis can cause high neutrophil consumption. In
combination with exhausted bone marrow reservoirs this might lead to neutropenia [60,
74, 75].
2.2. Innate immune response to Candida in blood and immune evasion
Candida spp. such as C. albicans and C. glabrata can enter the bloodstream through
catheters as well as through a disturbed intestinal barrier. In the bloodstream the yeast
cells face several innate humoral and cellular defence mechanisms as depicted in Figure
3 [76]. Upon entering the bloodstream the complement system is immediately activated
and the central components C3 and C5 are cleaved. Thus, yeast cells are opsonized by
C3b and the anaphylatoxins C3a and C5a contribute to an inflammatory milieu [77].
Thereby, the complement system triggers the activation of cellular immune responses,
where the most important cell types are monocytes, natural killer cells (NK cells) and
neutrophils [76].
Neutrophils are the most abundant leukocytes in blood and constitute the primary
effector cells against Candida spp. during bloodstream infection. They accomplish
highly effective killing by phagocytosis and the formation of a cytotoxic environment
as described in section 2.1 [76]. Thus, neutropenia constitutes a major risk factor for
candidiasis and is associated with increased mortality rates. Neutrophils are efficiently
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Figure 3.: Early immune response against C. albicans in human blood. Upon entering the
bloodstream complement is activated and the central complement proteins C3 and C5 are
cleaved. C. albicans cells are opsonized by C3b and C3a as well as C5a consitute a pro-
inflammatory milieu. Monocytes bind C. albicans via the PRR Dectin-1, can phagocytose
the fungal cells and secrete cytokines like TNFα and IL-6 leading to recruitment of
neutrophils. Neutrophils can phagocytose the C. albicans cells and build up a cytotoxic
milieu by secretion of anti-microbial peptides and ROS. As a final act of defence they can
form NETs, which has fungistatic activity. The figure was created based on figures by
Duggan et al. [76] and Netea et al. [78].
recruited by different cytokines, released by the complement and monocytes, to the site of
infection. Upon activation they release for example interleukin 8 (IL-8) leading to further
recruitment of neutrophils. A central surface molecule of neutrophils is the complement
receptor 3 (CR3) that can recognise both, C. albicans yeast and hyphae. CR3 can bind
the complement molecule C3b as well as the C. albicans membrane protein β-glucan
and the C. albicans surface molecule Pra1. Monocytes are the second most abundant
leukocytes in blood and are also involved in the immune response against Candida spp.,
although their killing ability is less effective in blood. Monocytes recognise Candida spp.
via the Dectin-1 receptor. Upon activation they release cytokines, such as TNFα and IL-6,
which contribute to the inflammatory milieu and mediate activation and recruitment of
other immune cells, such as neutrophils. Monocytes seem to play a more important role
in locations of dissemination, such as the kidney [76]. NK cells are cells of the innate
immune system that secrete perforins forming a cytotoxic environment that can act
against C. albicans germ tubes. Furthermore, NK cells can phagocytose yeast cells and
are able to trigger antifungal effector mechanisms of neutrophils, dendritic cells and T cells
by secretion of cytokines like interferon γ (IFNγ), TNFα and granulocyte-macrophage
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colony-stimulating factor (GM-CSF) [79].
Despite this orchestrated cellular and humoral immune response, Candida spp. are
not at the mercy of these immune defence mechanisms, but have developed themselves a
repertoire of immune evasion mechanism. This repertoire includes mechanisms to evade
the complement system, to prevent recognition and phagocytosis by immune cells as
well as phagosome maturation [77]. Candida spp. are able to bind several complement
regulators, such as Factor H, plasminogen or factor-H-like protein 1 (FHL-1) form the
human plasma to circumvent the attack by the complement system. Moreover, Candida
spp. are also able to release secreted aspartyl proteases (Saps) and pH-regulated antigen 1
(Pra1). Saps degrade and inactivate the complement molecules C3b, C4b and C5. Pra1 is
able to bind C3 and thereby blocks all downstream effects of the complement system [77,
80, 81]. During hyphal growth C. albicans shields β-glucan of the fungal cell wall with
a mannan layer that prevents binding of PRRs of phagocytes and thus phagocytosis.
The dimorphism of C. albicans constitutes an escape mechanism, i.e. if hyphal growth
exceeds a certain limit, macrophages are not able to phagocytose these cells [81]. However,
phagocytosis can often not be prevented by the fungal pathogens. Therefore, several
mechanisms developed to subvert phagocytosis. In case of C. albicans hyphal growth is
initiated upon intracellular CO2 production, which leads to disruption of the immune cell
membrane and thus killing of these cells [81]. In contrast, C. glabrata is a non-dimorphic
fungus but is still able to escape macrophages, since it can proliferate within macrophages
and is able to prevent phagolysosome formation and acidification. The proliferation also
leads to lysis of the immune cells [81, 82]. Furthermore, biofilm formation of C. albicans
and C. glabrata increases resistance against host defence mechanisms and allows the
fungi to grow and proliferate. Thus, the defence of the host and the evasion strategies of
C. albicans and C. glabrata constitutes an immunological cross talk or arms race.
2.3. Innate immune response to Aspergillus fumigatus in the lung and immune
evasion
When the conidia of A. fumigatus are inhaled they reach the alveoli in the lower respiratory
tract (see Figure 4). Each alveolus is composed of alveolar epithelial cells (AEC) that
are in close proximity to blood capillaries where the gas exchange takes place. The
inner surface of these alveoli is lined with a thin layer of pulmonary surfactant that
reduces the surface tension between alveolar epithelial cells and the air and therefore
contributes to the stability of the lung [83]. Once conidia of A. fumigatus enter an
alveolus, they are embedded within the surfactant, where the complement system is
immediately activated [40]. The complement regulators C3 and C5 are cleaved and C3b
opsonizes the conidium, while the anaphylatoxins C3a and C5a build up an inflammatory
milieu (see Figure 4 right side) [40, 84].
The resident phagocytes in the lung are alveolar macrophages (AM), which are the
first immune cells that get into contact with the conidia and therefore constitute the
first cellular line of defence. The complement receptor 3 (CR3) on the surface of the
AM enables recognition of opsonized conidia [84] and several PRRs are involved in
the immune response against A. fumigatus that can bind cell wall components, such
as β − 1, 3−glucan, and thus enhance the phagocytic activity of AM [85]. TLR2 and
TLR4 mediate cytokine production, such as TNF-α, IL-1α, IL-1β, IL-6, MIP-1, MIP-
2, G-CSF and GM-CSF. Thus, they constitute an inflammatory milieu that supports
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Figure 4.: Route of infection and early immune response against A. fumigatus in the human
lung. A. fumigatus is an airborne fungus and human individuals inhale several thousand
of its conidia every day. Due to their small size they can enter the lung alveoli, where they
are immediately faced with immune responses of the complement system and the resident
phagocytes, which are alveolar macrophages (AM). Complement and AM constitute an
inflammatory milieu leading to recruitment of neutrophils. The figure is based on figures
by Dagenais and Keller (2009) and Brakhage et al. (2010).
recruitment of neutrophils from the blood stream [84, 85]. However, in resting conidia
these PAMPs are covered by a rodlet layer, that makes resting conidia immunologically
inert. Swelling and growth of the conidia leads to breakage of the surface layer and
uncovers the underlying carbohydrates [85]. NK cells are recruited early during the
immune response and contribute mainly to the immune response by secretion of the
pro-inflammatory cytokine IFNγ, which increases the fungicidal activity of phagocytes.
The inflammatory milieu, established by the complement as well as AM and NK cells,
leads to recruitment of neutrophils from the bloodstream. Particularly, the susceptibility
of neutropenic patients to severe aspergillosis highlights their function during the immune
response [85]. The recognition of A. fumigatus in neutrophils is also mediated through
the aforementioned receptors. Upon recognition neutrophils are able to phagocytose
conidia and germ tubes of a certain size. The secretion of anti-microbial peptides allows
the attack of large hyphae. Furthermore, the formation of NETs enables trapping hyphae
and preventing further hyphal growth [85].
However, A. fumigatus also developed mechanism to evade this immune responses.
First, the rodlet layer of conidia, enables evasion of recognition by immune cells. Sec-
ondly, A. fumigatus produces melanin, a conidial pigment that prevents phagolysosome
acidification and ROS production [43, 81]. Furthermore, hyphae secrete proteases that
degrade the complement molecules C3, C4b and C5 and thereby inhibit complement
activation. A. fumigatus can also form biofilms, which increase resistance of fungal cells
against phagocytes, anti-microbial peptides and ROS [43, 81].
3. Virtual infection modelling
– complementing experimental studies –
The vast knowledge increase over the past decades in biology was mainly driven by
new techniques in molecular biology and biochemistry that allowed for investigation
of DNA, ribonucleic acid (RNA), proteins and other molecules as well as signalling
pathways [86–88]. These technologies constitute still valuable tools in biological research.
However, often considering only single aspects of a biological system is not enough but
that “the whole is more than the sum of its parts”.
Thus, systems biology has emerged as a concept that considers a more holistic view
on biology [86, 88]. It developed from two different roots that are on the one hand
biochemistry and molecular biology and on the other hand physics and mathematical
biology [88]. Therefore, systems biology aims to investigate complex biological phenomena
by the complementary work of wet-lab experiments and dry-lab studies (see Figure 5)
[89–91]. The development of systems biology is driven by (i) new molecular and imaging
technologies and (ii) by modern mathematical, physical and engineering concepts as well
as novel modelling strategies [87]. A system is a collection of entities within an enclosed
Figure 5.: Cycle of systems biology. Complex biological phenomena can be investigated using
complementary techniques of wet- and dry-lab. Experiments performed in wet-lab can
be analysed by automated data analysis and may serve as a data basis for modelling of
the biological system. Modelling itself constitutes a cycle within the cycle of systems
biology. After model conception and implementation parameters need to be determined by
calibration of the model to the experimental data basis. Model validation and refinement
can improve the model. From the generated model and the estimated parameters new
hypotheses and predictions can be generated, which can be tested in experiment, starting
the cycle of systems biology anew.
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domain that are interconnected or interacting. Biological systems can be considered
as complex systems that feature various characteristics, such as non-lineartity, nested
complexity and modularity, many interacting constituents, redundancy and robustness
as well as emergent behaviour [90, 92].
The cycle of systems biology constitutes a powerful tool to investigate complex bio-
logical systems by combining wet-lab and dry-lab investigations that mutually support
and complement each other (see Figure 5) [89–91]. The theoretical side of this cycle
comprises experimental data analyses as well as modelling of the biological system under
consideration. The data analysis involves all kind of data that is produced in experiments.
Especially, when large amounts of data are generated automated data analysis becomes
essential. For example, recent advances in microscopy technologies lead to increasing
amounts of microscopy data that can not be analysed by hand. Often, the results from
such data analyses form the basis for modelling and simulation of the biological system.
Systems biology has been successfully applied in a broad range of scientific fields, such as
systems based medicine, biotechnology and drug discovery [88]. For example, in the field
of immunology and infection research systems biology has been used to investigate viral
[93], bacterial and fungal infections [94]. Furthermore, it considers knowledge transfer
from bench to bed and vice versa as well as the interaction along various organisational
scales, such as genes, proteins and enzymes, cells, tissues, organs and whole organisms [95,
96]. Furthermore, the research of unknown physiological processes in health and disease,
such as interspecies interactions in the human microbiome is driven by the systems
biology approach.
In this thesis, systems biology has been applied in order to investigate host-pathogen
interactions in silico. Systems biology of infection often faces several problems: (i)
biological processes may not be directly accessible in experiments, (ii) in vivo studies
often rely on animal models, but the transferability and comparability of results from
these experiments to the human system is unclear and (iii) even in animal experiments
infection dynamics cannot be captured in all sites of infection, such as the lung.
Virtual infection modelling provides the possibility to overcome the aforementioned
limitations by integration of all available experimental data and thereby drives the
research in systems biology of infection.
The Cycle of Modelling
A model is a simplified mathematical description of a system and allows simulation of
temporal and/ or spatial dynamics. Models consists of entities that act or interact and
thus change over time. Modelling should follow the idea of “as much as necessary, as
little as possible”, i.e. the model should on the one hand map all necessary components
and processes in order to resemble certain biological phenomena and on the other hand
reduce complexity and enhance understandability. The process of modelling comprises
some essential steps that build up another cycle within the cycle of systems biology (see
Figure 5).
Conception First, the model needs to be designed. This process involves several steps:
(i) the problem description, (ii) the systems analysis and (iii) the set-up of a conceptual
model [92]. During this process the close work of experimentalists and theoreticians is
essential in order to create a meaningful model that maps the biological processes in an
appropriate manner. In addition, careful literature research needs to be done in order
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to determine the most important entities of the system as well as their behaviour and
relationships. Using this prior knowledge a mathematical description can be found that
includes all entities and describes their action and interaction processes that are defined
by parameters.
Implementation The model implementation is the transformation of the conceptual
model into an executable model, which is used for numerical simulations [92]. Thereby,
an appropriate modelling technique has to be chosen and the software package or
programming language that should be used to realise the implementation. Several
modelling techniques exists, such as differential equations, state-based and individual-
based modelling. Some of these modelling approaches will be explained in greater
detail in section 3.1. For the implementation existing software packages or self-written
frameworks can be used. Software packages and frameworks exist for several modelling
techniques that allow for a fast implementation of the model but are also often restricted
in their functionalities. Sometimes a more tailor-made solution is needed. In this case,
programming languages, such as Java and C++, or scripting languages as Python,
R, and Mathlab allow for more flexibility. Which programming language should be
used depends on various factors, such as the complexity of the model, the expected
computational costs and the time that needs to be invested into programming. While
scripting languages are usually easier and faster to implement they often require higher
simulation run times compared to programming languages that are based on program
compilation.
Parameter estimation All action and interaction processes of model entities are
defined by parameters that influence the simulation outcome. These parameters need to
be defined in order to perform simulations. Appropriate parameter values can either be
determined by literature research or have to be identified by a calibration of the model
to experimental data. During the calibration process parameters are estimated such that
the simulation result can reproduce experimental results as good as possible. Hence, the
process of parameter estimation is an optimization process, where a functional, such as
the residual sum of squares (RSS) that measures the differences of experimental and
in silico data, should be minimized. Different techniques for parameter estimation are
described in more detail in section 3.3 Model parameter estimation.
Model validation In order to validate the model and its parameters, uncertainty
and sensitivity analyses as well as parameter identifiability can be of help. Thereby, the
impact of uncertainty of experimental data and of the model on the simulation outcome is
evaluated. Parameter identifiability describes whether model parameters are identifiable
given the experimental data. Furthermore, sensitivity analysis investigates robustness
and importance of model parameters. In order to determine parameter robustness, local
sensitivity analysis can be performed. Thereby, parameters are changed in a certain
range and if the model outcome is not significantly affected the parameter is considered
to be robust [97, 98]. Furthermore, global sensitivity analysis allows to determine the
parameters that mainly influence the model and parameters that have no or low impact
on the model. Therefore, parameter identifiability and sensitivity analysis allow for model
simplification [97, 98].
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Hypothesis generation If a model is designed, implemented and validated properly
it can be used in various ways that pose a unique feature of modelling: (i) the system
behaviour can be predicted under any perturbation and (ii) redesign or perturbation of
the model can result in completely new emergent systems properties [90]. Thus, modelling
allows to generate relevant predictions and new hypotheses that can be tested in wet-lab
experiments starting the cycle of systems biology anew. These experiments might lead
to new findings that can result in new models or adjustment of existing models.
Model refinement Model validation or new experimental insights might reveal the
need for model adjustment. New findings have to be included in the model implementation
and the calibration has to be repeated, starting the cycle of modelling anew.
3.1. Mechanistic modelling of system dynamics
Virtual infection modelling can be applied to a broad spectrum of scientific questions
in immunology and infection biology, considering various pathogens, immunological
aspects and scales. These scales range from molecules like DNA, RNA and proteins
up to cells, tissues, whole organs or even organisms. According to the properties of
the biological system as well as the hypotheses and the available resources appropriate
modelling approaches have to be chosen. There exist several modelling approaches that
can be classified in many different ways. In the following a brief overview about the most
common modelling techniques used in infection modelling will be given.
First, modelling techniques can be classified into population-based and individual-based
approaches. Population-based approaches comprise for example ordinary differential
equations (ODEs), partial differential equations (PDEs), stochastic differential equations
(SDEs), Markov Models, the Master Equation and SBMs. Here, cells, molecules or
other types of individuals are viewed as average concentrations that can be simulated
in time (and space). Therefore, these approaches assume high concentrations of the
modelled entities. While ODEs assume well-mixed systems, spatial inhomogeneities can
be modelled using PDEs. On the contrary, individual-based approaches resolve entities
as discrete objects and do not assume high concentrations of them. These approaches
involve various techniques, such as cellular automata (CA), cellular Potts models (CPMs)
and ABMs.
Furthermore, modelling techniques can be distinguished whether they are deterministic
or stochastic. Deterministic modelling approaches neglect random processes and assume
that a certain process arises due to a defined cause. However, random processes are an
essential part of nature. Nevertheless, if entities occur in high concentrations the system
can be considered to be deterministic as random processes average each other out. If
this assumption can not be met stochastic modelling approaches, which include random
processes, should be chosen. Modelling of stochastic processes requires the generation of
random numbers during the simulation process as well as repeated simulations for the
same parameter set in order to yield statistically robust results. Thus, in comparison to
their deterministic relatives stochastic approaches in general require higher computational
costs. Deterministic models are for example ODEs and PDEs, while SDEs, SBMs and
individual-based models (IBMs) are stochastic modelling approaches.
In general, the choice for a certain modelling approach is often driven by the trade-off
between computational costs and the realism of the model. A higher degree of detail in
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terms of the resolution of space, entities and internal degrees of freedom increase realism
at the prize of higher computational costs. Since in this thesis the mechanistic modelling
techniques state-based and agent-based modelling have been primarily used, they will be
described in greater detail in the following.
3.1.1. State-based modelling
State-based modelling is a stochastic population-based modelling approach where the
dynamic behaviour of discrete entities is simulated in discrete time steps and space
is neglected. Typically, they are applied for biological systems where discrete events
take place with low frequency and space is not important or no information on spatial
properties is available. In order to simulate discrete events in biological systems with
SBMs, populations of entities are modelled as states and processes in the system are
modelled by transitions between states. All entities occupy a certain state and actions
and interactions of these entities are simulated by state transitions, which occur with
certain rates that denote the frequency of an event per time step. Thus, similar event-
based modelling techniques are Markov models [99], interacting-state machines [100]
and probabilistic finite state machines based on Turing machines [101]. By fitting SBM
simulations to experimental data, transition rate values can be determined, which allows
for quantification of immune and infection processes in virtual infection modelling.
3.1.2. Agent-based modelling
Contrary to SBMs, ABMs resolve model entities as single autonomous decision-making
individuals, also termed agents [102]. In virtual infection modelling agents can represent
for example cells or molecules. These discrete agents migrate, act and interact within
a two- or three-dimensional discrete or continuous environment, where the latter one
requires sophisticated collision handling of agents in order to keep run time within limits,
since pairwise collision checks would lead to quadratic runtime. An approach for agent
monitoring and neighbourhood handling in continuous space is the subdivision of the
environment, where a lattice is placed within the continuous environment and each agent
is associated to its nearest grid point [103]. Using this lattice-based agent monitoring
approach close to linear runtime can be reached, if the grid constant corresponds to the
diameter of the largest agent within the model [103]. Hence, the number of collision
checks is minimized and it is sufficient to examine all agents located in the agent’s Moore
neighbourhood.
Furthermore, boundary handling needs to be implemented that manages agent handling
across the boundaries of the environment. Such boundary conditions can be for example
fixed, where agents are not allowed to move across the boundaries, periodic, where agents
leave the system and enter the system at the opposite site or random periodic, where
agents leave the system and enter the system at a randomly chosen point.
Individuals in biology often feature versatile morphologies, that can be implemented
in the ABM, increasing the degree of detail of the model. Furthermore, agents consist of
a set of behavioural rules that determine their migration, action and interaction. These
rules are characterized by rates and can be influenced by environmental factors. Examples
for such rules in virtual infection modelling are phagocytosis, cell death, cell division and
the secretion and/or sensing of anti-microbial peptides, cytokines and chemokines. Due
to the consideration of space in ABM direct interaction processes, such as phagocytosis
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events, depend on the physical contact of cells. In general, it can be stated, that a greater
detail in terms of environmental structures, agent morphologies and behavioural rules
enhance model realism, but also increase computational costs and increase the number
of parameters that need be determined.
Several ABM frameworks have been developed in the area of immunology and disease
modelling [104]. These frameworks involve the true immune simulators IMMSIM [105,
106], SIMMUNE [107, 108], SIS [109] and ENISI [110] as well as several general disease
simulators, such as CyCell [111, 112] and PathSim [113, 114]. Furthermore, general
agent-based frameworks such as NetLogo [115] have been widely applied to immune and
infection modelling[116, 117] and several frameworks that concentrate on specific immune
processes or diseases have been developed [104].
3.2. Decision optimization to model system dynamics
In virtual infection modelling the aforementioned mechanistic modelling approaches are
commonly used. However, these approaches often require lot of a priori knowledge on
underlying processes and rely on many parameters. If the majority of these parameters
cannot be fixed with values from literature dimensions of the parameter space rapidly
increase rendering parameter estimation infeasible.
Game theory (GT) is a mathematical concept that provides a set of analytical tools
and solution concepts in order to recast and analyse (social) dilemmas. In particular,
it allows to elegantly condense different effector mechanisms and therefore reduces the
dimensions of the parameter space by still allowing for identification of key parameters
of the biological system. Neumann and Morgenstern [118] developed in 1944 the concept
of GT to resolve strategies in economy. Since then, GT has spread to various fields,
such as psychology, sociology, ethics, political science and military strategy, computer
science and biology [119] and allows also modelling of host-pathogen interactions during
infection and inflammation. Despite, the severity of the context the term game refers
to the complex situation, where conflicting entities, such as the host immune system
and invading pathogens, interact with each other. GT models comprise three major
components, which are:
Players: Individual agents with their own aims, goals, preferences and possibly
conflicting interests try to maximize their utility in an interactive decision
situation [119].
Strategies: Each player consists of a set of possible strategies that can be applied in
the context of the decision situation [119].
Payoffs: The strategy combination of the player and its opponent is associated
with a payoff that denotes the utility (satisfaction) of the player in the
game and is usually defined in the payoff matrix [119].
Nash developed in (1950) a concept to resolve such interactive decision situations [120].
This concept describes the static equilibrium in non-cooperative games, i.e. the strategy
profile of all players, where no player has the incentive to deviate from its strategy [119].
The original concept of GT is also termed classical game theory (CGT) or rational
game theory, since all players are considered to be perfectly rational, i.e. they have
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complete knowledge about possible strategies of themselves and their opponents and are
able to deduce the best strategy [119]. This concept is highly debated in the field of GT
and attempts have been made to soften this strong assumption. Particularly, in the field
of biology perfect rationality often cannot be justified, since living entities like cells or
organisms do not consciously optimize over strategic alternatives, but rather inherit a fixed
phenotype and replication depends on the fitness (payoff) of the individual [121]. Thus,
the concept of bounded rationality has been inferred in the framework of evolutionary
game theory (EGT) [119].
EGT aims to remedy the main weaknesses of CGT, which are (i) perfect rationality,
(ii) the lack of dynamics and (iii) the equilibrium selection in case of multiple Nash
equilibria. Thus, EGT is the theory of dynamic adaptation in repeated games played
by bounded rational agents [119]. Originally, EGT developed as a population-based
method at macroscopic level that can be applied to large populations. For biological
systems, where lower numbers of individuals are involved an individual-based approach is
more appropriate [119]. The behaviour of each individual is implemented by microscopic
strategy update rules, that depend for example on the local environment, the aims and
history of an individual and can be for example genetically coded Darwinian selection.
These microscopic update rules can be very diverse and depends on the modelled system.
They can be deterministic or stochastic representing random mutations. The strategy
update of all individuals in the model can be synchronized or performed in a randomly
sequential fashion.
Spatial inhomogeneities of a biological system can be represented by graphs, where nodes
refer to single individuals and edges between them pairwise interactions of individuals that
are for example in close proximity or genetically related [122, 123]. Microscopic strategy
update rules in individual EGT on graphs might lead to changes of the interaction graph
during evolution of the system [119].
Evolution in EGT refers to the evolution of strategy patterns of the simulated entities
and therefore does to resmeble temporal dynamics. However, as realized by Pollmächer
et al. [124] pseudo-temporal resolution of a EGT model can be achieved by coupling
several games to each other, such that games located later in the time line depend on
outcomes of prior games.
3.3. Model parameter estimation
After appropriate model design and implementation the model needs to be calibrated to
the experimental data basis in order to (i) quantify model parameters and/or (ii) use
the calibrated model for simulation of perturbations of the biological system. During
calibration rates that describe processes in the model are estimated such that the in
silico results match the experimental data as good as possible. In order to quantify the
agreement between experimental and in silico data a functional, such as the least squares
error (LSE), also termed RSS, is minimized for experimental data µexp and simulated




(µexpi − µsimi )2. (3.1)
Thus, the process of parameter estimation resembles an optimization problem. This
basic LSE is often used in an extended way, where data subsets are weighted in a certain
24 Chapter 3: Virtual infection modelling
manner or the standard deviation is considered [99].
Various techniques exist that can be used for the parameter estimation task, where the
model parameter space is searched in a certain way in order to find a set of parameters that
minimizes the aforementioned functional. Generally, these techniques can be classified
according to their search strategy and the solution property, which can be both global
or local [125]. In case of a global search strategy the whole search space is taken into
consideration. This also allows to find the global optimum, while local search strategies
typically search for optimal parameter values within a local area of the search space and
therefore only allow detection of local optima [125].
Local search strategies involve direct methods as well as gradient-based methods.
Gradient-based methods are based on the calculation of derivatives and, thus, the gradient
of model solutions. Based on the calculated gradients the search strategy converges
to a local optimum. Examples are Newton’s method, the steepest descent algorithm,
the Gauss-Newton algorithm and the Levenberg-Marquardt algorithm [99, 126]. These
methods are well suitable for equation-based modelling techniques, such as ODE or PDE,
where derivatives can be calculated relatively easy. In case of rule-based models, such as
ABM these derivatives can not be analytically derived, but can only be approximated
by performing simulations within a certain step size. However, this proceeding would
require large amounts of simulations, which, especially in case of ABM, would render the
computational load infeasible.
For non-equation-based models direct search strategies that do not rely on derivatives
are more appropriate. A simple approach is the discrete grid approach, where a local
region within the search space is scanned along a regular grid [127]. This method can
be extended by multiple iterations, where regions with low LSEs are scanned in a more
fine-grained manner in a subsequent step. Other direct methods are for example the
Hooke-Jeeves method [128] and the Nelder-Mead simplex algorithm [129].
Global search strategies consider the whole search space and therefore allow to
find the global optimum. These global methods involve heuristic strategies, such as
simulated annealing and evolutionary algorithms, and model-based approaches [125].
Simulated annealing is a stochastic global heuristic search strategy [130]. This approach
resembles the physical process of slowly cooling down melted material, where molecules
arrange in a crystalline structure with minimum energy that corresponds in the parameter
estimation process to minimizing a functional, such as the LSE [126]. The current
temperature determines the probability at which solutions with a worse LSE are accepted.
The further progressed the cooling process is, the lower the probability to accept worse
solutions. This method allows to leave local optima at the beginning of the optimization,
but prevents leaving the global optimum towards the end of the optimization. Thereby the
rate that determines the cooling process is of particular importance, since it determines,
if the algorithm gets stuck in a local minimum. In order to find the global minimum, the
algorithm is repeatedly executed.
Evolutionary algorithms, such as Differential Evolution [131] are population-based,
i.e. they simulate a population of points in the parameter space, which corresponds to
a certain parameter vector [126]. Concepts from evolutionary biology, such as fitness,
mutation, selection and crossover are applied to the population to vary the current
points and to generate a next generation. The fitness of each individual (parameter
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configuration) corresponds to its LSE.
Furthermore, there exist model-based approaches featuring a global search strategy,
which can be applied if little is known about the search space. Examples for model-
based optimisation strategies are nested partitioning and swarm intelligence. In nested
partitioning a model of the search space is build that subdivides the search space in an
inner interval, where the optimum is suspected and the search is performed in a fine-
grained manner, and an outer interval, in order to consider the whole search space [132].
Swarm intelligence tries to find the global optimum by resembling biological swarms,
where lot of entities are simulated, that can communicate in a certain way. Each individual
of the swarm performs a local optimisation, while considering the quality of neighbouring
solutions and thus changing its position within the search space [133].
The choice for a certain parameter estimation approach depends on various factors, such
as the computational costs of the underlying model, the required number of simulations
of a certain search strategy and the a priori knowledge about the search space. Often it
is advantageous to use hybrid methods, that combine global and local search strategies,
where the global one is applied to find the region where the global optimum is located
and, subsequently, the local strategy for a targeted search [99, 134].
In virtual infection modelling parameter values can often be restricted due to biologically
relevant ranges. Furthermore, the choice of the search strategy depends also on the type
of model. For example, ABMs are very demanding in terms of computational costs,




Objectives of this Thesis
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The research on host-pathogen interactions is essential for the development of new
diagnostics and therapeutics. Since the incidence of fungal infections is increasing in the
last years and these infections are associated with high mortality rates [7], host-pathogen
interactions of the immune system and human pathogenic fungi are of major interest.
The innate immune system is the first line of defence against fungal invaders and is
studied in many wet-lab experiments. However, wet-lab experiments alone can not always
elucidate the complex mechanisms of such interactions. For example, while some sites
of infections cannot be investigated under physiological conditions, others can not be
investigated due to technical limitations.
The goal of this thesis is to implement virtual infection models that allow to overcome
such limitations and are able to generate new hypotheses that can be tested in experiment
and further allow for uncovering of obscure processes. The studies that are part of
this thesis aim to understand host-pathogen interactions of the innate immune response
during:
(i) Candida blood stream infections and
(ii) A. fumigatus lung infections.
We generated various individual-based virtual infection models that allowed to overcome
experimental limitations and to investigate spatio-temporal aspects of these biological
systems.
Invasive Candida blood stream infections are intensively investigated in wet-lab ex-
periments, such as whole-blood infection assays. To date, microscopy of whole-blood
assays to investigate spatial dynamics of the infection process with Candida spp. is not
applicable, since the number of erythrocytes exceeds the number of immune cells by one
order of magnitude [135]. Individual-based modelling allows a glimpse on spatial aspects
of the host-pathogen interactions based on non-spatial data from whole-blood infection
assays, which are usually conducted with blood from healthy donors.
However, especially immunocompromised individuals, such as neutropenic patients,
are at high risk for invasive candidiasis [39, 78, 136, 137]. Using blood samples from
neutropenic patients for whole-blood infection assays is not straightforward due to
availability of these blood samples as well as ethical concerns. Thus, we applied the
virtual infection model to simulate virtual neutropenic patients that were subsequently
simulated an in silico cytokine treatment. In this topic of the thesis the following
questions will be addressed:
1. What are the migration parameters of monocytes and neutrophils during whole-
blood infection assays with C. albicans and C. glabrata?
2. How do possible immune-evasion mechanisms impact on the infection outcome
during C. albicans and C. glabrata whole-blood infection and how can they be
investigated in future experiments?
3. How does the condition of neutropenia affect the infection outcome with various
C. albicans and C. glabrata in virtual patients?
4. Can the infection outcome with Candida spp. in neutropenic patients be recovered
to that of non-neutropenic patients using a cytokine treatment?
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Experimental investigation of A. fumigatus lung infections in vivo under physiological
conditions is difficult, since appropriate technologies are not available to date. In vitro
studies are also limited, since alveolar epithelial cells (AEC) of type I are difficult to
isolate and experiments have only been conducted for AEC of type II. However, 95% of
the alveolar surface is composed of AEC type I [138]. Nevertheless, much is known about
the lung morphology as well as cell numbers and sizes. This enabled Pollmächer et al.
to overcome the aforementioned limitations by development of an agent-based virtual
infection model that simulates the early immune response of alveolar macrophages against
A. fumigatus in a single to-scale alveolus [139, 140]. Based on these studies, we used
evolutionary games on graphs to simulate the early immune response to A. fumigatus in a
broader context, i.e. considering a whole alveolar sac and, besides alveolar macrophages,
included the complement system and neutrophils. Furthermore, we used the previously
established agent-based model for a comparative study between natural lung infections
with A. fumigatus in humans and experimental A. fumigatus infections in mice. Both
systems have fundamental differences in their lung morphology, the number of immune
cells as well as the infection dose. Therefore, it is not trivial to conclude how knowledge
can be transferred from mouse experiments to the human system. In the scope of
A. fumigatus lung infections, we wanted to shed light on the following questions:
1. What are the key parameters of the innate immune response during A. fumigatus
infection clearance?
2. Which morphological states of A. fumigatus are favoured under different infection
doses and host immune states?
3. What is the role of alveolar macrophages during the innate immune response
against A. fumigatus?
4. How do differences in the lung morphology and in the infection dose affect the
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Image-based Systems Biology of Infection
Anna Medyukhina,1 Sandra Timme,1,2 Zeinab Mokhtari,1,2 Marc Thilo Figge1,2*
 Abstract
The successful treatment of infectious diseases requires interdisciplinary studies of all
aspects of infection processes. The overarching combination of experimental research
and theoretical analysis in a systems biology approach can unravel mechanisms of com-
plex interactions between pathogens and the human immune system. Taking into
account spatial information is especially important in the context of infection, since
the migratory behavior and spatial interactions of cells are often decisive for the out-
come of the immune response. Spatial information is provided by image and video
data that are acquired in microscopy experiments and that are at the heart of an image-
based systems biology approach. This review demonstrates how image-based systems
biology improves our understanding of infection processes. We discuss the three main
steps of this approach—imaging, quantitative characterization, and modeling—and
consider the application of these steps in the context of studying infection processes.
After summarizing the most relevant microscopy and image analysis approaches, we
discuss ways to quantify infection processes, and address a number of modeling
techniques that exploit image-derived data to simulate host-pathogen interactions
in silico. VC 2015 International Society for Advancement of Cytometry
 Key terms
systems biology; image analysis; mathematical modeling; live-cell imaging; infection;
host–pathogen interactions
INFECTIOUS diseases still remain one of the main causes of death, especially in
developing countries (1). To effectively treat infections, it is indispensable to under-
stand how the pathogenic microorganisms interact with the host immune system.
The mechanisms of these interactions can be extremely complex and also difficult to
observe in experiment under physiological conditions. For example, if contacts
between immune cells last longer than can be recorded in a typical microscopy study,
this hinders a direct measurement of their duration and complicates interpretations
(2). Computer simulations of immune processes can decrease the costs of systems
biology studies by reducing the need for time-consuming experiments, expensive
chemicals and animal testing. For instance, simulations by Beltman et al. (2,3) esti-
mated the duration of contacts between T cells and dendritic cells, which are not
accessible in laboratory experiments. Furthermore, the knowledge provided by data-
derived computer models can direct further experimental studies. For example, the
virtual infection model of a human whole blood assay by H€unniger et al. (4) pre-
dicted the importance of extracellular killing of the pathogenic fungus Candida albi-
cans by antimicrobial factors released from neutrophils during the first hour of
infection, suggesting to study this mechanism in this particular time-frame. This
iterative “experiment—modeling—experiment” cycle represents the central compo-
nent of systems biology and aims to reveal the mechanisms of a biological process by
quantifying the experimental data, building predictive computer models based on
these data, and suggesting new experimental settings (5).
Most applications of systems biology to immunology rely upon “omics” data,
which profile the activity of genes, RNA or proteins in a sample and by that unravel
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mechanisms of immune response regulation (6,7). However,
“omics” analyses do not capture the spatial and temporal dis-
tribution of infection-related cells and molecules necessary to
characterize dynamical, functional and morphological aspects
of infection. The required spatial and temporal features can be
accessed by combining systems biology with microscopic
studies, known as image-based systems biology (IbSB) (8,9).
The IbSB approach includes three essential steps (Fig. 1):
(i) acquisition and analysis of image data, (ii) quantitative
characterization of biological processes, and (iii) computer
simulations of image-derived models. The IbSB approach has
been successfully employed in a variety of biological applica-
tions (10–13). In this review, we discuss advantages of the
IbSB approach in the context of infection studies, with special
emphasis on the construction of predictive image-derived
models.
Acquisition and Analysis of Image Data
Imaging is a key technique in biological research to
acquire spatiotemporal information on the morphology and
dynamics of infection processes; such information is also
indispensable to construct spatiotemporal mathematical mod-
els (11–13). The imaging phase comprises image acquisition
and automated image analysis; both steps are essential to char-
acterize spatial and/or temporal aspects of infection in a high-
throughput manner.
Available image acquisition tools range from conven-
tional wide-field and confocal microscopy to super-resolution
PALM and STED techniques (12,14). For instance, contempo-
rary fluorescence microscopy can display the spatial distribu-
tion of almost any target protein by applying adequate
labeling strategies (15–17). One of the most valuable tools in
infection research is live-cell imaging (9) including, e.g.,
multi-photon microscopy (MPM) and fluorescence resonance
energy transfer (FRET) microscopy (Fig. 2). MPM is a type of
fluorescence microscopy where two or more excitation pho-
tons are simultaneously absorbed and a fluorescence photon
of higher energy is subsequently emitted (18). This enables
the use of near-infrared light, which penetrates deeper into
tissue and causes less damage (19). FRET microscopy can
detect two co-localized fluorescent proteins (20) where energy
is transferred from a donor protein to an acceptor protein,
producing the FRET signal, which has a spectrum different
from the spectra of the donor and the acceptor proteins.
Because this does only occur if any two proteins are closer
than about 10 nm, this technique allows detecting real interac-
tions at the molecular level—in contrast to the plain overlay
of images for two fluorescent proteins. Further advantages of
live-cell microscopy and its applications in infection research
are discussed in the comprehensive reviews by Coombes and
Robey (21) and Konjufka and Miller (22).
To quantify an infection process in an objective and
high-throughput manner, automated analysis of the images is
essential, comprising the steps of preprocessing, segmentation,
classification, and tracking in the case of time-lapse data. The
preprocessing step enhances the overall quality of an image by,
e.g., correcting the background illumination and reducing
noise and/or artifacts in the images. Segmentation—generally
the most challenging step—aims to separate the regions of
interest (ROI) from the background based on their intensity,
texture and other features. Extracted ROI are then classified as
different immune cells, pathogen cells and/or virus particles
based on the object’s size, shape, dye color and other proper-
ties. If time-lapse data are available, object tracking can be
performed, which refers to finding the correspondence
between objects in different time frames.
A large variation of image analysis techniques and speci-
alized software tools exist for different types of microscopy
GLOSSARY
Image-based systems biology (IbSB)—modeling of biological sys-
tems based on the analysis of image data with the aim to optimize
and direct further experimental studies
Omics data—the data obtained from, e.g., genome, transcriptome
or proteome analyses
Host–pathogen interactions—interactions between host cells (e.g.
immune cells) and pathogenic microorganisms.
Live-cell imaging—microscopy imaging of living cells, tissues, or
organisms.
Image segmentation—separation of an image into background and
regions of interest (ROI).
Region of interest (ROI)—the part of the image containing an
object that needs to be analyzed (e.g., an immune cell or a
pathogen).
Tracking—finding the correspondence between identical objects in
different time frames.
Mathematical model—a set of mathematical expressions that
describes a certain aspect of the system’s behavior in a simplified
manner.
Spatiotemporal model—a mathematical model that describes the
dynamics of the system in space and time.
Deterministic behavior—a model behavior that obeys defined
rules, excludes randomness, and always leads to the same outcome
given the same starting conditions.
Stochastic/probabilistic behavior—a model behavior that includes
randomness and can result in different outcomes even for the same
starting conditions.
Ordinary differential equations (ODE)—equations containing
functions of only one variable (usually time coordinates) and the
derivatives of these functions.
Partial differential equations (PDE)—equations containing func-
tions of multiple variables (usually time and spatial coordinates)
and partial derivatives of these functions.
State-based model (SBM)—a model that represents each individual
entity, its state properties, and transitions between the states accord-
ing to specified rules, but assumes that the entities are homogene-
ously distributed in space.
Individual-based model (IBM)—an extension of SBM that includes
spatial aspects such as migration and interactions of each individual
entity.
Cellular automata (CA)—an IBM where each entity is represented
by one lattice site (computational cell).
Cellular Potts Models (CPM)—an IBM where each entity is repre-
sented by several adjacent lattice sites.
Agent-based models (ABM)—an IBM where the shapes and posi-
tions of entities are not restricted by a lattice but can be defined flex-
ibly with regard to the space representation and the agent
properties.
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data (23–25). The choice of the most appropriate image analy-
sis workflow is not the subject of this review; a summary of
available techniques can be found elsewhere both for static
image analysis and for object tracking in time-lapse data
(24–27). Furthermore, an objective comparison of methods
for tracking virus-like particles and cells was presented by
Chenouard et al. (28) and Maska et al. (29), respectively.
Here, we briefly refer to an example of image analysis car-
ried out in the context of the IbSB approach (30). In this
study, the invasion dynamics of Candida albicans into epithe-
lial cells is quantitatively analyzed. Candida albicans is an
opportunistic fungal pathogen that can cause severe sepsis in
immunocompromised patients by switching from the com-
mensal yeast form into the pathogenic filamentous form. Fig-
ure 3A illustrates the automated image analysis workflow
implemented in the Definiens Developer XD software. The
procedure detects C. albicans cells and individual filaments
(hyphae), and classifies the hyphae as having invaded epithe-
lial cells or as being non-invasive, which yields such quantities
as the number of hyphae, the number of invasions per
C. albicans cell, the total length of hyphae, and the relative
lengths of noninvasive and invasive fragments. These quanti-
ties serve as the basis for constructing a mathematical model
of the invasion kinetics (Figs. 3B and 3C).
Quantitative Characterization of Infection Processes
Automated image analysis is closely connected with the
quantitative characterization of the biological process under
consideration. The set of quantitative measures that can be
extracted for each object during image analysis (e.g., size or
speed of an individual cell) is statistically evaluated to serve
either as the final readout of the image analysis or as input
parameters of virtual infection models that can be simulated
on the computer. A quantitative description of the infection
process allows for a comprehensive and detailed understand-
ing of pathogenicity mechanisms. For example, computing
the phagocytosis ratio from image data reveals, which patho-
gen strains are phagocytized more effectively (31,32) and
which drugs inhibit this process (33). Furthermore, image-
derived quantities can aid in disease diagnostics, for instance
with regard to detecting malaria parasites in blood smears
(34–36).
However, the quantitative characterization alone may fail
to reveal the complex infection mechanisms on the desired
level of detail, because not all quantities are accessible from
image data. From the viewpoint of a systems biology
approach, extracted quantitative parameters are intermediate
results serving as a basis for mathematical models. Thus,
Figure 1. Diagram of the image-based systems biology (IbSB)
approach.
Figure 2. Live-cell imaging. (A) A peripheral lymph node visualized with two-photon microscopy to investigate the motility of B cells dur-
ing infection with lymphocytic choriomeningitis virus (LCMV) (74). Red: CD35; brown: high endothelial venules (HEV); blue: B cells trans-
ferred 24 h before imaging; green: B cells transferred 2.5 h before imaging. Reproduced from Coelho et al. (74). (B) FRET microscopy
image of Yersinia pseudotuberculosis binding to a non-phagocytic host cell. Color coding represents the level of GTPase Rac1 promoting
the phagocytosis event. Reproduced from Hayward et al. (75)VC 2010 BioMed Central.
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computational models are used to interpret the experimental
outcome, to analyze different scenarios in a comparative fash-
ion, and to make quantitative predictions for parameters that
are unavailable in experiment. For example, the probability of
virus binding to a cell cannot be directly measured, but can be
estimated from a computer model that relies on the observ-
able virus concentration and distribution of cells in the culture
(37). Similarly, the migration and activation of alveolar mac-
rophages in response to infection with the human-pathogenic
fungus Aspergillus fumigatus cannot be directly observed
under physiological conditions in the human lung, but it can
be predicted from a virtual infection model that is based on
the information derived from images of histological sections
(38).
Although many parameters can be estimated during
model simulation and optimization, this process is computa-
tionally extremely intensive. Therefore, the more parameters
can be extracted from experimental data the more computa-
tional resources and computing times can be saved. For exam-
ple, quantifying the migration of cells or viruses is especially
relevant for spatiotemporal modeling: it can yield speed val-
ues, turning angles and motility coefficients of cells (39), or
more complex staggered track measures (40) that can be
essential for modeling the migratory behavior of cells. Thus—
in the context of the IbSB approach—experiment, parameter
quantification and modeling are tightly interconnected: quan-
tification provides essential parameters for theoretical model-
ing, while the predictive power of model simulations can
narrow down the space of relevant parameters and point to
new conclusive experiments.
Computer Simulations of Image-derived Models
Mathematical modeling is a common approach in vari-
ous fields of science describing real processes through mathe-
matical expressions. It simplifies complex processes and
focuses on their most important aspects in order to make rele-
vant predictions and initiate new experiments. A typical mod-
eling procedure consists of several stages: selection of a
modeling approach and its particular mathematical represen-
tation, optimization of model parameters, and computer sim-
ulation of the model.
A number of techniques exist that enable spatiotemporal
modeling. The choice of the approach depends on the level of
complexity of the biological process, as well as on the type
and amount of available image data (10). We categorize exist-
ing modeling techniques based on two criteria—space resolu-
tion and resolution of individual objects—and use additional
criteria to discriminate between model sub-types (see Table
1). In the following, we discuss three common types of model-
ing approaches and their applications to infection study: dif-
ferential equations, state-based models, and individual-based
models.
Differential Equation Models
The simplest way to describe the dynamics of a biological
system is offered by differential equations that can be either of
ordinary or partial type. Differential equations describe the
change of so-called state variables, e.g., molecular concentra-
tion, motion speed, chemical gradients, etc.
Ordinary differential equations (ODE) describe the tem-
poral evolution of state variables completely neglecting their
variation in space by assuming that the model entities—e.g.,
cells or molecules—are homogeneously distributed in space.
For instance, ODE served as a basis for the kinetic growth and
kinetic transition models for invasion of Candida albicans
into epithelial cells, which were constructed with the help of
image-derived quantities (30). The kinetic growth model (see
Fig. 3B for detail) quantified the change of total length of
invasive and non-invasive hyphae and predicted the propor-
tion of invasive and non-invasive hyphal lengths in the
Figure 3. Image-based systems biology approach applied to
study the epithelial invasion of Candida albicans (30). (A) Auto-
mated analysis of C. albicans invasion of epithelial cells in fluo-
rescence microscopy images: (a) Original image (z-slice). (b)
Maximum intensity transformation of the original z-stack. (c) C.
albicans cell separated from the background. (d) C. albicans cell
separated into its yeast region (red outline) and its two hyphae
(green outlines). (e) Hyphae separated into invaded (blue) and
non-invaded (pink) segments. Scale bar 10 mm. Reproduced, with
permission, from (30) VC 2013 International Society for Advance-
ment of Cytometry. (B) Kinetic growth model based on ordinary
differential equations (ODE) describing the growth of fungal
hyphae. L(t), Li(t), and Lni(t) refer to the total hyphal length, the
length of invasive and of non-invasive hyphae as a function of
time t, respectively; Fi(t) and Fni(t) refer to the number of invasive
and non-invasive filamentous cells, respectively; ai and ani denote
the growth rate constants in units of length over time for invasive
and non-invasive filamentous cells, respectively; ri denotes the
rate constant in units of inverse time for the transition from non-
invasive to invasive growth; r denotes the rate constant in units
of inverse time for the transition from yeast cell to non-invasive
filamentous cell; Y(t) denotes the number of yeast cells. (C)
Kinetic transition model based on the master equation (76)
describing the transitions between states with different number
of invasive or non-invasive hyphae. P(s,t) denotes the probability
to find a C. albicans cell in the state s at time t; R(s’! s) is the rate
of transition from state s’ 6¼s into state s; di,j is the Kronecker delta
(returning 1 if i5 j and 0 otherwise); s = na and s = 0 correspond
to non-adapted and adapted cells, respectively, taking into
account the usual adaptation phase of yeast cells in the medium.
A C. albicans cell in state s> 0 (s< 0) is non-invasive (invasive)
with a total number of |s| hyphae.
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subsequent invasion process. The kinetic transition model
(see Fig. 3C for detail) quantified transitions from yeast to fil-
amentous cells, from non-invasive to invasive growth, and
between the states with different number of hyphae. The com-
bination of these models revealed that the switch from the
commensal to the pathogenic form of C. albicans is associated
with immediate invasion after formation of the first hypha,
rather than forming further hyphae before invasion. This
result emphasizes the importance of suppressing the yeast-to-
hypha transition in order to prevent epithelial invasion and
illustrates the benefits of ODE models to study the time-
evolution of infection.
Not only temporal but also spatial changes of variables
(e.g., molecular gradients) play an important role in infection
processes. It can be characterized either by arranging an ODE
model as a so-called compartment model, or by the use of par-
tial differential equations (PDE). In a compartmentalized ODE
model, each compartment refers to a delimited area with its
own set of ODE that are coupled across the compartments to
effectively model the spatial change of state-variables. For
example, a two-compartment ODE model characterized the
immune response to Mycobacterium tuberculosis based on
bright-field microscopy and flow cytometry data (41). The two
compartments represented the lung and the draining lymph
nodes, and the ODE described the time evolution of the con-
centrations of different immune cells, bacteria and cytokines.
The model revealed that dendritic cells are crucial to establish
immunity in tuberculosis infection, which suggested a possible
way of treatment by activation of these immune cells.
A different way to introduce spatial gradients into a
model is to use partial differential equations (PDE), which
describe the change of variables depending on both time and
spatial coordinates. PDE are often used to characterize che-
mokine gradients, which are crucial in the process of guiding
immune cells to the site of infection (42). For instance, differ-
ent variations of the diffusion equation can describe the pro-
duction of chemokines by immune cells and the complex
landscape due to their spreading in the tissue (Fig. 4A). PDE
can also characterize various growth processes. For instance, a
PDE model based on electron microscopy images described
the growth of fungal hyphae: it predicted the existence of a
vesicle supply center, which was not known before, but could
be experimentally validated afterwards (43–45). Another PDE
model based on confocal fluorescence microscopy data char-
acterized the mechanism of phagocytosis by describing the
growth of a so-called phagocytic cup around IgG-coated par-
ticles (46). This model revealed the existence of a mechanical
bottleneck—the cup stops to grow if it does not deform suffi-
ciently strong—explaining the high variability in the size of
phagocytic cups observed in microscopy experiments.
Though differential equations are easy to implement,
they inherently assume that the nature of the modeled process
is continuous in the variables. This approach works well in
cases where similar objects occur in large amounts (e.g., che-
mokine molecules). However, biological entities like cells are
discrete, often occur in small amounts, and, hence, cannot be
represented by continuous variables such as concentrations.
Moreover, these discrete entities interact on an individual
basis, which again cannot be adequately modeled by differen-
tial equations. Such cases require modeling on a more
advanced level. Depending on whether the spatial aspects are
relevant, either state-based models or individual-based models
can be applied (Table 1). In both cases single entities are
treated as individuals by introducing rules that mimic their
interaction behavior.
State-based Models
In contrast to differential equations, state-based models
(SBM) characterize the state of each biological object individ-
ually. The states of objects evolve according to defined rules:
either deterministic or stochastic. For example, H€unniger
et al. (4) introduced a SBM for human whole blood infection
by Candida albicans, which simulated the states of C. albicans
(e.g., alive or killed) and different immune cells (e.g., phago-
cytizing monocytes and neutrophils) and quantified the tran-
sition rates between these states. The distribution of C.
albicans among immune cells, predicted by the model, agreed
with the microscopic study of Giemsa-stained blood smears.
The model predicted that neutrophils play the crucial role in
eliminating C. albicans—not only directly by phagocytosis,
but also indirectly by promoting extracellular killing, which
was subsequently confirmed in experiment (4).
Another example of a SBM is the modeling of cytoplas-
mic transport of human adenovirus based on virus trajectories
extracted from time-lapse confocal fluorescence microscopy
images (47). Stochastic simulation of binding and unbinding
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of microtubule motors (see Fig. 4B) predicted the number of
motors taking part in the virus transport and the number of
binding sites on the virus surface.
These examples demonstrate that SBM can contribute to
the study of the infection processes where characterizing the
states of the individual objects is crucial, while the spatial dis-
tribution of objects can be neglected. In most cases SBM do
not require image data for their adjustment and, hence, they
are rare in image-based systems biology. In contrast,
individual-based modeling is the prevailing approach for sim-
ulating microscopy-visualized processes, because it combines
individual characterization of objects with simulation of their
migration and interaction in the spatial environment.
Individual-based Models
Individual-based models (IBM) can be viewed as the spa-
tial extension of SBM. They represent biological objects as dis-
crete entities that can migrate and interact in space and time
according to defined rules of deterministic or stochastic type.
Depending on the level of model complexity and on specific
aspects of implementation, one can distinguish cellular
automata (CA), cellular Potts models (CPM), and agent-
based models (ABM), though the boundaries between these
three classes are not very strict.
Cellular automata (CA), first introduced by John von
Neumann (48), are the simplest type of IBM. The environ-
ment is represented by a discrete lattice consisting of compu-
tational cells (i.e., the unit cells of the lattice) that may be
empty or occupied by a single entity (e.g., a biological cell)
that can adopt different states (see e.g., Fig. 5A). The state of
each entity depends on its own previous states and on the
states of individuals in neighboring computational cells.
Movements and interactions of entities between computa-
tional cells are simulated by corresponding state changes
according to defined rules.
Bankhead et al. (37) implemented CA with probabilistic
rules, where each computational cell of the automaton was
empty or occupied by an epithelial cell, and the cell state indi-
cated the stage of a viral infection. This model simulated the
spread of viral infection in epithelial cells and enabled estimat-
ing such measure as, e.g., viral release and probability of virus
binding to the cell, which were inaccessible in experiment. A
similar approach based on live-cell fluorescence microscopy
simulated the spread of human adenovirus in a cell culture
and revealed the predominant role of the cell-free transmis-
sion in this process (49).
Bru and Cardona (50) introduced a model of granuloma
formation in tuberculosis, where they combined CA to simu-
late immune cells and bacilli (Fig. 5A) with PDE to describe
chemokine gradients. Segovia-Juarez et al. (51) exploited a
similar approach, but represented the concentration of bacilli
as a continuous variable. Both studies contributed to the
understanding of mechanisms of granuloma formation;
among other results, they demonstrated that the concentra-
tion of chemokines plays a crucial role in infection control by
attracting immune cells to the site of infection.
In contrast to CA, cellular Potts models (CPM) can rep-
resent the shape of objects. CPM are based on a lattice where a
biological cell is represented by numerous adjacent lattice sites
(see e.g., Fig. 5B), allowing for a realistic shape representation
of cells. To conserve the integrity of a cell under its shape
deformations, a specific surface- and volume-energy measure
must be minimized at each iteration step.
Ariotti et al. (52) exploited the advantage of CPM to rep-
resent cellular shape and simulated the migration of skin-
resident memory T cells based on two-photon microscopy
data. They revealed that memory T cells have to form den-
drites in order to persistently move in one direction and to
effectively scan the tissue for antigens.
In another study, Vroomans et al. (42) combined CPM
for cells (Fig. 5B) with PDE for chemokine gradients (Fig. 4A)
to model the interactions between T cells and dendritic cells
in a lymph node. This study demonstrated that the most effi-
cient way for dendritic cells to stimulate antigen recognition is
to chemo-attract T cells and desensitize them after contact:
cells still appear to perform random walk migration—as
observed in two-photon microscopy experiments—but the
impact of chemotaxis makes the recognition of rare antigens
much more efficient.
Agent-based models (ABM) are the most complex type
of IBM. Each agent (e.g., a cell or a molecule) possesses a set
of properties (e.g., size, shape, and spatial coordinate) and
obeys certain behavioral rules (Fig. 5C). In contrast to CA and
Figure 4. (A) Partial differential equation (PDE) model for chemo-
kine diffusion (42) and an exemplary profile of the chemokine
concentration c(t) in two-dimensional space at a fixed time point.
The reaction-diffusion equation contains the following parame-
ters characterizing the chemokine: D—diffusion coefficient, p—
production term, d—degradation term. (B) Stochastic state-based
model (SBM) describing the transport of human adenovirus
along a microtubule (green) by dynein (D, blue) and kinesin (K,
orange) motors (47). [1]/[2]—dynein/kinesin motor stepping with
stepping rates dm/km; [3]/[5]—dynein/kinesin binding to the virus
capsid and decrease of the number of available motor binding
sites q with binding rates da/ka; [4]/[6]—dynein/kinesin unbinding
from the virus capsid and increase of the number of available
motor binding sites q with unbinding rates dd/kd. Reproduced
from (47).
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CPM, the properties and behavior of agents are not attributed
to the lattice, but specified for each agent individually. The
positions of agents are also not bound to certain lattice sites;
hence, the environment can be either discrete or continuous.
The behavioral rules regulate, for example, cell migration,
morphology changes, release or uptake of molecules, occur-
rence of cell division and cell death. Interaction rules may be
specific for agents of the same type or of different types. The
framework provided by ABM can represent individual objects
in a highly realistic manner and capture the highest level of
details.
Tokarski et al. (53) combined ABM with PDE to simulate
the phagocytosis of Aspergillus fumigatus by neutrophils based
on fluorescence microscopy data (Fig. 5C). Neutrophils and
fungal spores were represented as discrete agents and the che-
mokine gradients as continuous variables in this hybrid ABM.
This study revealed that the chemo-attraction of neutrophils
toward the fungal spores significantly improves the phagocy-
tosis efficiency in comparison to random walk migration of
neutrophils, while the communication between these immune
cells by chemokines accelerates under certain conditions the
elimination of fungal spores even more.
In another study, an ABM was used to model the interac-
tion of the pathogenic bacterium Pseudomonas aeruginosa with
the gut epithelium after surgery (54). The simulation demon-
strated the crucial role of this bacterium in hindering the heal-
ing process, predicted potential sites for bacterial binding, and
suggested possible mechanisms of killing the epithelial cells.
These studies exemplify how image-derived ABMs can
improve our understanding of infection mechanisms. ABMs
enable modeling of a biological system in a highly realistic
fashion, but at the price of greater computational costs com-
pared to other modeling approaches. On the other hand,
models based on differential equations are easy to implement
and computationally cheap, but rely on many assumptions
that strongly simplify the processes under consideration. The
choice of the appropriate modeling approach is a crucial step
in systems biology and may involve combining several
approaches to adequately represent the complexity of the
infection process under consideration.
Model Implementation
The art of modeling complex biological systems relies on
solving the dilemma of describing these systems at a level
where they become computationally feasible but still have the
predictive power to motivate new testable hypotheses. Besides
selecting the adequate modeling approach, particular equa-
tions, behavioral rules and/or agents, two other important
aspects of model implementation should be mentioned:
parameter optimization and modeling software.
Each model requires adjusting model parameters, e.g.
diffusion rates or cell sizes. Many of these parameters can be
obtained from experimental data, as discussed above. How-
ever, some parameters may not be directly accessible from
experiment, e.g. growth rates or the probability of a pathogen
to be phagocytized after contact with an immune cell. Such
parameters have to be adjusted during model simulation by
minimizing a specific functional that measures the dissimilar-
ity between the simulation outcome and the outcome of the
real experiment. In the optimization procedure, the parame-
ters of the model are varied until the dissimilarity functional
is minimized and the modeling output fits the experimental
readout. Dissimilarity measures and search strategies can dif-
fer depending on the particular application and modeling
approach and can aim at finding of either a local or the global
minimum in the landscape of the dissimilarity functional.
Local search strategies resemble hill down-climbing: at each
iteration step only those changes of parameters are accepted
that decrease the dissimilarity functional. On the other hand,
global search strategies as, e.g., simulated annealing (55),
occasionally admit the parameter sets that increase the dissim-
ilarity: this can prevent solutions to be trapped in a local min-
imum. More dissimilar solutions are accepted with a certain
probability that is controlled to decrease over time simulating
Figure 5. Examples of individual-based models (IBM) of infection processes. (A) Cellular automata (CA) model for granuloma formation
in tuberculosis infection (50). RM—resting macrophage, ISM—infected sentenced macrophage, PMN—neutrophil, NK—natural killer cell,
Bextra—extracellular bacilli. Grid size 20 3 20 mm
2. Adapted from (50). (B) Cross-section of a 3D Cellular Potts model (CPM) for interactions
between T cells and dendritic cells in a lymph node (42). Blue—sensitive T cells, yellow—insensitive T cells, red—dendritic cells, green—
reticular network. Reproduce from (42). (C) Agent-based model (ABM) for phagocytosis of Aspergillus fumigatus by neutrophils (53): neu-
trophils (black) search for extracellular spores (orange), which they can drag (yellow) or phagocytize (red) and kill (gray); the levels of blue
represent the concentration of chemokines produced by the spores. Reproduced from (53).
Review Article
468 Image-based Systems Biology of Infection
50 Chapter 4: Image-based systems biology of infection
cooling of the system. A detailed overview and comparison of
various optimization strategies can be found in (56).
Finally, it should be mentioned that many specific soft-
ware tools exist that can aid to implement and simulate differ-
ent modeling approaches. For instance, CompuCell3D (57)
enables developing CPMs on a 3D lattice; CellSys (58) pro-
vides tools to simulate ABM and differential equation models
in 2D and 3D; Chaste (59) presents a C11 library for differ-
ential equation modeling and all types of IBM; CellOrganizer
(60) allows constructing models of subcellular organization
learned from 2D and 3D images. The detailed description and
comparison of available software tools for ABM and other
IBM can be found elsewhere (61). Simpler models can be
implemented using special mathematical tools (Mathematica,
MATLAB, Scilab), or even general-purpose programming lan-
guages (C11, Java, Python). Available modeling libraries can
considerably simplify the implementation process and—at the
same time—make it more flexible.
DISCUSSION AND FUTURE PERSPECTIVES
Image-based systems biology (IbSB) is a relatively new
scientific approach that comprises imaging, quantitative char-
acterization and modeling (10,11). IbSB contributed to
exploring viral, bacterial, fungal and protozoan infections. For
instance, in viral infection, image-based models describe how
viral particles move through the cell cytoplasm (47) and how
they spread in cell culture (37,49,62). Among bacterial infec-
tions, IbSB was intensively applied in the study of tuberculosis
(41,50,51), including aspects as, e.g., granuloma formation
(51). In host-fungal interactions, both the phagocytosis of
fungal spores (53) and the growth of fungal hyphae (30,44,45)
have been described by image-derived models. Furthermore,
IbSB helped to clarify some aspects of parasitic infections, e.g.
Toxoplasma gondii invasion and formation of cysts (63,64).
Finally, IbSB greatly advanced our understanding of many
aspects of migration and interaction behavior of immune
cells, which has been comprehensively reviewed in (10,65,66).
Although IbSB has contributed to the study of many
host-pathogen interactions, a lot of aspects of infection still
remain unclear. Recent advances in live-cell imaging provided
a unique opportunity to study the infection process in the
natural environment of living organisms (9,21,22). Computer
models can be constructed, virtually, for any host–pathogen
interaction that can be visualized by live-cell microscopy:
from initial encounter of pathogens in peripheral tissues to
complex immune responses in lymph nodes (21,22).
Further progress in systems biology of infection should
relate to multiscale modeling (6,67,68), since any biological
system encompasses multiple levels of complexity. Integrating
different modeling approaches into a hybrid model accounts
for different levels of complexity that exist in real biological
systems. For instance, combining ABM at the cellular level
with PDEs at the molecular level clarified mechanisms of anti-
body affinity maturation in germinal centers in response to
bacterial infections (69). This revealed the central role of Toll-
like receptors on follicular dendritic cells (70) and high-
affinity antibodies in regulating this process (71), as well as
the evidence that B cell migration in germinal centers com-
bines chemotactic signaling and random walks (72).
Multi-scale modeling can also refer to combining image-
derived data with genomic, proteomic, or other “omics” data.
While image and video data unravel the morphology, dynam-
ics and function of a biological system, “omics” data provide
information on gene/protein activity and gene regulatory net-
works. The combination of these approaches can aid to con-
nect the activity patterns of genes and proteins to their real
function in the context of infection processes (73). Comple-
mentary use of in vivo, in vitro and in silico studies—i.e., live-
cell microscopy, “omics” analyses, and modeling—should
advance our understanding of infectious diseases and aid in
the design of novel treatment methodologies.
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Opportunistic fungal pathogens can cause bloodstream infection and severe sepsis upon
entering the blood stream of the host. The early immune response in human blood
comprises the elimination of pathogens by antimicrobial peptides and innate immune
cells, such as neutrophils or monocytes. Mathematical modeling is a predictive method
to examine these complex processes and to quantify the dynamics of pathogen-host
interactions. Since model parameters are often not directly accessible from experiment,
their estimation is required by calibrating model predictions with experimental data.
Depending on the complexity of the mathematical model, parameter estimation can
be associated with excessively high computational costs in terms of run time and
memory. We apply a strategy for reliable parameter estimation where different modeling
approaches with increasing complexity are used that build on one another. This
bottom-up modeling approach is applied to an experimental human whole-blood
infection assay for Candida albicans. Aiming for the quantification of the relative impact
of different routes of the immune response against this human-pathogenic fungus, we
start from a non-spatial state-basedmodel (SBM), because this level of model complexity
allows estimating a priori unknown transition rates between various system states by the
global optimization method simulated annealing. Building on the non-spatial SBM, an
agent-based model (ABM) is implemented that incorporates the migration of interacting
cells in three-dimensional space. The ABM takes advantage of estimated parameters
from the non-spatial SBM, leading to a decreased dimensionality of the parameter space.
This space can be scanned using a local optimization approach, i.e., least-squares error
estimation based on an adaptive regular grid search, to predict cell migration parameters
that are not accessible in experiment. In the future, spatio-temporal simulations of
whole-blood samples may enable timely stratification of sepsis patients by distinguishing
hyper-inflammatory from paralytic phases in immune dysregulation.
Keywords: state-based model, agent-based model, pathogen-host interaction, parameter estimation,
whole-blood infection assay, Candida albicans
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1. Introduction
The human fungal pathogen Candida albicans is part of the
normal microbial flora inmore than half of the global population.
In immunocompromised patients it can become invasive and
may enter the blood stream via medical devices, e.g., catheters,
or translocation in the gut and can cause severe systemic
infections. The immune response against C. albicans in human
blood comprises the interplay of various complex biological
processes involving different immune mechanisms (Duggan
et al., 2015b). Most importantly, the whole-blood infection assay
allows multiple immune effector mechanisms to occur at the
same time and thus modulate the overall outcome (Luo et al.,
2013; Cunha et al., 2014; Hünniger et al., 2015). Applying a
systems biology approach, we quantified individual processes and
in this way revealed the main route of the immune response
against C. albicans in human blood (Hünniger et al., 2014). This
was achieved by an iterative systems biology cycle involving
experiment, mathematical modeling, hypothesis generation and
further experimental investigation.
The choice of an appropriate mathematical modeling
approach strongly depends on the questions to be answered
and the hypothesis, as well as the characteristics of the
underlying experimental data with regard to temporal and spatial
information. A wide range of modeling approaches exists that
differ by their computational complexity and can be classified
depending on the degree of spatial representation as well as
the internal degrees of freedom attributed to the model entities.
The computationally cheapest modeling approach for dynamic
systems is represented by ordinary differential equations (ODE),
where biological entities are assumed to be present in high
numbers and spatial information is not required such that they
can be collectively represented by a homogeneously distributed
concentration variable. State-based models (SBM) resolve the
biological entities as individuals that occupy states and are
able to perform transitions between states representing dynamic
processes. In contrast to ODE, this approach allows modeling
discrete events for any entity number in a biological system.
However, SBM are in turn limited in that they do not represent
spatial aspects. Individual-based models (IBM) such as cellular
automata (CA) and agent-based models (ABM) do simulate
discrete entities in space and time (Medyukhina et al., 2015).
In a CA simulation, these entities can undergo state changes
associated with their internal degrees of freedom as well as
positional changes on a pre-defined spatial grid of computational
cells (Von Neumann, 1951; Bittig and Uhrmacher, 2010).
The discrete number of individual entities as well as the
spatial representation of the environment result in increasing
computational costs in terms of run-time and memory. Even
more computationally expensive but biologically more realistic
simulations can be performed by the ABM approach. Here,
biological objects are represented as individual entities, so-called
agents, that are able to move in space and can act as well as
interact with other agents according to individual properties.
Examples of ABM for the pathogen-host interaction between the
human-pathogenic fungus Aspergillus fumigatus and phagocytes
were presented by Tokarski et al. (2012) and Pollmächer and
Figge (2014). In particular, the ABM developed by Pollmächer
and Figge (2014) simulates the detection of A. fumigatus conidia
by macrophages in a to-scale representation of human alveoli
and predicts the requirement of a chemotactic signal guiding the
phagocytes to the spatial positions of conidia.
In general, parameters of bio-mathematical models
characterize the components by their morphology and
their dynamic behavior. For example, cells may be defined
by parameters for size and shape as well as by parameters for
interactions in the spatial environment that are associated with
the typical frequency of interaction processes. Model parameters
associated with dynamical, functional and morphological aspects
of biological processesmay be extracted frommicroscopic images
by applying an image-based systems biology approach (Horn
et al., 2012; Mech et al., 2014; Medyukhina et al., 2015). However,
in many cases microscopy experiments cannot be performed for
technical reasons, as is also the case for whole-blood infection
assays where the majority of cells are erythrocytes blocking the
view on leukocytes, let alone fungal pathogens that are present
in even lower numbers. In situations like these, numerical
estimation of a priori unknown parameter values by comparison
with experimental time-series data becomes a highly relevant
issue. Parameter estimation algorithms are applied to find the
optimal match between the experimental data and simulated
model data. These optimization algorithms can be characterized
by their search technique within the parameter space, i.e., as
global or local approaches, and their mathematical procedures,
i.e., as stochastic or deterministic approaches (Moles et al.,
2003; Ashyraliyev et al., 2009). Local optimization techniques
search for better parameter values within a locally restricted
parameter space, where the direct search method and gradient
based methods are widely used (Ashyraliyev et al., 2009). They
show fast convergence to the optimal parameter values, but since
local optimization algorithms will get stuck in a nearby local
optimum, an educated guess of the initial parameter values is
absolutely required. In contrast, global optimization strategies
search a wide range of the parameter space with possibly various
local optima and the subclass of deterministic optimization
strategies can find the global optimum with pre-defined accuracy
(Ashyraliyev et al., 2009). High-dimensional parameter spaces
may be searched by stochastic optimization algorithms that
make use of probabilistic elements to avoid getting trapped in
local optima in order to find the global optimum. Common
stochastic search algorithms of this type are Metropolis Monte
Carlo (MMC) (Metropolis et al., 1953), adaptive random search
and evolutionary computation techniques such as differential
evolution (DE) (Storn and Price, 1997). Additionally, heuristics
can be applied in support of a fast convergence rate of global
or local optimization strategies, e.g., simulated annealing (SA)
(Kirkpatrick et al., 1983; Gonzalez et al., 2007), great deluge
(Dueck, 1993), or performing multiple searches from random
start parameters. The selection of the most suitable optimization
algorithm depends on specific model properties, such as the
dimension of the parameter space and the computational costs
for the model simulations that have to be repeatedly performed.
For computationally cheap ODE models, the computationally
expensive stochastic global optimization algorithms may be used,
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such as DE applied by Hernandez-Vargas et al. (2014) and SA
based on MMC applied by Hünniger et al. (2014) and Mech et al.
(2014).
The non-spatial virtual infection model of the immune
response against C. albicans in human blood was formulated
as a SBM and its parameters were fitted to the experimentally
determined time-evolution of concentrations for C. albicans
cells that are alive or killed and that can either reside in
extracellular space or inside immune cells of different types,
i.e., monocytes or granulocytes (polymorphonuclear neutrophils,
PMN) (Hünniger et al., 2014). Furthermore, we observed a
cell population of C. albicans that remained alive or killed
in extracellular space, i.e., these fungal cells are resistant
against phagocytosis and/or killing. The different C. albicans
cell populations were assigned states and individual cells could
perform transitions between states, such as phagocytosis by
immune cells, subsequent intracellular killing, extracellular
killing by antimicrobial peptides or acquiring resistance against
phagocytosis and/or killing. Resistant C. albicans cells are a
population of cells that were found to be protected against
phagocytosis and/or killing and that remained in the extracellular
space of the whole-blood infection assay (Hünniger et al., 2014).
Since the model is restricted to the dynamics of states occupied
by pathogenic cells we refer to the model by Hünniger et al.
(2014) as P-SBM. In the present study, motivated by newly
measured experimental data regarding the immune cell number
of monocytes and PMN in the whole-blood assays, we take the
next step and modify the P-SBM to drop its implicit assumption
that the number of immune cells for samples from different
individuals would be the same. Since in the modified SBM states
are assigned to the pathogenic cells as well as to the two types
of immune cells, which have been found to actively participate
in C. albicans elimination, we will refer to this model as PI-
SBM. Taking individual immune cells explicitly into account
obviously makes the simulations of the whole-blood infection
assaymore realistic, albeit at the expense of higher computational
costs for global parameter optimization that will be performed
using SA based on the MMC scheme as was the case for the
P-SBM.
A timely stratification of sepsis patients in different phases of
immune dysregulation requires spatio-temporal simulations of
whole-blood samples. To achieve this goal, an ABM of the whole-
blood infection assay was established that builds on the PI-SBM
and incorporates spatial properties of the blood sample in a three-
dimensional continuous representation. In particular, in the
ABM C. albicans cells as well as monocytes and PMN are agents
that canmigrate in the environment and interact with each other.
Apart from the model parameters associated with the migration
of cells, the ABMwas based on the transition rates of the PI-SBM
after appropriate conversion. This procedure strongly reduces
the number of a priori unknown parameters of agents to the
subset of migration parameters. The latter can be estimated
using the computationally cheap grid search algorithm and
enables the prediction of the migration behavior for the different
immune cell types that are otherwise not directly accessible in
experiment. The interrelations between the different modeling
approaches are schematically shown in Figure 1 demonstrating
that results are re-used across different modeling approaches to
simultaneously facilitate an increase in model complexity and
a decrease in computational expense for parameter estimation.
Our step-wise computational biology approach avoids typical
limitations of realistic models by focusing parameter estimation
on those parameters that arise at the next level of model
complexity.
2. Materials and Methods
2.1. Non-spatial State-based Model
The initial version of the non-spatial SBM describes the dynamics
of state transitions for the human-pathogenic fungus C. albicans
in whole-blood samples of healthy donors (Hünniger et al.,
2014). In agreement with experimental data, the time-evolution
of different C. albicans cells that are alive or killed and in
extracellular space or phagocytosed by either monocytes or PMN
can be simulated in this way. Since this SBM assumes the number
of immune cells to be constant across blood samples of different
donors and does only simulate the dynamics of the pathogenic
(P) cells, it is hereafter referred to as P-SBM. However, it is known
that the number of immune cells may strongly vary across human
individuals and in particular for patients. Therefore, we increase
the model complexity by advancing the P-SBM to a model that
does explicitly account for the number of immune cells being
present in a hemogram. Data including immune cell counts can
easily be obtained both in an experimental as well as in a clinical
setting. This model is hereafter referred to as PI-SBM to indicate
that state transitions are computed for pathogenic (P) as well as
immune (I) cells.
For comparison between the model predictions and the
experimentally determined kinetics in the whole-blood infection
assay, we introduce specific combinations of states, referred
to as combined units, that are measurable and useable for the
parameter estimation. These comprise all extracellularC. albicans
cells CE,
CE ≡ CAE + CKE + CAR + CKR , (1)
that are either alive (CAE) or killed (CKE) cells in extracellular
space as well as cells resistant against killing and/or phagocytosis
that are either alive (CAR) or killed (CKR). Next, the combined














Gi,j (i+ j) . (3)
Here, Mi,j and Gi,j refer to the number of monocytes and
granulocytes (PMN), respectively, with i alive and j killed
phagocytosed C. albicans cells. We limit the maximal number
of C. albicans cells that can be phagocytosed by an immune
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FIGURE 1 | Schematic representation of the bottom-up modeling
approach as a strategy for parameter estimation where different
mathematical models with increasing levels of complexity build
on one another. Using model outputs at one level for calibration of
models at a higher level is by way of example demonstrated for
Candida albicans infection in a human whole-blood assay (Hünniger
et al., 2014). The state-based model P-SBM, which focuses on the
viewpoint of pathogens, was modified into the state-based model
PI-SBM by accounting for actions of individual immune cells. After
calibration of transition rates in the non-spatial state-based model, these
were used to simulate the infection process in an agent-based model
(ABM) that accounts for the spatial representation of the whole-blood
infection assay. In the future, the calibration of migration parameters
may for example serve as input for a hybrid ABM that captures the
time-evolution of chemotactic signaling by solving reaction-diffusion
equations.
cell to 18, i.e., i, j < 10, being much larger than observed
in experiment (Hünniger et al., 2014). Furthermore, all killed
C. albicans cells are given by the combined unit





(Mi,j + Gi,j) j , (4)
and all alive C. albicans cells by the combined unit





(Mi,j + Gi,j) i . (5)
It should be noted that only three of the five combined units
are independent of each other, due to the conservation relations
C = CE + CG + CM and C = CK + CA for the total number of
C. albicans cells C.
The simulation algorithm for the time-evolution of the PI-
SBM is implemented in C++ that is available upon request. In
Figure 2A, the simulation algorithm is schematically depicted
and can be compared to the simulation algorithm of the P-SBM
in Supplementary Figure 1. We simulate a blood sample of 1
ml containing 5 × 105 monocytes, 5 × 106 PMN and 1 × 106
C. albicans cells that are initially extracellular and alive. In each
time-step, which we set to 1tPI−SBM = 1 min, the algorithm
tests for each individual cell in the system whether or not it does
undergo a state transition. To this end, a cell is first randomly
selected by sampling its relative frequency of occurrence among
all cell types in the system. Next, the state of this cell is updated
using a random selection procedure for the one transition in this
time-step that the cell can possibly make among all currently
enabled transitions. Once the type of transition between states
s and s′ with rate rs→s′ is selected, it will be executed with
probability Ps→s′ = rs→s′ 1tPI−SBM and the system is updated
accordingly. Table 1 provides an overview of the transition rates
for all possible state transitions of the model. After testing all
individuals in the system for performing a state transition, the
simulation time is advanced by one time-step and the whole
procedure is repeated until the total simulation time is reached.
Note that, since the ratio of the number of immune cells over the
number of pathogenic cells is larger than five, the simulation run
time of the PI-SBM is significantly increased compared with the
P-SBM.
Frontiers in Microbiology | www.frontiersin.org 4 June 2015 | Volume 6 | Article 608
57
Lehnert et al. Bottom-up modeling for pathogen-host interactions
FIGURE 2 | Simulation algorithms of virtual infection models for
whole-blood assays. (A) Flow-chart of the non-spatial PI-SBM simulation
algorithm. In each time-step 1tPI−SBM, all individuals are tested for possible
state transitions. Individuals of extracellular alive and killed C. albicans states,
i.e., CAE and CKE , respectively, are tested for becoming resistant and for
extracellular killing. Individuals of immune cell states (Mi,j or Gi,j ) are tested
for phagocytosis of C. albicans and for intracellular killing. (B) Flow chart of
the spatial ABM simulation algorithm. In each time-step 1tABM, the migration
and interaction handling is performed in random order for every randomly
chosen agent.
2.2. Spatial Agent-based Model
The spatial virtual infection model for C. albicans in human
blood is realized using an ABM approach. This model
is implemented in C++ based on a previously established
framework of Pollmächer and Figge (2014) and is the spatial
counterpart of the non-spatial PI-SBM introduced in Section 2.1.
The C++ source code of the ABM simulation algorithm
is available upon request. In the ABM, the two types of
immune cells—monocytes and PMN—as well as the pathogenic
C. albicans cells are incorporated as virtual objects. These
virtual objects are agents that are characterized by a spherical
morphology with the physiological diameters of dM = 16µm
for monocytes, dG = 13.5µm for PMN (Mak and Saunders,
2011) and dC = 7µm for C. albicans (Mendling, 2006) (see
Figure 3A) and that can migrate and interact with each other
on encounter in the three-dimensional spatial environment (see
Figure 3B). We impose a cuboid environment with an edge
length of 1000µm representing 1µl blood and use random
periodic boundary conditions for the cuboid, i.e., an agent
which leaves the environment at some boundary point is deleted
from the system and a new agent with identical properties
re-enters the environment at some other randomly chosen
boundary point. The cuboid environment is represented as a
continuous space, i.e., allowing agents to move in a manner
that is more realistic than could be captured by a lattice-based
approach. This advantage is accompanied by the drawback
that well-defined neighborhood relations as naturally existing
between neighboring sites on a lattice are not present in
continuous space representations. However, in order to efficiently
determine cell–cell encounters, we use a neighborhood list
method, which reduces the computational complexity to a close-
to linear dependency on the number of agents in the system
(Rapaport, 1996). At time point t = 0, agents are initialized with
all C. albicans cells being in the state alive-and-extracellular. The
time-evolution of the system is simulated by the random selection
method (Skvoretz, 2002; Figge, 2005) that handles the migration
and interaction of agents per time-step 1t in a random fashion
(see Figure 2B).
We use ratios in cell numbers that are equivalent to those in
the PI-SBM, where 1µl of blood contains 5×103 PMN, 5×102
monocytes and 1×103 C. albicans cells, i.e., in total 6.5×103 cells.
Viewing cells as interacting point particles, an average volume of
v ≈ 16.5×10
6 µm3 can be attributed to each cell, implying an
average distance of l ≈ v1/3 ≈ 55µm between immune cells
and C. albicans cells. Even though this distance is clearly larger
than the diameters of these cells, l≫ dM, dG, dC, we assume that
the migration behavior of immune cells and C. albicans cells in
blood resembles a random walk of agents without directional
persistence. This assumption is based on the fact that the total
number of erythrocytes in human blood ranges from 4×106−6×
106 cells/µl (McClatchey, 2003). Estimating the total number of
cells in 1µl of blood to be about six millions, an average volume
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TABLE 1 | Rates of state transitions in the non-spatial PI-SBM.
Transition rate Description State transition
φM Phagocytosis by monocytes Mi,j + CAE → Mi+1,j
Mi,j + CKE → Mi,j+1
κM Intracellular killing by monocytes Mi,j → Mi−1,j+1
φG Phagocytosis by PMN for first-time
phagocytosis event
G0,0 + CAE → G1,0
G0,0 + CKE → G0,1
φG⋆ Phagocytosis by PMN for repeated
phagocytosis events
Gi,j + CAE → Gi+1,j
Gi,j + CKE → Gi,j+1
κG Intracellular killing by PMN Gi,j → Gi−1,j+1
κEK (t) Extracellular killing by antimicrobial
peptides released by first-time PMN
phagocytosis with decreasing activity
CAE → CKE
Rate depends on the activity of
antimicrobial peptides (κ¯EK ) and the
decay of their antimicrobial activity (γ )
as defined in Hünniger et al. (2014)








3 µm3 can be attributed to each cell, implying a
mean free path of lfp ≈ v
1/3
c ≈ 5µm between point particles.
This distance is not only clearly smaller than the distance between
immune cells and C. albicans cells, lfp ≪ l, but also smaller
than the diameters of erythrocytes, C. albicans cells as well as
of the immune cells under consideration. It can be concluded
that cells are not migrating with directional persistence in blood,
because frequent collisions with the overwhelming number of
erythrocytes will induce diffusivemigration of cells with diffusion
coefficients in whole-blood that can be very different for the
different cell types. This is a consequence of the fact that
monocytes and PMN perform active migration, whereas C.
albicans cells are immotile due to the complete lack of cellular
organelles for motility (Margulies and Schwartz, 1998) and its
movement in whole blood is only passive.
Even though blood is a non-Newtonian fluid, i.e., showing
pseudoplastic properties with variable viscosity depending on
the exerted shear stress in capillaries of different sizes (Fahraus
and Lindqvist, 1931), the experimental setup of the whole-
blood infection assay is such that the viscosity as well
as the temperature in the mildly stirred test tube remain
constant (Hünniger et al., 2014). Therefore, the Stokes-
Einstein equation (Einstein, 1905) can be applied to infer
the diffusion coefficient DC for the passive movement
of C. albicans cells. Based on a whole-blood viscosity of
about η ≈ 4mPa s (Rosenson et al., 1996), Boltzmann
constant kB and temperature T = 37◦C (Hünniger et al.,
2014), this yields the relatively small diffusion coefficient
DC = kBT/(3πηdC) ≈ 1µm2/min. In contrast, the active
migration of monocytes and PMN requires to estimate their
diffusion coefficients numerically.
The time-step 1tABM for simulations in the ABM has to be
chosen such that a smooth migration of cells is sampled in time.
In order to ensure this, we require that during one time-step
1tABM cells do not migrate further than a certain distance, which






Here, Dmax ≡ max{DC,DM,DG} denotes the largest out of the
three diffusion coefficients for C. albicans cells (DC), monocytes
(DM), and PMN (DG). Since it can be expected that the active
migration of immune cells is associated with diffusion coefficients
DM and DG with DM,DG ≫ 1µm2/min in the whole-blood
infection assay, it follows from Equation (6) that the time-step
in the ABM will be much smaller than in the state-based model
PI-SBM: 1tABM ≪ 1tPI−SBM = 1min. Moreover, stochasticity
in the ABM requires that each simulation has to be repeated
multiple times, resulting into relatively high computational costs
compared with the PI-SBM, in particular, if we would have
envisaged to estimate each model parameter instead of following
the strategy of a bottom-up modeling approach.
Computational costs associated with parameter estimation in
the ABM can be significantly reduced by making use of the
previously estimated rates of state transitions in the state-based
model PI-SBM (see Section 2.1 and Table 1). In the course of a
simulation, migrating cells in the ABMmay either spontaneously
undergo state transitions or interact with each other upon spatial
contact. In Figure 3C, we present a schematic overview of
processes that occur according to defined rules associated with
certain probabilities. It is important to note that, due to the spatial
aspects that are captured by the ABM but not the PI-SBM, we
have to distinguish between processes that are contact-dependent
and contact-independent.
For contact-independent processes—such as intracellular and
extracellular killing as well as the occurrence of C. albicans
resistance against phagocytosis and/or killing—the conversion
of rates from the PI-SBM to the ABM is straightforward.
Since these processes are not determined by any spatial
requirements, a simple re-scaling is performed. For example, C.
albicans cells become resistant in the PI-SBM with probability
PPI−SBM(ρ) = ρ 1tPI−SBM . In the ABM, where the resolution of






whether this process occurs.
In contrast, contact-dependent processes in the ABM are
characterized by the requirement that two cells have to get
into spatial contact first, before such a process—for example,
a phagocytosis event of a C. albicans cell by a monocyte with
transition rate φM—can take place. In the PI-SBM, spatial contact
is not explicitly modeled; rather, the interaction partner for each
monocyte is randomly chosen once per time-step 1tPI−SBM .
The associated probability is determined by the time-dependent
ratio of non-resistant fungal cells over the sum of extracellular
fungal cells and immune cells. Once an interaction partner was
chosen, the phagocytosis event itself occurs with probability
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FIGURE 3 | Agent-based model (ABM) of the human whole-blood
infection assay. (A) Agents used in the ABM are Candida albicans cells in
the four states (i) alive and non-resistant (green), (ii) dead and non-resistant
(red), (iii) alive and resistant (yellow), and (iv) dead and resistant (gray).
Furthermore, granulocytes (polymorphonuclear neutrophils, PMN) and
monocytes are shown in blue and orange, respectively. (B) Schematic
overview of examples for interactions in the ABM. Each arrow indicates the
execution of an interaction event, either depending on spatial contact
between different cells or by a contact-independent process. C. albicans
cells that are in extracellular space and alive (CAE ) or killed (CKE ) can become
resistant with probability P(ρ). After spatial contact, alive or killed C. albicans
cells can be phagocytosed by PMN or monocytes with probabilities
P(φG|φG* ) or P(φM ), respectively. Intracellular alive C. albicans cells are killed
with probabilities P(κG ) or P(κM ) depending on the type of phagocyte. (C)
Visualization of the three-dimensional cuboid environment of the ABM that
corresponds to 1µl of the whole-blood infection assay, containing 5000
PMN, 500 monocytes, and 1000 C. albicans cells. The time-evolution of the
simulated infection scenario can be viewed in Supplementary Video 1.
PPI−SBM(φM) = φM 1tPI−SBM in the PI-SBM. Correspondingly,
in the ABM, we request that this process takes place with the same
probability,
PABM(φM) = PPI−SBM(φM) , (8)
on every encounter between a monocyte and a C. albicans cell.
This correspondence of event probabilities for the two modeling
approaches imposes a condition on the spatial dynamics of
cells, i.e., on the values of the diffusion coefficients in the ABM
and by that on the time-step 1tABM (see Equation 6). For
optimal migration parameters, i.e., parameters that result in
good agreement with the experimental data, it is expected that
measurement of the associated phagocytosis rate in the ABM
coincides with the corresponding rate from the PI-SBM.
2.3. Parameter Estimation
2.3.1. Simulated Annealing
The a priori unknown transition rates of the PI-SBM are
determined by the method of Simulated Annealing based on
the Metropolis Monte Carlo scheme (SA-MMC) that is depicted
in Figure 4A. This optimization method randomly explores the
parameter space of transition rates to find the global minimum of
the fitting error, i.e., themost suitable parameter set that produces
the best fit of the simulation to the experimental data obtained
from the whole-blood infection assay.
The parameter estimation algorithm starts with a randomly
chosen set of parameter values within the interval of [0, 1]
per minute, represented by the vector Ep, and calculates the
resulting time-evolution of state occupations from the simulation
algorithm of the PI-SBM (see Section 2.1). To score the
simulation result for a particular set of parameters, we combined
different kinetics of the PI-SBM, referred to as combined units,
which are identical with the experimental kinetics measured in
the whole-blood infection assay (see Section 2.1). In this way,
the experimental kinetics can be directly compared with the
combined units c obtained from the model simulation, which
is then scored by calculating the least-squares error (LSE) at













Here, ǫc is adjusted as to fit each combined unit comparably
well to the experimental data. The same values for ǫc were used
in the PI-SBM and the ABM and are given in Supplementary
Table 1. Next, the parameter set Ep is randomly varied within a
pre-defined neighborhood of 10% variation, leading to a new
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FIGURE 4 | Concepts of parameter estimation algorithms for
non-spatial state-based models (SBM) and spatial agent-based
models (ABM). (A) Flow chart of parameter estimation by the global
optimization method Simulated Annealing based on the Metropolis Monte
Carlo (SA-MMC). Light gray boxes describe Steps 1–4 of the algorithm;
equations and pseudo code applied in these steps are provided in the dark
gray boxes. (B) Schematic overview of the local optimization method
adaptive grid search algorithm used for estimation of ABM migration
parameters. Simulations are performed for sets of parameters on a regular
grid in a predefined area of the search space and are evaluated by the least
squares error (LSE). The initial grid (upper panel) contains sets of parameters
with smallest LSE (light gray area) and this area is refined for a more accurate
identification of the optimal parameter set (lower panel). Here, light gray dots
represent parameter configurations from the first refinement level and dark
gray squares represent parameter configurations of the subsequent
refinement level.
set of parameter values, Ep ′, as indicated in Figure 4A, Step 2.
Subsequently, the simulation of the PI-SBM is performed again
for parameter values Ep ′ and the corresponding score E[Ep ′] is
calculated. Whether the new simulated data will be accepted
or rejected is decided by applying the MMC scheme that is
depicted in Figure 4A, Step 3. The probability to accept worse
parameter values is influenced by τ (f ), representing the “inverse
system temperature” in a SA process. The simulation of the
annealing process involves a gradual decrease of the system
temperature with progressed fitting, i.e., τ (f ) is increased with
the number of performed fitting steps f (see Supplementary
Information 2.1).
After performing a total number of fitting steps, the fitting
algorithm is repeated starting from a newly chosen random
parameter set. This is done for a certain number of runs and
the set of parameters with the minimal fitting error (Epmin) is
saved from each fitting process. Themean values of the parameter
values and their standard deviations are computed over all runs
to determine the robustness of the estimated parameters.
We repeatedly perform the parameter estimation procedure
for different system sizes in terms of the total number of
individual cells. In doing so, the system size is stepwise increased
by factors of ten, which is associated with increasing computing
time for the model simulation but is partly compensated by a
decrease in the number of fitting steps to avoid computational
overload (see Supplementary Table 2). We start the estimation
algorithm with a low number of individuals and a large
number of fitting steps. The resulting parameter values are
subsequently used as start parameter values for the system
with next-higher number of individuals, i.e., for a 10-fold
larger system. This procedure is repeated until a system size
is reached where the number of individuals correspond to the
measured numbers of PMN (about 5 × 106) and monocytes
(about 5× 105).
2.3.2. Adaptive Regular Grid Search
As described in Section 2.2, probabilities for state transitions in
the ABM of the whole-blood infection assay can be derived from
the interaction rates of the PI-SBM. This reduces the space of
parameters that has to be searched in the process of parameter
estimation, leaving only two migration parameters—i.e., the
diffusion coefficients DM and DG, respectively, for monocytes
and PMN—to be calibrated. However, even for a reduced
parameter search space, there still is need for a calibration
strategy that keeps the number of ABM simulations within
limits, because simulating stochastic processes requires sufficient
numbers of repetitions in order to obtain numerical results that
are statistically sound.
We apply the adaptive regular grid search algorithm (Powell,
1998) to search iteratively for a local optimum in the parameter
space (see Figure 4B). Motivated by biological constraints this
is done for a pre-defined region of the parameter space. This
region is represented on a regular grid and for each grid point
the ABM is simulated with the corresponding set of parameter
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values. Afterwards, simulations are evaluated with the least-
squares error (LSE), scoring deviations between the simulation
results and the experimental data for all combined units
c = {CK,CA,CE,CM,CG} (see Section 2.1 and Equation 9). The
values for the LSE are used to determine the adaptive refinement
of the grid before the next iteration step, where intermediate grid
points are calculated by bisection of the grid constant for the sets
of parameters with lowest LSE. This imposes a grid refinement
that ensures a more detailed scanning of the parameter space in
relevant regions and defines the refinement level. The initial grid
constant and the number of refinement steps determine how fine-
grained the parameter space is represented by grid points and
their values have to be chosen depending on the LSE landscape.
We further decrease computational costs associated with
parameter estimation in the ABM by system scaling. Thus,
similar to the procedure applied for the state-based model PI-
SBM, we first scan the parameter space with a small system of
1/5 µl blood and subsequently re-scan the relevant parameter
region with the system of 1µl blood as defined in Section 2.2.
3. Results
3.1. Quantification of the Immune Response by
the State-based Model
We quantified innate immune mechanisms in human whole-
blood assays of infection with the pathogenic fungus C. albicans
using a SBM. To this end, we modified a previously introduced
SBM, referred to as P-SBM. This model was derived with the
focus on state transitions of the pathogen (P) that may be
induced by immune cells. However, immune cells in the P-
SBM were only effectively modeled and not explicitly account
for as individual cells (Hünniger et al., 2014). In the present
work, we modified the P-SBM to model the interaction with
individual immune cells—monocytes and granulocytes (PMN)—
in detail. Since the focus of this model is on state transitions
of both pathogen (P) and immune cells (I), we term this model
PI-SBM. For reasons of comparison with the P-SBM, we used
the same experimental data as in Hünniger et al. (2014) to
quantify innate immunemechanisms by estimating the transition
rates that yield the best fit to the data. Specific combinations of
C. albicans states, referred to as combined units, were introduced
that are directly related to different C. albicans populations
measured over 4 h post-infection in experiment. As explained in
detail in the Materials and Methods Section, the combined units
include all extracellular C. albicans cells (CE), C. albicans cells
that are phagocytosed, respectively, by monocytes (CM) or by
granulocytes (CG). Furthermore, all killed and alive C. albicans
cells are given by the combined units CK and CA, respectively.
The manually adjusted scores ǫc of combined units c are given
in Supplementary Table 1. We simulate a blood sample of 1ml
containing 5 × 105 monocytes, 5 × 106 PMN and 1 × 106
C. albicans cells that are initially extracellular and alive.
To estimate the values of transition rates in the PI-SBM
that yield the best fit to experimental data, i.e., the fit with the
smallest least squares error (LSE), we applied the method of
SA-MMC scheme (for details see Section 2.3.1). In Figure 5,
the resulting transition rates of the PI-SBM are compared with
those previously obtained within the P-SBM (for a quantitative
comparison see also Supplementary Tables 3, 4). The direct
comparison between the P-SBM and PI-SBM revealed that most
transition rates are quantitatively similar in the two models.
The largest deviations in the values of transition rates between
the two models were observed for the phagocytosis rate of
monocytes (φM) and the killing rate of monocytes (κM). This
was further investigated by performing the parameter estimation
for the PI-SBM again, where only φM and κM were randomly
varied while all other rates were kept fixed. We performed 50
runs and obtained very different standard deviations for these
transition rates: while the standard deviation of φM was only
4%, this was 16% in the case of κM . We conclude that the PI-
SBM is generally robust in all transition rates, except for κM
that is also not directly determined by the data, because alive
and killed C. albicans cells in phagocytes were not distinguished
in these experiments. Similar observations were made for the
P-SBM, where it was shown that variations in κM did not lead to
significant differences in the fitting error (Hünniger et al., 2014).
To determine the impact of variations in the transition
rates on the kinetics of the combined units in the PI-SBM,
we performed 50 simulations with transition rates that were
randomly sampled within their respective standard deviations.
The kinetics of individual sub-populations are plotted in
Supplementary Figure 2 while the results for the combined units
are given in Figure 6. It can be seen that the simulated combined
units agree well with the corresponding experimental data. In
FIGURE 5 | Transition rates obtained from the model calibration to
experimental data of the whole-blood infection assay. The results for the
modified state-based model PI-SBM are compared to the P-SBM (Hünniger
et al., 2014). The values are compared for the rate of phagocytosis by
monocytes (φM ), and by PMN on initial and subsequent events (φG,φG*), rate
of killing by monocytes (κM ) and PMN (κG), rate of acquiring resistance against
phagocytsis and/or killing (ρ) as well as the values of parameters for
extracellular killing (γ , κ¯EK ). Error bars correspond to standard deviations.
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particular, the resulting kinetics of the PI-SBM revealed that
4 h post-infection 82% C. albicans cells were phagocytosed by
PMN, whereas only 4% C. albicans cells were phagocytosed
by monocytes. Furthermore, PMN play a major role in the
immune response, because these phagocytes are associated with
97% of all killed C. albicans cells (see Supplementary Figure
2A). This is achieved either directly, via phagocytosis and
intracellular killing (66.5%) of the pathogen, or indirectly by
the release of antimicrobial peptides on a pathogen’s first event
of phagocytosis (30.5%) (see Supplementary Figure 2H). Four
hours post-infection, most C. albicans cells were killed (89%)
while a minority of 11% cells were extracellular and became
resistant against killing and phagocytosis. These results are in
quantitative agreement with those obtained previously for the
P-SBM (Hünniger et al., 2014).
3.2. Predictions on Monocytopenia and
Neutropenia from PI-SBM
The state-based model PI-SBM opens the possibility to study the
dependence of the immune response against C. albicans on the
number of PMN and monocytes in blood. Simulating the virtual
infection scenario with the previously estimated parameters (see
Supplementary Table 3), we considered various cases of immune
cell deficiencies. The model predictions at 4 h post-infection and
for gradual decreases in the immune cell numbers are presented
in Figure 7 for the cases of monocytopenia and neutropenia
separately.
We found, as expected from the above quantification of the
immune response, that monocytopenia is not a critical condition
with regard to C. albicans infections: deficiency of monocytes
and even their complete absence was fully compensated by
PMN-mediated killing. In fact, patients with monocytopenia
have not been reported to develop systemic candidiasis to
date (Lionakis, 2014). The situation is extremely different in the
case of neutropenia. In the absence of PMN, the number of killed
C. albicans cells is predicted to decrease from about 89% under
physiological conditions down to 45%, i.e., CK = 89% for 5×106
PMN and CK = 45% for ≤ 5 × 103 PMN (see Figure 7B).
Monocytes compensated PMN deficiency by phagocytosis of
C. albicans cells only partly, where the fraction increased from
3% under physiological conditions up to 48%. However, 42% of
the C. albicans cells acquired resistance against killing and/or
phagocytosis, resulting from the combined effect of absent PMN
phagocytosis and extracellular killing that is normally mediated
by PMN release of antimicrobial peptides.
For a decrease in PMN number by one order of magnitude
from physiological conditions, we found that monocytes can
sustain the immune response fairly well. In this case, the fraction
of killed C. albicans cells was still 79% and the phagocytosis
by monocytes and PMN reached, respectively, 20% and 55%
of C. albicans cells. A significant deterioration of the immune
response was observed for PMN concentrations below 5 ×
105 cells/ml (see Figure 7). Interestingly, this concentration
was reported to mark the transition from moderate to severe
neutropenia (Munshi and Montgomery, 2000), which is a
FIGURE 6 | Comparison of the time-evolution for the combined
units from the experimental whole-blood infection assay (dotted
lines as a guide for the eye) with the PI-SBM in (A,B), and the
ABM in (C,D). In (A,B), the thickness of the solid lines represents the
standard deviation of the PI-SBM simulation results as obtained from 50
simulations for normally distributed transition rates as given in
Supplementary Table 3. The thickness of the solid lines in (C,D)
represents the standard deviation obtained by 30 simulations of the
stochastic ABM. Time-evolution of killed (CK ) and alive (CA) C. albicans
cells are depicted in (A,C), and the dynamics of C. albicans cells that
are in extracellular space (CE ), phagocytosed by monocytes (CM ) and
PMN (CG) are shown in (B,D).
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condition that is known to be associated with high risks for
candidemia in cancer patients (Lunel et al., 1999; Alangaden,
2011).
3.3. Agent-based Model Captures Immune
Response in Time and Space
State-based models (SBM) do not account for any spatial aspects.
For example, cells in the PI-SBM do not actually migrate during
the immune response and, therefore, do not have to get into
contact before a phagocytosis event can take place. In contrast,
agent-basedmodels (ABM) do capture spatial aspects in a defined
environment. Applying a bottom-up modeling approach, we
implemented an ABM that is—apart from its spatial aspects—
the exact analog of the non-spatial PI-SBM. As depicted in
Figure 1, all transition rates that were previously estimated for
the PI-SBM were fed into the ABM (see Section 2.2 for details).
The only parameters left to estimate were those related to
cell migration, which in the dense cell system of the whole-
blood assay resembles a random walk. In particular, while the
diffusion coefficient associated with the passive movement of
C. albicans cells could be inferred from the Stokes-Einstein
equation to be DC ≈ 1µm2/min, the active migration behavior
of immune cells requires a rigorous parameter estimation of
the diffusion coefficients DM and DG for monocytes and PMN,
respectively.
It should be noted that, even in the case of low-
dimensional parameter spaces, the estimation of parameters
for ABM generally turn out to be computationally intensive.
This is a consequence of the fact that ABM simulate the
interactions between thousands of agents in continuous space
as stochastic processes. To simultaneously facilitate an increase
in model complexity and a decrease in computational expense
for parameter estimation, we applied the local optimization
algorithm adaptive regular grid search. This algorithm compares
ABM simulations by evaluating the least squares error (LSE)
regarding the experimental data of the whole-blood infection
assay. Stochastic effects of the ABM were investigated by
comparing simulation results for a fixed set of parameter values
with varying number of in silico replicates. Using 100 in silico
replicates as a reference for the mean value of the LSE, we
generally observed for relevant parameter sets, i.e., parameter sets
that yield reasonable agreement with the experimental data, that
relative variations in the mean LSE were already well below 10%
for 30 in silico replicates. Therefore, we set the number of in silico
replicates to 30 throughout the whole parameter space.
The adaptive regular grid search algorithm searches the
space of DM and DG on a pre-defined grid of diffusion
coefficients, 0 < DM,DG < 800µm2/min. This range for the
diffusion coefficients implies that the time step 1tABM varies
between 5.2× 10−3min ≤ 1tABM ≤ 4.2min (see Equation 6).
As described in Section 2.3.2, we started with a relatively
coarse grid of step size 100µm2/min and computed at each
grid point the LSE by comparing the experimental data with
a small ABM system, i.e., representing 1/5µl of blood (see
Supplementary Figure 3). These results were used to determine
the regime of parameters in which the parameter estimation was
continued for the large ABM system simulating 1µl of blood. The
parameter regime was determined by the rectangle that contains
all pairs of diffusion coefficients (DG,DM) for which the LSE
values were found to be minimal from separately varying each
parameter. The corner points of this rectangle were (DG,DM) =
(100, 0)µm2/min and (DG,DM) = (600, 800)µm2/min (see
gray region in Supplementary Figure 3). Subsequently, the
grid was refined based on simulations of the large ABM by
determining the path of minimal LSE values and adding grid
points around this path by adaptive bisection. After simulation
of the ABM for parameter sets corresponding to the added grid
points, the procedure of grid refinement was repeated. This can
be seen in Figure 8, where we plot a map of the LSE landscape
together with the paths of minimal LSE values for each level of
refinement. It was observed that the course of these paths covers
a relatively broad range of diffusion coefficients for monocytes,
DM , whereas this is a fairly narrow range of DG-values for
PMN.
FIGURE 7 | Simulation results of the PI-SBM with different immune
cell numbers at 4 h post-infection for the conditions (A)
monocytopenia and (B) neutropenia. The relative numbers of
C. albicans cells of killed cells (CK ), phagocytosed cells in monocytes
(CM ) and in PMN (CG) as well as cells that became resistant (CR)
against killing and/or phagocytosis are depicted for different numbers of
monocytes and PMN. The number of (A) monocytes and (B) PMN in
the simulations are reduced separately, starting from physiological
concentrations of 5×105 /ml monocytes and 5×106 /ml PMN down to
vanishing concentrations. In (B), the light gray region represents the
range of light neutropenia (< 1.5× 106 PMN per ml), medium gray
region represents the range of moderate neutropenia (< 1× 106 PMN
per ml) and dark gray region represents the range of severe neutropenia
(< 5× 105 PMN per ml).
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FIGURE 8 | Result of ABM parameter estimation by adaptive regular
grid search. The diffusion coefficients for monocytes, DM, and PMN, DG,
were scanned within the regime that was determined by parameter scanning
for the small ABM (1/5µl blood). At each grid point, 30 ABM simulations were
performed for the large system (1µl blood) and the mean least squares error
(LSE) is depicted. By determining the path of minimal LSE values and adding
grid points around this path by adaptive bisection, three refinement levels are
considered. Dots represent grid points of the first refinement level, squares
represent grid points of the second refinement level, and triangles represent
grid points of the third refinement level. The paths of minimal LSE values for
the first, second and third refinement level are traced by light gray, medium
gray, and dark gray lines, respectively.
In Figure 9, we present the LSE values as a function of
DM(DG) along the paths of minimal LSE values for the three
levels of refinement. From the third level of refinement we
inferred the point of absolute LSE minimum to be located
at (DminG ,D
min
M ) = (425, 275)µm
2/min. However, since the
landscape of DM(DG) resembled an extended valley across
neighboring data points, we performed a statistical analysis by
applying the Wilcoxon rank sum test between the absolute LSE
minimum and its neighboring points to check for significant
differences between them. Imposing a p-value of p < 0.05 for
significant difference, we obtained points with similar values
of the LSE ranging in the interval DM = 100µm2/min to
DM = 350µm2/min for monocytes and DG = 400µm2/min
to DG = 425µm2/min for PMN (see Figure 8). These
findings imply that the immune response in the whole-blood
infection assay was much more sensitive to variations in the
diffusion coefficients of PMN than of monocytes, emphasizing
the dominant role of PMN over monocytes from the viewpoint
of cell migration.
Our results are consistent with the absolute LSE minima
of refinement level one and two, which were both at
(DminG ,D
min
M ) = (400, 200)µm
2/min and that also belong
to this interval (see Figure 9). Interestingly, while we expected
that monocytes are less migratory active than PMN, i.e.,
restricting the relevant parameter regime in Figure 8 to
FIGURE 9 | The least squares error (LSE) of the paths of grid points
along the diffusion coefficients for monocytes (DM) as a function of the
minimal diffusion coefficient for PMN (DG): DM(DG). Mean values and
standard deviations were obtained from averaging over 30 ABM simulations.
The paths of the first, second, and third refinement level are shown,
respectively, as red, green, and blue lines (guide for the eyes). The horizontal
bars indicate regions of diffusion coefficients with values comparable to the
absolute LSE minimum of each refinement level. All values outside these
regions are significantly different from the absolute LSE minimum (Wilcoxon
rank sum test with p < 0.05).
the region below the dashed line, we also found that the
interval around the absolute LSE minimum contains the
parameter set (DG,DM) = (425, 350)µm2/min. The ratio of
these diffusion coefficients, DM/DG ≈ 0.82, resembles the
value expected from the Stokes-Einstein equation (Einstein,
1905) implying DM/DG = dG/dM (dotted line in Figure 8).
Taken together, we consider the diffusion coefficients
(DminG ,D
min
M ) = (425, 275)µm
2/min to represent the immune
cell dynamics reasonably well and use these values in our further
analyses below.
Next, we compared the ABM simulation results for the
absolute LSE minimum with those of the PI-SBM. These are
plotted together with the experimental data of the whole-blood
infection assay in Figure 6 and in Supplementary Figure 4 for the
time evolution of C. albicans sub-populations. Thus, we found
that both modeling approaches, the non-spatial SBM and the
spatial ABM, yielded excellent agreement with the experimental
data. Furthermore, we found that our simulation results obtained
from the stochastic ABM were robust, which can be seen from
the line thicknesses in Figures 6C,D representing the standard
deviations obtained from 30 ABM simulations.
3.4. Predictions on Hyper- and
Hypo-inflammation from ABM
To investigate the impact of hyper- and hypo-inflammation
associated with the dynamics of immune cells, we varied the
diffusion coefficients of monocytes and PMN separately around
the absolute LSEminimum (DminG ,D
min
M ) = (425, 275)µm
2/min.
Keeping the diffusion coefficient DG fixed and varying the DM
for monocytes between 100µm2/min and 600µm2/min, we
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observed at 4 h post-infection no substantial changes in the
populations of killed, resistant and phagocytosed C. albicans cells
(see Figure 10A). At extreme values DM > DG, a slight increase
(decrease) in the number of killed (resistant) C. albicans cells was
observed accompanied by a slight increase in the phagocytosis by
both monocytes and PMN. This may be attributed to a stronger
mixing of the cell system for high diffusion coefficients DM . In
general, however, the immune response does not appear to be
sensitive to this parameter, which is in agreement with the finding
for monocytopenia that did not have a substantial impact on
infection clearance (see Figure 7A).
In the opposite case, where DM was fixed and DG was varied
between 100µm2/min and 600µm2/min, it was again observed
that for increased values DG > 425µm2/min the impact on the
immune response against C. albicans is only weak. In contrast,
for decreased values DG < 400µm2/min the immune response
was strongly affected by the reduced migratory activity of PMN.
This could be observed by a substantial increase (decrease) in the
number of resistant (killed) C. albicans cells (see Figure 10B).
In particular, for DG = 100µm2/min the phagocytosis of
C. albicans cells by PMN was reduced by more than 20% and the
relative number of resistant C. albicans cells reached the value
of 28%. Comparing this scenario with the condition of PMN
deficiency (see Figure 7B), we found that this PMN paralysis
resembles moderate to severe neutropenia associated with a
relative number of about 20% and 30% of resistant C. albicans
cells, respectively.
4. Discussion
In this study, we applied a bottom-up modeling approach to
simulate an experimental infection assay for C. albicans in
human blood. As illustrated in Figure 1, this approach combines
different mathematical models with increasing complexity that
build on one another. We started from a previously developed
state based model (SBM), here referred to as P-SBM (Hünniger
et al., 2014), that neglects all spatial aspects and describes
the time-evolution of pathogens in different states—e.g., alive,
phagocytosed and killed—during the early response of the innate
immune system. To include the immune response mediated by
monocytes and granulocytes (PMN), in this work we modified
the P-SBM into a SBM that does as well-explicitly account for
the immune cell states and is therefore referred to as PI-SBM.
The rates of state transitions in the PI-SBM were estimated by
comparison with experimental data (Hünniger et al., 2014) using
the global optimizationmethod simulated annealing based on the
Metropolis Monte Carlo scheme (SA-MMC).
The resulting model kinetics of both SBM were found to be
in quantitative agreement with experimental data and confirmed
that PMN play the major role in the immune defense against
C. albicans in human blood. This is indicative for the general
validity of both models, despite the structural difference of the
simulation algorithms regarding the level of detail at which
immune cells are modeled. Furthermore, the PI-SBM allows
making predictions on infection scenarios in patients with
immune cell deficiencies, i.e., neutropenia and monocytopenia.
Performing in silico experiments with varying numbers of either
monocytes or PMN, revealed that loss of monocytes was mainly
compensated by PMN. In contrast, decreasing PMNnumber lead
to a strongly reduced immune response against C. albicans for
PMNnumbers below 5×105 /ml (see Figure 7). Our quantitative
prediction is substantiated by published data that account
this PMN concentration as severe neutropenia (Munshi and
Montgomery, 2000). It is also reported that neutropenia impairs
the outcome of candidemia and is a risk factor, in particular, for
cancer patients developing candidemia (Guiot et al., 1994; Bow
et al., 1995; Lunel et al., 1999). From the quantitative agreement
between predictions of the PI-SBM and reported findings for C.
albicans infection, we attribute a high predictive potential to this
virtual infection model that may be exploited in future studies,
e.g., focusing on conditions of immune dysregulation and/or
comparing the impact of different pathogens. The possibility
to quantify functional alteration of immune cells rather than
pure numerical aberrations is of particular interest in this
regard.
In order to account for spatial aspects of the immune response,
we extended the SBM to an agent-based model (ABM), where
cells are simulated as agents that can migrate in continuous
FIGURE 10 | Simulation results of the ABM at 4h post-infection for
varied diffusion coefficients around the absolute least squares





for (A) monocytes keeping DG fixed and (B) PMN keeping DM
fixed. The relative numbers of C. ablicans cells of killed cells (CK ),
phagocytosed cells in monocytes (CM ) and in PMN (CG) as well as cells
that became resistant (CR) against killing and/or phagocytosis are
depicted.
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three-dimensional space and can interact with each other on
encounter in space. Applying the bottom-up modeling approach,
we made use of the rates that were determined by fitting the
PI-SBM to the experimental data and estimated the diffusion
coefficients of immune cells in blood (see Figure 1). Due to
high computational costs of ABM simulations, applying the
global optimization method SA-MMC was no realistic option
and we chose the computationally affordable local optimization
method adaptive regular grid search. This method searches for
the optimum within a pre-defined parameter space, which in
the present case was a two-dimensional space spanned by the
diffusion coefficients for monocytes and PMN. In contrast,
applying SA-MMC was beneficial in the case of PI-SBM for
three reasons: (i) the parameter space was eight-dimensional,
(ii) limitations of the parameter space would have been difficult to
motivate biologically, and (iii) computational costs for repeated
simulations were still acceptable due to the neglect of spatial
aspects.
As live cell imaging in whole-blood assays cannot yet
be performed today, computer simulations are the only tool
to predict diffusion coefficients of immune cells. Parameter
estimation of the ABM predicted intervals for the diffusion
coefficients that yielded quantitatively comparable results.
For monocytes this interval, DM = 100µm2/min to
DM = 350µm2/min, was substantially broader than for PMN
with DG = 400µm2/min to DG = 425µm2/min, indicating the
importance of fine-tuned PMNmotility.
Furthermore, by varying the diffusion coefficients of the
immune cells, we demonstrated the impact of hyper- and hypo-
inflammation in immune dysregulation. In general, reducing
(increasing) immune cell motilities around optimal values
reduced (increased) the number of interaction events between
cells and by that the phagocytosis of C. albicans cells. In the
case of PMN, reduction of cell motility and phagocytosis events
was additionally associated with a decrease in the release of
antimicrobial peptides contributing to the decrease in killing
of C. albicans cells. This in turn lead to an increase in
the number of resistant C. albicans cells reaching levels that
were well-beyond those observed for paralytic monocytes (see
Figure 10). Comparing the hypo-inflammatory condition with
PMN deficiency, we found that diffusion coefficients around
DG = 100µm2/min resembled the outcome of moderate to
severe neutropenia.
The bottom-up modeling approach presented here may be
extended in various ways. For example, the implementation of
a hybrid ABM could be envisaged where molecular interactions,
e.g., as mediated by antimicrobial peptides, are not simulated
in a rule-based fashion but in an explicit way by a molecular
diffusion solver. Other directions of future research include (i)
focusing on conditions of immune dysregulation, (ii) comparing
the impact of different pathogens, and (iii) including other
types of innate immune cells. Furthermore, it is conceivable
to combine modeling approaches with microscopy experiments
of infection scenarios in vitro in an image-based systems
biology approach (Mech et al., 2014; Figge and Murphy, 2015;
Medyukhina et al., 2015). First steps into this direction have
recently been made, e.g., by establishing algorithms for the
automated image analysis of phagocytosis assays (Mech et al.,
2011; Kraibooj et al., 2014) and for the automated tracking and
classification of PMN from time-lapse microscopy (Mokhtari
et al., 2013; Brandes et al., 2015) that was applied in the context
of comparing C. albicans and C. glabrata infection (Duggan
et al., 2015a). In the future, we expect that a systems medicine
approach exploiting the predictive power of virtual infection
models will play an important role in the context of infectious
disease diagnosis.
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1 SUPPLEMENTARY DATA
Supplementary Video 1. Typical time evolution of the virtual infection scenario in the spatial ABM.
The three-dimensional environment corresponds to 1µl of blood containing 500 monocytes, 5000 PMN
and 1000 C. albicans cells. The cells are represented as spherical agents that migrate depending on their
respective diffusion coefficients and interact depending on rules as depicted in Figure 3 (B). C. albicans
cells occur in the four states (i) alive and non-resistant (green), (ii) dead and non-resistant (red), (iii) alive
and resistant (yellow) and (iv) dead and resistant (gray). Furthermore, granulocytes (polymorphonuclear
neutrophils, PMN) and monocytes are shown in blue and orange, respectively. The video comprises the
immune response during four hours post infection. In the beginning of the video, most C. albicans cells
are non-phagocytosed and are frequently found to be alive and non-resistant (green). Towards the end of
the video, non-phagocytosed C. albicans cells are mostly resistant (i.e., yellow and gray) while most of
C. albicans cells have been phagocytosed.
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2 SUPPLEMENTARY INFORMATION
2.1 ANNEALING FUNCTION τ
The function τ(f) determines the acceptance of worse parameters during the applied fitting procedure
Metropolis Monte Carlo based on Simulated Annealing. This function of fitting steps f is defined in form
of the Hill equation, i.e.
τ(f) = τ0 +
fn
(Pn + fn)
(τ∞ − τ0) , (1)
that ranges between τ0 and τ∞ (see Supplementary Table 1 for applied values) and is characterized by the
coefficient n = 3 describing the slope of the function as well as the point of inflection P = 0.5 ftotal
(with ftotal the total number of fitting steps). We determined the value for n and P by manual adjustment.
3 SUPPLEMENTARY TABLES AND FIGURES
Supplementary Table 1. Score values c for combined units c.






Manually adjusted score values c of the combined units c
that are used for comparison with experimental data from
whole-blood infection assay. All states of the PI-SBM that
represent alive (killed) C. albicans cells are summarized to
the combined unit CA (CK ). States of C. albicans cells in
extracellular space, in monocytes or in PMN are represented
by the combined units CE , CM or CG, respectively.
Supplementary Table 2. Individual start conditions of the fitting algorithm.
CAE(0) M0,0(0) G0,0(0) number of runs number of fitting steps τ
100 50 500 100 3 000 [0.05,5.0]
1 000 500 5 000 50 1 000 [5.0;30.0]
10 000 5 000 50 000 20 250 [5.0;80.0]
100 000 50 000 500 000 10 50 [50.0;80.0]
Start conditions for the parameter fitting algorithm. The number of individuals of alive C. albicans cells in
extracellular space (CAE(0)), monocytes (M0,0(0)) and PMN (G0,0(0)) at time t = 0 min was stepwise
increased by keeping their ratio constant. For each step, the number of runs with corresponding number of fitting
steps per run and the range of τ was adjusted.
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Supplementary Table 3. Transition rates for PI-SBM.
standard standard
rate [min−1] deviation [min−1] deviation [%]
φG 2.83 · 10−2 0.49 · 10−3 1.7
φG∗ 4.75 · 10−2 3.86 · 10−3 8.13
φM 1.25 · 10−2 0.74 · 10−3 5.9
κM 3.59 · 10−2 3.74 · 10−3 10.4
κG 4.69 · 10−2 4.25 · 10−3 9.1
ρ 0.45 · 10−2 0.19 · 10−3 4.2
γ 1.93 · 10−2 2.76 · 10−3 14.3
κ¯EK 26.07 · 10−2 22.65 · 10−3 8.7
The transition rates of the P-SBM are given by the phagocytosis rate φG of
PMN that phagocytose for their first time, the phagocytosis rate φG? of PMN
that phagocytose for at least the second time, the phagocytosis rate φM of
monocytes, the intracellular killing rate κM of monocytes, the intracellular
killing rate κG of PMN, the resistance rate ρ and the rates that determine the
extracellular killing κEK and γ.
Supplementary Table 4. Transition rates for P-SBM.
standard standard
rate [min−1] deviation [min−1] deviation [%]
φG 2.69 ·10−2 0.33 ·10−3 1.24
φG? 3.58 ·10−2 1.88 ·10−3 5.24
φM 0.63·10−2 0.33 ·10−3 5.25
κM 6.08 ·10−2 4.04 ·10−3 6.64
κG 4.26 ·10−2 2.03 ·10−3 4.76
ρ 0.41 ·10−2 0.13 ·10−3 3.25
γ 3.16 ·10−2 2.15 ·10−3 6.8
¯κEK 29.13 ·10−2 14.35 ·10−3 4.93
The transition rates of the PI-SBM are given by the phagocytosis rate φG of
PMN that phagocytose for their first time, the phagocytosis rate φG? of PMN
that phagocytose for at least the second time, the phagocytosis rate φM of
monocytes, the intracellular killing rate κM of monocytes, the intracellular
killing rate κG of PMN, the resistance rate ρ and the rates that determine the
extracellular killing κEK and γ.
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Supplementary Figure 1. Flow-chart of the non-spatial P-SBM simulation algorithm. In each time-step
∆tP−SBM , all individuals of C. albicans cell states are tested for possible state transitions. Individuals of
alive C. albicans cells in monocytes (CAM ) or PMN (CAG) are tested for intracellular killing. Individuals
of the state killed-and-extracellular C. albicans cells (CKE) are tested for phagocytosis and for becoming
resistant. The individuals of the state alive-and-extracellular C. albicans cells (CAE) are tested for
phagocytosis, for extracellular killing and for becoming resistant.
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Supplementary Figure 2. Kinetics of PI-SBM simulations (red solid lines) for the minimal least squares
error (LSE) relative to the experimental data from whole-blood infection assays (red dotted lines as guide
for the eye). The error bars correspond to the standard deviations of five independent experiments. The
thickness of the solid lines represents the standard deviation of the simulation results as obtained from 50
simulations for normally distributed transition rates as given in Supplementary Table 2. Colored symbols
refer to different C. albicans states, where their time courses are indicated by continuous lines with the
same color. (A) Time-dependent relative number of killed C. albicans cells (CK) that were experimentally
measured by survival plates. The experimental results were compared with the combination of simulated
data representing all killed C. albicans of the model, i.e. extracellularly killed C. albicans (CKE),
killed resistant C. albicans (CKR), killed C. albicans that are in monocytes (CKM ) or PMN (CKG).
(B) Alive C. albicans (CA) that were measured by survival plates and simulated by the combination of
alive C. albicans that are in extracellular space (CAE), in monocytes (CAM ), in PMN (CAG) or became
resistant against phagocytosis (CAR). (C) Time course of C. albicans cells that are in extracellular space
of blood (CE). Experimental data was obtained by FACS analysis and simulated data is represented
by the combination of C. albicans cells that are extracellular alive (CAE), extracellularly killed (CKE)
and resistant against phagocytosis (CR). (D) The simulated resistant C. albicans (CR) are the sum of
alive and dead resistant C. albicans cells at each time point of the simulation time. (E) Time course of
C. albicans cells that were phagocytosed by monocytes (CM ). This is defined as sum of alive and killed
C. albicans cells in monocytes, i.e. CAM and CKM , respectively. The corresponding experimental data
was obtained by FACS analysis. (F) Relative number of C. albicans cells in PMN (CG) during the whole-
blood infection, where internalized C. albicans cells can be alive (CAG) or dead (CKG). (G) Simulation
result of killed C. albicans cells within monocytes (CKM ), that is defined as the sum of internalized
C. albicans that were intracellularly killed(CMKM ) and those who were extracellularly killed (CEKM ).
(H) Simulated time course of killed C. albicans cells in PMN (CKG), that is composed of intracellularly
killed C. albicans cells (CGKG) and extracellularly killed C. albicans cells (CEKG) in PMN.
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Supplementary Figure 3. Result of ABM parameter estimation by adaptive regular grid search applied
to the small ABM representing 1/5µl blood. The space of diffusion coefficients of monocytes (DM ) and
PMN (DG) was scanned at the grid points in the pre-defined area. At each grid point the mean value of
the least squares error (LSE) and the standard deviation over 30 simulations are shown. The gray region
represents the rectangle that contains all pairs of diffusion coefficients for which the LSE values were
found to be minimal from separately varying each diffusion coefficient. The dashed line corresponds
to DM = DG and the dotted line corresponds to diffusion coefficients that follow the Stokes-Einstein
equation for monocytes and PMN, i.e. DG/DM = dM/dG with monocyte diameter dM = 16µm and
PMN diameter dG = 13.5µm.
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Supplementary Figure 4. Kinetics of ABM simulations with (DminG , D
min
M ) = (425, 275)µm
2/min (red
solid lines) for the minimal least squares error (LSE) relative to the experimental data from whole-blood
infection assays (red dotted lines as guide for the eye). The error bars correspond to the standard deviations
of five independent experiments. The thickness of the solid lines represents the standard deviation of the
simulation results as obtained from 30 simulations. Colored symbols refer to different C. albicans states,
where their time courses are indicated by continuous lines with the same color. (A) Time-dependent
relative number of killed C. albicans cells (CK) that were experimentally measured by survival plates.
The experimental results were compared with the combination of simulated data representing all killed
C. albicans of the model, i.e. extracellularly killed C. albicans (CKE), killed resistant C. albicans
(CKR), killed C. albicans that are in monocytes (CKM ) or PMN (CKG). (B) Alive C. albicans (CA)
that were measured by survival plates and simulated by the combination of alive C. albicans that
are in extracellular space (CAE), in monocytes (CAM ), in PMN (CAG) or became resistant against
phagocytosis (CAR). (C) Time course of C. albicans cells that are in extracellular space of blood (CE).
Experimental data was obtained by FACS analysis and simulated data is represented by the combination
of C. albicans cells that are extracellular alive (CAE), extracellularly killed (CKE) and resistant against
phagocytosis (CR). (D) The simulated resistant C. albicans (CR) are the sum of alive and dead resistant
C. albicans cells at each time point of the simulation time. (E) Time course of C. albicans cells that
were phagocytosed by monocytes (CM ). This is defined as sum of alive and killed C. albicans cells
in monocytes, i.e. CAM and CKM , respectively. The corresponding experimental data was obtained by
FACS analysis. (F) Relative number of C. albicans cells in PMN (CG) during the whole-blood infection,
where internalized C. albicans cells can be alive (CAG) or dead (CKG). (G) Simulation result of killed
C. albicans cells within monocytes (CKM ), that is defined as the sum of internalized C. albicans that were
intracellularly killed(CMKM ) and those who were extracellularly killed (CEKM ). (H) Simulated time
course of killed C. albicans cells in PMN (CKG), that is composed of intracellularly killed C. albicans
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Deciphering the Counterplay of 
Aspergillus fumigatus Infection and 
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Peter F. Zipfel2,5 & Marc Thilo Figge1,2
Microbial invaders are ubiquitously present and pose the constant risk of infections that are opposed by 
various defence mechanisms of the human immune system. A tight regulation of the immune response 
ensures clearance of microbial invaders and concomitantly limits host damage that is crucial for host 
viability. To investigate the counterplay of infection and inflammation, we simulated the invasion of 
the human-pathogenic fungus Aspergillus fumigatus in lung alveoli by evolutionary games on graphs. 
The layered structure of the innate immune system is represented by a sequence of games in the virtual 
model. We show that the inflammatory cascade of the immune response is essential for microbial 
clearance and that the inflammation level correlates with the infection-dose. At low infection-doses, 
corresponding to daily inhalation of conidia, the resident alveolar macrophages may be sufficient to 
clear infections, however, at higher infection-doses their primary task shifts towards recruitment of 
neutrophils to infection sites.
The great efficiency of the human immune system with regard to the recognition and elimination of infectious 
microbes is due to its layered and redundant structure and its well-orchestrated response across elevating levels. 
For example, the complex immune system is divided into the two main interacting levels of innate and adaptive 
immunity. Many infectious microbes are cleared already by the innate immune response that is immediately 
active but only grossly specific1. However, if the infectious microbe cannot be cleared in this way, inflammatory 
signals elevate the response from the level of innate immunity to the level of adaptive immunity. Activation of 
an adaptive response, e.g. involving affinity maturation of antibodies by B-cells in germinal centres, takes days to 
weeks, however, at the benefit of being highly specific for the invader2.
The layered structure of the immune system is also recognised within the levels of innate and adaptive immu-
nity itself. For example, adaptive immunity does not necessarily require to mount the tedious process of antibody 
affinity maturation, if the infectious microbe was encountered before and can be defeated by the activation of 
previously generated memory cells that directly go into production of the highly specific antibodies2. Similarly, 
innate immunity comprises the immediate response of humoral immunity, like the complement system, that may 
eliminate the infectious microbes by opsonisation associated with inflammatory signalling to recruit and activate 
phagocytic cells within a few hours and/or the formation of membrane attack complexes3. Furthermore, one can 
distinguish phagocytic cells that are resident in organs from those that are recruited in support from the blood-
stream to the site of infection within tens of hours1.
Apart from the fact that the layered structure of the immune system is beneficial for the strength and efficiency 
of the response, it is obvious that an elevating regulation between infection and inflammation is beneficial in 
being protective for the host itself. The danger for the human host due to dysregulation of the immune response 
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becomes impressively evident in the case of sepsis, i.e. a whole-body inflammatory response to an infection that 
may induce multi organ failure4. Thus, as important as it is that the human host responds with inflammation 
against infection, it is mandatory for the protection of the host against its own immune system to avoid unnec-
essary overshoots and to ensure a proper shut down of the response after infection clearance5. In what follows, 
we refer to the pathogen-induced infection and the host-driven inflammation, which are opposing actions from 
positions of defence, as counterplay.
Virtual infection-inflammation models can be constructed by different modelling techniques like for example 
by ordinary differential equation models (ODE), state-based models (SBM), agent-based models (ABM) and game 
theory. The purpose of a theoretical study and the complexity of a biological system determine how suitable a 
certain approach is.
ODE allow for straightforward modelling and have previously been applied in the context of bacterial infec-
tions6–9 as well as for A. fumigatus infection10. However, ODE assume spatially homogeneous environments, 
where the constituents occur in high concentrations, making them inappropriate for a realistic simulation of the 
infection-inflammation scenarios of A. fumigatus conidia in the lung. SBM and ABM allow for the stochastic 
simulation of biological systems at the level of single events11,12. While SBM neglect spatial resolution, ABM 
simulate single individuals within a real spatial structure that may be represented on a grid or in continuous 
space. For example, a virtual infection-inflammation model of the human-pathogenic fungus Candida albicans 
in human blood was recently formulated in terms of a bottom-up modelling approach using SBM and ABM 
for quantitative parameter estimation13,14. Another ABM was developed for investigation of spatio-temporal 
dynamics of A. fumigatus infection of in vitro experiments15 and in a virtual human alveolus with regard to 
inflammation-induced chemotaxis of AM16. The latter model was extended to a hybrid ABM that enabled inves-
tigation of molecular diffusion using partial differential equations to decipher quantitative properties of candidate 
chemokines17.
The aforementioned modelling techniques simulate the time course of an underlying biological system by 
means of mechanistic processes. As a consequence, the dimensions of the parameter space are rapidly increasing 
and, since many of these parameters are unknown to date, a rigorous parameter estimation may render these 
approaches infeasible14. Therefore, to investigate the innate immune response against A. fumigatus in the human 
lung at the humoral and cellular level, we here pursue a game-theoretical approach that resolves the counterplay 
of infection and inflammation at the different levels.
Game theory is a mathematical concept of optimisation and the main advantage of this approach is that differ-
ent effector mechanisms can be elegantly condensed into a reduced number of combined parameters. This ren-
ders computational simulations tractable and still allows for the identification of the key parameters that deserve 
particular attention in future experimental investigations. Classical game theory (CGT) was originally developed 
as decision support18 in interactive situation in which the aims, goals and preferences of individual actors, i.e. the 
players of a game, are in conflict with each other19. The decisions available to the players correspond to strategies 
from which they can choose. Based on its own strategy and the strategies of the other players with which interac-
tions are carried out players receive a benefit – also termed payoff  20. However, each player in CGT was assumed 
to act perfectly rationally, to have the complete set of information about all possible outcomes of the game and 
their related payoffs as well as the cognitive capabilities to deduce from this information the optimal strategy19. 
To represent phenomena observed in interactions between living organisms, the paradigm of CGT turned out to 
be too restrictive.
The restrictions were softened by the concept of evolutionary game theory (EGT)21. This concept allowed for 
more flexibility and – inspired by evolution theory – implemented irrational behaviour, e.g. in terms of mutation. 
Thus, players do not simply optimise their payoff with regard to their strategic alternatives; rather, they replicate, 
survive or die based on the fitness associated with their respective strategy22. As a consequence, the dynamics of 
strategies involves a series of iterative evolutionary steps, a feature completely missing in CGT19. Moreover, the 
field of evolutionary games on graphs emerged, where not all players interact with each other, but the number of 
interactions is reduced to the ones that can be reasoned for by neighbourship relations between individuals, e.g. 
based on spatial proximity, social connections or genetic relationships19. There have been several contributions 
to the field of fungal infections using game-theoretic approaches in the recent past23: Hummert et al. investigated 
the cooperative behaviour between Candida albicans cells that were phagocytosed by macrophages24. In another 
study on C. albicans infection, the dynamics of the yeast-to-hyphal transition in response to various actions of the 
host was investigated by EGT25. It was found that the host requires a differentiated response to the distinct mor-
phological states of C. albicans in order to keep the fungus in the least pathogenic state. Other examples, going 
beyond the context of fungal infections, have been reviewed by Hummert et al. regarding cellular interactions20 
and by Bohl et al. regarding molecular interactions26.
In this study, we theoretically investigate the counterplay of infection and inflammation during the innate 
immune response against invading microbes by applying EGT. The main advantages of this stochastic modelling 
approach are that (i) systems with a small number of constituents are adequately captured, (ii) model parame-
ters are reduced by a relative representation of processes, and (iii) spatial system resolution can be realized on 
a graph. While such a modelling approach is generally applicable to infection-inflammation scenarios caused 
by any kind of infectious microbe, for illustrative purposes we here focus on the concrete example of the sap-
rophytic human-pathogenic fungus Aspergillus fumigatus27. This fungus represents a prime example, because 
humans inhale several thousands of its ubiquitously present airborne conidia every day28. Thus, while this fungus 
constitutes a common challenge to the human host, its potential threat can obviously be permanently managed 
under physiological immune conditions. This implies that an innate immune response against this infectious 
agent is generally sufficient, involving moderate inflammatory conditions that are usually mounted unnoticed 
in immunocompetent individuals. However, the situation is different for immunocompromised individuals and/
or when high fungal doses are inhaled, in which case the pathogen can become a major cause of life-threatening 
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infections29. The immune system of immunocompromised individuals may not be able to clear the lung from 
A. fumigatus conidia in due time, before the onset of conidial germination that may be followed by invasive 
growth30. Inhaled conidia typically are in a resting state, covered by a rodlet layer that renders them immunolog-
ically inert31. However, taking advantage of nutrient-rich conditions in the lung alveoli, resting conidia may swell 
and germinate, ultimately leading to the formation of hyphae and the ability of the fungus to penetrate tissue and 
eventually enter the bloodstream, disseminating through the whole body. As a consequence, invasive pulmonary 
aspergillosis is associated with high mortality rates ranging from 30–90%32.
On invading the human organism, fungal cells are partly intercepted by mucosal epithelial cells, however, due 
to their small size of about 2–3 μ m, significant amounts of the conidia can enter the lower respiratory tract of the 
lung (see Fig. 1(a)). They end up in so-called alveolar sacs (AS)33 that consist of alveoli, which are the smallest 
units of the human lung27. Alveoli exist in various polyhedral shapes with a surface to volume ratio that optimises 
the gas exchange through their thin epithelial layers34. Once conidia enter the alveoli, they are embedded within 
the nutrient-rich and highly viscous alveolar lining layer, also called pulmonary surfactant, where they are faced 
with several defence mechanisms of the host27,35. During the innate immune response different sequential phases 
can be involved. Depending on how successful the pathogen can be cleared from the human host in one phase, 
the next phase, which is associated with a higher level of inflammation, may be initiated. As depicted in Fig. 1(b), 
the innate immune response against A. fumigatus conidia comprises humoral factors, like the complement system 
that is subject of Game I, and phagocytic cells, such as alveolar macrophages (AM) and polymorphonuclear neutro-
phils (PMN) being subjects of Game II and III, respectively.
As soon as conidia get into contact with the surfactant, complement is activated and proteins start to opsonise 
their surfaces, with amounts of bound complement proteins being proportional to the surface area of the fungal 
cell36. Opsonisation by complement proteins induces inflammation at the site of infection and the release of che-
moattractants, e.g. C3a and C5a3. In addition to that, opsonisation of the fungal surface increases phagocytosis 
and the production of reactive oxygen intermediates (ROI) by AM and PMN enhancing phagocyte activation 
on direct physical contact with the pathogen30. Taken together, while the complement system drives the innate 
immune response against A. fumigatus by inflammatory signals, the formation of terminal membrane attack 
complexes are expected to be prohibited by the thickness of the cell wall37.
Upon contact of A. fumigatus conidia with type II alveolar epithelial cells (AEC), these cells secrete inflamma-
tory molecules, such as IL-6 and TNF-α as well as the chemoattractant IL-838. AM are resident phagocytes in lung 
alveoli and are the first immune cells that get into contact with inhaled pathogens like A. fumigatus conidia34,39. 
Figure 1. Lung architecture and design of evolutionary games. (a) Organisation of densely packed alveoli in 
alveolar sacs in the lower respiratory tract of the lung. An example distribution of eight fungal cells (shown in 
green) over a cross-sectioned alveolar sac and their proximity-based interactions (black connections). (b) Model 
design of the consecutive sequence of evolutionary games on graphs for the innate immune response against  
A. fumigatus infection in the lung.
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They are able to phagocytose both resting and swollen conidia, but only swollen conidia are effectively killed 
intracellularly39. AM lack the ability to phagocytose the hyphal morphotype of A. fumigatus, but are critical for 
hyphal recognition because this leads to the chemotactic recruitment of circulating phagocytes, like PMN, from 
the bloodstream to the site of infection29,40.
PMN phagocytose and kill conidia but also hyphal structures. If hyphal structures are too large for being 
phagocytosed, PMN may release the content of their granules into extracellular space30. These extracellular fac-
tors are involved in killing hyphae, but also cause damage to the surrounding host tissue27. Furthermore, PMN 
may commit an altruistic suicide as a final act of defence against hyphae, thereby releasing DNA fibers into the 
environment that may trap the fungus41. These so-called neutrophilic extracellular traps (NETs) were shown to 
have fungistatic rather than fungicidal effects41. AM and PMN are thought to be key players in the defence against 
A. fumigatus and an impairment of either phagocyte type is commonly associated with a relatively high suscepti-
bility for severe infections by this fungus42.
As is clear from the example of the human-pathogenic fungus A. fumigatus, investigating the counterplay of 
infection and inflammation is highly important in order to gain insights into the complex host-pathogen interac-
tions that may ultimately reveal possibilities for therapeutic interventions. However, since it is virtually impossible 
to investigate these processes in alveoli of the human lung in vivo and under physiological conditions16, we here 
pursue a systems biology approach starting with theoretical modelling. We apply EGT on graphs to investigate the 
counterplay of pathogen-induced infection and increasing levels of host inflammation during A. fumigatus infec-
tion in AS of the human lung according to the time course depicted in Fig. 1(b). The model is constructed on the 
firm basis of experimental data available today (see Methods section) and is applied to generate new hypothesis 
that can direct future experimental investigations (see Discussion section).
The present study, using infections by the human-pathogenic fungus A. fumigatus as an example, reveals the 
importance of the immune response to be tightly regulated and that this regulation is realised by the layered 
structure of the immune system. In particular, our simulations reconcile the contradictory view on the role of AM 
in the immune response43,44: We observe that AM have a key role in the regulation of the first steps of the immune 
response and that this regulation depends on the strength of the infection-dose. While the phagocytic activity of 
AM is sufficient to limit low infection-doses – corresponding to values of daily inhalation – inflammatory signal-
ling by AM for recruitment of PMN becomes their primary task at higher infection-doses.
Results
In this section, we first analyse the degree of proximity between conidia of A. fumigatus in AS of the human lung. 
Based on the derived interaction graphs between fungal cells, we then consider the results of three evolution-
ary games representing distinct stages of the innate immune response against this human-pathogenic fungus 
(see Fig. 1(b)). These stages comprise the humoral response by the complement system (Game I), the cellular 
immune response by AM (Game II) and PMN (Game III). Finally, by linking these three individual games in a 
time-ordered fashion, we present the results of infection-inflammation scenarios in the human host. To quantify 
the infection-inflammation scenarios, we defined the infection score (see Eq. 6) and normalised inflammations 
that mediate between Game I and II (see Eq. (7)) and Game II and III (see Eq. (8)).
Virtual infection-inflammation model reveals degree of fungal interactions in alveolar 
sacs. We performed in silico experiments to simulate the counterplay of A. fumigatus infection and host 
inflammatory response by evolutionary games on graphs. A graph defines the proximity-based interactions 
between fungal cells in AS of the human lung (see Fig. 1(a)). Each game of the infection-inflammation scenario 
represented a consecutive sequence of three stages of innate immunity (see Fig. 1(b)). Within each AS, consisting 
on average of 21 densely packed alveoli, the drawn number of conidia nfc were uniformly distributed over its 
alveoli. As shown in Fig. 2(a), we found that irrespective of the fungal dose, most likely there will be no conidium 
at all in a randomly chosen AS. However, of all the AS that contained fungal cells, their number clearly depended 
on the fungal dose and was associated with quite different upper limits of conidia that could be expected in the 
AS. For a fungal dose that corresponds to daily inhalation (6.3 · 103 conidia), two conidia per AS are conceivable, 
whereas for extremely high doses (107 conidia) up to eight conidia may be encountered in a single AS.
Fungal individuals in the same AS may become engaged in a game among each other under the influence of 
the immune response at a certain stage. As described in the Methods section, the graph-based approach defines 
interactions between fungal cells, where the number of interactions per fungal cell depends on their number in 
the corresponding AS. As shown in Fig. 2(b), this analysis revealed that two fungal cells in an AS most likely stay 
solitary, whereas three to eight individuals in an AS typically lead to one expected interaction per conidium.
Complement activity drives emergence of fungal morphotypes. In Game I, different morphotypes 
emerge from the interaction of fungal cells with the complement system that are shown in Fig. 3 for different 
parameter combinations and for low (nfc = 2) and high (nfc = 8) infection-doses. As could be expected, with rising 
nutrient availability ES for swollen conidia or diminishing complement effects cS against swollen conidia, their 
fraction increases over that of resting conidia, fS > fR. Regions with comparable fractions of resting and swollen 
conidia, fR ≈ fS, were found for both infection-doses, however, these regions were more extended for the lower 
infection-dose. At high infection-doses, where conidia had on average more interaction partners per alveolus, it 
was frequently observed that one of the two populations dominated over the other one with a fraction above 80 %. 
This effect could be attributed to the dose-dependent impact of adaptation and mutation events in each simula-
tion time-step. For low relative to high infection-doses, mutations occur more often than adaptation events due 
to a lack of interaction neighbours among the widely separated fungal cells.
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Alveolar macrophages reach phagocytic limits for high fungal doses. We performed simulations 
of Game II to identify the most relevant parameters under the impact of the immune response by AM. Using the 
concept of mutual information, as explained in the Methods section, we found that the activity of AM was of 
central importance regarding the infection score ISII (see Eq. (6) and Table S2). Our investigations revealed that 
AM were in the position to keep the fungal cells in check for low infection-doses of fungal cells and for sufficiently 
high phagocytosis activity of AM. However, as shown in Fig. 4, AM were not able to remove the infectious agents 
in high-dose scenarios due to their inability to counteract hyphal cells appropriately. It can be expected that their 
function regarding elevation of the immune response via inflammatory and chemoattracting signals plays an 
important role in this case.
Figure 2. Number of conidia and their interactions per alveolar sac. (a) Dose-dependent probability 
distribution for the number of conidia entering the alveolar sac. Rescaling of the probability values were used to 
determine the expected number of affected alveolar sacs in the human lung, as shown by the scale on the right 
hand side. (b) Probability distribution for the number of interactions per fungal individual depending on the 
number of conidia inserted into the alveolar sac. Distributions were obtained from 106 interaction graphs.
Figure 3. Fractions of A. fumigatus morphotypes and degrees of inflammation in response to the 
complement system. Equilibrium fractions of conidia in the resting state were determined from averaging 
over 100 repetitions per parameter configuration. Parameters were scanned in a lattice-based fashion at distinct 
points of the parameter space. Isolines (colored lines) for fractions of conidia in the resting state and isobands 
(red shaded areas) for different degrees of inflammation were generated using a modified version of the 
marching-squares algorithm for bilinear interpolation over rectangular grids. Parameters ER = 1, cR = 0.5 were 
kept fixed.
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Recruitment of neutrophils can be essential for successful clearance. In Game III, A. fumigatus 
conidia were faced with the professional phagocytes PMN. First, we identified the most relevant parameters by 
computing the mutual information between each of the game’s parameters and the infection score (see Eq. 6). 
The PMN recruitment ρPMN and phagocytosis activity αPMN against live fungal cells were found to be most rel-
evant for the outcome of the infection (see Table S2). We further analysed these parameters for low and high 
infection-doses and the results are shown in Fig. 5. It should be noted that the infection score ISIII = 0.25 rep-
resented the special case of one resting conidium in the AS that survived the immune response of the host. 
Consequently, infection scores ISIII < 0.25 and ISIII ≥ 0.25 represent, respectively, clearance and persistence of the 
A. fumigatus infection. The measure p(ISIII ≥ 0.25), plotted in Fig. 5, denotes the fraction of parameter combina-
tions over all performed simulations for which the fungal infection persisted in the host. We identified the most 
important parameters for infection clearance and found that, for a low number of infectious agents, PMN were 
able to clear the infection in most of the cases, whereas reduced recruitment and activity of PMN eventually led to 
the persistence of infection. In the limit of high infection-dose, PMN activity and a sufficiently high recruitment 
were pivotal to remove A. fumigatus. We further found that a reduced PMN activity could be partly compensated 
by an increase in the PMN recruitment. Moreover, independent of the precise value of PMN activity, sufficient 
PMN recruitment was generally found to be an essential prerequisite for successful infection clearance.
Infection-inflammation scenarios reveal regulatory role of alveolar macrophages. Going 
beyond the separated analysis of evolutionary games for the three distinct stages of the innate immune response 
against the human-pathogenic fungus A. fumigatus, we linked the games in a time-ordered fashion to simulate 
infection-inflammation scenarios in the human host. Thus, starting with Game I, we determined the infection 
score ISI (see Eq. 6) due to the immune response by the complement system. Next, we linked Game I to Game 
II by computing the normalised inflammation NII→II (see Eq. (7)), which determined AM activity in the second 
stage of the immune response. The infection-inflammation scenario at this stage was evaluated by the infection 
Figure 4. Dose-dependent infection scores according to simulations of Game II. The average infection 
score ISII over all parameter combinations shown as a function of AM activity. Error bars denote one standard 
deviation. The black short-dashed line marks the infection score threshold IS = 0.25 below which clearance of 
infection is achieved.
Figure 5. Dose-dependent connection between infection score and PMN parameters. Landscape of the 
persistent infection probability for different fungal doses in scenarios with (a) low and (b) high infection-
doses. Isobands (colored areas) for different probability ranges were generated using a modified version of the 
marching-squares algorithm for bilinear interpolation over rectangular grids.
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score ISII (see Eq. 6) and linking to Game III was realised by the normalised inflammation NIII→III (see Eq. (8)), 
which determined PMN recruitment in the third stage of the immune response and gave rise to the infection 
score ISIII (see Eq. 6 and Fig. 1(b)).
The simulation results for low and high infection-doses as well as for varying AM and PMN activities are pre-
sented in Fig. 6. The counterplay between A. fumigatus infection and the complement system (Game I) yielded 
values for the infection score and the normalised inflammation that are shown in Fig. 6 for (a) low (nfc = 2) and 
(b) high (nfc = 8) infection-doses. The infection score ISI resulting from Game I is depicted on the left-hand side 
in the black histograms in Fig. 6(a,b), while the corresponding normalised inflammation NII→II is shown on the 
Figure 6. Dose-dependent relation between infection and inflammation across the consecutive sequence 
of evolutionary games. Two infection-inflammation scenarios were simulated: low infection-dose in (a,c,e) 
and high infection-dose in (b,d,f). In (a,b) the distribution of infection scores and corresponding values for 
the normalised inflammation are shown as black histograms. The distribution of higher (lower) values for the 
normalised inflammation with NII→II ≥ 0.75 (NII→II < 0.75) are shown by circles colored in red (blue). The 
inflammatory signal NII→II was fed into Game II scaling AM activity. The effects of high and low values for 
the normalised inflammation are shown in (c,d) using red and blue inline histograms grouped by different 
levels of AM activity. The red and blue inline histograms were combined in the notched box plots and shown in 
orange, violet and green color, respectively, for low, medium and high AM activity with average values marked 
by (× ). (e,f) Connection between Game II and Game III was set by the recruitment parameter ρPMN = NIII→III. 
Distributions for the different AM activities are presented in the same colors as in (d,e) grouped by PMN 
activities. The black short-dashed lines in (c–f) mark the infection score threshold IS = 0.25 below which 
clearance of infection is achieved.
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right-hand side. The normalised inflammation revealed a bimodal distribution that subdivides all simulations 
into infection-inflammation scenarios with low (blue) and high (red) NI-values. Interestingly, a comparison with 
the corresponding classes for the infection score did not show this clear separation. This result was observed for 
both low and high infection-doses and an in-depth analysis revealed that, while low (blue) inflammation values 
were associated with lower infection scores, higher (red) inflammation values were not only associated with 
higher infection scores but, quite unexpectedly, also with lower infection scores. It turned out that the reason 
for this behavior is in the effect that the complement system exerted on resting and swollen conidia. As can be 
observed in Fig. 3, high inflammation (dark red areas) exist for fR > 0.5 and corresponds indeed to lower infec-
tion scores where the fraction of resting conidia is larger than that of swollen conidia. Furthermore, it could 
be observed that these cases were associated with approximately equal complement activity against resting and 
swollen conidia (cR ≈ cS) in combination with only small differences between the nutrient contributions ER and ES.
The normalised inflammation NII→II that was induced by the response of the complement system (Game I) 
had direct impact on AM activity in Game II. The corresponding results are depicted in Fig. 6 for (c) low and 
(d) high infection-doses. In both cases, the highest impact on the infection scores could be attributed to the 
AM activity αAM, where higher AM activity was associated with more strongly reduced infection and vice versa. 
Interestingly, only marginal differences were induced by low (blue) and high (red) infection-inflammation sce-
narios from the complement response with regard to the resulting distributions of infection scores after AM 
response in Game II (see Fig. 6(c,d), blue and red inline histograms). Of note, we generally observe that the 
level of infection is reflected by the level of inflammation (see Fig. 6(c,d)). In scenarios with low infection-dose, 
as shown in Fig. 6(c), AM with high activity were in the position to clear the infection in most of the cases 
(p(ISII < 0.25) = 95%), in contrast to scenarios with high infection-dose (see Fig. 6(d)), where even high AM 
activity could only reduce but not entirely clear the infection in most of the cases (p(ISII < 0.25) = 10%). In 
both infection scenarios and irrespective of AM activity, a statistically relevant number of different parameter 
configurations resulted in the PMN recruitment by AM to support in the elimination of the infectious agents. 
Interestingly, distributions of infection scores in Game II (ISII) generally induced qualitatively comparable distri-
butions for the normalised inflammation (NIII→III).
Linking Game II and Game III by the normalised inflammation NIII→III, we found that, since AM with lower 
activity induced on average higher infection scores, they gave rise to increased levels of inflammation associated 
with increased PMN recruitment. In general, low infection-doses were found to be cleared for a wide range of 
PMN activities as indicated by infection score ISIII < 0.25 in Fig. 6(e). This implies, in agreement with our earlier 
observations (see Fig. 5(a)), that the amount of recruited PMN was always sufficient and could even compensate 
lower PMN activities. The situation is different for the case of high infection-doses, where a minimum-activity 
of PMN was required to ensure statistically firm clearance of infection (see Fig. 6(f)). Interestingly, we observed 
an advantageous effect for fungal clearance by PMN for AM with reduced activity in counteracting the fungal 
pathogens and consequently higher production of inflammatory signals increasing PMN recruitment. As can for 
example be seen for high PMN activity and high infection-dose, the probability for a persistent infection rose 
from p(ISIII ≥ 0.25) = 0.7% in cases with low AM activity to p(ISIII ≥ 0.25) = 2.5% in cases with high AM activity. 
This stresses once again the pivotal role of AM with regard to PMN recruitment. For low and medium PMN activ-
ity, the probability for a persistent infection p(ISIII ≥ 0.25) was ranging, respectively, from 32% to 86% and from 
12% to 43%. For pathogen removal, high PMN activity was required the higher the infection-dose and the lower 
the AM induced inflammatory signal produced for PMN recruitment.
Discussion
In this study, we applied EGT on graphs to investigate the dynamic counterplay between pathogens and the 
human immune system in various infection-inflammation scenarios. For illustrative purposes we focused on 
the concrete example of A. fumigatus infection, because even though this human-pathogenic fungus constitutes 
a common challenge, its potential threat can obviously be permanently managed under physiological immune 
conditions. Our virtual infection-inflammation model combined the three temporally distinct stages of the innate 
immune response against this fungal pathogen, i.e. the direct and immediate response by the complement system 
(Game I), followed by the phagocytic activity of AM (Game II) and the subsequent recruitment and immune 
response by PMN (Game III). Thus, going beyond separate in silico experiments of the three stages, we linked the 
three individual games in a time-ordered fashion. This is achieved by accounting for the quantitative elevation 
in the host inflammation, depending on the evolution of the various morphotypes that A. fumigatus can exhibit 
in the course of an infection. We performed stochastic computer simulations of various infection-inflammation 
scenarios scanning the parameter space of the model to identify and predict the relative importance of specific 
mechanisms in the innate immune response against A. fumigatus.
The activity of the complement system and the availability of nutrients determine the evolution of the fungal 
morphotypes, i.e. how the population of fungal cells is composed of resting and swollen conidia. In line with 
earlier experiments in mice, where a major inflammatory complement component (C5a) was depleted inducing 
a higher virulence of the pathogen45, it was observed in the model that conidia did shift from the resting state to 
the swollen state associated with a higher infection potential. It can be concluded, that in this case the pressure of 
the complement system became so low that the uptake of nutrients made this state transition beneficial. We also 
found this effect to be increased in the limit of high infection-doses.
While the complement system is believed not to contribute to direct killing of this fungus, in agreement with 
previous experimental investigations29,30,46, our simulations predicted a substantial contribution of the comple-
ment system to AM activity in AS via inflammatory signalling. Interestingly, on the one hand, it is well-known 
that AM comprise the largest population of resident cells in the respiratory tract47 and that impairment of 
their function is one of the risk factors for invasive mycoses43. On the other hand, based on experiments with 
mice, Mircescu et al. claimed that PMN but not AM play the essential role in the immune response against 
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A. fumigatus44. Our simulations revealed that these seemingly contradictory view points could be reconciled by 
accounting for the impact of the infection-dose on the time course of the infection-inflammation scenario. In par-
ticular, we observed in the in silico experiments that AM have a key role in the regulation of the immune response 
and that this regulatory effect depended on the strength of the infection-dose. As a matter of fact, infections could 
generally be cleared by AM alone and without considerable PMN recruitment in the limit of low infection-doses 
corresponding to the typical dose of daily inhalation, where AM were mainly confronted with conidia in the 
resting and swollen state. In contrast, higher infection-doses were associated with higher inflammation and, con-
sequently, inflammation-dependent PMN recruitment by AM was pronounced, such that PMN but not AM were 
ultimately playing the essential role in the phagocytosis of the fungal cells. This simulation-derived interpretation 
is in agreement with the fact that the study by Mircescu et al. was indeed performed with infection-doses that 
were orders of magnitude above the dosis of daily inhalation44.
The regulatory function of AM was of paramount importance in the simulations, due to the quantitative and 
qualitative limitations of AM to phagocytose and kill A. fumigatus in the hyphal state39. However, apart from AM 
activities directed against the pathogen itself, these immune cells do also play an important role in shutting down 
inflammation and in initiating tissue recovery at sites of damage in later stages48–50. PMN are essential and highly 
skilled phagocytes that are equipped with various antifungal capabilities that can be fungicidal and/or fung-
istatic30,34,39. Our simulation results confirmed the importance of PMN, however, their recruitment and defensive 
function were most important in the limit of high infection-doses. Interestingly, impairment of PMN function 
in the scenarios with low infection-doses was compensated by an increased recruitment of these cells, however, 
this could consequently imply an increase in self-damage of tissue, e.g. by neutrophilic respiratory burst, which 
constitutes a threat for the host itself 51. Nevertheless, PMN recruitment was found to play an important factor 
across all possible infection-doses, because lack of PMN function was associated with increased probabilities for 
pathogen persistence, as could be expected from findings in previous experimental studies52. Even though beyond 
the scope of the current modelling approach, it is very well conceivable that PMN recruitment by AM-induced 
inflammation occurs more quickly in the limit of high infection-doses.
Systems biology relies on the cross-fertilisation between theory and experiment. While uncertain or even 
unknown biological parameters can only be determined in wet-lab experiments, theoretical approaches can 
direct this exploration by generating concrete hypotheses. Obviously, parameters in the payoff matrices of EGT 
relate to the abstract concept of reproductive fitness in terms of nutrient uptake and immune response and, 
therefore, may be difficult and/or impossible to be separately measured in experiment. However, our study 
suggests that quantitative insights about the metabolic activities of different A. fumigatus morphotypes would 
narrow down the range of relevant nutrient contributions in the model and by that render scanning of sev-
eral parameters obsolete. In turn, the model could be refined, extended and reviewed to focus investigations on 
particular aspects in the reduced parameter space with higher attention to details. Furthermore, guided by the 
outcome of our simulations, we suggest experimental investigations that may clarify the dependence between 
the infection-dose and the inflammatory signalling, e.g. by determining the cytokine profile secreted from AM 
and/or PMN. Similarly, A. fumigatus infection in mice with fully and/or partly impaired AM and/or PMN pop-
ulations could as well be systematically investigated as a function of the infection-dose to specify the model 
dynamics of infection-inflammation scenarios. These investigations could be performed using different micros-
copy techniques: light-sheet microscopy could reveal cellular distributions, i.e. of conidia, AM and PMN, in the 
lung, whereas multi-photon microscopy could even allow monitoring dynamical aspects of cells in the lung. 
Furthermore, processes like phagocytosis of fungal cells by AM and PMN as well as recruitment of PMN could 
be quantified using fluorescence-activated cell sorting (FACS) at different time points and as a function of the 
infection-dose. Spatial-temporal insights from imaging experiments will support realistic mathematical modeling 
within the image-based systems biology approach11.
The current version of the virtual infection-inflammation model captures the most relevant aspects of the 
innate immune response against A. fumigatus, but could be extended by other mechanisms, even including 
aspects of adaptive immunity, to more comprehensively resemble the full complexity of the infection process. For 
example, the first cells getting into physical contact with inhaled conidia are AEC of type I and type II, where type 
II cells were reported to internalise conidia and to generate inflammatory signals38. In this study, we intentionally 
omitted responses by AEC due to considerable gaps in our knowledge about type I AEC53 that, in fact, make up 
the alveolar surface almost entirely54. Dendritic cells were also shown to contribute to fungal clearance55 and a 
dysregulation in Th1/Th2 responses lead to invasive pulmonary aspergillosis despite a non-neutropenic status of 
the host56, thus, revealing substantial evidence for the importance of adaptive immune responses in A. fumigatus 
infection. In future work, extensions of the virtual model might include responses mediated by adaptive immu-
nity to study the relative contributions from innate and adaptive immune effectors and functions. This could be 
realised by a network of evolutionary games, where the immune response of the host is adapting regarding the 
activity against pathogenic attacks. The charming aspects of EGT lie, on the one hand, in the elegant reduction of 
model parameters to the ratios of parameters and, on the other hand, in the inherent extensibility that allows to 
realistically capture the characteristic features of complex host-pathogen interactions.
Methods
Modelling the dynamics of host-pathogen interactions by EGT on graphs. The game-theoreti-
cal description of the infection-inflammation scenario considered in this study is constructed as a consecutive 
sequence of three evolutionary games (see Fig. 1(b)). These games comprise the time course of the innate immune 
response and are played on graphs in order to perform in silico experiments of A. fumigatus infection using a 
pseudo-spatial representation of AS. Here, each fungal cell represents an infectious individual that interacts with 
other proximal fungal cells under the elevating inflammatory response of the host. In what follows, we present 
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a detailed description of the interaction graph construction, the distribution of different cell types in an AS, the 
design of the sequentially organised games and the evolutionary dynamics algorithm.
Environmental setting: alveolar sacs. Evolutionary dynamics take place in a typical AS. AS are organisa-
tional structures in the lower respiratory tract of the lung and are composed of 21 alveoli on average33,57. Alveoli in 
an AS are inter-connected via alveolar entrance rings and pores of Kohn53,58, whereas different AS are considered 
as fairly independent units. In order to reflect connectivity properties between alveoli in a cylindrically shaped 
AS, we represent them by densely packed spheres as shown in Fig. 1(a). A relationship between any two neigh-
bouring alveoli is assumed if their spheres touch each other.
Distribution of cells in alveolar sacs. Each alveolus represents a virtual site in which typical numbers of 
fungal and immune cells are placed. The number of fungal cells present in one AS emerges from a dose-dependent 
distribution over all AS upon inhalation or upon administration. The fungal dosis ranges from ndose = 6.3 · 103 
conidia (daily inhalation for humans) to ndose = 107 conidia (administration in experiments with mice). First, the 
number of fungal cells per AS, nfc, is drawn from the Binomial distribution:
= − −( )B n p n nn p p( , , ) (1 ) , (1)n n nfc/AS dose fc dosefc fc dose fc
where p = 1/nAS denotes the probability to choose the AS under consideration and the total number of AS is about 
nAS = 2.3 · 107 in humans33,57. Second, the number of fungal cells per AS, nfc, is uniformly distributed over the alve-
oli of the AS. Similarly, the number of resident AM (nAM) and recruited PMN (nPMN) follow the same distribution 
process over AS. In this case, ndose in Eq. 1 is replaced by the total number of 2.1 · 109 macrophages in humans, 
whereas for PMN this number can be up to eight times higher depending on the strength of PMN recruitment40.
Construction of the interaction graph. The interaction graph is based on the spatial proximity between 
A. fumigatus conidia in the AS. Interactions between the fungal cells of an AS are generated in a rule-based fash-
ion: Two fungal cells interact,
1. If they are located in the same alveolus or
2. If they are randomly selected from two neighbouring alveoli and do not yet have another inter-alveolar 
interaction.
These rules give rise to a proximity-based interaction graph between all fungal cells in the same alveolus or 
fungal cells that are nearby in neighbouring alveoli, e.g. reflecting intra-alveolar localisation close to one of the 
pores of Kohn or the alveolar entrance ring. An example for a fungal interaction graph is shown in Fig. 1(a).
Sequential design of host-pathogen games. Fungal cells are viewed as infectious agents that play 
against each other for survival under the inflammatory pressure of the immune system. The different morpho-
types that conidia of A. fumigatus can develop with time correspond to the strategies that the fungal cells may 
adopt in each game and are summarised in Table S1. We consider three different stages of innate immunity that 
are reflected by three distinct evolutionary games and that are played on the interaction graph of fungal individ-
uals as depicted in Fig. 1(b).
In each of the three games, beneficial effects like the consumption of nutrients as well as the pressure of the 
immune system are aggregated in an utility function per individual, which contains quantitative information 
about the reproductive fitness of the fungal cell. This utility function has the general structure
= +U (nutrients) (immune response) , (2)i i i
where i denotes the i-th fungal individual. Nutrients generally increase the reproductive fitness and their con-
tributions enter the expression with a positive sign, in contrast to payoffs associated with the immune response 
that have values below zero. The amount of nutrient uptake by fungal individuals depends on the strategy 
adopted by the cell, where ED, ER, ES and EH denote the nutrient contributions for fungal cells in the state “dead”, 
“resting”, “swollen” and “hyphal”, respectively. Since the reproductive fitness of hyphae is higher than for swol-
len conidia and swollen conidia outperform resting conidia, we set the relation between the nutrient contri-
butions to ED < ER ≤ ES ≤ EH with ED = 0 for dead cells. Reduction of reproductive fitness induced by immune 
responses either acts on single fungal individuals or on pairs of individuals that are interacting with each other in 
a game-specific context.
Game I–Complement system. The proteins of the complement system are always present in the alveolar lining 
layer (surfactant) and immediately surround each fungal cell starting from its entry into the AS. Opsonisation of 
conidia induces inflammation and phagocyte attraction to the site of infection. This is the predominant immune 
response in the first minutes. At this stage, conidia of A. fumigatus may either stay in the “resting” state or initiate 
radial growth and switch to the “swollen” state. This game is restricted to these two states, because, during the 
first hour after entry into the lower respiratory tract, conidia do not germinate. Opsonisation and chemoat-
traction are represented by morphotype-specific negative payoffs as a function of the complement responses cR 
and cS that are associated with resting and swollen conidia, respectively. These effects are taken into account for 
each fungal individual irrespective of alveolar localisation and interaction partners. Both, resting and swollen 
conidia, can not evade opsonisation by the complement, but swollen conidia do activate the complement system 
more intensively, implying that cS ≥ cR36. In addition, proximal fungal individuals interfere with each other due 
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to superimposed inflammatory and chemoattracting complement signals and by that induce further negative 
payoffs PI that depend on the number of interaction partners.
The utility function of fungal cell i in this game is described as
∑= − +
∈








where si ∈ {R, S} is the morphotypic strategy of fungal individual i, csi is the complement response associated with 
strategy si,  i are the interaction partners of fungal cell i and P s s( , )i i j
I  the payoffs as defined by the payoff matrix 
for Game I in Table 1. The utility function indicates that the more interaction partners a fungal individual has, the 
more it will be under pressure by complement activity.
Game II–Alveolar macrophages. The second game refers to the time scale of a few hours after entrance of conidia 
in the AS, which is the phase where germination of conidia becomes possible. In this phase, A. fumigatus conidia 
get into contact with professional phagocytes, i.e. AM being resident in alveoli. They are able to phagocytose 
conidia and have the potential to kill swollen conidia, while they fail to phagocyte fungal cells that filamented and 
have hyphae. The AM activity αAM measures the ability to phagocytose and kill the fungal cells. At this stage of the 
immune response, conidia are enabled to adopt the four strategies “resting”, “swollen”, “hyphal” and “dead”, where 
the latter strategy is preferred in the case of a strong immune response that is not compensated by a nutrient con-
tribution (ED = 0). The number of AM present in an alveolus is drawn from a Binomial distribution, as was done 
previously in our agent-based virtual A. fumigatus infection models16,17 and as described before.
In this game, pairs of fungal cells are interacting under the pressure of the immune response mediated by AM. 
Each fungal cell of a pair aims to adopt a strategy that improves its reproductive fitness, at the risk of increasing 
the pressure by the immune system for both fungal cells. Fungal cells with no interaction partner receive the full 
immune exertion by AM, as if they would interact with a dead fungal cell. Thus, in the simulation algorithm a 
solitary fungal cell was virtually connected with a fungal cell in the state “dead”.
AM respond with morphotype-specific activities, including phagocytosis, killing, inflammation and recruit-
ment, which are summarised in the immune responses mR, mS, mH against resting, swollen and hyphal fungal 
cells, respectively. Dead fungal cells receive a zero payoff from immune activities by AM (AM response mD = 0). 
The response of AM against swollen conidia mS is set to be strongest, followed by resting conidia mR and the 
hyphal morphotype mH, i.e., the relation between the AM responses is given by mD < mH ≤ mR ≤ mS, which is in 
line with experimental observations39.
The utility function of fungal cell i is defined as follows:
P s s( , )G1 1 2
s2
R S H D
Game I
s1
R − cR/2 − cS/2 – –
S − cR/2 − cS/2 – –
H – – – –
D – – – –
Game II
s1
































− 1/2 × mH − mH
D 0 0 0 0
Game III
s1
































− 1/2 × gH − gH
D 0 0 0 0
Table 1.  Payoff matrices for Game I, II and III. Payoffs P s s( , )1
I
1 2 , P s s( , )1
II
1 2  and P s s( , )1
III
1 2  of Game I, Game II 
and Game III are shown for fungus 1 interacting with fungus 2. R, S, H and D denote resting, swollen, hyphal 
and dead fungal cells, respectively. The complement response for resting and swollen fungal cells in the Game I 
are represented by cR and cS, respectively. mH, mR, mS and gR, gS, gH are the responses by AM or PMN on 
encounter of resting condia, swollen conidia or hyphae. The complement responses satisfy the condition cR ≤ cS 
as well as the AM responses mH ≤ mR ≤ mS and the PMN responses gR ≤ gS ≤ gH, which determine the payoffs.
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AMR N  denotes the set of interactors for which the fungal pair (i, j) with ∈j i
AM  is randomly selected 
for AM–A. fumigatus interaction. The payoffs related to the AM immune response, P s s( , )i i j
II , are defined in the 
payoff matrix shown in Table 1.
Game III–Polymorphonuclear neutrophils. AM have important immune regulatory functions for the recruit-
ment of cells from the bloodstream. For example, once recruited to the site of infection, PMN have an armory 
of weapons to attack pathogens. They can kill the fungus intracellularly after successful phagocytosis or extra-
cellularly by the secretion of reactive oxygen species. Furthermore, they can undergo NETosis by committing an 
altruistic suicide in which they release their DNA and by that trap the fungus to prevent it from further spreading. 
After the recruitment of PMN to lung alveoli, these phagocytes govern the immune response and their overall 
activity is measured by the parameter αPMN.
We introduce the parameter ρPMN to control the relative number of recruited PMN to the site of infection, 
where we impose – in agreement with observations in wet-lab experiments40 – an upper PMN recruitment limit 
of eight times the number of present AM. As in Game II, pairs of conidia interact with PMN in a randomised 
fashion and can adopt the four strategies “resting”, “swollen”, “hyphal” and “dead” in this game. However, in 
contrast to Game II, the various defence mechanisms of PMN give rise to different relations in their specific 
responses. The relations between the PMN responses gR, gS and gH against fungal cells in the resting, swollen and 














PMN defines the interaction pairs (i, j), which randomly interact with a PMN. P s s( , )i i j
III  is the payoff 
imposed by interaction with a PMN as defined in Table 1.
The three games are linked in sequential order – Game I → Game II → Game III – to investigate the counter-
play of A. fumigatus infection and host inflammation. Game linking is associated with the inflammatory signal-
ling in response to the infectious agent, initiating the next higher instance along the cascade of the innate immune 
response. To this end, we introduce measures that enable quantifying the degree of infection and inflammation.
Quantification of infection and inflammation for game linking. To quantify the degree of infection 
induced by the human-pathogenic fungus A. fumigatus we define the infection score (IS) that is computed after 















Here nfc denotes the number of fungal cells in the AS and fR, fS, fH and fD with fR + fS + fH + fD = 1 refer to the 
fractions of fungal cells in the resting, swollen, hyphal and dead state, respectively. By construction, the infection 
score assumes increasing values ISG = nfc/4, ISG = nfc/2 and ISG = nfc for populations consisting of increasingly 
challenging morphotypes fR = 1, fS = 1 and fH = 1, respectively. Furthermore, particular infection scores ISG cor-
respond to specific numbers of persisting fungal cells, irrespective of the infection-dose. For example, ISG = 0.5 
either corresponds to one fungal cell in the swollen state or to two conidia in the resting state, whereas ISG = 0.25 
represents one remaining fungal cell that is in the resting state. This threshold, ISG = 0.25, is set in the further 
analysis to distinguish between persistent (ISG ≥ 0.25) and cleared (ISG < 0.25) infections.
Game linking is associated with the inflammatory signalling in response to the infectious agent. In particular, 
we link the complement system (Game I) with AM response (Game II) by the normalised inflammation (NI) 






















Based on literature data36, this measure accounts for the relative difference in the complement response against 
the fractions of resting (fR) and swollen (fS) conidia. Furthermore, NII→II accounts for relative differences in the 
complement response against resting and swollen conidia by the scaling factor cR/cS. The normalised infection 
value NII→II regulates the response of AM in Game II by scaling the AM activity αAM: α α= ×→ NIAM I II AM. 
Similarly, we link Game II to Game III by modelling PMN recruitment to depend on AM-secretion of the 
PMN-chemoattractant MIP-1. The secretion of MIP-1 is known to depend on the different A. fumigatus morpho-
types40. Thus, we consider the relative recruitment number ρPMN = NIII→III, with the normalised inflammation:





[0, 1], (8)II III H S R
where the coefficients conserve the relative responses of AM to MIP-1 for the different A. fumigatus morphotypes, 
as deduced from Ref. 40. Note that, in case the A. fumigatus infection can be cleared by AM, i.e. all fungal cells 
are dead fD = 1 and fR = fS = fH = 0 after Game II was played, no PMN-chemoattractant would be secreted and no 
PMN would be recruited.
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Evolutionary dynamics. In each game, iterations over repetitive evolutionary steps tevo are performed as 
depicted in Fig. S1. To ensure equilibration of the evolutionary dynamics, we set the number of iterations to 104. 
In each iteration step fungal cells receive nutrients and are confronted with the respective immune response. 
Each individual fungal cell evaluates its utility function in every time step tevo containing the information on its 
reproductive fitness. Mutation and adaptation are evolutionary mechanisms performed in response to differences 
in the utility functions of individuals in the following way.
Mutation. Random change between strategies with probability p = 0.01.
Adaptation. Probabilistic change of an individual’s current strategy si into a strategy s′ applied by at least one 
fungal individual in the neighbourhood with higher reproductive fitness. Proportional imitation is applied as 
microscopic update rule and a distinction is drawn between the strategy “dead” (sdead) and strategies related to 
individuals that are alive:
Case s′ ≠ sdead: if strategy s′ is played in the neighbourhood  i of individual i, it adopts strategy s′ with 
probability:




















where ′s( )  is the set of all individuals playing strategy s′ and λ a normalisation factor to ensure p(si →  s′ ) ∈ [0, 1].
Case s′ = sdead:
λ




Statistical measures. In order to distinguish parameters of the games by their relevance for the outcome of 
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( ) ( ) (11)x X y Y
2
Here, X is the set of values related to one unknown parameter and Y the corresponding set of infection scores 
ISG of game G. Furthermore, p(x, y) denotes the joint probability function, p(x) and p(y) are marginal probability 
distributions of X and Y, respectively59. Since ISG is a continuous measure, Y is discretised using different bin 
sizes for the calculation of MI(X, Y). We checked that the dependence of the mutual information MI(X, Y) on the 
binning of the infection score ISG does not affect the ranking of the most important parameters. These are the AM 
activity αAM in Game II (see Table S2 and Fig. S2 (a)) and both PMN activity αPMN and PMN recruitment ρPMN in 
Game III (see Table S2 and Fig. S2 (b)).
Implementation and Simulation. All parameters used in the evolutionary games are scanned in reason-
able ranges to capture their influence on the outcome of each game and the ultimate outcome of the infection. 
The evolutionary game-theoretical algorithm is implemented in the object-oriented programming language C+ + 
and simulations are performed by the simulation algorithm depicted in Fig. S1. Statistical analyses are carried out 
using R. To reduce effective runtime, the algorithm is parallelised and is executed on a SUSE Linux Enterprise 
Server version 11 based on a x86-64 architecture with 512 GB RAM and 48 AMD Opteron processors, each run-
ning on 1781 MHz.
Virtual infection-inflammation scenarios were performed for different fungal doses and varied parameter 
configurations. To account for the stochastic nature of the in silico experiments, 100 repetitions were executed and 
from each simulation long-term density distributions of resting and swollen conidial fractions with their related 
averages and standard deviations were extracted.
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Table S1: Game-dependent morphotype options of A. fumigatus.
A. fumigatus strategy/morphotype
permitted morphotype (yes/no) resting (R) swollen (S) hyphal (H) dead (D)
Game I: complement system yes yes no no
Game II: AM yes yes yes yes
Game III: PMN yes yes yes yes
Possible strategies for fungal cells in the three different games. In Game I only resting and swollen
conidia occur, while in Game II and Game III all four strategies are possible.
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Figure S1: Simulation algorithm of each evolutionary game. Schematic overview of the simula-
tion algorithm as applied for each evolutionary games on the fungal interaction graphs in alveolar sacs.
Iterations over evolutionary steps tevo include the computation of payoffs per fungus and microscopic
strategy updates based on the concepts of mutation and adaptation. The number of fungal cells for
which simulations are performed in the alveolar sac is denoted by nfc.
2
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Figure S2: Dependence of mutual information on the bin size. Mutual information for the
parameters of (a) Game II and (b) Game III as a function of the bin size of the infection score.
Table S2: Mutual information between infection score and parameters of Game II and
Game III.
parameter condition MI (Game II) MI (Game III)
eS = ES/ER eS ≥ 1 0.3679 0.0434
eH = EH/ES eH ≥ 1 0.3463 0.0338
αAM = mR/ER 1.1439 –
µR = mR/mH µR ≥ 1 0.3220 –
µS = mS/mR µS ≥ 1 0.3324 –
αPMN = gR/ER – 0.4847
ρPMN ρPMN ∈ [0, 1] – 0.5708
γS = gS/gR γS ≥ 1 – 0.0632
γH = gH/gS γH ≥ 1 – 0.2161
The mutual information (MI) as a function of the infection score (IS) was computed for bin size 0.01
and for each of the games parameters. ER, ES, EH describe the nutrient contributions for resting,
swollen and hyphal fungal cells, respectively. µR, µS and γR, γS are fractions of response variables for
the encounter of resting and swollen conidia and hyphae by either AM or PMN. Bold numbers denote
the most relevant parameters of the respective evolutionary game, which are the AM activity αAM in
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Bloodstream infections by the human-pathogenic fungi Candida albicans and Candida 
glabrata increasingly occur in hospitalized patients and are associated with high mor-
tality rates. The early immune response against these fungi in human blood comprises 
a concerted action of humoral and cellular components of the innate immune system. 
Upon entering the blood, the majority of fungal cells will be eliminated by innate immune 
cells, i.e., neutrophils and monocytes. However, recent studies identified a population 
of fungal cells that can evade the immune response and thereby may disseminate and 
cause organ dissemination, which is frequently observed during candidemia. In this 
study, we investigate the so far unresolved mechanism of fungal immune evasion in 
human whole blood by testing hypotheses with the help of mathematical modeling. 
We use a previously established state-based virtual infection model for whole-blood 
infection with C. albicans to quantify the immune response and identified the fungal 
immune-evasion mechanism. While this process was assumed to be spontaneous in the 
previous model, we now hypothesize that the immune-evasion process is mediated by 
host factors and incorporate such a mechanism in the model. In particular, we propose, 
based on previous studies that the fungal immune-evasion mechanism could possibly 
arise through modification of the fungal surface by as of yet unknown proteins that are 
assumed to be secreted by activated neutrophils. To validate or reject any of the immune- 
evasion mechanisms, we compared the simulation of both immune-evasion models 
for different infection scenarios, i.e., infection of whole blood with either C. albicans or 
C. glabrata under non-neutropenic and neutropenic conditions. We found that under non- 
neutropenic conditions, both immune-evasion models fit the experimental data from 
whole-blood infection with C. albicans and C. glabrata. However, differences between the 
immune-evasion models could be observed for the infection outcome under neutropenic 
conditions with respect to the distribution of fungal cells across the immune cells. Based 
on these predictions, we suggested specific experimental studies that might allow for the 
validation or rejection of the proposed immune-evasion mechanism.
Keywords: Candida albicans, Candida glabrata, immune evasion, state-based model, innate immune response, 
polymorphonuclear neutrophils, whole-blood infection assay
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Figure 1 | Schematic depiction of two immune-evasion mechanisms. PMN 
(purple) with granula and fungal cells are either alive (green), killed (red), or 
immune evasive (gray). (a) Illustration of spontaneously evading fungal cells. 
(B) Illustration of the PMN-mediated immune-evasion mechanism, which is 
associated with degranulation on first-time phagocytosis of fungal cells by 
PMN. Degranulation is assumed to mediate the release of proteins into 
extracellular space that enables fungal cells to evade subsequent killing and 
phagocytosis by modification of their surface.
2
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inTrODucTiOn
Even though pathogenic microbes constantly colonize the 
human skin or are inhaled, the human immune system is usually 
able to protect the body against infections. Thus, immunocom-
promised individuals have an increased risk for infections by 
opportunistic pathogens (1). In case of injuries or disturbed 
cellular integrity, the pathogens can easily overcome physical 
skin barriers and/or mucosal surfaces, and enter the host tissue 
or the blood stream (2, 3). Innate immune responses defend 
the host against microbial invaders (4–6), however, the exact 
interplay between pathogens and the immune defense is in 
many cases not fully resolved (7, 8). In order to investigate such 
unknown mechanisms, mathematical modeling is an appropri-
ate approach to investigate complex biological systems at a 
quantitative level. Furthermore, mathematical models allow for 
hypothesis testing by varying single parameters or comparing 
various possible scenarios. This approach allows going beyond 
experimental limitations, for example, by quantifying biologi-
cal processes that are not amenable to a direct measurement in 
experiment. Moreover, ethical concerns and financial efforts of 
experimental studies can be considerably reduced by computer 
simulations, because systematic variations of model parameters 
allow narrowing down the number and kind of further experi-
mental investigations necessary to identify causal relationships 
responsible for experimentally observed effects (9). The iterative 
cycle of such a systems biology approach combines wet-lab and 
dry-lab experiments to their best advantage (10, 11).
In previous studies, we have applied a systems biology 
approach to investigate the complex interaction of the human-
pathogenic fungus, Candida albicans with innate immune cells 
in human whole blood (12, 13). Interestingly, we observed that 
a relatively high proportion of C. albicans can survive in human 
blood and evades the immune response by a so far unknown 
mechanism. The experimental part of this study comprised 
human whole-blood infection assays, where blood samples 
from healthy donors were infected with fungal cells to acquire 
time-resolved data on the interaction of C. albicans with immune 
cells as well as fungal survival over the course of infection. Based 
on these experimental results, a bio-mathematical model was 
developed using a state-based modeling approach (12, 13). The 
model is composed of states that represent different C. albicans 
cell populations of the biological system. These include alive and 
killed C. albicans cells, which are either in extracellular space 
or phagocytosed by the immune cells, i.e., PMN or monocytes. 
Moreover, the model represents a population of fungal cells 
that can evade the immune defense, since these cells appear to 
be neither phagocytosed by immune cells nor killed extracel-
lularly. Transitions between various states of cell populations 
can occur and these state changes represent biological processes 
like phagocytosis and killing. In the original state-based model 
(SBM), transition rates were defined to characterize the different 
transitions between the states, which represent the biological 
processes. The a priori unknown values for these transition rates 
were evaluated by applying the global parameter estimation 
algorithm Simulated Annealing that is based on the Metropolis 
Monte Carlo scheme (12, 13). This algorithm explores the space 
of transition rates and searches for the global minimum of 
the fitting error, i.e., the deviation between the simulated and 
experimentally measured kinetics, and by that yields values for 
the transition rates that together achieve optimal agreement 
between these kinetics. The resulting rates indicated that the 
larger number of C. albicans cells inside PMN, in comparison 
to the much smaller number of fungal cells inside monocytes, 
is not merely a consequence of the higher number of PMN 
than monocytes, but is also due to a larger phagocytosis rate of 
PMN compared to monocytes. This quantification, which is not 
directly accessible from the experimental data alone, allowed 
us to generally conclude that elimination of C. albicans cells in 
human blood is governed by PMN.
In the SBM, fungal cells that evaded the immune response 
were assumed to undergo a spontaneous process with a constant 
transition rate and we will refer to it as spon-IE model from 
now on (see Figure 1A). While the exact mechanism causing 
immune evasion of C. albicans in human blood has not been 
identified yet, our previous studies already allowed for the 
rejection of various hypotheses. In the work by Hünniger et al. 
(12) it has been shown that the non-filamentous efg1Δ, cph1Δ 
mutant of C. albicans, and even thimerosal-killed C. albicans 
yeast cells are both able to evade the immune response. These 
observations imply that the fungal cells do not play an active 
role in the acquisition of immune-evasive properties. Therefore, 
we addressed aspects of the host. However, we found that the 
addition of fresh blood of the same donor to an infected blood 
sample after 2 h did not result in higher elimination of fungal 
cells, implying that the hypothesis of early PMN exhaustion in 
the infection assay could be rejected. Additionally, we observed 
that during the 4  h of whole-blood infection the number of 
immune cells remained fairly constant. Thus, acquisition of 
immune evasion by fungal cells inside the phagocytes, which 
might then be followed by the destruction of phagocytic immune 
cells, appears to be unlikely. This lytic escape mechanism, which 
has been observed for macrophages (14), has not been reported 
for human PMN in C. albicans infection.
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In this study, we investigate the unresolved mechanism of 
immune evasion by pathogens in human whole blood. This 
is realized by making predictions based on mathematical 
modeling of the infection kinetics and by comparing various 
infection scenarios that may be tested in experiment. Based on 
our previously developed state-based virtual infection model 
(12, 13), we hypothesize that the immune-evasion process is 
mediated by host factors and incorporate such a mechanism 
in the model. Our hypothesis is motivated by the experimental 
observation that even thimerosal-killed C. albicans cells can 
acquire immune-evasive properties. Thus, pathogen immune 
evasion may be actively driven by the host. Although PMN are 
the main actors in the defense against C. albicans, immune cells 
also have been shown to cause remodeling of the C. albicans cell 
wall (15). However, while it is known that PMN degranulation 
is associated with the release of antimicrobial effector proteins 
that can kill C. albicans cells in extracellular space (16, 17), the 
consequences of the cell wall remodeling is yet not clear, e.g., 
whether or not it enables the immune evasion by the pathogen. 
We here consider the possibility that PMN degranulation is 
associated with the secretion of effector molecules that may 
cause immune evasion. We investigate the possibility that these 
PMN-derived molecules may change the pathogen surface 
and thereby render the pathogen undetectable for immune 
cells (see Figure 1B). We will refer to the model that assumes 
a PMN-mediated evasion mechanism as PMNmed-IE model in 
the following.
The PMNmed-IE model will be compared with the spon-IE 
model by simulating the immune response to pathogens in 
healthy individuals as well as in virtual patients with neutro-
penia. Furthermore, we also extend this analysis to the fungus 
C. glabrata, which attributes to the rise of microbial infection in 
the clinics, especially in elderly individuals and immunocom-
promised patients (18). The two fungal pathogens are part of 
the normal microbial flora of the majority of people and remain 
in a commensal state under healthy conditions (19). C. albicans 
and C. glabrata, respectively, rank first and second in isola-
tion frequency in humans (20) and in immunocompromised 
patients can switch into a pathogenic state, overcome physical 
barriers, enter the bloodstream, and disseminate throughout 
the body (4, 7). In blood, the microorganisms are attacked and 
cleared by the innate immune response. However, we find that 
both pathogens—albeit to a different quantitative extent—have 
the ability to evade the immune response. This emphasizes 
once more the importance of investigating immune-evasion 
mechanisms by mathematical modeling in order to generate 
testable hypothesis that may be checked in experiment and 
ultimately enable medical intervention that cuts the pathogen 




This study was conducted according to the principles expressed 
in the Declaration of Helsinki. All protocols were approved by 
the Ethics Committee of the University Hospital Jena (permit 
number: 273-12/09). Written informed consent was obtained 
from all blood donors.
Fungal strains and culture
The GFP expressing C. albicans strain was constructed as 
described in Hünniger et al. (12) and grown in liquid yeast extract-
peptone-dextrose (YPD) medium at 30°C. The GFP expressing 
C. glabrata strain (21) was incubated at 37°C in YPD medium. 
After overnight culture both strains were reseeded in fresh YPD 
medium followed by growing at 30 and 37°C, respectively, until 
they reached the mid-log-phase. Finally, the fungal cells were 
washed and harvested in HBSS until use.
human Whole Blood infection assay
Human peripheral blood samples from healthy individuals 
were infected with either C. albicans or C. glabrata. The assay 
was performed as described previously (12). In short, 1⋅106 
Candida cells were added per ml of anti-coagulated blood and 
incubated at 37°C with gentle rotation for indicated time points. 
Subsequent to the confrontation, samples were maintained at 
4°C and further analyzed by flow cytometry. Flow cytometry 
gating strategy was performed as previously described using 
FlowJo 7.6.4 software to investigate the distribution of fungal 
cells in human blood (12). Survival of fungal cells was determined 
in a plating assay by analysis of recovered colony forming units 
after plating appropriate dilutions of all time points on YPD agar 
plates.
sBM of Whole-Blood infection
Recently, we established a virtual infection model to simulate 
the immune response against the fungal pathogen C. albicans in 
human whole blood (12, 13). This enabled us to quantify innate 
effector mechanisms as well as C. albicans immune evasion 
based on experimental data as obtained by FACS analysis and 
survival assays during a time course of 4  h. The time-resolved 
data comprised C. albicans viability as well as its association to 
innate immune cells, i.e., monocytes and PMN. In the SBM, 
immune cells and fungal cells can populate specific states. We 
identified five combined units of these states that could be directly 
compared with the experimentally measured cell populations. 
The combined unit PE involves all extracellular pathogens and is 
given by
 P P P PE AE KE AIE KIE≡ ++ + P  (1)
Here, the states PAE and PKE represent extracellular cells 
that are alive and killed, respectively. The states PAIE and PKIE 
describe pathogens that are either alive and evade the immune 
response or kill and evade the immune response. Note that 
alive extracellular cells do not comprise alive immune- 
evasive cells and that these combined units are excluding each 
other.
Pathogens PAE and PKE can be phagocytozed by immune cells 
and in the SBM we account for phagocytosis by monocytes 
(M) and PMN (N), where the latter may also be referred to as 
102 Chapter 7: Pathogen immune evasion in human whole-blood
4Prauße et al. Predictive Modeling of Fungal Immune Evasion
Frontiers in Immunology | www.frontiersin.org March 2018 | Volume 9 | Article 560
neutrophils and are, therefore, labeled with N. An intracellular 
pathogen is either phagocytosed by a PMN
 P i j NN i jji≡ ,( )≥ +∑∑ ≥ ,00  (2)
or by a monocyte
 P i j MM i jji≡ .( )+≥≥ ∑∑ ,00  (3)
Here, the indices i and j refer to the immune cell state that is 
defined by the number of internalized alive and killed pathogens, 
respectively. The combined unit of killed pathogens is given by
 P P P M N jK KE KIE i j i jji≡ ( ) ,+ + +≥≥ ∑∑ , ,00  (4)
whereas the combined unit of alive pathogens is defined by
 P P P M N iA AE AIE i j i jji≡ + + +≥≥ ∑∑ ( ) ., ,00  (5)
Note that the total number of pathogens is given by 
P ≡ PE+PN+PM+PKIE or P ≡ PK+PA.
The states are connected by transitions that indicate possible 
state changes and thereby enable to simulate the dynamics of 
the model (see Figure S1 in Supplementary Material). Transition 
rates characterize these state changes and are defined as the 
probability of a transition per simulation time step Δt. The SBM 
by Hünniger et  al. (12) and Lehnert et  al. (13) distinguished a 
rate for first and subsequent phagocytosis events by PMN, 
since it was assumed that a phagocytosis event activates the 
PMN and leads to a higher phagocytosis rate. Since this fact is 
not experimentally validated for whole-blood infection with 
C. glabrata, we here implement a single phagocytosis rate of PMN 
that accounts for both, first and subsequent phagocytosis events. 
Therefore, the SBM of whole-blood infection comprises seven 
different transition rates that are given by the phagocytosis rate 
ϕM of monocytes, the phagocytosis rate ϕN of PMN, the intracel-
lular killing rates κM and κN of both monocytes and PMN, the 
transition rates γ and κEK, which define the extracellular killing, 
and the spontaneous immune-evasion rate ρ (see Table S1 in 
Supplementary Material). As already noted in our previous study 
(12), occasional filamentation of fungal cells but no budding 
could be observed in samples of blood smears. Therefore, prolif-
eration of fungal cells is not included in the SBM. An overview 
of the SBM simulation algorithm is briefly described in Section 
S1 in Supplementary Material and schematically illustrated in 
Figure S1 in Supplementary Material. For a detailed description 
of the SBM, including the definition of rates for state transitions 
and their estimation by the Simulated Annealing algorithm that 
is based on the Metropolis Monte Carlo scheme (22, 23), we refer 
to our previous studies by Hünniger et al. (12) and Lehnert et al. 
(13). Here, we briefly mention that the values of the transition 
rates in the virtual infection model were estimated such that 
deviations from the kinetics of the combined units as obtained 
from the experiments are minimized. A brief overview of the 
parameter estimation algorithm is given in Section S2 and Figure 
S2 in Supplementary Material.
Our object-oriented framework combining the SBM simu-
lation algorithm and the parameter estimation is implemented 
in the programming language C++ and available for down load 
from https://asbdata.hki-jena.de/publidata/PrausseEtAl2018_ 
FrontImmunol/.
Modeling of immune evasion by 
Pathogens
As was observed in our previous analysis for C. albicans, patho-
gens can evade the immune response in the states alive (PAIE) 
or killed (PKIE), i.e., these cells can neither be phagocytosed nor 
killed by PMN and monocytes, and their total number is denoted 
by PIE ≡ PKIE + PAIE (12). Note that immune evasion of C. albicans 
in human whole blood was first predicted by our state-based vir-
tual infection model and then also verified experimentally. Since 
the mechanisms of the immune evasion could not be identified 
yet, this process was assumed to occur spontaneously with time-
independent transition rate
 ρ = constant (6)
and we refer to this model as spon-IE model. In this study, spon-
taneous immune evasion of pathogens (see Figure 1A) was com-
pared to an immune-evasion mechanism, which was assumed 
to be mediated by PMN. Since PMN secrete antimicrobial 
peptides upon initial phagocytosis of pathogens, we speculated 
that these pathogens may also secrete proteins that can mediate 
the immune evasion (see Figure 1B), e.g., inducing alterations 
of pathogens by modulating its molecular surface. We accounted 
for this mechanism in the SBM by replacing the constant tran-
sition rate of the spon-IE model with the time-dependent rate
 
ρ ρ γ( = ) =
( )
















in the PMNmed-IE model. In close analogy to the rate of extracel-
lular killing of pathogens by antimicrobial peptide-release from 
PMN (1), Eq. 7 represents the rate of pathogen immune evasion 
at time t as mediated by the sum of PMN-released proteins upon 
first phagocytosis events (NNP) up to time point t. Note that the 
simulation algorithm performs n simulation steps with step size 
Δt to calculate the system dynamics at time point t = nΔt. The 
impact of secreted molecules is determined by the parameters 
ρ and γR, where the latter describes the half-life associated with 
the molecular degradation, such that the molecules’ immune-
evasive effect is exponentially decreasing after their release at 
time tʹ  =  mΔt. Therefore, the PMNmed-IE model comprises 
eight parameters, i.e., one more rate than the spon-IE model for 
spontaneous immune-evasion processes.
simulation of Virtual Patients With 
neutropenia
In order to study the difference between the two models, spon-IE 
and PMNmed-IE, we simulated infection scenarios in human 
whole blood under neutropenic conditions. More specifically, vir-
tual patients were considered with gradually decreasing amounts 
of PMN within the range of medically established severity levels of 
neutropenia (24) (see Table 1) and the impact of these conditions 
was compared with regards to the two mechanisms of immune 
evasion. The simulation algorithm described in Lehnert et  al. 
(13) was applied to human whole-blood samples of 1 ml contain-
ing 5  ⋅105 monocytes and 1  ⋅106 pathogens. For each infection 
103
TaBle 1 | Number of PMN per ml blood for different severity levels of 
neutropenia.
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scenario, we performed 50 simulations with transition rate values 
that were randomly sampled within their respective SD.
resulTs
Whole-Blood infection show Pathogen-
specific immune response Kinetics
Whole-blood infection assays were performed for the two fungal 
pathogens, C. albicans and C. glabrata. At specific time points, 
whole-blood samples were analyzed using flow cytometry and 
survival assays to acquire time-resolved data for the association 
between pathogens and immune cells as well as viability of the 
pathogens. Figures  2A,B,D,E depict these experimental data 
(dashed lines) for C. albicans and C. glabrata, respectively.
Comparing the two pathogens, the fraction of extracellular 
fungal cells at 4  h post infection was highest for C. albicans 
with 15  ±  5.8%and lowest for C. glabrata with 8.9  ±  7.5%, 
where the sub-populations of alive and killed cells are com-
parable in size (see Figures  2A,B,D,E). In the case of an 
infection with C. albicans, a fraction of 6.5 ±  4.2% cells still 
remained alive at 4 h post infection, whereas survival assays 
revealed that 1.3 ± 1.5% of C. glabrata cells were not killed at 
that time point. Interestingly, the association of fungal cells to 
monocytes was markedly higher for C. glabrata with a frac-
tion of 10.1 ± 2.7% compared to C. albicans with a fraction of 
2.7  ±  1.9%. Furthermore, C. albicans showed only a slightly 
higher association of 82.3  ±  7.0% to PMN than C. glabrata 
(81.0  ±  8.1%), as was previously observed by Duggan et  al. 
(25). Nevertheless, for both pathogens, the fraction of asso-
ciation to PMN was dominant over association to monocytes, 
i.e., by a factor eight for C. glabrata and by a factor 30 for 
C. albicans. Furthermore, Hopke et al. showed that degranula-
tion of PMN has an impact on cell wall modulation in fungi, 
but whether this could enable pathogenic immune evasion is 
still unclear (15). These findings motivated our decision to 
focus on a PMN-mediated immune-evasion mechanism in 
comparison to spontaneous immune evasion.
spontaneous and PMn-Mediated  
immune evasion in agreement  
With experimental Data
We investigated the possibility that PMN secrete upon initial 
phagocytosis of pathogen proteins that can mediate immune 
evasion, e.g., inducing alterations of the surface of pathogens 
(15) (see Figure 1B). This mechanism was studied by applying 
mathematical modeling for hypothesis testing, i.e., we compared 
the impact of spontaneous versus PMN-mediated immune 
evasion on the infection outcome. To this end, we modified a 
previously implemented state-based virtual infection model 
(12, 13) to realize the PMN-mediated evasion mechanism. We 
refer to this model as PMNmed-IE model to distinguish it from 
the previously modeled spontaneous immune evasion, which we 
refer to as spon-IE model.
The transition rate values of the SBM were determined by 
the global parameter estimation algorithm Simulated Annealing 
based on Metropolis Monte Carlo scheme. This algorithm aims 
at searching for the optimal agreement between the simulated 
kinetics and the experimental data obtained from the whole-
blood infection assays. The resulting transition rate values of 
both models are given in the Tables S2 and S3 in Supplementary 
Material and the corresponding simulated kinetics are depicted 
in Figure  2. Here, the experimental kinetics correspond to 
the combined units introduced in the Section “Materials and 
Methods” plotted in Figure 2. The excellent agreement between 
experiment and simulation can be seen for the whole-blood 
infection assays with either C. albicans (see Figures  2A,B) or 
C. glabrata (see Figures 2D,E) with their transition rate values 
in Figures 2C,F.
For C. albicans infection, the comparison between the spon-
IE model and the PMNmed-IE model revealed comparable 
values for most transition rates, such as ϕN, ϕM, κN, and κEK (see 
Figure  2C; Table S2 in Supplementary Material). The largest 
differences were observed for intracellular killing in monocytes 
κ κM MPMNmed IE spon IE− − = .1 66( ) and the decrease of the antimicrobial 
effect γPMNmed IE spon IE− −γ =( )1 26. . However, the whole-blood 
infection assay does not allow to directly measure differences in 
these values in order to distinguish between the two immune-
evasion models. Similarly, quantitative differences could also 
be observed for the kinetics of extracellular killing due to anti-
microbial peptides (see Figure 3A) as well as for the kinetics of 
immune evasion (see Figure 3B). However, these readouts of the 
simulations either yield only small quantitative differences (time-
dependent killing by antimicrobial peptides) or are, despite the 
qualitatively different time course, again not directly accessible in 
experiment (time-dependent immune-evasion rate). Thus, while 
it is possible to reconcile both models with the experimental 
data, differences in directly measurable quantities could not be 
identified (see Figures S3 and S4 in Supplementary Material for 
C. albicans).
While the experimental kinetics for C. glabrata infection were 
also found to be in excellent agreement with both the spon-IE and 
the PMNmed-IE models (see Figures 2D,E), differences between 
the estimated transition rate values were relatively large with up 
to 23% (see Figure 2F; Table S3 in Supplementary Material). The 
time-dependent extracellular killing due to antimicrobial factors 
was found to be strongly different between the two models, i.e., 
the peak values were six times higher for spon-IE model than 
PMNmed-IE model (see Figure  3A) and also the kinetics of 
immune-evasion were indicative for a larger effect in the spon-
IE model than the PMNmed-IE model (see Figure  3B). The 
amount of fungal cells that became immune-evasive increased 
until 45 min post infection and then leveled off at the predicted 
104 Chapter 7: Pathogen immune evasion in human whole-blood
Figure 2 | Kinetics of combined units and corresponding transition rate values of the spon-IE model and the PMNmed-IE model. Experimental data from 
whole-blood infection assays (dashed lines) with corresponding SDs are compared to the simulated data (solid lines) by the spon-IE model (left column) and the 
PMNmed-IE model (middle column). The thickness of solid lines indicates the mean ± SD of 50 simulations with transition rate values that were randomly sampled 
within their corresponding SD. Mean values (data points) and SDs (error bars) of transition rates (right column) were quantified by the global parameter estimation 
algorithm Simulated Annealing based on Metropolis Monte Carlo scheme for the spon-IE model (black data points) and PMNmed-IE model (gray data points). The 
transition rates are given by the phagocytosis rate ϕ N of PMN and the phagocytosis rate ϕM of monocytes, the intracellular killing rates κM and κN of both monocytes 
and PMN, the transition rates γ and κEK which define the extracellular killing, and the spontaneous immune-evasion rate ρ and the PMN-mediated immune-evasion 
rates ρ  and γR, respectively. The time-course of the relative number of killed pathogens (PK), which are indicated by red dashed lines, were experimentally measured 
by survival assays. The relative number of fungal cells that were associated with monocytes (PM), PMN (PN), or in extracellular space (PE) were measured by 
association assays and indicated by orange, blue, or green dashed lines, respectively. The experimental results were compared with the corresponding combined 
units calculated for the simulated data. Black solid lines refer to the simulated time-course of immune-evasive fungal cells (PIE). Kinetics of a Candida albicans 
infection simulated by (a) the spon-IE model and (B) the PMNmed-IE model. (c) Transition rates quantified by both models for a C. albicans infection. Kinetics  
of a Candida glabrata infection simulated by (D) the spon-IE model and (e) the PMNmed-IE model. (F) Transition rates quantified by both models for a C. glabrata 
infection.
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value 7.47 ± 0.58% in the spon-IE model and 4.09 ± 1.0% in the 
PMNmed-IE model.
The comparison of whole-blood infections with the two 
pathogens revealed the estimated phagocytosis rate values ϕN and 
ϕM to be in both immune-evasion models lower for C. albicans 
than the phagocytosis rates of C. glabrata. Furthermore, for 
C. albicans, we found that ϕN  >  ϕM, whereas this relation is 
reversed for C. glabrata, reflecting the observed higher association 
of this pathogen to monocytes. Interestingly, the spon-IE model 
for infection with C. glabrata in comparison to infection with 
C. albicans predicted a higher peak value of the antimicrobial effect 
by a factor three (see Figure 3A). In contrast, the PMNmed-IE 
model predicted a peak value of the antimicrobial effect that is 
lower by a factor 0.5 for infection with C. glabrata compared to 
C. albicans. Apart from these observations, the two immune-
evasion models could equally well explain the experimental 
105
Figure 3 | Kinetics of the extracellular killing rate (a) and immune-evasion rate (B) predicted by spon-IE model and PMNmed-IE model. In both subfigures, purple 
lines represent results of infection with Candida albicans and blue lines depict results of infection with Candida glabrata. Predictions by the spon-IE model and 
PMNmed-IE model are indicated by dark colored lines and pale colored lines, respectively.
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kinetics of infection in whole-blood samples as obtained from 
the healthy blood donors. To work out differences between the 
two immune-evasion models, we addressed the question how 
the models differ in their predictions on the infection kinetics 
for virtual patients with varying severity levels of neutropenia.
simulations for Virtual Patients With 
neutropenia reveal Differences Between 
immune-evasion Models
The main difference between the spon-IE model and the 
PMNmed-IE model is that immune evasion in the latter is medi-
ated by PMN and, therefore, is directly associated with the number 
of PMN in whole blood. Although most patients with candidemia 
are non-neutropenic, it is well known that neutropenia results 
in an impaired prognosis and facilitates disseminated infection 
and organ manifestation (16). Taking the previously estimated 
transition rate values for healthy blood donors as a reference, we 
gradually decreased the PMN number in the simulations within 
the range of medically established severity levels of neutropenia 
(see Table 1) and kept the number of monocytes and fungal cells 
fixed at 5  ⋅105 cells and 1  ⋅106 cells per milliliter, respectively. 
The predictions of simulations at 4 h post infection for the two 
immune-evasion models and for each of the two fungal patho-
gens are shown in Figure 4. As could be expected, an increase in 
the severity level of neutropenia was accompanied by a decreased 
interaction of fungal cells with PMN.
Virtual infections with C. albicans cells under neutropenic 
conditions revealed clear differences between the spon-IE 
model (see Figure  4A) and the PMNmed-IE model (see 
Figure 4B) at 240 min post infection. Differences in the models 
could be observed at the transition from moderate to severe 
neutropenia, where the fraction of immune-evasive fungal cells 
increased to 25.2 ± 1.0% in the spon-IE model and decreased to 
10.4 ± 1.1% in PMNmed-IE model. These values for immune-
evasive cells changed to 42.7 ± 1.6% for the spon-IE model and 
0.24  ±  0.03% for the PMNmed-IE model in the simulations 
with the lowest PMN number (5  ⋅103 cells/ml). Even though 
the latter immune-evasion model predicted the number of 
immune-evasive C. albicans cells after 240 min post infection 
to be vanishingly small, the fraction of extracellular alive fungal 
cells was larger with 24.5  ±  5.6% for the PMNmed-IE model 
than for the spon-IE model with 9.7 ± 1.1%. In the simulations 
with the lowest PMN number, the spon-IE model predicted an 
association of 46.4  ±  1.9% fungal cells to monocytes, which 
is clearly lower compared to 73.3 ±  5.8% in the PMNmed-IE 
model. Furthermore, the number of killed C. albicans cells dif-
fers between the two models with being predicted as 41.2 ± 2.3% 
in the spon-IE model and 67.1  ±  5.5% in the PMNmed-IE 
model. In general, we observed that the differences in various 
fractions of C. albicans cells between the two immune-evasion 
models clearly increase with progressing simulation time 
under neutropenic conditions. This can be seen in Video S1 in 
the Supplementary Material showing the development of the 
various fungal cell fractions at specific time points between time 
point 0 and 240  min post infection. Furthermore, differences 
between the models were observed for the distribution of fungal 
cells in immune cells for the condition of severe neutropenia 
with 5 ⋅103 PMN per milliliter. As shown in (Figures 5A,B), the 
distribution of alive and killed fungal cells across immune cells 
revealed differences between the immune-evasion models. Here 
it can be seen that the maximum of the distribution refers to 
PMN that contain two C. albicans cells for the spon-IE model 
(see Figure 5A) and three C. albicans cells for the PMNmed-IE 
model (see Figure  5B). Regarding the distribution of fungal 
cells in monocytes, the spon-IE model and the PMNmed-IE 
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Figure 4 | Simulation results of the spon-IE model and of the PMNmed-IE model for different severity levels of neutropenia at the time point 240 min. The white 
region represents the physiological concentration of a whole-blood sample with 5⋅105 monocytes per milliliter and 5 ⋅106 PMN per milliliter. The PMN concentration 
declines with increasing severity levels of neutropenia: light gray area represents mild neutropenia (<1.5⋅106 PMN/ml), medium gray area represents moderate 
neutropenia (<1⋅106 PMN/ml), and dark gray area represents severe neutropenia (<5⋅105 PMN/ml). The error bars indicate SDs of 50 simulations with transition rate 
values that were randomly sampled within their corresponding SD. (a,B) Depict simulation results of a virtual Candida albicans infection, respectively, for the spon-IE 
model and of the PMNmed-IE model and (c,D) accordingly for Candida glabrata infection. The relative numbers of killed fungal cells (red), alive extracellular fungal 
cells (green), phagocytosed fungal cells by monocytes (yellow), and by PMN (blue), as well as fungal cells which evaded the immune defense (black) are depicted. 
Note that alive extracellular cells do not comprise alive immune-evasive cells and that these combined units are excluding each other.
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model predicted that the maximum number of monocytes 
which contained no fungal cells (see Figure 5C) and one fungal 
cell (see Figure 5D), respectively. These differences are accom-
panied by an overall shift of the distributions to higher numbers 
of phagocytes with more fungal cells in the PMNmed-IE model 
relative to the spon-IE model (see Figures 5A–D). In addition, 
the spon-IE model predicted a fraction of 7.0 ± 0.5% PMN that 
contain alive C. albicans cells (see Figure 5A), whereas this frac-
tion of PMN was predicted to be more than two times larger in 
the PMNmed-IE model (19.9 ± 1.5%) (see Figure 5B).
Simulations for C. glabrata infection revealed as well differ-
ences between the spon-IE model and the PMNmed-IE model 
(see Figures 4C,D). The fraction of immune-evasive cells attained 
the value 10.2 ± 1.6% for the spon-IE model and 0.02 ± 0.00% 
for the PMNmed-IE model in the limit of lowest PMN number 
(5 ⋅103 cells/ml). While these fractions reached different values, 
the fractions of extracellular alive cells were found to be vanish-
ingly small in both models. At the PMN number of 5 ⋅103 cells/ml, 
the spon-IE model predicted 84.1 ± 1.6% of C. glabrata cells to be 
killed and the majority of cells were phagocytosed by monocytes 
(89.2 ± 1.7%). Analysis of simulations of the PMNmed-IE model 
revealed that 70.6 ± 2.8% of C. glabrata cells were killed and the 
majority of cells were phagocytosed by monocytes (99.3 ± 0.06%). 
The time courses of each of these C. glabrata fractions at specific 
time points between 0 and 240 min post infection are shown in 
Video S2 in the Supplementary Material. Here it can be seen that 
at early time points post infection, the differences between the 
immune-evasion models is clearly visible. But with increasing 
simulation time these differences become smaller. While the 
distribution of killed and alive C. glabrata cells in PMN was 
similar for both immune-evasion models (see Figures  5E,F), 
differences in the distributions of fungal cells in monocytes, 
and their state of viability were observed (see Figures  5G,H). 
As can be seen in Figure  5G, the spon-IE model predicted 
that monocytes contained one to six fungal cells, where only 
a small fraction of fungal cells was alive, i.e., up to 7.1 ± 0.9% 
of monocytes contained alive fungal cells. This is in contrast 
to the PMNmed-IE model (see Figure 5H), which predicted a 
four times larger fraction of monocytes containing alive fungal 
cells (31.7 ± 1.0%). Thus, under severe neutropenic conditions, 
the most remarkable differences between the immune-evasion 
models were obtained with regard to the distribution of alive 
C. glabrata cells in monocytes.
Taken together, comparing the simulations of virtual patients 
under neutropenic conditions for the two immune-evasion 
models revealed, except for the number of immune-evaded cells, 
107
Figure 5 | Continued
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Figure 5 | Distribution of total and alive fungal cells in PMN and monocytes for the most severe neutropenic condition 500 PMN/ml for the spon-IE model (left 
column) and PMNmed-IE model (right column). Relative numbers of PMN and monocytes are depicted corresponding to their association with fungal cells while 
each bar represents the immune cell type with the total number (0–11) of phagocytosed fungal cells. The error bars refer to SDs of 50 simulations with transition rate 
values that were randomly sampled within their corresponding SD. Gray-colored bars refer to “no alive” fungal cells, i.e., phagocytes contain killed cells only, bars in 
pink color refer to phagocytes with one alive fungal cell, orange bars refer to two alive fungal cells, green bars refer to phagocytes with three alive fungal cells, blue 
bars refer to phagocytes with four alive fungal cells, and purple bars refer to phagocytes with five alive fungal cells. (a–D) Candida albicans cell distribution for a 
virtual infection under the condition of severe neutropenia. (e–h) Candida glabrata cell distribution for a virtual infection under the condition of severe neutropenia.
10
Prauße et al. Predictive Modeling of Fungal Immune Evasion
Frontiers in Immunology | www.frontiersin.org March 2018 | Volume 9 | Article 560
a qualitative agreement for both pathogens (see Figure  4). 
Comparing the infection outcome between the two pathogens 
for each immune-evasion models revealed qualitative agree-
ment, except for the alive extracellular fungal cells that increase 
(decrease) in the case of C. albicans (C. glabrata) with higher 
severity levels of neutropenia. As previously observed for whole 
blood from healthy donors, the fraction of immune-evasive 
cells for neutropenic patients was predicted to be higher for 
C. albicans than for C. glabrata in the spon-IE model. In con-
trast, the PMNmed-IE model predicted for both pathogens a 
quantitatively comparable fraction of immune-evasive cells that 
vanishes with the severity level of neutropenia. The phagocytosis 
by monocytes was found to be much lower for C. albicans than 
for C. glabrata, for both immune-evasion models, as previously 
observed for whole blood from healthy donors. This observation 
was also reflected by the distribution of fungal cells in immune 
cells (see Figure 5). C. glabrata was also represented by relatively 
large numbers of alive cells in monocytes at 4 h post infection. 
These findings indicate that infection in neutropenic whole 
blood could shed light on the mechanism of immune evasion 
by pathogens.
DiscussiOn
In this study, we applied mathematical modeling to investigate 
the yet unresolved mechanism of immune evasion by patho-
gens in human blood. The mechanism of immune evasion was 
first described in a systems biology study that quantified 
the immune response to C. albicans in human whole blood 
using a state-based virtual infection model (12, 13). Since the 
mechanism of immune evasion has not been identified so far, 
the immune evasion was assumed to occur spontaneously with 
a time-independent rate in the SBM (spon-IE model). In this 
study, we modified the spon-IE model by implementing a time-
dependent immune-evasion mechanism mediated by PMN and 
refer to this virtual infection model as PMNmed-IE model. This 
is based on experimental findings, which show that neutrophils 
can modulate the composition of the fungal cell surface (15). 
The state-based modeling approach enables realization of such 
a process by a transition rate that is time-dependent and reflects 
PMN dynamics of phagocytosis and release of neutrophilic 
peptides. In order to verify the PMNmed-IE model and the 
spon-IE model, we estimated the a priori unknown transition 
rates of these models by fitting the simulated kinetics to the 
experimental data from human whole-blood infection assays 
with either C. albicans or C. glabrata. To further work out 
differences between the immune-evasion models, we simu-
lated infection scenarios with reduced numbers of PMN that 
correspond to the range of medically established severity levels 
of neutropenia.
The comparison of the simulated kinetics for infections of 
blood with physiological and reduced numbers of PMN, the 
estimated transition rate values, as well as the pathogen distribu-
tion across immune cells revealed pathogen-specific differences 
between the two immune-evasion models. Based on these 
results, we suggest future experiments that could be performed 
to distinguish between the two immune-evasion mechanisms. 
While the kinetics of the experimental whole-blood infection 
assays for both pathogens could be reconciled with the virtual 
infection kinetics for both immune-evasion models, simula-
tions for reduced PMN numbers revealed differences between 
the two immune-evasion models. These differences were largest 
for C. albicans infection and relatively small for infections with 
C. glabrata. In particular, the fractions of fungal cells that were 
killed, associated with monocytes or that became immune-
evasive in simulations with reduced numbers of PMN, showed 
deviations between the two immune-evasion models most 
clearly for C. albicans (see Figures 4A,B). With decreasing PMN 
number, the PMNmed-IE model for this pathogen predicted 
that the fraction of immune-evasive pathogens remarkably 
decreased. Instead of becoming immune-evasive, C. albicans 
cells were mainly phagocytosed by monocytes and killed in 
this model. Furthermore, a significant fraction of fungal cells 
(24.5 ± 5.6%) was still alive and in extracellular space at 240 min 
post infection. In contrast to the PMNmed-IE model, the spon-
IE model predicted the fractions of C. albicans cells that are 
(i) phagocytosed by monocytes, (ii) killed, or (iii) remained viable 
in extracellular space to be notably smaller, whereas the fraction 
of immune-evasive C. albicans cells is larger, because the con-
stant rate of immune evasion does not depend on the decreasing 
number of PMN. Interestingly, both immune-evasion models 
predict even at 240 min post infection a remarkable fraction of 
C. albicans cells that are capable of dissemination. However, in 
the PMNmed-IE model these cells are mainly alive and extracel-
lular due to absent phagocytosis whereas in the spon-IE model 
they are mostly immune-evasive fungal cells. Thus, both models 
would explain the observation that dissemination of C. albicans 
is more frequent in a neutropenic setting, albeit with different 
mechanisms (26–28). In order to verify the predicted differences 
for the two immune-evasion models, we suggest studying whole-
blood infection assays either with depleted PMN numbers or 
with blood samples from neutropenic patients.
Regarding the pathogen distribution across immune cells, 
virtual infection scenarios for C. albicans with the low PMN 
number of 5 ⋅103 cells/ml revealed differences between the two 
immune-evasion models in the pathogen distributions within 
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PMN and monocytes as well as in the fraction of alive C. albicans 
cells in PMN (see Figures 5A–D). The experimental validation 
of the pathogen distribution in PMN and monocytes could be 
performed by Giemsa-stained blood smears obtained from 
C. albicans-infected blood samples of neutropenic patients. The 
overall distribution of C. albicans cells in PMN and monocytes 
could lead to further conclusions by comparing the experimen-
tal observations to simulated results, although information 
about viability cannot be obtained by Giemsa-stained blood 
smears. For the experimental validation of pathogen distribu-
tion across immune cells during infection of neutropenic 
blood samples it is necessary to differentiate between alive and 
killed fungal cells to unravel the immune-evasion mechanism 
of C. glabrata. The virtual infection of neutropenic blood by 
this pathogen showed clear differences between the immune-
evasion models with regards to the distribution of alive patho-
gen cells in monocytes (see Figures 5G,H). The PMNmed-IE 
model predicted a relatively large fraction of alive fungal cells in 
monocytes at 240 min post infection. With increasing infection 
time in neutropenic patients, the high amount of alive fungal 
cells in monocytes may result in higher amounts of fungal 
cells in macrophages, which are professional phagocytes of the 
monocytic lineage. Since it is reported that C. glabrata cells are 
able to proliferate within macrophages and subsequently can 
leave these phagocytes (21, 29), this process could contribute to 
the increased risk for disseminated candidiasis in neutropenic 
patients (30).
Another suggestion for the experimental investigation of 
the immune-evasion mechanisms is to measure the activity of 
antimicrobial effector proteins inducing extracellular killing, 
because these kinetics are predicted to be different for the two 
immune-evasion models. This difference was observed to be 
relatively high for virtual C. glabrata infection at physiological 
numbers of PMN: in the spon-IE model the maximum value 
for the extracellular killing rate was much larger for C. glabrata 
infection compared to C. albicans, whereas in the PMNmed-IE 
model this peak value was predicted to be much smaller for 
C. glabrata infection (see Figure  3A). We, therefore, suggest 
measuring and comparing the activity of antimicrobial effec-
tor proteins inducing extracellular killing, such as lactoferrin, 
elastase 2 and myeloperoxidase, for both pathogens. In a previ-
ous study by Duggan et al. (25), where the differential recogni-
tion of C. albicans and C. glabrata by PMN was investigated, the 
concentration of these proteins were measured in supernatants 
of confrontation assays of PMN with the fungi 4 h after infec-
tion. For each of these antimicrobial proteins, the concentra-
tion in confrontation assays with C. albicans was observed 
to be higher than in confrontation assays with C. glabrata. We 
now suggest measuring not only the concentration of these 
antimicrobial peptides but also their fungicidal effect on the 
different pathogens in a comparative fashion. Moreover, our 
analysis predicts the time-window, where the largest difference 
for the kinetics of extracellular killing between both pathogens 
occurs, i.e., at 10 to 50 min post infection.
In future studies, the predictive power of virtual infection 
modeling can be further exploited by simulating infection sce-
narios with modified models that enable generating predictions 
for other hypotheses. For example, while the present study 
focused on the role of PMN-mediated immune evasion, a 
similar mechanism could be studied for monocytes, as well as a 
combination of contributions from both types of immune cells. 
Future computational studies could also benefit from spatial 
agent-based modeling. By applying a bottom-up approach, as 
previously performed by Lehnert et al. (13), the transition rate 
values of the SBM could be used as input for an agent-based 
model, where also spatial system properties are captured, such 
as the cells’ morphology and/or migration pattern. This agent-
based virtual infection model could, for example, be applied to 
investigate the impact of the various immune-evasion models 
on a hyper- and hypo-inflammatory immune response in 
human blood. In addition, the impact of the spatial distribu-
tion of PMN-secreted proteins causing immune evasion could 
be investigated by advancing the cellular agent-based virtual 
infection model to a hybrid agent-based model that simulates 
diffusion at the molecular level by partial differential equations. 
For example, in previous studies related to fungal infections, 
a hybrid agent-based model enabled to investigate the immune 
response against Aspergillus fumigatus in the alveoli of the 
human lung (31, 32). It could be shown that the migration 
pattern of immune cells is of high importance for the timely 
infection clearance and this lead to the prediction that chemo-
tactic signaling molecules are essential for recruitment of 
phagocytes to the spatial position of fungal cells in the lung. 
Moreover, image-based systems biology approach combining 
mathematical modeling with microscopy experiments could 
be pursued (9, 33, 34). While imaging in whole blood is not 
performed today, host–pathogen interactions can be investi-
gated by microscopy experiments under controlled conditions 
in a Petri dish. Recently, we have developed algorithms for the 
fully automated analysis of host–pathogen confrontation from 
microscopic endpoint experiments (33, 35–38), as well as from 
live cell imaging (39, 40). Similar to our recent comparative 
studies on C. albicans and C. glabrata phagocytosis (16, 41), 
host–pathogen confrontation assays could be performed and 
analyzed by automated image analysis to visualize surface 
alterations of immune-evading fungal cells.
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ViDeO s1 | Time-course of simulation results of both immune-evasion models 
for C. albicans infection for different severity levels of neutropenia. The error 
bars indicate standard deviations of 50 simulations with transition rate values 
that were randomly sampled within their corresponding standard deviation. 
The white region represents the physiological concentration of a whole-blood 
sample with 5⋅105 monocytes per milliliter and 5⋅106 PMN per milliliter. The 
PMN concentration declines with increasing severity levels of neutropenia: 
light gray area represents mild neutropenia (<1.5⋅106 PMN/ml), medium gray 
area represents moderate neutropenia (<1⋅106 PMN/ml) and dark gray area 
represents severe neutropenia (<5⋅105 PMN/ml). (a,B) depict simulation results 
of a virtual C. albicans infection, respectively, for the spon-IE model and of 
the PMNmed-IE model. The relative numbers of killed fungal cells (red), alive 
extracellular fungal cells (green), phagocytosed fungal cells by monocytes (yellow) 
and by PMN (blue), as well as fungal cells which evaded the immune defense 
(black) are depicted. Note that alive extracellular cells do not comprise alive 
immune-evasive cells and that these combined units exclude each other.
ViDeO s2 | Time-course of simulation results of both immune-evasion models 
for C. glabrata infection for different severity levels of neutropenia. The error 
bars indicate standard deviations of 50 simulations with transition rate values 
that were randomly sampled within their corresponding SD. The white region 
represents the physiological concentration of a whole-blood sample with 5⋅105 
monocytes per milliliter and 5⋅106 PMN per milliliter. The PMN concentration 
declines with increasing severity levels of neutropenia: light gray area represents 
mild neutropenia (<1.5⋅106 PMN/ml), medium gray area represents moderate 
neutropenia (<1⋅106 PMN/ml) and dark gray area represents severe neutropenia 
(<5⋅105 PMN/ml). (a,B) depict simulation results of a virtual C. glabrata infection, 
respectively, for the spon-IE model and of the PMNmed-IE model. The relative 
numbers of killed fungal cells (red), alive extracellular fungal cells (green), 
phagocytosed fungal cells by monocytes (yellow) and by PMN (blue), as well as 
fungal cells which evaded the immune defense (black) are depicted. Note that 
alive extracellular cells do not comprise alive immune-evasive cells and that  
these combined units exclude each other.
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1 Supplementary Data 
1.1 Supplementary Information 
S1. Simulation algorithm of the state-based whole-blood infection model. 
The temporal evolution of the state-based model (SBM) within the simulation time 𝑡 = 0, … , 𝑡𝑒𝑛𝑑 is 
calculated for each simulation time step Δt (with Δt = 1 min) by updating all individuals of the 
system with respect to their current state. In particular, an individual of state s will be updated by 
testing for transition into another state s’. Each state transition is associated with a rate, 𝑟𝑠→𝑠′, and 
will be executed with probability 𝑃𝑠→𝑠′ =  𝑟
𝑠→𝑠′Δt. The system is updated accordingly. As 
schematically depicted in Figure S1 in Supplementary Material, the simulation of the SBM for 
whole-blood infection comprises updating individuals of the states 𝑃𝐴𝐸 and 𝑃𝐾𝐸, which are 
respectively alive extracellular pathogens and killed extracellular pathogens, as well as individuals of 
the states 𝑀𝑖,𝑗 and 𝑁𝑖,𝑗, which respectively represent monocytes and neutrophils containing i alive 
and j killed pathogens. Individuals of the states 𝑃𝐴𝐸 and 𝑃𝐾𝐸 are tested for extracellular killing and 
immune evasion, whereas individuals of the states 𝑀𝑖,𝑗 and 𝑁𝑖,𝑗 are tested for phagocytosis and 
intracellular killing. A description of the transition rates of the SBM and the respective state 
transitions are given in Table S1 in Supplementary Material.  
This SBM simulation algorithm was implemented in the programming language C++ and is available 
for download from https://asbdata.hki-jena.de/publidata/PrausseEtAl2018_FrontImmunol/ . 
 
S2. Parameter estimation by the global optimization method Simulated Annealing based on the 
Metropolis Monte Carlo scheme.  
By randomly exploring the parameter space of transition rates used in the spon-IE model and 
PMNmed-IE model, the algorithm is able to find the global minimum of the least-square error (LSE) 
between the simulated data of the models and the experimental data acquired from the whole-blood 
infection assays. The flowchart of this algorithm is depicted in Figure S2 in Supplementary Material.  
The time-evolution of the state-based model kinetics, referred to as combined units, is simulated 
using parameter set ?⃗? and compared with the experimental data by calculating the weighted sum of 
LSE (𝐸(?⃗?)). This is followed by choosing a parameter set 𝑝′ within a pre-defined range of ±10% 
from ?⃗?. Next, the model is simulated with the parameter set 𝑝′ and the corresponding score 𝐸(?⃗?′) is 
calculated. If 𝐸(?⃗?′) attains a smaller value than 𝐸(𝑝), the new parameter set 𝑝′ is accepted because of 
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the better fitting result. However, ?⃗?′ may also be accepted for 𝐸(?⃗?′) larger than 𝐸(𝑝) with a 
probability that depends on the Boltzmann distribution (Metropolis Monte Carlo Step, see Step 3 in 
Figure S2 in Supplementary Material). This probability is decreased with progressing number of 
fitting steps 𝑓, simulating the system’s annealing by a decreasing of temperature parameter 𝜏(𝑓) in 
the Boltzmann distribution. Thus the risk to accept an unfavorable parameter set 𝑝′ decreases with 
the ongoing fitting procedure by the system’s temperature decrease. The choice of a new parameter 
set ?⃗?′, its evaluation and acceptance or rejection is repeated for a specific number of fitting steps 
making up one fitting run. Fitting runs are repeated as wells starting from different initial parameter 
sets and the means and standard deviations of the determined optimal parameter sets resulting from 
these repetitions are calculated. Due to large numbers of fungal cells (𝑃), monocytes (𝑀) and 
polymorphonuclear neutrophils (𝑁) in infected whole-blood samples, the state-based model 
simulation of such a system size is accompanied with large computation times. Therefore, the fitting 
procedure is designed in a step-wise fashion: The system size is gradually increased by factors of ten 
starting at 𝑃 = 100, 𝑀0,0 = 50 and 𝑁0,0 = 500 up to 𝑃 = 10
6, 𝑀0,0 = 5 ⋅ 10
5 and 𝑁0,0 = 5 ⋅ 10
6. 
i.e. keeping the ratio of cell numbers constant. Here, the optimal parameter values of a model system 
as determined by the above described estimation procedure serves as start values in fitting the state-
based model for the next in size system.  
This framework for parameter estimation of the state-based whole-blood infection model was 
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1.2 Supplementary Videos 
Video S1. Time-course of simulation results of both immune-evasion models for C. albicans 
infection for different severity levels of neutropenia. The error bars indicate standard deviations of 50 
simulations with transition rate values that were randomly sampled within their corresponding 
standard deviation. The white region represents the physiological concentration of a whole-blood 
sample with 5 ⋅ 105 monocytes per milliliter and 5 ⋅ 106 PMN per milliliter. The PMN concentration 
declines with increasing severity levels of neutropenia: light gray area represents mild neutropenia 
(< 1.5 ⋅ 106  
𝑃𝑀𝑁
𝑚𝑙
), medium gray area represents moderate neutropenia (< 1 ⋅ 106  
𝑃𝑀𝑁
𝑚𝑙
) and dark 
gray area represents severe neutropenia (< 5 ⋅ 105  
𝑃𝑀𝑁
𝑚𝑙
). (A) and (B) depict simulation results of a 
virtual C. albicans infection, respectively, for the spon-IE model and of the PMNmed-IE model. The 
relative numbers of killed fungal cells (red), alive extracellular fungal cells (green), phagocytosed 
fungal cells by monocytes (yellow) and by PMN (blue), as well as fungal cells which evaded the 
immune defense (black) are depicted. Note that alive extracellular cells do not comprise alive 
immune-evasive cells and that these combined units exclude each other. 
Video S2. Time-course of simulation results of both immune-evasion models for C. glabrata 
infection for different severity levels of neutropenia. The error bars indicate standard deviations of 50 
simulations with transition rate values that were randomly sampled within their corresponding 
standard deviation. The white region represents the physiological concentration of a whole-blood 
sample with 5 ⋅ 105 monocytes per milliliter and 5 ⋅ 106 PMN per milliliter. The PMN concentration 
declines with increasing severity levels of neutropenia: light gray area represents mild neutropenia 
(< 1.5 ⋅ 106  
𝑃𝑀𝑁
𝑚𝑙
), medium gray area represents moderate neutropenia (< 1 ⋅ 106  
𝑃𝑀𝑁
𝑚𝑙
) and dark 
gray area represents severe neutropenia (< 5 ⋅ 105  
𝑃𝑀𝑁
𝑚𝑙
). (A) and (B) depict simulation results of a 
virtual C. glabrata infection, respectively, for the spon-IE model and of the PMNmed-IE model. The 
relative numbers of killed fungal cells (red), alive extracellular fungal cells (green), phagocytosed 
fungal cells by monocytes (yellow) and by PMN (blue), as well as fungal cells which evaded the 
immune defense (black) are depicted. Note that alive extracellular cells do not comprise alive 




2 Supplementary Figures and Tables 
2.1 Supplementary Tables 
rate description state transition 
𝝓𝑵 phagocytosis by neutrophils 𝑁𝑖,𝑗 + 𝑃𝐴𝐸 →  𝑁𝑖+1,𝑗 
𝑁𝑖,𝑗 + 𝑃𝐾𝐸 →  𝑁𝑖,𝑗+1 
𝝓𝑴 phagocytosis by monocytes 𝑀𝑖,𝑗 + 𝑃𝐴𝐸 →  𝑀𝑖+1,𝑗 
𝑀𝑖,𝑗 + 𝑃𝐾𝐸 →  𝑀𝑖,𝑗+1 
𝜿𝑵 intracellular killing by neutrophils 𝑁𝑖,𝑗 →  𝑁𝑖−1,𝑗+1 
𝜿𝑴 intracellular killing by monocytes 𝑀𝑖,𝑗 →  𝑀𝑖−1,𝑗+1 
𝜿𝑬𝑲(𝒕) extracellular killing by antimicrobial peptides 
released upon first-time PMN phagocytosis with 
decreasing activity 
rate depends on the activity of antimicrobial peptides, 
characterized by the rate  ?̅?𝐸𝐾, and the decay of their 
antimicrobial activity, characterized by 𝛾, as defined 
in Hünniger et al. (2014) (1) and Lehnert et al. (2015) 
(2) 
 𝑃𝐴𝐸 →  𝑃𝐾𝐸 
𝝆 constant rate for the acquisition of immune evasion 
for spon-IE model 
𝑃𝐴𝐸 →  𝑃𝐴𝐼𝐸 
𝑃𝐾𝐸 →  𝑃𝐾𝐼𝐸 
𝝆(𝒕) time dependent rate for the acquisition of immune 
evasion for PMNmed-IE model 
rate depends on the activity of effector molecules, 
characterized by  ?̅?  and the decay of their activity as 
characterized by 𝛾𝑅 (see Eq. (7) in the manuscript) 
𝑃𝐴𝐸 →  𝑃𝐴𝐼𝐸 
𝑃𝐾𝐸 →  𝑃𝐾𝐼𝐸 
Table S1. Transition rates of the PMNmed-IE model and the spon-IE model for modeling the whole-
blood infection assays. For details of the latter model, see Hünniger et al. (2014) (1) and Lehnert et 
al. (2015) (2). 
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C. albicans mean × 𝟏𝟎−𝟐 [𝒎𝒊𝒏−𝟏]  ± SD × 𝟏𝟎−𝟐 [𝒎𝒊𝒏−𝟏] (CV [%]) 
rate spon-IE model PMNmed-IE model 
𝝓𝑵 2.97 ± 0.061(2.1) 2.86 ± 0.054(1.9) 
𝝓𝑴 1.23 ± 0.075 (6.1) 1.2 ± 0.13 (10.6) 
𝜿𝑴 2.1 ± 0.31 (14.6) 3.5 ± 0.42 (12.2) 
𝜿𝑵 5.3 ± 0.49 (9.2) 5.7 ± 0.97 (16.9) 
?̅?𝑬𝑲 21.8 ± 1.8 (8.0) 20.44 ± 3.33 (16.3) 
𝜸 2.13 ± 0.19 (8.8) 2.69 ± 0.34 (12.5) 
𝝆 0.44 ± 0.021 (4.8)  
?̅?  10.75 ± 0.34 (7.1) 
𝜸𝑹  3.0 ± 0.35 (11.6) 
Table S2. The transition rates of a virtual whole-blood infection with C. albicans for the spon-IE and 
PMNmed-IE model are given by the phagocytosis rate 𝜙𝑁 of PMN and the phagocytosis rate 𝜙𝑀 of 
monocytes, the intracellular killing rates 𝜅𝑀 and 𝜅𝑁 of both monocytes and PMN, the transition rates 
𝛾 and ?̅?𝐸𝐾 which define the extracellular killing and the spontaneous immune evasion rate 𝜌 and the 
PMN-mediated immune evasion rates ?̅? and 𝛾𝑅, respectively. The mean values and standard 
deviations (SD) were obtained by several repetitions of the parameter estimation procedure which is 
described in the work of Lehnert et al. (2014) (1,2). CV refers to the coefficient of variation which 









C. glabrata mean × 𝟏𝟎−𝟐 [𝒎𝒊𝒏−𝟏]  ± SD × 𝟏𝟎−𝟐 [𝒎𝒊𝒏−𝟏] (CV [%]) 
rate spon-IE model PMNmed-IE model 
𝝓𝑵 10.0 ± 0.55 (5.5) 6.5 ± 0.49 (7.6) 
𝝓𝑴 14.3 ± 1.4 (9.6) 9.9 ± 0.64 (6.5) 
𝜿𝑴 2.2 ± 0.23 (10.6) 1.10 ± 0.073 (6.6) 
𝜿𝑵 4.9 ± 0.43 (8.7) 13.8 ± 2.5 (18.3) 
?̅?𝑬𝑲 47.5 ± 9.9 (20.8) 10.7 ± 1.6 (15.1) 
𝜸 3.1 ± 0.34 (10.9) 5.4 ± 1.3 (23.1) 
𝝆 0.76 ± 0.047 (6.2)  
?̅?  7.3 ± 1.7 (22.8) 
𝜸𝑹  7.9 ± 1.8 (22.7) 
Table S3. The transition rates of a virtual whole-blood infection with C. glabrata for the spon-IE 
(left column in each split) and PMNmed-IE model (right column in each split) are given by the 
phagocytosis rate 𝜙𝑁 of PMN and the phagocytosis rate 𝜙𝑀 of monocytes, the intracellular killing 
rates 𝜅𝑀 and 𝜅𝑁 of both monocytes and PMN, the transition rates 𝛾 and ?̅?𝐸𝐾 which define the 
extracellular killing and the spontaneous immune evasion rate 𝜌 and the PMN-mediated immune 
evasion rates ?̅? and 𝛾𝑅, respectively. The mean values and standard deviations (SD) were obtained by 
several repetitions of the parameter estimation procedure which is described in the work of Lehnert et 
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2.2 Supplementary Figures 
  
 
Figure S1. Flowchart of the simulation algorithm for the state-based whole-blood infection 
model. This algorithm is explained in detail in section S1 in Supplementary Material. The 






Figure 2. Flowchart of the parameter estimation algorithm. The algorithm is explained in detail 
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Figure S3. Kinetics of Combined Units of the spon-IE model by the use of the computed transition 
rates. Experimental data from whole-blood infection assays (red dotted lines) with corresponding 
121
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standard deviations are compared to the simulated data by the spontaneous evasion model. The 
thickness of solid lines indicates the mean ± standard deviation of 50 simulations with transition rate 
values that were randomly sampled within their corresponding standard deviation. The breakdown of 
each combined unit is depicted the following way. (A) Time-dependent relative number of killed 
C. albicans cells (𝑃𝐾) that were experimentally measured by survival plates. The experimental results 
were compared with the total number of simulated killed C. albicans cells. 𝑃𝐾 is defined as the sum 
of killed immune-evasive C. albicans (𝑃𝐾𝐼𝐸), extracellularly killed C. albicans (𝑃𝐾𝐸), and killed 
C. albicans in monocytes (𝑃𝐾𝑀) and PMN (𝑃𝐾𝑀) (B) Alive C. albicans (𝑃𝐴) were also measured by 
survival plates. The simulated result was then compared to the experimental data. (C) Time course of 
C. albicans cells that are in extracellular space in the blood. Here, experimental data was gathered via 
FACS analysis and compared to the simulated data. (D) Simulated immune-evasive C. albicans cells 
(𝑃𝐼𝐸) are the sum of alive and killed C. albicans cells, which are able to evade the immune defense, 
over the time course of the simulation. (E) Time course of the total number of alive and killed 
C. albicans cells that were phagocytosed by monocytes (𝑃𝑀). (F) Relative number of C. albicans 
cells in PMN (𝑃𝑁) during the whole-blood infection assay and comparison to the simulated result. 
(G) Simulation result of killed C. albicans cells within monocytes  (𝑃𝐾𝑀), that is defined as the sum 
of internalized C. albicans that were intracellularly killed (𝑃𝑀𝐾𝑀) and those who were extracellularly 
killed (𝑃𝐸𝐾𝑀). (H) simulated time course of killed cells in PMN (𝑃𝐾𝑁), that is composed of 
intracellularly killed C. albicans cells (𝑃𝑁𝐾𝑁) and extracellularly killed C. albicans cells (𝑃𝐸𝑁) in 
PMN. 
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Figure S4. As in Figure S3 in Supplementary Material but for PMNmed-IE model in the case of 




Figure S5. As in Figure S3 in Supplementary Material but for spon-IE model in the case of 
C. glabrata infection. 






Figure S6. As in Figure S3 in Supplementary Material but for PMNmed-IE model in the case of 
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The condition of neutropenia, i.e., a reduced absolute neutrophil count in blood,
constitutes a major risk factor for severe infections in the affected patients. Candida
albicans and Candida glabrata are opportunistic pathogens and the most prevalent
fungal species in the human microbiota. In immunocompromised patients, they can
become pathogenic and cause infections with high mortality rates. In this study, we use a
previously established approach that combines experiments and computational models
to investigate the innate immune response during blood stream infections with the two
fungal pathogens C. albicans and C. glabrata. First, we determine immune-reaction rates
and migration parameters under healthy conditions. Based on these findings, we simulate
virtual patients and investigate the impact of neutropenic conditions on the infection
outcome with the respective pathogen. Furthermore, we perform in silico treatments of
these virtual patients by simulating a medical treatment that enhances neutrophil activity
in terms of phagocytosis and migration. We quantify the infection outcome by comparing
the response to the two fungal pathogens relative to non-neutropenic individuals. The
analysis reveals that these fungal infections in neutropenic patients can be successfully
cleared by cytokine treatment of the remaining neutrophils; and that this treatment is more
effective for C. glabrata than for C. albicans.
Keywords: fungal infections, neutropenia, treatment strategies, bottom-up modeling approach, computer
simulations
INTRODUCTION
The human immune system protects the body against various environmental cues, such as microor-
ganisms. It covers mechanisms on different levels ranging from physical barriers, like the skin and
mucosal surfaces, down to cellular and molecular components of the innate and adaptive immune
system (1). However, congenital or acquired diseases as well as medical treatments may impair
proper functioning of the immune system, which can result in the loss of its protective ability.
Neutrophils constitute the highest fraction of blood leukocytes, as theymake up over 70%of all blood
leukocytes (2). Since they can migrate to sites of infection and clear the organism from pathogens,
they constitute an important part of the immune system.
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Candida spp. cause 5–15% of all bloodstream infections and are
associated with high mortality rates of 30–40% (3). A significant
proportion (>50%, depending on the study setting) of the human
population is colonized with Candida spp. The most prevalent
species are Candida albicans and Candida glabrata that are both
human commensals and reside predominantly on the human skin
andmucosal surfaces (4–6).C. albicans is amorphotype-switching
yeast, which in its commensal state exhibits the typical yeast form,
while it forms hyphae when switching to its pathogenic state (7, 8).
By contrast,C. glabrata does not form hyphae, neither in the com-
mensal nor in the pathogenic state and is smaller than C. albicans
(4, 9). In healthy people, both species usually stay in their com-
mensal state. However, in immunocompromised patients, these
human-pathogenic fungi can switch to their pathogenic state and
cause superficial as well as systemic infections that are associated
with high mortality rates.
To investigate host–pathogen interactions between the human
innate immune system and these fungal pathogens, we applied a
systems biology approach, where wet-lab experiments were com-
binedwith virtual infectionmodels (10–13). Such virtual infection
models have the great advantage of allowing for the identification
and quantification of essential parameters that govern the biolog-
ical system under consideration. This also makes them a powerful
tool for hypothesis generation and uncovering new mechanisms,
which consequently allows for minimizing the amount of animal
experiments (14).Depending on the purpose, such in silicomodels
can be built with different modeling techniques, such as differ-
ential equations, state-based models (SBMs) or spatial modeling
techniques such as cellular automata, cellular Potts models or
agent-based models (ABMs) (15). In a previous systems biology
study, we established a human whole-blood infection assay (16),
where blood was taken from healthy volunteers and infected
with C. albicans cells. Then, subpopulations of alive, killed and
extracellular fungal cells as well as fungal cells phagocytosed by
monocytes and neutrophils were measured by association assays
and survival assays. Based on these experimental data, we imple-
mented an SBM that allowed for the quantification of immune-
reaction rates, such as phagocytosis and killing rates, by fitting
the simulated kinetics to the experimental data. In a subsequent
study, we developed a bottom-upmodeling approach that enabled
not only quantification of immune-reaction rates but also the
investigation of spatial aspects (17). Since the SBM simulates the
temporal but not the spatial dynamics, we also developed an
ABM that was based on a previous ABM implementation (18, 19).
We combined both models in a bottom-up modeling approach
(17): the SBM was used to determine non-spatial rates that were
afterward transformed and used in the ABM to fit migration
parameters of immune cells in human whole blood. We found
that the in silico infection outcome for C. albicans was sensitive to
changes in the diffusion coefficient of neutrophils, whereas that
of monocytes had only minor impact on the system dynamics.
This result reflected the more prominent role of neutrophils over
monocytes in fightingC. albicans infection of humanwhole blood.
Furthermore, immune dysregulation was investigated using the
ABM, and the results showed that a reduced diffusion coefficient
for neutrophils resembled conditions of neutropenia (17). This
important observation is themainmotivation of the present study,
because it suggests how neutropenic patients may be treated to
cope with bloodstream infections. Thus, increasing neutrophil
activation in terms of phagocytic activity as well as migration
strength is hypothesized to have the potential of balancing neu-
tropenic conditions and clearance of infection. Based on this rea-
soning, we address infections in humanwhole blood byC. albicans
and C. glabrata under neutropenic conditions in this study.
Diseases or medical treatments can evoke a reduced absolute
neutrophil count (ANC) in blood and result into a condition
called neutropenia. Neutropenia may result from congenital or
acquired impairments, where the latter case is more frequent.
A reduced ANC may arise due to a disturbed development of
neutrophils in the bone marrow, a disturbed migration to the
blood stream or a rapid consumption during an infection (20).
In anti-cancer chemotherapy, neutropenia is the most abundant
disorder of the immune system due to the relatively short life-
span of these terminally differentiated cells (21). Neutropenia
emerges in different degrees of severity that are classified by the
Severe Chronic Neutropenia International Registry (SCNIR) (20).
The SCNIR distinguishes three degrees of severity: mild neu-
tropenia with an ANC of 1,000–1,500 neutrophils/μl, moderate
neutropenia with an ANC of 500–1,000 neutrophils/μl and severe
neutropenia with an ANC of <500 neutrophils/μl. In this study,
we focus on neutropenia treatment by stimulation and activation
of present neutrophils by inflammatory cytokines and quantita-
tively investigate the impact on fungal infections by computer
simulations. Thus, we aim to investigate a possible treatment
strategy where the neutrophil activity is increased by a higher
diffusion coefficient and/or phagocytosis rate. For this purpose,
we apply the previously established protocol for whole-blood
infection assays and perform the bottom-up modeling approach
for the two human-pathogenic fungi. As is schematically shown in
Figure 1, we first determine quantitative values for the immune-
reaction rates aswell as for diffusion coefficients ofmonocytes and
neutrophils as the key immune cells of innate immunity in whole
blood. Furthermore, we use this modeling approach to simulate
neutropenia in silico and compare effects on the infection outcome
between the different pathogens. To evaluate a possible treatment
strategy, we simulate virtual neutropenic patients (VNP) with
different degrees of severity and increase stepwise the phagocyto-
sis rate and/or the diffusion coefficient of neutrophils to classify
the infection outcome. Taken together, we could show that the
increase of the phagocytosis rate and/or the migration parameter
of neutrophils generally allowed balancing neutropenic condi-
tions and clearance of infection. Furthermore, we predict that
C. albicans compared with C. glabrata always requires stronger
increases in the phagocytosis rate and the diffusion coefficient for
the same conditions of neutropenia.
MATERIALS AND METHODS
Ethics Statement
This study was conducted according to the principles expressed
in the Declaration of Helsinki. All protocols were approved by the
Ethics Committee of the University Hospital Jena (permit num-
ber: 273-12/09). Written informed consent was obtained from all
blood donors.
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FIGURE 1 | Workflow for studying neutropenia in silico. First, whole-blood infection assays with Candida albicans and Candida glabrata were performed in wet lab.
Second, non-spatial immune-reaction rates were fitted using the state-based model. Third, the agent-based model (ABM) was used to estimate migration
parameters for neutrophils and monocytes. Based on the fitted non-spatial immune-reaction rates and the fitted migration parameters, virtual neutropenic patients
were simulated in the ABM by gradually reducing the neutrophil count. Eventually, a medical treatment of the virtual patients was simulated by increasing the diffusion
coefficient and/or the phagocytosis rate of neutrophils.
Fungal Strains and Culture
GFP expressingC. albicans strain [constructed as described in Ref.
(16)] was grown in liquid yeast extract–peptone–dextrose (YPD)
medium at 30◦C. C. glabrata expressing GFP (22) was incubated
at 37◦C in YPD. In preparation for the whole-blood assay, both
strains were reseeded after overnight culture in YPD medium
and grown at 30 and 37◦C, respectively, until they reached the
mid-log-phase and finally harvested in HBSS until use.
Whole-Blood Infection Assay
Human peripheral blood from healthy individuals was infected
with either of the two fungi C. albicans and C. glabrata, respec-
tively. The assay was performed as described previously (16). In
short, 1 × 106 Candida cells were added perml of anti-coagulated
blood and incubated at 37◦C with gentle rotation for time points
indicated. Following the incubation, cells were maintained at 4◦C
and analyzed immediately via flow cytometry. Flow cytometry
gating strategy to investigate the distribution of fungal cells in
human blood was performed as previously described (16) using
FlowJo 7.6.4 software. Survival of fungal cells was determined
in a plating assay by analysis of recovered colony-forming units
after plating appropriate dilutions of all time points on YPD agar
plates.
Bottom-Up Modeling Approach
We established a bottom-up modeling approach for simulation
and fitting of whole-blood infection assays in a previous study
(17). This bottom-up modeling approach incorporates models
with increasing complexity that build on one another, where each
model focuses on different aspects of the infection process.
SBM—Immune-Reaction Rates
First, we applied the SBM to quantify and characterize immune-
reaction rates for discrete entities of pathogens and innate immune
cells. Therefore, the populations of innate immune cells, i.e., neu-
trophils and monocytes, as well as the pathogens were modeled
by different states in the SBM. For the comparison with experi-
mentally measured cell populations, we identified five combined
units that are composed of specific states. The states representing
extracellular cells are combined in the combined unit PE that is
given by the following equation:
PE ≡ PAE + PKE + PAIE + PKIE, (1)
where the states PAE and PKE represent extracellular cells that are
alive and killed, respectively. The states PAIE and PKIE describe
pathogens that are either alive and evading the immune response
or killed and evading the immune response. Pathogens that are
in extracellular space and either alive (PAE) or killed (PKE) can be
phagocytosed by two different immune cells, i.e., neutrophils (N)
and monocytes (M). The combined unit PN comprises pathogens








Similarly, pathogens that are phagocytosed by monocytes are







In Eqs 2 and 3, the indices i and j refer to the immune cell
state that is defined by the number of internalized alive and killed
pathogens, respectively.
Furthermore, the states representing alive and killed pathogens
are combined in PK and PA, respectively, that are defined by the
following equations:





(Mi,j + Ni,j) j, (4)





(Mi,j + Ni,j) i. (5)
The total number of pathogens is given by P≡ PE + PN + PM
or P≡ PK + PA.
Transitions between these states are characterized by so-called
transition rates and allow for dynamic state changes over time. The
SBM of whole-blood infection comprises seven different transi-
tion rates that are given by the phagocytosis rate φM of mono-
cytes, the phagocytosis rate φN of neutrophils, the intracellular
killing rates κM and κN of both monocytes and neutrophils, the
transition rates γ and κ¯EK, which define the extracellular killing
by antimicrobial peptides, and the spontaneous immune evasion
rate ρ. Note that, in the previous study by Lehnert et al. (17),
a distinction between first and subsequent phagocytosis events
by neutrophils was made, where the first phagocytosis event was
assumed to activate the neutrophils and induce granulation. Since
this fact is not experimentally validated for whole-blood infection
with C. glabrata, we here did not distinguish between these two
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processes and used only one transition rate (φN) referring to both
first and subsequent phagocytosis events. To determine a priori
unknown transitions rates, the in silico data were fitted to the
experimental data by applying themethod of Simulated Annealing
based on the Metropolis Monte Carlo scheme (SA-MMC). For a
more detailed description of the model and the parameter estima-
tion method, we refer to Hünniger et al. (16) and Lehnert et al.
(17).
ABM—Immune Cell Migration
The ABM is based on a previous ABM implementation (18, 19)
andwas already used in the previous study by Ref. (17). In contrast
to the SBM, it allows studying spatial aspects, such as immune cell
migration, in whole-blood infection assays. The ABM simulates
all cell types, i.e., pathogens as well as immune cells, as individual
spherical objects that are referred to as agents. All agents migrate,
act and interact in a rule-based fashion within a spatially con-
tinuous, three-dimensional environment that represents 1μl of
blood.
Furthermore, the ABM was fitted to the experimental data
to determine diffusion coefficients of neutrophils (DN) and
monocytes (DM). This was done by the bottom-up modeling
approach, where the previously determined transition rates from
the SBMwere used in the ABM. However, space-dependent rates,
like phagocytosis rates, had to be adequately transformed (17).
Regarding the fitting procedure, we used an adaptive regular grid
search that scans the parameter space within reasonable ranges
and uses a more fine-grained grid in regions with relatively small
least squares errors (LSEs).
Simulation Workflow
The work flow of this study, comparing wet-lab and in silico
experiments with different models is displayed in Figure 1. First,
we performed whole-blood infection assays for the two fungal
pathogens C. albicans and C. glabrata. Afterward, we applied
for each of the two pathogens the following steps. The results
from association and survival assays were used to fit the model
parameters of the SBM to these data. The transition rates of the
fit with the lowest LSE were then appropriately transformed and
fed into the ABM. Subsequently, the grid search in the parameter
space was applied to fit the ABM to the experimental data and,
in this way, to estimate the diffusion coefficients of neutrophils
and monocytes. The determined transition rates and migration
parameters form the basis for all following investigations on neu-
tropenia and possible treatment strategies in virtual patients with
varying degree of neutropenia. In the following, each step of this
work flow is described in more detail.
Infection in Virtual Patients With Normal Neutrophil
Counts
For the quantification of the immune response against the human-
pathogenic fungi C. albicans and C. glabrata with normal neu-
trophil counts, we first determined the transition rates by fitting
the SBM to the corresponding data from whole-blood experi-
ments. These rates were used in the ABM and diffusion coeffi-
cients for neutrophilsDN and monocytesDM were determined by
fitting the ABM to the experimental data.
Infection in Virtual Patients Under Neutropenic
Condition
To examine the immune response of virtual patients under condi-
tions of neutropenia, we performed simulationswith the immune-
reaction rates and migration parameters that were identified
under non-neutropenic conditions and gradually decreased the
number of neutrophils. Subsequently, we compared the infection
outcome at 4 h post infection for varying degrees of severity of
neutropenia.
Patterns and Classification of Simulations
Since the health of a patient is critically determined by the amount
of killed pathogens PK as well as by the amount of alive and
immune-evasive pathogens PAIE, we used these measures to char-
acterize the infection outcome for the virtual patients.
We distinguish four different casesC for the infection outcome:
an infection outcome corresponding to non-neutropenic
immune conditions as well as the infection outcome under mild,
moderate or severe neutropenia, i.e., C= {non–neutropenic,
mild, moderate, severe}. To discriminate these classes, we
calculated the patterns ψ= (μ(PK)± σ(PK), μ(PAE)± σ(PAE),
μ(PAIE)± σ(PAIE)) at the transition between consecutive degrees
of neutropenia severity, in terms of themean and SD. This resulted
in the three patterns ψ= {ψnm, ψmm, ψms} at the transitions
between two neutropenia severity levels: non-neutropenic–mild
(nm), mild–moderate (mm), and moderate–severe (ms). For the
classification of a particular simulation, we calculated the class of
the values PsimK and PsimAIE at 4 h post infection. Then, we classified
each of the three values of v(PK)= (μ(PK)+ σ(PK), μ(PK),
μ(PK)− σ(PK)) and v(PAIE)= (μ(PAIE)+ σ(PAIE), μ(PAIE),
μ(PAIE)− σ(PAIE)) separately. Thus, for each of the three values
vi, we set:
C (vi (PK)) =
μ (PnmK )− σ (PnmK ) ≤ vi ≤ 1, C = non-neutropenic
μ (PmmK )− σ (PmmK ) ≤ vi ≤ μ (PnmK ) + σ (PnmK ) , C = mild
μ (PmsK )−σ (PmsK ) ≤ vi ≤ μ (PmmK )+σ (PmmK ) , C=moderate
0 ≤ vi ≤ μ (PmsK ) + σ (PmsK ) , C = severe
,
(6)
C (vi (PAIE)) =
0 ≤ vi < μ (PnmAIE) + σ (PnmAIE) , C = non-neutropenic
μ (PnmAIE)− σ (PnmAIE) ≤ vi ≤ μ (PmmAIE) + σ (PmmAIE) , C = mild
μ (PmmAIE)−σ (PmmAIE)≤vi≤μ (PmsAIE)+σ (PmsAIE) , C=moderate
μ (PmsAIE)− σ (PmsAIE) ≤ vi < 1, C = severe
.
(7)
The simulation’s infection outcome C is then assigned to the
class that received the highest number of votes from the nine
values of vi(PK) and vi(PAIE).
In Silico Treatment of Neutropenia and Identification
of Optimal Treatment Strategies
After the simulation of VNP, we simulated the medical treat-
ment of these patients. Therefore, we selected virtual patients
with certain degrees of severity of neutropenia. These are the
number of neutrophils that are specific for a transition between
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two degrees of severity as well as the number of neutrophils
between these transitions. Therefore, we simulate the following
five VNP that are characterized by specific ANC: VNP-1 with
1,250 neutrophils/μl, VNP-2 with 1,000 neutrophils/μl, VNP-3
with 750 neutrophils/μl, VNP-4 with 500 neutrophils/μl, VNP-
5 with 250 neutrophils/μl. Thus, the ANC of these VNP corre-
sponds to a decrease in neutrophil number from the standard
value by VNP-1: 75%, VNP-2: 80%, VNP-3: 85%, VNP-4: 90%,
and VNP-5: 95%. Since the treatment with different drugs might
improve the phagocytic activity and/or the migration parameter
of neutrophils, we performed simulations with the ABM where
the phagocytosis rate of neutrophils φN as well as their diffusion
coefficient DN was increased. In the following, we refer to these
parameters that are affected by the treatment as φTN and DTN.
For the sake of comparability of both values, we increased
both values in a stepwise fashion. The increase of these values
lead to an improvement in the infection outcome. For example,
a virtual patient with moderate neutropenia and a simulated
treatment might attain an infection outcome that corresponded
to that of a patient with mild neutropenia or even to an infec-
tion outcome for an individual with a non-neutropenic immune
status. Therefore, after simulating with a certain parameter set
(φTN, DTN) we classified the simulation outcome as described
earlier.
The stepwise increase of the parameters was continued until a
parameter configuration was found with an infection outcome for
non-neutropenic individuals. For quantification of the improve-
ment of the infection outcome, we fitted an exponential function
fφN = 1+ a · e−b ·fDN at the transitions between two consecutive
degrees of neutropenia severity. Here, the factors fφN and fDN are
given by fφN = φTN/φminN and fDN = DTN/DminN , and denote the
ratios between the treatment parameter values (φTN, DTN) and the
parameter values (φminN , DminN ) obtained fromminimizing the LSE
under non-neutropenic conditions.
RESULTS
Whole-Blood Infection Assays Differ for
C. albicans and C. glabrata
In this study, we performed human whole-blood infection assays
with C. glabrata and compared the measured data with exper-
imental measurements for C. albicans by applying a previously
established protocol (16). The kinetics of pathogens associated
with either neutrophils ormonocytes can be seen in Figures 2A,B,
respectively. In case of C. glabrata, 81.0± 8.1% cells were asso-
ciated with neutrophils, which is similar to C. albicans with
82.3± 7%. However, the experimental data show different kinet-
ics for the two species, since C. glabrata is phagocytosed by
neutrophils in a shorter time. By contrast, the association with
monocytes is higher for C. glabrata with 10.1± 2.7%, while only
2.7± 1.9% C. albicans cells were associated with monocytes 4 h
post infection. Due to the phagocytosis of the pathogens by
the immune cells, 4 h post infection, 8.9± 7.5% cells remained
extracellular for C. glabrata and 15.0± 5.8% for C. albicans (see
Figure 2C). The remaining extracellular cells are referred to as
immune-evasive cells, as already introduced in previous studies
(16, 17). Furthermore, 1.3± 1.5%C. glabrata cells remained extra-
cellular and alive 4 h post infection (seeFigure 2D), which is lower
compared with C. albicans with 6.5± 4.2%. In comparison with
FIGURE 2 | Experimental data of whole-blood infection assays for Candida albicans (light color) and Candida glabrata (dark color), respectively. After incubation
populations of extracellular cells (A), alive cells (B), as well as pathogens phagocytosed by either neutrophils (C) or monocytes (D), were measured by flow cytometry
and plating assays.
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C. albicans, the decrease in alive C. glabrata cells mainly occurred
during the first 2 h of the experiment exhibiting a much faster
kinetics than for C. albicans.
Quantification of Immune-Reaction Rates
Reveals Differences Between Pathogens
To quantify infection scenarios for the two pathogens, immune-
reaction rates of the SBM were estimated by fitting to the exper-
imental data as done previously for C. albicans in human whole
blood (17). As explained in detail in Section “Material and Meth-
ods,” this was done by computing the so-called combined units,
which are combinations of different pathogen states and were
directly accessible in experiment. In terms of these combined
units, we evaluated the quality of a simulation by calculating the
LSE between the experimental data and the in silico data. To
determine the immune-reaction rates representing the best fit to
the experimental data, i.e., that are associated with the lowest
LSE, we applied the method of Simulated Annealing based on the
Metropolis Monte Carlo scheme. The resulting immune-reaction
rates from the fitting procedure where used to simulate the infec-
tion with the pathogens in 1ml of blood, containing 5 × 106
neutrophils, 5 × 105 monocytes, and 1 × 106 cells, and are shown
in Figure 3 and in Table S1 in Supplementary Material.
The values of immune-reaction rates forC. albicans infection of
whole blood are in linewith our previous results (17). The reaction
rate values for C. glabrata infection mostly differ in comparison
to reaction rates for C. albicans infection (see Figure 3). The
phagocytosis rate of neutrophils in the infection scenario with
C. glabrata is φN = 10.11× 10−2 min−1, which is 3.5 times higher
than forC. albicans infection. The phagocytosis rate formonocytes
FIGURE 3 | Transition rates obtained from the calibration of the state-based
model (SBM) to experimental data of the whole-blood infection assay for
Candida albicans (blue) and Candida glabrata (pink), respectively. The values
are compared for the phagocytosis rate for neutrophils (φN), and by
monocytes (φM), killing rate for neutrophils (κN) and monocytes (κM), the rate
at which the pathogens can evade the immune response with regard to
phagocytosis and/or killing (ρ) as well as the rates that define the extracellular
killing, i.e., γ and κ¯EK. Error bars correspond to SDs.
is with φM = 13.69 × 10−2 min−1 an order of magnitude higher
than in the case ofC. albicans infection. These higher phagocytosis
rates arise due to the faster kinetics measured for C. glabrata in
the experimental data (see Figure 2). Furthermore, the order in
the magnitude of phagocytosis rates is reversed in comparison
to C. albicans infection, because for C. glabrata the phagocytosis
rate of monocytes is 1.4 times higher than that for neutrophils.
The killing rate of neutrophils is for C. glabrata κN = 6.98 ×
10−2 min−1, which is only slightly higher than for C. albicans
infection. Furthermore, differences between the fungal pathogens
are again observed in the killing rate for monocytes, which is
1.5 times higher for C. glabrata with κM = 3.22 × 10−2 min−1
compared withC. albicans.Aswas previously observed forC. albi-
cans (16, 17), also C. glabrata was found to evade the immune
response and to remain even hours post infection alive and non-
phagocytosed in humanwhole blood (Figures 2C,D). The rate for
fungal cells becoming evasive against the immune response is for
both pathogens comparably low, i.e., ρ= 1.173 × 10−2 min−1 for
C. glabrata and ρ= 0.439 × 10−2 min−1 for C. albicans. A com-
parison of both rates that define the extracellular killing by antimi-
crobial peptides (κEK(t)) showed that the value of κ¯EKis similar for
both pathogens (see Table S1 in Supplementary Material) and γ is
2.5 times larger for infection scenarioswithC. glabrata (γ= 5.39×
10−2 min−1).
The time-resolved kinetics of the fits with the lowest LSE for
the two fungal pathogens can be seen in Figures S1 and S2 in
Supplementary Material, where the thickness of the simulation
curves reflect random variations within the SDs of the immune-
reaction rates. For both pathogens, the SBM adequately resembled
the experimental data. Since the SBM neglects all spatial aspects
of the infection scenarios, we performed a bottom-up modeling
approach by combining the SBM with the ABM (17).
Migration Parameters of Phagocytes in
Response to Various Pathogens Differ
Quantitatively
To determine themigration parameters of neutrophils andmono-
cytes in whole-blood infection scenarios with the respective
pathogens, we used the experimentally measured data as well
as the fitted immune-reaction rates from the SBM to perform
stochastic spatiotemporal simulations by the ABM in 1μl of
blood. As a result of this bottom-upmodeling approach for whole-
blood infection assays, we obtained the diffusion coefficients of
the immune cells in response to C. albicans. This can be seen in
Figure 4A, where the best solution, i.e., the parameter configura-







425 μm2/min, 175 μm2/min
)
. In line
with our earlier findings (17), for C. albicans the LSE was sensitive
for variations inDN but not for variations inDM. The range ofDM
that still lead to comparably low LSE values spans from approxi-
mately 100μm2/min up to 500μm2/min, whereas the range with
comparably low LSE for DN was limited to 400–425μm2/min. As
shown in Figure S3 in Supplementary Material, the fitting results
are in excellent agreement with the experimental data, and the
stochasticity of the in silico experiments still give rise to low SDs
in the simulation curves, as can be inferred from the thickness of
the curves representing 30 runs.
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FIGURE 4 | Result of the agent-based model (ABM) parameter estimation for whole-blood infection assays with Candida albicans (A) and Candida glabrata (B).
Adaptive regular grid search was applied to fit the ABM to the experimental data and diffusion coefficients for neutrophils (DN) and monocytes (DM) were determined.
At each grid point 1μl blood was simulated, and 30 realizations for each parameter configuration were performed. Three different refinement levels were performed:
simulations of the first level are represented as dots, simulations of the second level are represented as squares, and simulations of the third level are represented as
triangles. The best fit to the experimental data was found at (DminN , D
min
M ) = (425 μm2/min, 175 μm2/min) for C. albicans and at (DminN , DminM ) = (600 μm2/min,
425 μm2/min) for C. glabrata.
The best fit of the simulation curves to the experimental data
of whole-blood infection assays for C. glabrata was achieved for
diffusion coefficients for neutrophils and monocytes with values
(DminN , DminM ) = (600 μm2/min, 425 μm2/min) (see Figure 4).
We note that the range in which the diffusion coefficient of
monocytes can vary for comparable LSE values was found to
be much more restricted than in the case of C. albicans, i.e.,
this range for DM was from 350μm2/min up to 575μm2/min
for fitting results with comparable LSE. However, in the case of
C. glabrata, neutrophils were not found to be restricted to the
small range of only ±12μm2/min as for C. albicans, but could
vary in a range of ± 80μm2/min. As can be seen in Figure S4 in
Supplementary Material, the experimentally determined kinetics
of the infection scenario with C. glabrata is in excellent agreement
with the simulation curves of the ABM.
Immune Response in Virtual Patients With
Neutropenia Is Strongly Pathogen
Dependent
Our previous considerations reveal that immune cells exhibit a
qualitatively and quantitatively different response against C. albi-
cans and C. glabrata in human whole-blood infection assays.
Comparing C. glabrata to C. albicans infection, this is reflected
by (i) increased phagocytosis rates and (ii) increased diffusion
coefficients by factors of 1.4 and 2.4, respectively, for neutrophils
and monocytes. In line with our previous work on the com-
parison between C. glabrata with C. albicans by live-cell imag-
ing of phagocytosis assays (23–26), these quantitative differences
are accompanied with the qualitative variation in the immune
response that involves much stronger monocyte activation in
the case of C. glabrata. Nevertheless, a prominent role is played
by neutrophils that are quantitatively prevalent in cell number
and qualitatively important in differently directing the immune
response against these fungal pathogens (23).
To investigate the impact of neutropenia on the infection out-
come with a specific pathogen, we simulated VNP using the
ABM. Here, the optimal immune-reaction rates and diffusion
coefficients were used as previously determined for normal ANC
values. In the virtual patients, we stepwise decreased the number
of neutrophils to resemble different degrees of severity of neu-
tropenia and simulated the early immune response during 4 h
post infection. The contributions of the combined units—such
as killed, phagocytosed and immune-evasive Candida cells at 4 h
post infection—are shown in Figure 5.
The phagocytosis by neutrophils is for both pathogens quite
similar. For mild neutropenia the phagocytosis by neutrophils
ranges for both fungal pathogens between ~40 and 50%, for
mild neutropenia between ~25 and 40%, and is below ~25% for
severe neutropenia. Interestingly, despite these similarities, the
infection outcomes for the two pathogens under the condition of
neutropenia are predicted to be remarkably different. As shown
in Figure 5A, a stronger impact on the infection outcome can
be observed for C. albicans, where in the scenario of severe neu-
tropenia the number of killed fungal cells achieves only 10–45%.
By contrast, killing of C. glabrata in severe neutropenia is more
efficient, and the fraction of dead cells ranges between 45 and 60%
of total fungal cells (see Figure 5B).
This difference is governed by the behavior of monocytes in
response to the two fungal pathogens. Higher phagocytosis rates
in case ofC. glabrata compared withC. albicans enable monocytes
to partially compensate for the loss of neutrophils under condi-
tions of neutropenia. This compensatory effect is relatively low
for C. albicans, where the fraction of cells that were phagocytosed
by monocytes increased from 3% for normal ANC to only 12%
under the condition of severe neutropenia (see Figure 5A). For
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FIGURE 5 | In silico infections under neutropenic conditions with Candida albicans (A) and Candida glabrata (B) were performed by gradually decreasing the
absolute neutrophil count in the agent-based model. Plots show the fraction of killed cells (red), alive and extracellular cells (green), phagocytosed cells by neutrophils
(blue), and monocytes (yellow) as well as (alive) cells that are able to evade the immune system (turquoise) at 4 h post infection.
C. glabrata, this increase in monocyte phagocytosis rose from 10
to 46% of the C. glabrata cells (see Figure 5B). Furthermore, the
infection outcome is also characterized by the number of cells
that are able to evade the immune response. Immune evasion is
more pronounced for C. albicans, where also for normal ANC
15% of all fungal cells are able to evade the immune response (see
Figure 5A). However, with stronger degrees of neutropenia the
fraction of these cells even increases to about 60%. In the case of
C. glabrata, only 10% of the cells can evade the immune response
for normal ANC, while this fraction rises up to 50% under con-
ditions of severe neutropenia (see Figure 5B). As explained in
Section “Materials andMethods,” the infection outcome is mainly
characterized by the fraction of killed as well as the fraction of
alive and immune-evasive Candida cells. Therefore, we assigned
the values of PK and PAIE at the boundaries to pattern that charac-
terize the different degrees of severity of neutropenia (see Table
S2 in Supplementary Material). Subsequently, with the help of
these patterns, we were able to classify simulations of medical
treatments in neutropenic patients.
Simulation of Medical Treatment for VNP
After we simulated the infection with the pathogens C. albicans
and C. glabrata in VNP, we selected five types of VNP with
different severity degrees of neutropenia for in silico treatment.
The VNP-1 is characterized by an ANC of 1,250 neutrophils/μl
representing patients with mild neutropenia. At the transition
between mild and moderate, the ANC is 1,000 neutrophils/μl,
and the corresponding VNP is referred to as VNP-2. Similarly,
we defined VNP-3, VNP-4 and VNP-5 that are characterized,
respectively, by ANC of 750 neutrophils/μl (moderate neutrope-
nia), 500 neutrophils/μl (transition between moderate and severe
neutropenia), and 250 neutrophils/μl (severe neutropenia). The
in silico treatment involves the increase of neutrophil activation
in terms of their phagocytosis rate and/or diffusion coefficient
to quantitatively investigate its impact on the reduced numbers
of neutrophils in these patients. Thus, increasing the phagocy-
tosis rate and/or diffusion coefficient of neutrophils in a step-
wise fashion, we simulated the infection with either of the two
pathogens C. albicans and C. glabrata under neutropenic con-
ditions. Afterward, the infection outcome of the simulation was
classified according to the previously determined pattern (see
Patterns and Classification of Simulations). To find a formal
description of the increase of neutrophil phagocytosis rate and
diffusion coefficient required for reaching the infection outcome
for non-neutropenic individuals, we fitted an exponential func-
tion of the form fφN = 1 + a · e−b ·fDN at the transition
where the non-neutropenic infection outcome is reached. Here,
the factors fφN and fDN are defined as fφN = φTN/φminN and
fDN = DTN/DminN , where φTN and DTN denote parameters that are
affected by the treatment, and φminN andDminN refer to the parameter
values obtained by minimizing the LSE under non-neutropenic
conditions. We varied φTN and DTN over one order of magnitude,
i.e., fφN , fDN ∈ [1, 10], and plotted the resulting curves for each
type of VNP in Figure S5 in SupplementaryMaterial for the fitting
parameters a and b as provided in Table S3 in Supplementary
Material.
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FIGURE 6 | In silico treatment of virtual neutropenic patients (VNP) infected with Candida albicans was simulated using the agent-based model. Stepwise increase of
phagocytosis rate and diffusion coefficient of neutrophils was performed for VNP with various severity degrees of neutropenia: VNP1–5: 1,250 (A), 1,000 (B), 750
(C), 500 (D), and 250 (E) neutrophils/μl. Simulated points are classified according to the previously determined patterns: green points show a non-neutropenic
infection outcome, yellow points show an infection outcome comparable to a mild neutropenia, orange points show an infection outcome comparable to a moderate
neutropenia, and red points show an infection outcome comparable to a severe neutropenia. Solid lines depict the fitted exponential function fΦN = 1+ a · e
−b·fDN
at the transition to the non-neutropenic infection outcome. For comparison the fitted curves for the five VNP with their severity degrees of neutropenia are shown in
panel (F).
The results for the in silico treatment of VNP with C. albicans
and C. glabrata infection are shown in detail in Figures 6 and
7, respectively. Performing more than 4× 104 simulations, we
generally found that all VNP do reach the infection outcome
of non-neutropenic patients by increasing neutrophil activation
in terms of phagocytosis rate and/or diffusion coefficient. As
could be expected, the required increase in neutrophil activation
depends on the severity degree of neutropenia in VNP. For VNP
with severe neutropenia (VNP-5), reaching the infection outcome
of non-neutropenic patients would require relatively high values
for φTN with fφN > 10, whereas the treatment was always successful
for DTN with fDN ≪ 10. To compare the two fungal pathogens
with each other, we first fixed either φTN = φminN (fφN = 1)
or DTN = DminN (fDN = 1) and varied only one parameter,
respectively, DTN or φTN. As can be seen in Figure 8A, for both
fungal pathogens increasing the diffusion coefficient yields the
infection outcome of non-neutropenic patients at smaller factors
than increasing the phagocytosis rate, i.e., fDN < fφN . Interestingly,
increasing only the neutrophil diffusion, the in silico treatment
was found to be more effective for C. glabrata, whereas it turned
out to be more effective for C. albicans if only the phagocyto-
sis rate was increased. The combined impact of increasing φTN
and DTN yielded a pair (f ∗φN , f
∗
DN) of optimal values with minimal
distance from (fφN = 1, fDN = 1) where the infection outcome
of non-neutropenic patients was reached. The results are shown
in Figure 8B, where the comparison between C. albicans and
C. glabrata predicts that f ∗φN < f
∗
DN for the optimal in silico treat-
ment, i.e., the required relative increase of the diffusion coefficient
is larger than that for the phagocytosis rate. Moreover, the optimal
in silico treatment was reached for factors (f ∗φN , f
∗
DN) with lower
values for all VNP in the case of C. glabrata.
DISCUSSION
In this study, we investigated bloodstream infections with the
fungal pathogens C. albicans and C. glabrata in human whole
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FIGURE 7 | In silico treatment of virtual neutropenic patients (VNP) infected with Candida glabrata was simulated using the agent-based model. Stepwise increase of
phagocytosis rate and diffusion coefficient of neutrophils was performed for VNP with various severity degrees of neutropenia: VNP1–5: 1,250 (A), 1,000 (B), 750
(C), 500 (D), and 250 (E) neutrophils/μl. Simulated points are classified according to the previously determined patterns: green points show a non-neutropenic
infection outcome, yellow points show an infection outcome comparable to a mild neutropenia, orange points show an infection outcome comparable to a moderate
neutropenia, and red points show an infection outcome comparable to a severe neutropenia. Solid lines depict the fitted exponential function fΦN = 1+ a · e
−b·fDN
at the transition to the non-neutropenic infection outcome. For comparison, the fitted curves for the five VNP with their severity degrees of neutropenia are shown in
panel (F).
blood. Special focus was put on the infection scenario under
neutropenic conditions as well as possible treatment strategies.
These conditions are clinically relevant as it is well established
that neutropenia promotes dissemination of Candida spp. during
bloodstream infection and impairs prognosis. We used a previ-
ously established bottom-up modeling approach that combines
different mathematical modeling approaches of increasing com-
plexity based onwet-lab experiments (17). To investigate infection
by different fungal pathogens, we first performed whole-blood
infection assays using blood of healthy individuals. In the past,
these whole-blood infection models have already been success-
fully applied to analyze the early immune response to clinically
relevant pathogens (27–29) and to identify their virulence factors
(30, 31). Furthermore, the influence of genetic polymorphisms on
the immune response have been tested (32, 33) as well as potential
therapeutic approaches and vaccine efficacy (34–38). In this study,
we applied this experimental modeling approach to investigate
early immune responses to the two Candida spp. in blood. The
resulting experimental data showed that the immune response
followed a faster kinetics forC. glabrata than forC. albicans, which
is reflected by an earlier phagocytosis of this pathogen. In line
with our previous studies (16, 17, 23), monocytes were found
to contribute more to the immune response against C. glabrata
compared with C. albicans.
The system behavior was quantified by estimating values for
immune-reaction rates, such as phagocytosis and killing rates,
based on fitting a SBM to the experimentally measured data
(17). As expected from the observed difference in the kinetics
of the immune response between C. albicans and C. glabrata, we
found that the phagocytosis rates were orders ofmagnitude higher
for C. glabrata with monocytes reaching the highest values (see
Table S2 in Supplementary Material). Thus, for C. glabrata the
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FIGURE 8 | The increase in neutrophil activation required to reach the infection outcome of non-neutropenic patients depends on the severity degree of neutropenia
in VNP. (A) Comparison of Candida albicans (blue) and Candida glabrata (pink) infection for various VNP in terms of the factors fDN and fφN keeping either fφN = 1 or





) with minimal distance from (fφN = 1, fDN = 1) at
which the infection outcome of non-neutropenic patients is reached.
phagocytosis rate for monocytes is higher than for neutrophils
and this relation is inverted for C. albicans. Applying a bottom-up
modeling approach (17), we used an ABM to estimate migration
parameters for neutrophils and monocytes in response to the two
fungal species. For C. glabrata these migration parameter were
higher than for C. albicans. As previously shown for C. albicans
the outcome of the immune response was restricted to a narrow
regime of migration parameters for the neutrophils (17), whereas
these migration parameters in the case of C. glabrata infections
could vary over a significantly wider range to fit the experimental
data. This is another indication for the observable fact that mono-
cytes play a more important role in the defense against C. glabrata
compared with C. albicans (23, 39).
Since fungal infections by Candida spp. are a major risk for
immunocompromised patients, we extended the computer sim-
ulations for normal ANC by numerically studying infection sce-
narios in virtual patients with different severity degrees of neu-
tropenia. Due to the pronounced importance of neutrophils in
the immune response against C. albicans, these computer simu-
lations predicted a strong negative impact on the infection out-
come for VNP depending on the severity degree of neutropenia.
Although the impact of neutropenia on the infection outcome
during C. glabrata infection was not as strong as for C. albicans,
the immune response was still to a large extent impaired. For
example, this was observed by the prediction that the fraction
of killed pathogens at 4 h post infection decreased from around
90% for both species under normal ANC to about 50 and 10%
for C. glabrata and C. albicans for severe neutropenic conditions,
respectively. Moreover, at 4 h post infection, a fraction of 30%
C. albicans cells are still alive and extracellular in humanblood that
could contribute to the dissemination to other body parts in real
patients. While the fraction of alive and extracellular C. glabrata
cells is negligible at 4 h post infection, a large fraction of about 50%
is phagocytosed by monocytes including a few percent of fungal
cells that are still alive andmay disseminate by eventually escaping
from the monocytes. These data again point toward different
virulence traits in the two Candida spp. (40).
The bottom-up modeling approach for the simulation of infec-
tion scenarios under neutropenic conditions was established to
simulate the effects ofmedical treatments. To date there exist three
different ways to approach neutropenia in the clinical setting,
which comprise (i) the stimulation and activation of remain-
ing neutrophils by medical treatment of the patient, (ii) the
internal stimulation of neutrophil maturation and release from
the bone marrow by medication of patients with granulocyte
colony-stimulating factor (G-CSF), and (iii) the transfusion of
G-CSF/steroid mobilized neutrophils from a donor. The latter
treatment of healthy donors leads to a vast increase of peripheral
blood neutrophils (41–44), which are subsequently extracted from
the donor by leukapheresis and administered to the patient to
increase the ANC in blood. This therapy shows higher rates of
patient survival in the context of bacterial infections (43), whereas
improvement in patient survival was not consistently observed for
fungal infections (45–47). In particular, Gazendamet al. (48) show
that the G-CSF/dexamethasone stimulation of donor neutrophils
leads to a change in their granular content, which impairs the
fungal killing capacity with regard to C. albicans. The cytokine
treatment with G-CSF to trigger the neutrophil release from the
bonemarrow in patients is mainly applied in congenital neutrope-
nia and causes a significant increase of the ANC in blood (49,
50). Before effective drugs were available, childrenwith congenital
neutropenia typically died in their first year of life due to bacterial
and fungal infections (51, 52). The G-CSF treatment makes use
of the emergency mobilization of neutrophils in response to an
inflammatory signal and the secretion of chemokines leading to
neutrophil migration into blood vessels (53). However, patients
Frontiers in Immunology | www.frontiersin.org April 2018 | Volume 9 | Article 66711
138 Chapter 8: In silico treatment of virtual patients
Timme et al. In silico Treatment of Virtual Patients
can be also low-responders or even non-responders exhibiting
reduced effects of G-CSF (49, 54). Finally, instead of increasing
the circulating number of neutrophils, the option to medically
treat neutropenia by inflammatory cytokines, such as interferon
γ and tumor necrosis factor α, yields a modulation of the immune
response by the stimulation and activation of neutrophils in blood
(41, 44). Both cytokines have been reported to enhance the neu-
trophil response against fungi, e.g., Candida spp. (55), Aspergillus
spp. (56), and Cryptococcus spp. (57).
In this study, we focused on investigating the treatment of neu-
tropenic patients by inflammatory cytokines to quantify the possi-
bility of balancing neutropenic conditions and clearance of infec-
tion. The simulations of this in silico treatment revealed that an
increase of the phagocytosis rate and/or the migration parameter
of neutrophils generally improved the infection outcome. For both
Candida spp. under investigation, conditions of mild neutropenia
can be compensated resembling an infection outcome of non-
neutropenic individuals by an increase in either the phagocytosis
rate or the diffusion coefficient, or a combination of both, by less
than 25% percent. The computer simulations allowed us to rigor-
ously quantify the relative change in these parameters needed for
any severity level of neutropenia. In the case of severe neutropenia,
medical treatments would need to increase these parameters by
at least 250% for the phagocytosis rate and at least 300% for
the diffusion coefficient to reach infection outcomes in VNP
comparable to individuals with normal ANC. It should be noted
that the modulation of parameters has to be combined, because
even a 10-fold increase of the phagocytosis rate alone would not
recover the infection outcome of non-neutropenic individuals.
Thus, the quantitative simulation of in silico treatments generates
concrete predictions regarding the relative impact that treatments
with inflammatory cytokines are required to exert on these two
parameters. Moreover, our numerical experiments predict that
C. albicans compared with C. glabrata always requires stronger
increases in the phagocytosis rate and the diffusion coefficient for
the same conditions of neutropenia.
Clearly, the underlying model assumptions (such as spatial
homogeneity and absence of external forces) cannot be 1:1 trans-
lated into the in vivo situation—neither in small vessels nor in
tissue. Despite this, several predictions resulting from the model
could be confirmed in vivo or are in line with clinical findings
(16). For this study, this also applies to the observations that (i)
neutropenia may result in poor prognosis and a higher ratio of
disseminated candidiasis [e.g., Ref. (58, 59)] and (ii) monocytes
play a more important role in C. glabrata infection (23). Even
though clinical studies will ultimately be required to validate
our hypotheses, the first step would be to test these treatment
strategies in whole-blood infection assays and our simulations for
VNP can be used for this testing.
Our study may be extended in different ways. For example,
computer simulations for various pathogens, such as Staphylo-
coccus spp. and Streptococcus spp., which were shown to cause
bacteremia and sepsis under conditions of neutropenia, could
be performed (52, 60). Moreover, treatment strategies that lead
to an increased ANC in neutropenic patients, like the transfu-
sion therapy as well as the G-CSF treatment, could be simu-
lated and compared with the cytokine treatment considered in
this study. Furthermore, the bottom-up approach provides the
possibility to investigate the impact of other immune disorders
on the infection outcome with the pathogens under considera-
tion. Moreover, the generated predictions of this study could be
examined in future wet-lab experiments. Therefore, whole-blood
infection assays with C. albicans or C. glabrata in human blood
with reduced ANC could be performed. Such neutropenic blood
samples could be taken from patients with neutropenia, where it
should be considered that primary diseases of the patient may
affect the experimental results. Another possibility may be to
generate neutropenic blood samples in the wet lab by a controlled
reduction of the neutrophil number. However, this poses a high
challenge, since the remaining blood constituents will be affected
by side effects that cannot be well controlled. Investigating such
host–pathogen interactions by combining wet-lab and dry-lab
studies is in the spirit of system biology. This approach provides
a powerful tool to investigate biological systems in a qualitative as
well as quantitative fashion and enables hypothesis generation in
dry-lab as well as hypothesis testing in wet-lab studies.
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Supplementary Figure 1 Dynamics of combined units simulated by the SBM (red solid lines) with 
minimal least-squares error (LSE) to the experimental data from whole-blood infection assays with 
C. albicans (red dashed lines as guide for the eye). The error bars correspond to the standard 
deviations of five independent experiments. The thickness of the solid lines represents the standard 
deviation of the simulation results as obtained by 30 simulations for uniformly distributed transition 
rates as given in Table S1. The colored continuous lines represent the in silico kinetics of the fungal 
states that are referred to as the symbol with the same color. (A) The dynamics of killed fungal cells 
that were experimentally measured by survival assays. The corresponding combined unit 𝑃𝐾 
comprises the states of fungal cells that are killed and immune-evasive (𝑃𝐾𝐾𝐾), killed and extracellular 
(𝑃𝐾𝐾), killed in monocytes (𝑃𝐾𝐾) and killed in neutrophils (𝑃𝐾𝐾). (B) Time course of alive fungal 
cells that were measured by survival assays and simulated by the combined unit 𝑃𝐴. This is calculated 
by the sum of all states representing alive fungal cells, i.e. fungal states that are alive and immune-
evasive (𝑃𝐴𝐾𝐾), alive and extracellular (𝑃𝐴𝐾), and alive and in monocytes (𝑃𝐴𝐾) or in neutrophils 
(𝑃𝐴𝐾). (C) Kinetics of extracellular fungal cells that were measured by FACS analysis. These are 
compared with the dynamics of the combined unit 𝑃𝐾 that comprises states of fungal cells that are 
extracellular and alive (𝑃𝐴𝐾), extracellularly killed (𝑃𝐾𝐾) and immune-evasive (𝑃𝐾𝐾). (D) The in silico 
dynamics of fungal cells that are immune-evasive (𝑃𝐾𝐾) are the sum of alive (𝑃𝐴𝐾𝐾) and killed (𝑃𝐾𝐾𝐾) 
immune-evasive fungal cells at each time point of the simulation time. (E) The relative number of 
fungal cells in monocytes are experimentally measured by FACS analysis and simulated by the 
combined unit 𝑃𝐾 that is defined by the sum of fungal states in monocytes that are alive or killed, i.e. 
𝑃𝐴𝐾, 𝑃𝐾𝐾, respectively. (F) The kinetics of fungal cells in neutrophils were measured using FACS 
analysis and are comparable with in silico dynamics of the combined unit 𝑃𝐾. This is defined as the 
sum of all fungal states that are in neutrophils and either alive (𝑃𝐴𝐾) or killed (𝑃𝐾𝐾). (G) In silico 
kinetics of killed fungal cells in monocytes (𝑃𝐾𝐾) that are defined as the sum of intracellularly killed 
(𝑃𝐾𝐾𝐾) and extracellularly killed (𝑃𝐾𝐾𝐾) pathogens at each simulation time point. (H) In silico time 
course of fungal cells in neutrophils that were killed (𝑃𝐾𝐾). These cells were either killed 
intracellularly in neutrophils (𝑃𝐾𝐾𝐾) or killed extracellularly (𝑃𝐾𝐾𝐾). 
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Supplementary Figure 2 Dynamics of combined units simulated by the SBM (red solid lines) with 
minimal least-squares error (LSE) to the experimental data from whole-blood infection assays with 
C. glabrata (red dashed lines as guide for the eye). The error bars correspond to the standard 
deviations of five independent experiments. The thickness of the solid lines represents the standard 
deviation of the simulation results as obtained by 30 simulations for uniformly distributed transition 
rates as given in Table S1. The colored continuous lines represent the in silico kinetics of the fungal 
states that are referred to as the symbol with the same color. (A) The dynamics of killed fungal cells 
that were experimentally measured by survival assays. The corresponding combined unit 𝑃𝐾 
comprises the states of fungal cells that are killed and immune-evasive (𝑃𝐾𝐾𝐾), killed and extracellular 
(𝑃𝐾𝐾), killed in monocytes (𝑃𝐾𝐾) and killed in neutrophils (𝑃𝐾𝐾). (B) Time course of alive fungal 
cells that were measured by survival assays and simulated by the combined unit 𝑃𝐴. This is calculated 
by the sum of all states representing alive fungal cells, i.e. fungal states that are alive and immune-
evasive (𝑃𝐴𝐾𝐾), alive and extracellular (𝑃𝐴𝐾), and alive and in monocytes (𝑃𝐴𝐾) or in neutrophils 
(𝑃𝐴𝐾). (C) Kinetics of extracellular fungal cells that were measured by FACS analysis. These are 
compared with the dynamics of the combined unit 𝑃𝐾 that comprises states of fungal cells that are 
extracellular and alive (𝑃𝐴𝐾), extracellularly killed (𝑃𝐾𝐾) and immune-evasive (𝑃𝐾𝐾). (D) The in silico 
dynamics of fungal cells that are immune-evasive (𝑃𝐾𝐾) are the sum of alive (𝑃𝐴𝐾𝐾) and killed (𝑃𝐾𝐾𝐾) 
immune-evasive fungal cells at each time point of the simulation time. (E) The relative number of 
fungal cells in monocytes are experimentally measured by FACS analysis and simulated by the 
combined unit 𝑃𝐾 that is defined by the sum of fungal states in monocytes that are alive or killed, i.e. 
𝑃𝐴𝐾, 𝑃𝐾𝐾, respectively. (F) The kinetics of fungal cells in neutrophils were measured using FACS 
analysis and are comparable with in silico dynamics of the combined unit 𝑃𝐾. This is defined as the 
sum of all fungal states that are in neutrophils and either alive (𝑃𝐴𝐾) or killed (𝑃𝐾𝐾). (G) In silico 
kinetics of killed fungal cells in monocytes (𝑃𝐾𝐾) that are defined as the sum of intracellularly killed 
(𝑃𝐾𝐾𝐾) and extracellularly killed (𝑃𝐾𝐾𝐾) pathogens at each simulation time point. (H) In silico time 
course of fungal cells in neutrophils that were killed (𝑃𝐾𝐾). These cells were either killed 
intracellularly in neutrophils (𝑃𝐾𝐾𝐾) or killed extracellularly (𝑃𝐾𝐾𝐾). 
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Supplementary Figure 3 Dynamics of combined units simulated by the ABM (red solid lines) with 
minimal least-squares error (LSE) to the experimental data from whole-blood infection assays with 
C. albicans (red dashed lines as guide for the eye). The error bars correspond to the standard 
deviations of five independent experiments. The thickness of the solid lines represents the standard 
deviation of the simulation results as obtained by 30 simulations for uniformly distributed transition 
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 7 
rates as given in Table S1. The colored continuous lines represent the in silico kinetics of the fungal 
states that are referred to as the symbol with the same color. (A) The dynamics of killed fungal cells 
that were experimentally measured by survival assays. The corresponding combined unit 𝑃𝐾 
comprises the states of fungal cells that are killed and immune-evasive (𝑃𝐾𝐾𝐾), killed and extracellular 
(𝑃𝐾𝐾), killed in monocytes (𝑃𝐾𝐾) and killed in neutrophils (𝑃𝐾𝐾). (B) Time course of alive fungal 
cells that were measured by survival assays and simulated by the combined unit 𝑃𝐴. This is calculated 
by the sum of all states representing alive fungal cells, i.e. fungal states that are alive and immune-
evasive (𝑃𝐴𝐾𝐾), alive and extracellular (𝑃𝐴𝐾), and alive and in monocytes (𝑃𝐴𝐾) or in neutrophils 
(𝑃𝐴𝐾). (C) Kinetics of extracellular fungal cells that were measured by FACS analysis. These are 
compared with the dynamics of the combined unit 𝑃𝐾 that comprises states of fungal cells that are 
extracellular and alive (𝑃𝐴𝐾), extracellularly killed (𝑃𝐾𝐾) and immune-evasive (𝑃𝐾𝐾). (D) The in silico 
dynamics of fungal cells that are immune-evasive (𝑃𝐾𝐾) are the sum of alive (𝑃𝐴𝐾𝐾) and killed (𝑃𝐾𝐾𝐾) 
immune-evasive fungal cells at each time point of the simulation time. (E) The relative number of 
fungal cells in monocytes are experimentally measured by FACS analysis and simulated by the 
combined unit 𝑃𝐾 that is defined by the sum of fungal states in monocytes that are alive or killed, i.e. 
𝑃𝐴𝐾, 𝑃𝐾𝐾, respectively. (F) The kinetics of fungal cells in neutrophils were measured using FACS 
analysis and are comparable with in silico dynamics of the combined unit 𝑃𝐾. This is defined as the 
sum of all fungal states that are in neutrophils and either alive (𝑃𝐴𝐾) or killed (𝑃𝐾𝐾). (G) In silico 
kinetics of killed fungal cells in monocytes (𝑃𝐾𝐾) that are defined as the sum of intracellularly killed 
(𝑃𝐾𝐾𝐾) and extracellularly killed (𝑃𝐾𝐾𝐾) pathogens at each simulation time point. (H) In silico time 
course of fungal cells in neutrophils that were killed (𝑃𝐾𝐾). These cells were either killed 
intracellularly in neutrophils (𝑃𝐾𝐾𝐾) or killed extracellularly (𝑃𝐾𝐾𝐾). 
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Supplementary Figure 4 Dynamics of combined units simulated by the ABM (red solid lines) with 
minimal least-squares error (LSE) to the experimental data from whole-blood infection assays with 
C. glabrata (red dashed lines as guide for the eye). The error bars correspond to the standard 
deviations of five independent experiments. The thickness of the solid lines represents the standard 
deviation of the simulation results as obtained by 30 simulations for uniformly distributed transition 
149
 9 
rates as given in Table S1. The colored continuous lines represent the in silico kinetics of the fungal 
states that are referred to as the symbol with the same color. (A) The dynamics of killed fungal cells 
that were experimentally measured by survival assays. The corresponding combined unit 𝑃𝐾 
comprises the states of fungal cells that are killed and immune-evasive (𝑃𝐾𝐾𝐾), killed and extracellular 
(𝑃𝐾𝐾), killed in monocytes (𝑃𝐾𝐾) and killed in neutrophils (𝑃𝐾𝐾). (B) Time course of alive fungal 
cells that were measured by survival assays and simulated by the combined unit 𝑃𝐴. This is calculated 
by the sum of all states representing alive fungal cells, i.e. fungal states that are alive and immune-
evasive (𝑃𝐴𝐾𝐾), alive and extracellular (𝑃𝐴𝐾), and alive and in monocytes (𝑃𝐴𝐾) or in neutrophils 
(𝑃𝐴𝐾). (C) Kinetics of extracellular fungal cells that were measured by FACS analysis. These are 
compared with the dynamics of the combined unit 𝑃𝐾 that comprises states of fungal cells that are 
extracellular and alive (𝑃𝐴𝐾), extracellularly killed (𝑃𝐾𝐾) and immune-evasive (𝑃𝐾𝐾). (D) The in silico 
dynamics of fungal cells that are immune-evasive (𝑃𝐾𝐾) are the sum of alive (𝑃𝐴𝐾𝐾) and killed (𝑃𝐾𝐾𝐾) 
immune-evasive fungal cells at each time point of the simulation time. (E) The relative number of 
fungal cells in monocytes are experimentally measured by FACS analysis and simulated by the 
combined unit 𝑃𝐾 that is defined by the sum of fungal states in monocytes that are alive or killed, i.e. 
𝑃𝐴𝐾, 𝑃𝐾𝐾, respectively. (F) The kinetics of fungal cells in neutrophils were measured using FACS 
analysis and are comparable with in silico dynamics of the combined unit 𝑃𝐾. This is defined as the 
sum of all fungal states that are in neutrophils and either alive (𝑃𝐴𝐾) or killed (𝑃𝐾𝐾). (G) In silico 
kinetics of killed fungal cells in monocytes (𝑃𝐾𝐾) that are defined as the sum of intracellularly killed 
(𝑃𝐾𝐾𝐾) and extracellularly killed (𝑃𝐾𝐾𝐾) pathogens at each simulation time point. (H) In silico time 
course of fungal cells in neutrophils that were killed (𝑃𝐾𝐾). These cells were either killed 
intracellularly in neutrophils (𝑃𝐾𝐾𝐾) or killed extracellularly (𝑃𝐾𝐾𝐾). 
 
 
Supplementary Figure 5 The fitted curves 𝒇𝝓𝑵 = 𝟏 + 𝒂 ⋅ 𝒆−𝒃⋅𝒇𝑫𝑵  at the transition to the non-
neutropenic infection outcome with C. albicans (blue) or C. glabrata (pink) for VNP-1 – 3 (𝐀) and 
VNP-4 and VNP-5 (𝐁). 
  
150 Chapter 8: In silico treatment of virtual patients
  Supplementary Material 
 10 
1.2 Supplementary Tables 
 
Supplementary Table 1 Immune Reaction Rates estimated by fitting the state-based model (SBM) 
to the experimental data. The SBM comprises seven rates: the phagocytosis rate for neutrophils (𝚽𝑵) 
and for monocytes (𝚽𝑴), the rate for intracellular killing by neutrophils (𝜿𝑵) and by monocytes 
(𝜿𝑴), the rate for immune evasion by the pathogens (𝝆), the rates that define the extracellular killing 
by antimicrobial peptides, i.e. 𝜸  and 𝜿�𝑬𝑬.𝜸). 
Rate C. albicans C. glabrata 
 
mean 10−2 𝑚𝑚𝑚−1 sd 10−3 𝑚𝑚𝑚−1 sd [%] mean 10−2 𝑚𝑚𝑚−1 sd 10−3 𝑚𝑚𝑚−1 sd [%] 
𝚽𝑵 2.966 0.611 2.06 10.11 1.953 1.93 
𝚽𝑴 1.228 0.746 6.07 13.69 4.003 2.92 
𝛋𝑵 5.319 4.868 9.15 6.98 4.959 7.11 
𝛋𝑴 2.098 3.056 14.57 3.219 3.433 10.66 
𝝆 0.439 0.211 4.81 1.173 0.481 4.1 
𝜸 2.129 1.868 8.77 5.389 4.028 7.47 
𝜿�𝑬𝑬 21.78 17.46 8.02 22.98 27.74 12.07 
 
 
Supplementary Table 2 Values for killed cells (𝑷𝑬) as well as alive and immune-evasive cells 
(𝑷𝑨𝑨𝑬) at the transitions between different severity degrees of neutropenia for C. albicans and C. 
glabrata infection at four hours post infection. These values are used as a pattern for classification of 
the outcome of in silico treatment of virtual neutropenic patients. 
  mild moderate severe 
C. 
albicans 
𝑃𝐾 0.713 ± 0.014 0.623 ± 0.017 0.464 ± 0.02 
𝑃𝐴𝐾𝐾 0.26 ± 0.015 0.322 ± 0.016 0.417 ± 0.016 
C. 
glabrata 
𝑃𝐾 0.757 ± 0.012 0.707 ± 0.015 0.612 ± 0.018 





Supplementary Table 3 In silico treatment of VNP in infection with C. albicans and C. glabrata is 
predicted to reach the transition to the non-neutropenic infection outcome for VNP with various 
severity degrees of neutropenia. The function 𝒇𝝓𝑵 = 𝟏 + 𝒂 ⋅ 𝒆−𝒃⋅𝒇𝑫𝑵  is fitted to this transition with 
the parameters 𝒂 and 𝒃. 
Virtual Neutropenic 
Patient Type (VNP) 
C. albicans C. glabrata 
a b a b 
𝟏 12637.28 10.91 16974577.77 18.36 
𝟐 28.37 3.86 755.76 7.09 
𝟑 13.63 2.36 27.11 3.02 
𝟒 12.71 1.5 46.56 2.37 
𝟓 20 0.83 56.66 1.3 
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Comparative Assessment of
Aspergillosis by Virtual Infection
Modeling in Murine and Human Lung
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Aspergillus fumigatus is a ubiquitous opportunistic fungal pathogen that can cause
severe infections in immunocompromised patients. Conidia that reach the lower
respiratory tract are confronted with alveolar macrophages, which are the resident
phagocytic cells, constituting the first line of defense. If not efficiently removed in time, A.
fumigatus conidia can germinate causing severe infections associated with high mortality
rates. Mice are the most extensively used model organism in research on A. fumigatus
infections. However, in addition to structural differences in the lung physiology of mice
and the human host, applied infection doses in animal experiments are typically orders
of magnitude larger compared to the daily inhalation doses of humans. The influence
of these factors, which must be taken into account in a quantitative comparison and
knowledge transfer from mice to humans, is difficult to measure since in vivo live cell
imaging of the infection dynamics under physiological conditions is currently not possible.
In the present study, we compare A. fumigatus infection in mice and humans by virtual
infection modeling using a hybrid agent-based model that accounts for the respective
lung physiology and the impact of a wide range of infection doses on the spatial infection
dynamics. Our computer simulations enable comparative quantification of A. fumigatus
infection clearance in the two hosts to elucidate (i) the complex interplay between alveolar
morphometry and the fungal burden and (ii) the dynamics of infection clearance, which
for realistic fungal burdens is found to be more efficiently realized in mice compared to
humans.
Keywords: virtual infection modeling, Aspergillus fumigatus lung infection, mouse model, human model, hybrid
agent-based computer simulations
INTRODUCTION
The concept of systems biology constitutes a powerful approach to investigate biological
phenomena by combining wet-lab and dry-lab investigations that mutually support and
complement each other (1–3). However, systems biology of infection faces problems that can
interrupt the experiment-theory-cycle of systems biology (4–6). First, since in vivo experiments
are predominantly conducted in animals, the general transferability of findings in the context
of immunology to the human system is a matter of ongoing dispute (7, 8). Secondly, even in
animal experiments it may be impossible to capture the spatio-temporal dynamics of infection
processes. For example, in the case for lung infection in vivo time-lapse imaging is challenging due
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to animal breathing. In these cases, virtual infection modeling is
of particular importance, since it has the potential to advance
our knowledge despite the aforementioned limitations and to
generate hypotheses that direct future experiments in a targeted
manner (9, 10). In particular, building in silicomodels of infection
on the available experimental data basis, gives rise to realistic
to-scale models that can be used to compare the outcome of
computer simulations for animal and human systems.
In this study, we use virtual infection modeling to investigate
Aspergillus fumigatus lung infections. A. fumigatus is an
environmentally wide-spread fungus that is an opportunistic
pathogen causing severe infections in immunocompromised
patients (11–14). The fungal conidia are small in size of 2–3µm
(12, 13) and can reach the alveoli in the lower respiratory tract
of the lung. Because alveoli make up about 50% of the lung
volume and also make the largest contribution to lung surface
area, they are by far the most likely niche for infection (15).
If not efficiently removed by the innate immune system, A.
fumigatus can cause invasive pulmonary aspergillosis (IPA) with
high mortality rates of 30–90% (11). The resident immune cells
in the lung are alveolar macrophages (AM) that constitute the
first line of immune defense by phagocytosing the inhaled conidia
(11, 14, 16). Without efficient clearing by innate immunity, A.
fumigatus conidia can undergo morphological changes: Upon
contact to the surfactant layer, which covers the alveolar epithelial
cells (AEC) (15), resting conidia can swell and after ∼6 h start
forming hyphae. These hyphae are able to penetrate the epithelial
tissue of the alveolus and can thereby reach the bloodstream,
from where they may disseminate and cause severe systemic
infections (12, 13, 17). The first six hours after entrance of the
conidia in the lung are therefore considered as a critical time
frame, during which conidia need to be found in order to prevent
damage of host tissue. This implies that the role of adaptive
immunity can be neglected compared to a required rapid
response by innate immunity, e.g., involving the complement
system as well as phagocytic activity by AM and neutrophils.
The condition of neutropenia, i.e., the considerable reduction
in the absolute neutrophil count, poses a major risk factor
for IPA (14, 18). Therefore, the nowadays increasing number
of immunocompromised patients leads to a rising clinical
prevalence, making A. fumigatus a relevant target for fungal
infection research. Due to its complex interactions with the host
immune system and its ability to adopt different morphologies,
various levels of pathogenicity have to be considered in the
development of effective therapy (13, 19).
Various mammalian species have been used for experimental
research on A. fumigatus infection. Besides rats, rabbits, and
guinea pigs, mice models have been used most extensively (20).
It is important to note that—in order to provoke measurable
numbers of interactions between pathogens and host cells—the
experimentally applied infection doses typically are orders of
magnitude higher compared to the natural inhalation dose for
humans, which ranges between a few hundred and thousands of
conidia per day (21–25). Thus, in addition to studying animal
systems with host environments that are quite different from
the human system, the significant differences in the applied
infection doses need as well to be taken into consideration
in the knowledge transfer from animals to humans. However,
little is known about the comparability and transferability of
mouse infection models in wet-lab and natural A. fumigatus
infections in human. Therefore, in this study we compare A.
fumigatus infection in mice and humans using virtual infection
modeling to account for the respective lung morphologies and
study the impact of the infection doses. In passing we note
that, even though daily inhalation doses will be associated with
homeostatic clearance and will typically pass unnoticed, we
here use throughout the more general term infection clearance
involving inflammation, tissue damage and a multifactorial host
response in the case of high fungal doses.
In previous studies, we already implemented an infection
model for the simulation of A. fumigatus infection in humans.
The agent-based model (ABM) was built on an extensive
experimental data basis available from literature and represents
a typical human alveolus in three-dimensional continuous space
(26, 27). The human alveolus was composed of AEC of type I and
II, as well as of Pores of Kohn (PoK) representing connections
between neighboring alveoli (28, 29). Our computer simulations
revealed that AM performing random walk migration are not
able to reliably detect a conidium in the alveolus before the
onset of germination, i.e., before 6 h post infection (17, 26). This
led to the hypothesis that a not yet experimentally identified
chemotactic signal must exist that guides AM to the position of
the conidium in the alveolus (26). The virtual infection model
was then extended to explicitly incorporate chemokine secretion
and diffusion by solving partial differential equations in a hybrid
ABM (27). Scanning all unknown parameters within reasonable
ranges, we determined those relevant for efficient pathogen
clearance. For example, we found that a preferably high ratio
of chemokine secretion by AEC with rate sAEC over chemokine
diffusion with diffusion coefficient D is required to establish a
chemokine gradient that facilitates AM to detect a conidium
before the onset of germination.
While these studies considered the immune response in
human alveoli for daily inhalation doses of A. fumigatus conidia,
the focus of the present study is on comparing A. fumigatus
infections in mice and humans taking into account natural
as well as experimental infection doses. Thus, we significantly
adapted the agent-based virtual infection model to the to-
scale morphometry of mouse alveoli. This enables generating
comparative and quantitative predictions on the influence of
morphological factors as well as dose-dependent effects during
A. fumigatus infection in mice and humans.
RESULTS
Aspergillus fumigatus lung infection is commonly investigated
using mouse models (20), where the pathogens can be
administered in different ways (30): Intranasal deposition
and intra-tracheal/intra-bronchial instillation bring the conidia
directly in the nose or trachea/bronchia and are based on liquid
solutions, while a more natural administration is realized in
inhalation chambers with air-soluted conidia. All methods have
in common that relatively high doses of 106 − 108 conidia
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are applied; however, the amount of conidia which is actually
reaching the lower respiratory tract, i.e., the fungal burden in the
alveoli of the mouse lung is found to be in the range of 103 −
105 conidia (31, 32). On the other hand, it is reported that the
distribution of conidia is fairly uniform only for administration
by inhalation, whereas intranasal administration is accompanied
with the accumulation of conidia in specific lung sections,
i.e., inducing distributions with local variations in the fungal
burden (33). This implies that our in silico experiments need to
incorporate three major issues that differ from simulations of the
human infection scenario: (i) implementing the differences in the
morphometry of the lung for human andmouse, (ii) scanning for
a larger range of infection doses, and (iii) studying the limit of
high local fungal burdens due to the non-uniform distribution of
conidia for administration based on liquid solutions.
As a measure of fungal clearance, we introduced an infection
score ISs=H,M , where the superscript refers to the human (s = H)
or mouse (s = M) system and ISs=H,M = 0 (ISs=H,M = 1)
implies that infections were cleared in each (none) simulations
(for details see Materials and Methods section, Readout of
Simulations).
Putative Morphology-Related Impact on
Infection Clearance in Humans and Mice
As can be seen in Figure 1, the alveoli for human and mouse
have been implemented as to-scale models that are composed
of AEC of type I and II, as well as PoK. Given the differences
in the size and composition of alveoli for the two organisms
(see Table 1 and Supplementary Table 1), it can be expected
that infections may be cleared with different efficiency. For
example, the surface area of the human alveolus is about 20
times larger compared to that of the murine alveolus and the
number of AM per alveolus is about 6 times higher in the
human alveoli. This gives rise to a scanning area per AM, which
is about three times higher in humans suggesting that mice
could cope much better with the detection of alveolar pathogens.
However, the situation is complicated by the fact the number
of PoK per alveolar area is higher by a factor 5.7 in the mouse
alveolus, which together with the alveolar entrance ring gives
rise to an increase of the relative alveolus’ open boundary length
by a factor 3.4 compared to the human alveolus. On the one
hand, since AM can enter and leave the alveolus only across
these boundaries (28, 29), this may result in a faster infection
dynamics of the murine system. On the other hand, chemotactic
signaling molecules can as well flow out of the alveolus via these
boundaries implying that their increased length in the murine
alveolus may be of disadvantage with regard to establishing an
efficient chemokine gradient. Again, this argument may only
be valid for a low pathogen density in the alveolus, because
for high pathogen densities the induced chemokine profile may
TABLE 1 | Comparison of morphometric parameters and innate immune cells.
Parameter Human alveolus Mouse alveolus (references)
Radius of alveolus 116.5 µm 26.2 ± 7.2 µm (29, 34–41)
Number of type 1 AEC 48 4 (42)
Number of type 2 AEC 84 4 ± 2.4 (42–44)
Number of PoK 24 7 (45)
Type 1 AEC radius 27 µm 22 µm
Type 2 AEC edge length 9.34 µm 8.12 µm (42)
Number of alveoli per lung 4.8 × 108 3.3 ± 1.3× 106 (34, 41)
Number of AM 2.1 × 109 2.4 ± 0.7× 106 (42, 46)
Radius of AM 10.6 µm 9.5 µm (47)
The parameters of the human alveolus were taken from the literature search by Pollmächer
et al. (26) and those of the mouse alveolus have been retrieved from the indicated
references.
FIGURE 1 | Visualization of a to-scale alveolus in the hybrid agent-based model for mouse (A) and human (B). The alveolar entrance ring (left) and Pores of Kohn
(black) represent entry/exit points for AM (green) and chemokine flow (white isolines) induced by conidium (red). Alveolar surface is covered with epithelial cells of type
1 (yellow) and 2 (blue).
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provide an ambiguous signal for AM guidance. For the same
fungal burden inmice and humans, the pathogen density is much
higher in the murine alveolus, due to their much lower number
and smaller size. Therefore, A. fumigatus may be much more
efficiently cleared from the human lung. Taken together, these
considerations imply that the efficiency of the infection dynamics
will depend on the combination of the alveolarmorphometry and
the fungal burden that together impact on the chemokine profile
for AM migration in a way, which is impossible to quantitatively
predict without performing comparative computer simulations
of to-scale models.
Case of Low Fungal Burden: A. fumigatus
Infection More Efficiently Cleared in Mice
We first consider the case of low fungal burden, which we define
as the case where one A. fumigatus conidium per alveolus is the
highest alveolar occupation number (AON) that is statistically
expected to occur in the whole lung. The corresponding fungal
burden can be derived from the binomial distribution (see
Methods section for details) and is 2.5 × 103 in mice and
3 × 104 in humans (see Figure 2). This implies that the limit of
low fungal burden covers the dose of daily inhalation for humans,
but is relatively low for experimental conditions in typical mice
experiments. Examples of the infection dynamics can be seen for
humans and mice in Supplementary Videos 1, 2, respectively.
Our previous work on A. fumigatus infection in human
alveoli for low fungal burden revealed that a high secretion rate
sAEC of chemotactic molecules combined with a low diffusion
coefficient D of the chemokine is beneficial for a small infection
FIGURE 2 | Alveolar occupation number, the maximal expected number of
present conidia per alveolus, as a function of the fungal burden in mouse (blue)
and human (red). Black line represents the experimental range of fungal
burden, which is reached in typical mice model experiment.
score ISH in humans (27). In the present study, we screened





µm2/min and sAEC =[
1.5 × 103, 5× 105
]
min−1 for alveoli of mice and humans.
The numerical results for the quantitative comparison between
human and mouse is shown by the infection scores ISH,M in
Figure 3A. It can be observed that, for all combinations of D
and sAEC, the infection score in mice is significantly smaller:
ISM < ISH . Furthermore, it can be seen that the relation of a high
secretion rate and a low diffusion coefficient also leads to a more
efficient infection clearance in mice. The relative difference in the
infection scores of the two organisms, 1IS = 1− ISM/ ISH , is in
the range 50− 90 %, indicating that the murine system performs
always better than the human system in the limit of a low fungal
burden.
Case of Low Fungal Burden: Size of
Alveolus Governs Infection Dynamics
To dissect whether the infection dynamics is governed by the
chemotaxis or the alveolar size, we compared the probability
of directed AM migration resulting from one conidium in the
alveolus ofmice and humans. The chemokine concentration itself
falls off with the distance from the source AEC, i.e., the AEC in
contact with the conidium. In order to avoid that AM perform
mostly random walk migration, the chemokine gradient (i) must
not exceed a certain value to avoid saturation of AM chemokine
receptors and (ii) must not fall below a certain value to provide a
detectable signal. As a qualitative measure of gradient efficiency
we calculated the probability that AM follow the gradient
depending on the distance to the source AEC. This probability
reflects the impact of the chemokine gradient on AM migration
and was computed as explained in Supplemantary Methods (see




) in the human (s=H) and mouse (s=M) system.
The optimal parameters were computed from the 36 scanned
parameter combinations, {D1 . . .D6} × {sAEC1 . . . sAEC6}, for the
diffusion coefficient and the secretion rate as follows: Based on
the simulation results in terms of the infection score ISDi ,sAECi and
the limits of its respective 95%-confidence interval, we computed






weights wi = 1− ISDi ,sAECi for all those parameter combinations
that had infection scores not exceeding the minimal upper
limit of all confidence intervals (see Supplementary Video 3).
The optimal secretion rate sAECopt was determined in the same
way yielding for the human host DoptH = 34µm2min−1 and
sHAECopt = 1.5× 10
4min−1 and for the murine host DoptM =
61µm2min−1 and sMAECopt = 4.9× 10
4min−1 as the optimal
parameters in the limit of low fungal burden.
The probability of directed AM migration for both host
systems and for their respective optimal chemokine parameters
is plotted in Figure 3B. The two curves exhibit quantitative
similarity suggesting that the infection dynamics in the case
of a low fungal burden is mainly governed by the size of the
alveolus rather than the chemokine profile itself. Thus, in contrast
to the significantly larger human alveolus, AM in the murine
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FIGURE 3 | (A) Infection scores IS for random walk migration and selected examples of chemokine parameters in the limit of low fungal burden with AON = 1.
Dashed-dotted black line indicates the threshold infection score at ISt = 5%. Error bars represent 95%-confidence intervals received from bootstrapping. (B) Mean
probability for directed AM migration pdirected following the underlying chemokine gradient as a function of the distance from the source AEC. Chemokine parameters
are set to the corresponding optima Dopt and sAECopt in mice and men.
counterpart will typically perform directed migration across the
entire alveolus.
A. fumigatus More Efficiently Cleared in
Mice for Any Alveolar Occupation Number
Increasing the AON from one to higher conidia numbers, we
again performed computer simulations for various infection
scenarios that differ in the parameters for chemokine secretion
sAEC and diffusion coefficient D. However, multiple conidia
within the alveolus can lead to more complex chemokine
profiles derived from the various conidia-associated AEC that
are simultaneously serving as sources of chemokine secretion. In
Figure 4A the infection scores IS obtained from 103 simulations
are summarized for AON between one and six and for selected
secretion rates sAEC, while the numerical results for the full range
of studied parameter values is shown for human and mouse
in Supplementary Figure 1. Parameter regimes of efficient
infection clearance in these plots resemble those previously
found for one conidium in the human alveolus (27), indicating
that low ratios D/sAEC are as well preferred in the mouse
system.
Extending the computation of optimal chemokine parameters
for one conidium to larger AON enables computing
for both systems the average optimal parameter set (see
Supplementary Figure 2). We obtain for one to six conidia per
alveolus the averaged optimal valuesDoptH = 26±6.6µm2min−1
and sHAECopt = 1.1× 10
4 ± 6× 103 min−1 for the
human host and DoptM = 74 ± 22.4 µm2min−1 and
sMAECopt = 8.0× 10
4 ± 4, 1× 104 min−1 for the murine
host. In Figure 4B, we show that the resulting infection score IS
as a function of the AON is always significantly lower in mice
compared to humans.
Case of High Fungal Burden: Chemokine
Profile Can Deteriorate Clearance
Efficiency
Due to morphometric differences between the lungs of mice and
humans, the AON is not directly related to the fungal burden.
This follows from our earlier statistical considerations on the
highest AON that is expected to occur in the whole lung for
a given fungal burden (see Figure 2) exhibiting a significant
quantitative difference between mice and humans. Since the
number of more than 108 alveoli in the human lung exceeds that
of mice by more than two orders of magnitude, even in the case
of an extremely high fungal burden with 106 conidia in the lung,
the maximal AON for humans does not exceed two. In contrast,
the same fungal burden in the lung of mice yields a maximal
AON between five and six conidia in one alveolus. It thus follows
that a comparison between mice and humans for the same fungal
burden requires contrasting infection scenarios with different
AON. Of note, our analysis focuses on the maximal AON for a
given fungal burden, because it is argued that this configuration
will be directly correlated with the estimated time needed to
clear all occupied alveoli from the pathogen. In Figures 4C,D
the numerical results for the infection score IS are shown for
mice and humans as a function of the fungal burden, respectively,
for identical chemokine parameters and for the respective
optimal chemokine parameters. Supplementary Figure 3 shows
the infection score IS as a function of the fungal burden for
all the scanned parameter combinations. It can be seen by the
smaller infection scores in the murine host that infections are
still more efficiently cleared for the entire experimentally relevant
range of 103−105 conidia in the lung. In Supplementary Video 3
we indicated all combinations of chemokine parameters for
which the infection score reaches values below the threshold of
ISt = 5%.
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FIGURE 4 | Infection scores IS as a function of the AON (A,B) and the fungal burden (C,D) for selected secretion parameters with diffusion coefficient
D = 200 µm2min−1 (A,C) and for optimal chemokine parameters Dopt and sAECopt (B,D) in mice and men. Dashed-dotted black line indicates the threshold
infection score at ISt = 5%. Error bars represent 95% confidence intervals. Black line represents the experimental range of fungal burden, which is reached in typical
mice model experiment.
However, as we have mentioned before, administration of
conidia based on liquid solutions is reported to be associated
with higher local fungal burdens due to a more non-uniform
distribution of conidia (33). It can be seen in Figure 2 for a
uniform distribution of conidia that a high fungal burden in the
range 105 − 106 conidia per lung is associated with an AON
of two in the human system, whereas this value ranges between
three and six for the murine system. Consequently, for a non-
uniform distribution of conidia, such high AON can be reached
in the murine lung and these can result in infection scores that
are much higher than for the human system with AON of two,
even if the respective optimal chemokine parameters are applied
(see Figure 4B). Our spatio-temporal computer simulations of
the infection scenarios reveal that higher AON are associated
with chemokine profiles that deteriorate clearance efficiency.
Since the mouse alveolus contains more than 10 times fewer
AEC compared to the human alveolus (see Table 1), multiple
randomly positioned conidia will occupy most of the alveolus’
AEC associated with chemokine secretion from various source
AEC. First of all, this can lead to chemokine saturation that
will turn directed AM migration into random walk migration.
Secondly, if the number of conidia is increased further, this
will not alter the chemokine gradient anymore. Consequently,
AM will perform the inefficient random walk migration until a
sufficient number of conidia is detected, such that AMmigration
becomes again dominated by the chemokine gradient. Obviously,
this complex interplay between the morphometry of the alveolus
and the chemokine profile will be much less pronounced for
the larger human alveolus that consists of many more AEC. To
validate this hypothesis, we computed the mean values of the
chemokine concentration across all alveolar surface grid points
in the simulations and found that significant deviations arise
between the human and mouse alveolus starting at AON of
four. As can be seen in Figure 5, for AON above four the mean
concentration value in the murine alveolus does change only
slightly providing no additional chemotactic guidance to AM,
whereas it is still increasing in the human alveolus and can
provide chemotactic guidance associated with lower infection
scores IS in the human alveolus and in the limit of fungal burdens
well above the typical experimental range.
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FIGURE 5 | Mean of the normalized alveolar chemokine concentration as a
function of the AON in mice and men obtained from simulations. Error bars
represent the standard deviation of this measurement.
Simulation Results Are Qualitatively
Robust Against Variations of Model
Parameters
In the quantitative comparison of infection scenarios in mice
and humans, we so far assumed the same values for the
model parameters. For example, we assumed that the chemokine
secretion rates from human and murine alveolar epithelial cells
are similar. However, it may be argued that this does not
reflect the physiological reality correctly, since murine AEC are
effectively about 33% smaller in area and may thus exhibit a
reduced potential of chemokine secretion. Similarly, it is an
open question today whether the postulated chemotactic signals
in human and mice are transmitted by chemokines that are
structural homologs and can therefore be expected to have similar
diffusion coefficients in the surfactants of mice and humans.
While these uncertainties cannot be avoided, we estimated the
impact of variations in these parameters on the infection score in
humans andmice. To this end, we calculated the relative infection
score between the human andmurinemodel1IS = 1−ISM/ ISH ,
over all simulated parameter combinations in the experimental
range of fungal burdens. Setting both diffusion parameters in
humans and mice to identical values, the mouse shows lower
relative infection scores with a median value of 1IS = 0.49.
Next, we analyzed the robustness of the infection outcome
with regard to the diffusion coefficient and the secretion rate.
To this end, we compared the infection scores for humans and
mice for those simulated parameter combinations that obey the
scaling factors fD = DH/DM for the diffusion coefficient




AEC for the chemokine secretion rate.
For example, comparing diffusion coefficients with scaling factor
fD = 3−1 (i.e., DH = (20, 200, 2000) µm2/min, DM =
(60, 600, 6000) µm2/min) revealed a reduction in the median
FIGURE 6 | Median of the relative infection score between human and mouse,
1IS = 1− ISM/ISH, depending on the scaling factor for chemotaxis
parameters: fD = D






for the secretion rate (orange). Error bars represent the
standard errors.
value of the relative infection score to 1IS = 0.27 over the
scanned fungal burdens. This indicates that the infection score in
mice is higher in > 50% of all selected parameter combinations,
even if the diffusion coefficient is three times higher in the
murine alveolus (see Figure 6). The scaling factor of the secretion
rate fsAEC has a reversed impact on the relative infection score
reflecting that a high ratio sAEC/D induces low infection scores
(see Figure 6).
Taken together, our simulation results imply that our main
conclusions are qualitative robust against variations in the
chemotaxis parameters. As long as the associated scaling factors
have values fD > 10−1 or fsAEC < 10, the murine system
still shows better infection scores in more than half of all
screened fungal burdens, even if chemotactic signaling becomes
deteriorated. We therefore conclude that within these limits our
simulation results are qualitatively robust against variations in
the chemotaxis parameters.
DISCUSSION
In this study, we investigated clearance of Aspergillus
fumigatus infection from the lung of mice and humans by
computer simulation of the complex interplay between alveolar
morphometry and fungal burden in the dynamics of infection
clearance. Since in vivo live cell imaging of these processes in
the whole lung is still not possible today, we here extended a
previously developed model of IPA in humans (25, 26) to the
murine alveolus. The virtual infectionmodel represents a realistic
to-scale representation that was built on detailed experimental
data available on the morphometry of the alveolus in the two
hosts. Furthermore, alveolar macrophages as well as chemokine
secretion and diffusion were incorporated into the model and
we screened the physiologically relevant parameter ranges for
as small as possible infection scores IS, which represent the
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percentage of simulations for which clearance of all A. fumigatus
conidia from the lung took longer than 6 h.
One important finding of this study is that, for realistic fungal
burdens comprising daily inhalation doses in humans as well as
typical doses in mice experiments, infection clearance is more
efficiently realized in mice compared to humans. This result
holds true in the limit of low fungal burden, where at most
one conidium is present in the alveolus, as well as for larger
fungal burdens with a maximal number of two and three conidia,
respectively, in the alveolus of humans and mice. As we observed
before for the human system (27), a low ratio of chemokine
diffusion over secretion, D/sAEC, leads to more efficient infection
clearance in the murine system. However, our simulations
revealed that in the limit of low fungal burden the dominating
factor of efficient infection clearance in mice is the relatively
short distances between AM and conidia in the relatively small
murine alveolus. On the other hand, the chemokine profile played
a dominant role in the limit of high fungal burden, because for
four and more conidia in the relatively small murine alveolus
this is associated with a featureless chemokine profile that cannot
provide sufficient guidance to AM.
A quantitative comparison revealed that distinct optimal
chemokine parameters exist that ensure minimal infection scores
IS in the different alveoli of the two hosts. We therefore
performed simulations comparing the infection results for both
identical and optimal chemokine parameters. It should be noted
that, even for the same chemotactic molecule in mice and
humans, differences between optimal chemokine parameters can
be induced by various factors that are different in the two hosts,
such as the secretion competence of AEC and the viscosity
of the alveolar surfactant. In any case, the importance of a
well-established chemokine gradient as well as the functional
sensing by AM is reflected by the fact that conidia, which
are not detected within 6 h post infection, pose the risk of
germination, invasion, and systemic infection. We also studied
the case of non-uniform conidia distribution in the lung leading
to locally high AON in alveoli. In this limit, which is more
likely realized by the administration of conidia based on liquid
solutions, our calculations predict that four and more conidia
per alveolus can occur, leading to infection scores that are
clearly higher in mice than in humans. However, in general,
clearance of uniformly distributed conidia in the lung seems
to be more efficiently realized in mice than in humans and we
have demonstrated that this results are qualitatively robust over
a broad range of variations in the chemokine parameters. These
considerations are important with regard to the comparability
and transferability of mouse infection models to the human
system, e.g., with regard to estimating the efficiency of new
therapeutics. Virtual infection modeling in the scope of systems
biology has been applied to a broad range of biological systems
and pathogens, such as bacteria (48) and fungi (9, 10, 49–53),
since it provides a valuable tool to investigate infection processes
that are not directly accessible in experiment. Moreover, this
approach can direct future experiments by identifying key factors
that govern the counterplay of infection and inflammation and
require most attention. It should be mentioned that our results,
indicating that AM are not able to clear the infection in the
limit of a high fungal burden, are in line with previous findings
based on a more phenomenological modeling approach. We
applied evolutionary game theory on graphs to simulate several
aspects of the immune response against A. fumigatus lung
infection, including the complement system, phagocytosis by
AM as well as recruitment and phagocytosis by neutrophils in
one comprehensive model framework (54). This enabled us to
reconcile the contradictory view on AM in the literature (55,
56) and predicted an infection dose-dependent switch in their
function: While under low infection doses AM manage infection
clearance, their role switches to a regulatory function under high
infection doses by recruiting neutrophils (54).
In the future, validation of theoretical predictions needs to
be addressed in experimental investigations. To date, one of the
main limiting factors in understanding host response during
A. fumigatus infections is the poor experimental accessibility
and stable cultivation of alveolar tissue. However, new research
approaches including organ-on-a-chip systems, which reduce
the physiological complexity and bring nature closer to the
simplifying virtual infection models, are promising for a better
validation of e.g., alveolar epithelium properties or chemokine
parameters (57–59). A lung-on-a-chip model will enable testing
chemokine candidates for AM guidance, such as IL-8 that
binds to the AM surface receptor CXCR2 (60). Similarly, the
chemoattractant C5a is known to be activated by A. fumigatus
conidia along the alternative pathway of the complement system
(61, 62) and is able to trigger the secretion of macrophage
inflammatory protein-2 and neutrophil chemoattractant-1 by
AEC (63). Once chemokine parameters will have been identified
and inflammatory conditions in terms of cytokine profiles will be
accessible, the next step will be to extend the hybrid ABM toward
neutrophil recruitment and an explicit phagocytosis model along
the lines of our previous investigations based on evolutionary
game theory (54). This will allow for the investigation of
migration and phagocytic dynamics of AM, neutrophils and
AEC in the alveolar environment during the interaction with
pathogens. Furthermore, morphological changes of A. fumigatus
including swelling and hyphae formation have a strong impact
on phagocytosis of the fungus (17, 64) and can be included in
such a virtual infection model. A further advancement will be in
the scale-up of the alveolus to the higher organizational units of
alveolar sacs for a more comprehensive simulation of infection
scenarios.
MATERIALS AND METHODS
In this study, we extended our previously developed ABM
of in silico infections by Aspergillus fumigatus in the human
alveolus (26, 27) to the mouse alveolus in order to perform
comparative analyses. The ABM is a spatio-temporal multi-scale
model that simulates host-pathogen interactions on the cellular
and molecular level. Thus, cells like the fungal conidia and AM
are simulated as individual agents that migrate and interact in a
rule-based fashion, while the chemokine secretion by AEC and
the molecular diffusion of chemokines is simulated using partial
differential equations. Chemokines are uniformly secreted with
rate sAEC at the surface of each AEC, which is associated with at
least one conidium. The implementation of the ABM is described
in more detail in the Supplementary Material, while here the
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focus is on the main aspects associated with the extension to the
mouse alveolus.
Morphometry of the Mouse Alveolus and
Implementation
A comprehensive literature research was performed to design
the virtual infection model of the mouse alveolus as realistic
as possible. The most important morphology parameters are
summarized and compared with the human alveolus in Table 1,
from which other characteristics can be derived (see for examples
Supplementary Table 1). For example, it can be seen that the
radius (surface area) of a typical human alveolus is about 4.5 (20)-
fold larger compared to a murine alveolus. The numbers of AEC
of type 1 and 2 differ significantly in both organisms, i.e., a human
alveolus contains about 12.0-fold more type 1 and 21-fold more
type 2 AEC. Furthermore, the number of PoK is about 3.4 times
higher in the human alveolus. A video of both model alveoli is
provided in the (Supplementary Videos 1, 2).
Implementation of Mouse Alveolus in
Virtual Infection Model
The ABM was adjusted for the implementation of the mouse
alveolus with parameters as summarized in Table 1 and
Supplementary Table 1. This also required changes in the
algorithm for cell positioning on the alveolar surface. Type 1
AEC were placed as described before around the three-quarter
sphere (see Supplementary Material for details). Previously, type
2 AEC and PoK were placed at the borders between type 1
AEC. However, due to the larger ratio of type 2 AEC and PoK
with respect to type 1 AEC in mice, the positioning of PoK
and type 2 AEC had to be changed. We adjusted the position
of type 2 AEC and PoK uniformly across the whole border of
the type 1 AEC. While these changes in the cell positioning
were required for realistic configurations of mouse alveolus
morphometries, quantitative results of the ABM for the human
alveolus remained within the 95%-confidence interval. Moreover,
the smaller size of the mouse compared to the human alveolus
required adjustment of the Delaunay-triangulated grid, on which
the diffusion equation is solved (27). The number of grid points
could be reduced from 104 in the human alveolus to only
5.1 × 102, keeping the spatial resolution in the mouse alveolus
the same as in the human system (see Supplementary Table 1).
Readout of the Simulations
As a measure of fungal clearance we compute for various
infection scenarios the first-passage-time (FPT) of AM, i.e., the
time required for migrating AM to find all conidia in a particular
alveolus (26, 27). The relation between the FPT and the time
point of conidia germination, which corresponds to about 6 h
post conidia arrival, is obtained from repeating the simulation
of each infection scenario 103 times. From the corresponding
FPT distribution, we then compute an infection score, IS, as the
percentage p of simulations with FPT above 6 h: ISs=H,M =
p(FPT > 6 h), where the superscript refers to the human (s = H)
or mouse (s = M) system and ISs=H,M = 0 (ISs=H,M = 1) implies
that conidia were cleared in each (none) of the 103 simulations.
The various infection scenarios correspond to scanning the
parameter space in terms of AMmigration, chemokine secretion,
and diffusion, as well as conidia infection doses in alveoli of mice
and humans.
Comparison of Fungal Burden
For a given fungal burden δ, the conidia are distributed across
all alveoli nalv of the host’s lung. Assuming an independent
and uniform distribution of these conidia, we can describe the
probability of having ncon conidia present in one alveolus by






for δ repeats. To estimate the maximal AON that
is associated with a specific fungal burden, we computed ncon





The resulting number corresponds to the maximal AON that
can be expected to occur in the whole lung for a specific fungal
burden (see Figure 2). The corresponding IS was determined
by linear interpolation of the results from our simulations for
various AON.
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1 Supplementary Methods 
In this study, we implemented a to-scale model of the murine alveolus following our previous work 
on the implementation of the human alveolus. For details on the hybrid agent-based model (ABM), 
the reader is referred to the extended description of this model in the work by Pollmächer et 
al.(Pollmächer and Figge, 2014, 2015). This Supplementary Information presents essential aspects of 
the algorithmic implementation that are important in view of the current study.   
1.1 Alveolus Setup 
In close analogy to our previous work(Pollmächer and Figge, 2014, 2015), the human and murine 
alveoli were modeled as three-dimensional three-quarter spheres, with radius 𝑟𝐴𝑙𝑣
𝐻 = 116.5 𝜇𝑚  and 
𝑟𝐴𝑙𝑣
𝑀 = 26.2 𝜇𝑚 , respectively. The polyhedral shape of the alveolus was approximated by a spherical 
representation with surface points ?⃗? = 𝑐(𝑟𝐴𝑙𝑣, ϑ, 𝜑) and an entrance ring at the lower threshold value 
of the polar angle 𝜗𝑐 ≤ 𝜗 ≤ 𝜋.  Alveolar epithelial cells (AEC) of realistic dimensions were placed at 
the inner surface of the alveolus as follows: Centroids of type 1 AEC were placed in an equidistant 
fashion using a Voronoi tessellation to project cells on the curved geometry of the alveolus. Type 2 
AEC were placed randomly on the border between two neighboring type 1 AEC. The same procedure 
was applied for the positioning of Pores of Kohn. All cells were represented with realistic cell sizes 
and in realistic amounts as obtained from an in-depth literature search (see Table 1 and 
Supplementary Table S1).  
1.2 Chemokine Secretion and Diffusion 
The hybrid ABM(Pollmächer and Figge, 2014, 2015) was used to simulate chemokine secretion and 
diffusion on an equidistant grid of points on the surface of the alveolus. Placing 𝑛 points uniformly 
on a spherical surface is known as the Thompson problem(Thomson, 1904) and we used established 
algorithms(MacWilliam and Cecka, 2013) to generate a near-equidistant solution of a grid with 
10000 points and 513 points, respectively, for the human and murine alveolus, i.e. keeping the same 
spatial resolution in both systems. Chemokine diffusion was modeled solving the reaction-diffusion 
equation on the grid. The reaction-diffusion equation 
𝛿𝑐(𝑟, 𝑡)
𝛿𝑡
= 𝐷Δ𝑐(𝑟, 𝑡) − 𝜆𝑐(𝑟, 𝑡) + 𝑆(𝑟, 𝑡) − 𝑄(𝑟, 𝑡) 
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describes molecule diffusion with diffusion coefficient 𝐷 and molecule degradation with degradation 
rate 𝜆 of the concentration 𝑐(𝑟, 𝑡) at position 𝑟  and time point 𝑡. Furthermore, the terms 𝑆(𝑟, 𝑡) and 
𝑄(𝑟, 𝑡) describe chemokine secretion and consumption at position 𝑟  and time point 𝑡, where 
molecule consumption involves molecule-receptor binding by alveolar macrophages. Chemokine 
secretion was induced at all grid points on the surface of the AEC associated with a conidium. The 
reaction-diffusion equation was numerically integrated in time using a finite difference method for 
unstructured grids, as described by Sukumar(Sukumar, 2003). When multiple conidia were present in 
the alveolus, all associated cells secrete chemokines with the same secretion rate. When a conidium 
was found by an alveolar macrophage (AM) the associated cell stopped chemokine secretion. 
1.3 AM Migration 
Migration of AM was realized along surface vectors of length 𝑣Δ𝑡, where 𝑣 denotes the macrophage 
speed and Δ𝑡 refers to the time step of the simulation. A new migration direction was chosen after 
persistence time 𝑡𝑝, either randomly to simulate random walk migration or biased by chemotactic 
signals to simulate directed AM migration. AM sensing of the chemokine concentration was realized 
by the receptor-ligand model that was previously introduced by Guo and Tay (2008)(Guo et al., 
2008) and Guo et al.(Guo and Tay, 2008) and applied here to the spherical alveolar surface. This 
model consisted of an independent system of three differential equations reflecting the state of 
ligands and receptors on the AM surface. In short, the chemokine receptors were able to bind free 
chemokines with binding rate 𝑘𝑏, building a receptor-ligand complex, which was internalized by the 
AM with rate 𝑘𝑖 and finally recycled and re-expressed on the cellular surface with rate 𝑘𝑟. The most 
favorable direction of migrating AM was determined by computing the sum of weighted gradients 
over one period of directional persistence. Then, after each period of directional persistence, the 
respective AM migrates in the direction of the weighted cumulative gradient ?⃗?𝐴𝑀 with probability 
𝑝𝑑𝑖𝑟𝑒𝑐𝑡𝑒𝑑 = min (||?⃗?𝐴𝑀||𝜎𝐴𝑀, 1), where the sensitivity factor 𝜎𝐴𝑀 was determined by Tranquillo et 




and with persistence time 𝑡𝑝 = 1 𝑚𝑖𝑛. 
1.4 Agent Distribution 
AM were placed randomly on the inner surface of the alveolus. Placing 𝑛𝐴𝑀 AM uniformly over 𝑛𝐴𝑙𝑣 
alveoli leads to the binomial distribution 𝐵𝐴𝑀(𝑛𝐴𝑀, 𝑝, 𝑘) = (
𝑛𝐴𝑀
𝑘
)𝑝𝑘(1 − 𝑝)𝑛𝐴𝑀−𝑘, where the 
probability 𝑝 = 1/𝑛𝑎𝑙𝑣  refers to the probability to have 𝑘 AM per alveolus. In close analogy, the 
probability to have 𝑗 conidia present in one alveolus is 𝐵𝑐𝑜𝑛(𝑛𝑐𝑜𝑛, 𝑝, 𝑗).  The alveolar system was 
implemented with absorbing boundaries, i.e. each agent that crosses a system boundary was taken out 
of the system. To account for these randomly exiting AM and to preserve the binomial distribution 







), where 𝑢 is uniformly distributed in (0,1]. The input rate 𝜆𝑖𝑛 is calibrated for each 
set of migration parameters (𝑣 and 𝑡𝑝) and alveolar system (murine and human). The entry point of 
newly entering macrophages was modeled to depend on gradient of the local chemokine 
concentration, ||?⃗?𝐴𝑀,𝑖





 at entry point 𝑖 and ||?⃗?𝐴𝑀,𝑚𝑎𝑥
𝑏 || is the 
maximum gradient of all boundary points. The acceptance-rejection method is applied in the 
following way: An entry point is accepted if 𝑝𝑖 < 𝑙 with a randomly chosen 𝑙 in [0,1] from a uniform 
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distribution for each candidate position; otherwise a new position is chosen randomly over all 
boundary points of the alveolus as the next candidate entry point. 
1.5 Implementation 
The simulation framework was implemented in C++ to provide maximum expandability. Model 
dynamics as agent migration, interaction handling and diffusion were realized by asynchronous 
random-order updating for each time step independently. Two agents interact if their associated 
spheres were overlapping. In case of contact between an AM and a conidium, the conidium was 
assumed to be phagocytosed by the AM. 
1.6 Simulation Result Robustness 
We provide a statistical estimate on how reliable our results are. As explained before, we run each 
simulation for a particular set of model parameters 103 times. One option to estimate the robustness 
of the resulting readouts would be to repeat these 103 simulations multiple times and to calculate 
statistical measures. Since this would be very time consuming, we decided to bootstrap(Efron and 
Tibshirani, 1986) the simulation results as follows: We randomly chose a set of 103 simulations out 
of the 103 computed simulations with replacement and computed readouts like the infection score 𝐼𝑆 
for a number 𝐵 of repetitions. From the resulting 𝐼𝑆 distribution we calculated the 95%-confidence 
interval as an estimation of the real quantiles. We here chose 𝐵 = 300 to produce stable results. 
To evaluate the results of the bootstrapping procedure, we compared it to an estimated standard 
deviation, which we received from 10 repetitions of 103 simulations for the human and mouse system 
with 1 conidium for all parameter combinations of chemotactic signaling. The standard deviation in 
these 72 simulations differed on average by 6% between the bootstrapped and the repetition 
estimates, indicating that our bootstrapping procedure produced valid results.  
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2  Supplementary Videos 
2.1 Video S1 – Human Alveolus Model Video 
The video shows one exemplary simulation in the to-scale hybrid ABM for the human alveolus. The 
video starts with a rotation of the alveolus. The simulation of an infection scenario with one 
conidium starts when the time stamp is visible. AM (green) migrating towards the conidium (red) 
along the chemokine gradient (white isolines) produced by the source AEC. The conidium is found 
by an AM after 55 minutes in this simulation. 
2.2 Video S2 – Mouse Alveolus Model Video 
The video shows one exemplary simulation in the to-scale hybrid ABM for the murine alveolus. The 
video starts with a rotation of the alveolus. The simulation of an infection scenario with one 
conidium starts when the time stamp is visible. AM (green) migrating towards the conidium (red) 
along the chemokine gradient (white isolines) produced by the source AEC. The conidium is found 
by an AM after 21 minutes in this simulation. 
2.3 Video S3 – Infection scores and parameter optima 
The video provides a slide show of simulation results for increasing alveolar occupation number 
comparing the human (left) and mouse (right) system. The infection score is represented in a color-
coded fashion as a function of all chemokine parameter combinations. Small grey dots represent all 
those data points that did not exceed the minimal upper limit of all 95%-confidence intervals. Gold 
points indicate their respective weighted mean. A black border around a data point indicates an 
infection score below the threshold 𝐼𝑆𝑡 = 5%. 
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3 Supplementary Figures 
 
Supplementary Fig. S1: Infection scores for all scanned alveolar occupation numbers and all 
combinations of chemokine parameters in the human (dashed line) and mouse (dotted line) alveolus. 
Black dashed-dotted line indicates an infection score of 𝑰𝑺𝒕 = 𝟓%. Error bars represent the 95%-confidence 
interval. 
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Supplementary Fig. S2: Optimal chemokine parameters for alveolar occupation numbers AON = 
[1,6] in the human and mouse system. For the respective mean with standard deviations across the six 
data points, we the values  𝐷𝑜𝑝𝑡
𝐻̅̅ ̅̅ ̅̅ ̅̅ = 26 ± 6.6 µ𝑚2𝑚𝑖𝑛−1 and  𝑠𝐴𝐸𝐶𝑜𝑝𝑡
𝐻̅̅ ̅̅ ̅̅ ̅̅ ̅ = 1.1 × 104  ± 6 ×
103 𝑚𝑖𝑛−1 for the human host and 𝐷𝑜𝑝𝑡
𝑀̅̅ ̅̅ ̅̅ ̅̅ = 74 ± 22.4 µ𝑚2𝑚𝑖𝑛−1  and 𝑠𝐴𝐸𝐶𝑜𝑝𝑡
𝑀̅̅ ̅̅ ̅̅ ̅̅ ̅ = 8.0 × 104 ±
4,1 × 104 𝑚𝑖𝑛−1 for the murine host. 
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Supplementary Fig. S3: Infection scores for all scanned fungal burdens and all combinations of 
chemokine parameters in the human (dashed line) and mouse (dotted line) alveolus. Black dashed-
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4 Supplementary Tables 
 
Supplementary Table 1: Average characteristics derived per alveolus for the human and murine 
system.  
Parameter Human Mouse Mouse/Human [%] 
Surface area 127 × 103 𝜇𝑚2 6.5 × 103 𝜇𝑚2 5.1 
Volume 5 588 × 103 𝜇𝑚3 64 × 103 𝜇𝑚3 1.1 
Length of boundary 743.2 𝜇𝑚 128.2 𝜇𝑚 17.2 
Surface to boundary ratio 170.1 𝜇𝑚 50.7 𝜇𝑚 29.8 
Mean AM number 4.38 0.74 16.9 
Surface area per AM 28.9 × 103 𝜇𝑚2 8.8 × 103 𝜇𝑚2 30.4 
Mean distance to boundary*  95.4 𝜇𝑚 21.3 𝜇𝑚 22.3 
Surface grid points 10 000 513 5.13 
 
*The mean distance to boundary was computed for random points in the respective alveolar systems 
measuring their distance to the closest border point from 1000 random realizations. 





Human-pathogenic fungi constitute a serious problem in medical health care due to
the increasing number of immunocompromised patients and are associated with high
mortality rates [12]. Among others, the most prevalent fungal isolates associated with
severe fungal infections are the human commensals C. albicans and C. glabrata as
well as the airborne fungus A. fumigatus [7]. In this thesis, several individual-based
virtual infection models have been developed and used to investigate host-pathogen
interactions of the host immune system and the aforementioned human-pathogenic fungi.
This cumulative dissertation comprises six manuscripts as depicted in Figure 6. These
manuscripts belong to three main topics: (i) image-based systems biology, (ii) Candida
bloodstream infection and (iii) A. fumigatus lung infection. The first topic (see Figure 6
Manuscripts Topic Modelling Method
1 Medyukhina et al., 2015
Cytometry Part A (Review) IbSB
Image-based Systems Biology
2 Lehnert and Timme et al., 2015
Frontiers in Microbiology
3 Prauße et al., 2018
Frontiers in Immunology





5 Pollma¨cher et al., 2016
Nature Scientific Reports
6 Blickensdorf et al., 2018
Nature Sytems Biology and
Applications (submitted)
Aspergillus fumigatus lung infection
Evolutionary Game Theory on Graphs
Agent-based Modelling
Figure 6.: Overview of Manuscripts. This thesis comprises six manuscripts that cover various
topics in fungal infection biology combined with a number of state of the art modelling
techniques. (1) The first manuscript reviews the workflow and techniques in image-based
systems biology [143], (2-4) The first research topic on Candida whole blood infection
comprises three publications [142, 144, 145] and (5-6) the second topic on A. fumigatus
lung infection comprises one publication and one submitted manuscript [124].
upper panel) involves a publication that reviews the workflow, techniques and state of
science in image-based systems biology [143].
The second topics (see Figure 6 middle panel) involves three publications, which
address different aspects of the host-pathogen interactions of the innate immune response
against the two Candida spp., C. albicans and C. glabrata, in human whole blood [142,
144, 145]. In particular, a bottom-up modelling approach was developed that combines
modelling techniques of different complexity. This innovative multi-model approach allows
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rigorous investigation of the infection-inflammation process of Candida spp. in human
whole-blood and was used to predict immune reaction rates and migration parameters of
immune cells. Furthermore, hypothesis testing of an immune evasion mechanisms of these
fungal pathogens, which enables escape from killing and phagocytosis by immune cells,
was performed. Additionally, the bottom-up modelling approach was used to simulate
immune dysregulation, neutropenic conditions and in silico cytokine treatment of virtual
neutropenic patients.
The third topic (see Figure 6 lower panel) involves two manuscripts on A. fumigatus
lung infection. The first publication within this topic uses evolutionary game theory
(EGT) to investigate innate immune processes under various infection doses and host
immune states [124]. Furthermore, in a submitted manuscript we used a realistic to-scale
hybrid agent-based model for comparative analysis between A. fumigatus lung infection
in human and mice under natural daily inhalation and experimental inhalation doses.
Due to the modular structure of the developed virtual infection models, they feature
a high degree of extensibility and flexibility that allows studying further aspects of the
aforementioned human-pathogenic fungi as well as their adaptation to other biological
systems. The results and generated hypotheses within this thesis add knowledge on
host-pathogen interactions with human pathogenic fungi and will form the basis for
future experimental and computational research initiating multiple cycles of systems
biology. Chapter 10 and chapter 11 discuss the main results and outline perspectives on
experimental validation, clinical relevance and future model developments of Candida
bloodstream infections and A. fumigatus lung infections, respectively.
10. Candida bloodstream infection
Upon entering the bloodstream via catheters or a disturbed intestinal barrier the human
commensals C. albicans and C. glabrata are able to cause severe systemic infections
in immunocompromised individuals. Thus, research on the infection process and the
immune response against these pathogens is of great importance.
Experimentally, this infection process can be investigated using human whole-blood
infection assays as established by Hünniger et al. [141]. In this assay, human whole blood
is infected with Candida yeast cells and incubated for four hours. At several time points
post-infection fluorescence-activated cell sorting (FACS) analyses and survival assays are
performed in order to measure pathogen killing and association to specific immune cells.
Based on these temporal infection dynamics immune reactions can be investigated in
a quantitative manner using state-based modelling. However, spatial aspects of these
dynamics remain disguised, since imaging of whole blood is not possible to date. Virtual
infection modelling allows to overcome this limitation by integrating experimental data
and estimated immune reaction rates within a spatial model.
Bottom-up modelling enables efficient virtual infection modelling of
Candida bloodstream infections
In the first publication within the topic of Candida bloodstream infections (see Fig-
ure 6 middle panel), a bottom-up modelling approach was developed, which enabled
investigation of the host-pathogen interaction between innate immune mechanisms and
Candida spp. by incorporating wet-lab experiments as well as multiple models with
increasing complexity that build on one another [144]. With this sophisticated approach
several non-spatial and spatial aspects of the biological system can be addressed and
simultaneously computational costs remain manageable.
Non-spatial rates that quantify the immune reactions in human blood can be determined
using a state-based model (SBM) that was previously developed by Hünniger et al. [141]
and extended within this framework, in order to resolve also immune cell states. The
higher degree of detail in the extended SBM enabled the transfer of estimated immune
reaction rates to the spatial model within the bottom-up approach. Parameter estimation
was performed using the global optimization method simulated annealing.
In order to resolve spatial dynamics of the biological system, we developed a spatial
counterpart of the SBM. This spatial model is based on a previously established agent-
based framework by Pollmächer and Figge [139] that was implemented using the object-
oriented programming language C++, which features a high degree of flexibility. During
my PhD project this framework was extended to model whole-blood infection assays with
the human-pathogenic fungi C. albicans and C. glabrata. For cost-efficient parameter
estimation, the ABM makes use of previously estimated immune reaction rates from
the SBM. Therefore, contact-independent and contact-dependent processes have to be
distinguished and transformed, i.e. event probabilities of contact-dependent processes,
such as phagocytosis, have to be equalized. Thus, the dimensionality of the parameter
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space in the ABM can be drastically reduced and values of diffusion coefficients of immune
cells remain to be estimated. Since ABMs are cost-intensive in terms of computational
runtime and diffusion coefficients can be restricted to biologically relevant ranges, the
local optimization approach adaptive regular grid search, which requires comparably little
simulations, was applied.
Typically, in systems biology, single-model approaches are applied in order to investigate
a certain biological system. However, depending on the choice of modelling technique
this approach can be limited by various complications. If the modelling technique is very
general, such as ODEs, either the predictive potential may not be fully utilized, or when
new types of data become available over time, they cannot be integrated into the model.
In contrast, modelling techniques with a high degree of detail, such as ABMs, may be too
complex to start with, since many parameters are not known in the beginning, leading to
unreliable predictions. Combining several modelling techniques to simulate biological
systems is already used in multi-scale modelling, where different modelling approaches
are applied to represent different biological scales. For example, in hybrid agent-based
modelling the ABM is typically used to simulate cells, while a PDE is used to account
for molecule diffusion. However, such multi-scale models are even more complex than
ABMs and, thus, rely on even more parameters. In the scope of the bottom-up modelling
approach various modelling approaches with different complexity are combined within
one framework, which allows investigation of biological systems in a systematic manner
and generation of relevant predictions.
Immune reaction rates can be quantified by state-based modelling
Immune reaction rates, such as phagocytosis rates, intra- and extracellular killing rates as
well as the effect rate of anti-microbial peptides, are not directly accessible in experiments.
Simulation and fitting of the SBM to the underlying experimental data basis allows
estimation of these rates. Additionally, temporal kinetics of pathogen subpopulations
can be uncovered using this virtual infection model.
Within the bottom-up modelling approach we extended the SBM to additionally account
for immune cell states and we repeated parameter estimation for C. albicans human
whole-blood infection. The resulting immune reaction rates were to those previously
estimated by Hünniger et al. [141] comparable, indicating the validity of both models
and the robustness of the predicted solution. With this, we could further confirm the
major role of neutrophils during the immune response against C. albicans.
In the third publication within this topic (see Figure 6 middle panel), we applied the
bottom-up modelling approach also in the context of human whole-blood infection with
C. glabrata [142]. Here, we observed pathogen-specific differences to C. albicans in the
estimated immune reaction rates. On the one hand, phagocytosis rates of neutrophils
and monocytes were higher for C. glabrata. On the other hand, monocytes showed
a more important role in the immune response against C. glabrata, which is in line
with experimental observations [146]. Duggan et al. [146] showed that C. glabrata is
able to trigger neutrophils to secrete soluble factors leading to an increased monocyte
recruitment as well as an increased anti-fungal activity of monocytes and, thus, higher
phagocytosis. This is indicative for a fungal evasion strategy, since C. glabrata cells can
survive and replicate intracellularly within monocytes [146], which increases the risk for
dissemination.
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Spatial modelling allows for prediction of immune cell migration
Live cell imaging of whole blood is not possible to date. Therefore, spatial properties
of the host-pathogen interactions between the human immune system and the fungal
pathogens C. albicans and C. glabrata remain disguised. However, virtual infection
modelling has the potential to overcome this limitation by simulation of spatial models
and the generation of predictions that can be tested in future experiments. Hence, we
developed an ABM as spatial counterpart of the SBM that is able to resolve spatial
dynamics of the system. Using transformed estimated non-spatial immune reaction rates
from the SBM we performed simulations with the ABM in order to determine immune cell
migration parameters. We estimated diffusion coefficients of the two immune cell types –
monocytes and neutrophils – by fitting ABM simulations to the experimental data basis.
We found that during C. albicans infection, large variations of the diffusion coefficient of
monocytes have only a vanishingly low impact on the infection outcome. In contrast, the
infection outcome was very sensitive to the diffusion coefficients of neutrophils, which
has, therefore, to be fine-tuned in a narrow range. This further promotes the importance
of neutrophils in response to C. albicans in human blood. In comparison to C. albicans,
diffusion coefficients for both immune cell types in response to C. glabrata were in general
higher. Interestingly, the diffusion coefficient for monocytes was much more restricted
in case of C. glabrata infection. This is in line with previous findings that monocytes
play a more important role during C. glabrata infections [146]. In contrast, the impact of
the diffusion coefficients for neutrophils on the infection outcome with C. glabrata was
smaller than for C. albicans and could vary in a significantly larger range.
State-based modelling enables hypothesis testing of Candida immune
evasion mechanism
Hünniger et al. [141] detected a population of C. albicans cells during human whole-
blood infection assays that was not phagocytosed. While some of these cells were killed
extracellularly, others remained viable [141]. Since these alive cells that evade the immune
system increase the risk for dissemination, it is important to unravel the underlying
mechanisms leading to this immune evasive population.
In order to clarify this mechanism Hünniger et al. [141] performed several experiments,
such as testing for immune cell exhaustion by reinoculation of new fungal cells and
by adding fresh immune cells, respectively [141]. However, both experiments falsified
the hypothesis of immune cell exhaustion. Furthermore, immune escape due to hyphae
formation could be excluded, since an immune evasive population was also observed using
a non-filamentous mutant [141]. Furthermore, after inoculation of killed fungal cells the
same amount of immune evasive cells was detected.
Since the mechanism of fungal immune evasion could not be deciphered until now, we
tested for several hypotheses and generated predictions that can be addressed in future
experiments, using our previously established SBM. Therefore, we implemented two
different mechanisms for immune evasion, which are: (i) a spontaneous mechanism and
(ii) a neutrophil-mediated mechanism, that is based on the assumptions that neutrophils
secrete peptides that (not on purpose) remodel fungal surface molecules by shaving or
masking. Both models could be fitted to the experimental data with similar quality.
For C. albicans major differences could be observed in the intracellular killing rates
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intracellular killing in monocytes and the decrease of the anti-microbial killing effect,
which are, however, not directly measurable in experiment. Furthermore, quantitative
differences could also be observed for the kinetics of extracellular killing due to anti-
microbial peptides and the kinetics of immune evasive cells, which are too small to
distinguish both models using the experimental data. For C. glabrata, immune reaction
rates for both mechanisms showed relatively large differences. Similar to C. albicans
differences in the time-dependent extracellular killing due to antimicrobial factors were
observed, which were much stronger for C. glabrata. Although, both mechanisms will
not be distinguishable in experiment within one pathogen, the comparison of the relative
differences in the pathogen-specific effect of anti-microbial peptides could be measured
in future experiments. We predict that the strongest differences in the anti-microbial
peptides will be visible at ten to 50 minutes post infection.
To more clearly distinguish both models, we simulated the condition of neutropenia,
since the neutrophil-mediated mechanism is largely influenced by the number of neu-
trophils in the system. The infection outcome four hours post-infection showed clear
differences between the two immune evasion mechanisms in the fractions of phagocytosed,
alive, killed and immune-evasive fungal cells as well as in the distribution across immune
cells. These differences were larger for C. albicans, since in the immune response against
C. glabrata monocytes can partly compensate the loss of neutrophils.
Immune dysregulation resembles conditions of neutropenia
We further used the established bottom-up approach and the previously determined
immune reaction rates and migration parameters to vary specific parameters and investi-
gate their impact on the infection outcome. We used the SBM in order to simulate the
infection process with C. albicans during immune cell deficiency. Here we, according to
medically relevant ranges, steadily decreased the number of monocytes or neutrophils,
respectively. While we could not observe an effect on the infection outcome for monocy-
topenia, neutropenia led to a strong impairment in pathogen killing. This result is in line
with the impaired prognosis of neutropenic patients during C. albicans infection [76].
Additionally, we varied immune cell migration parameters in the ABM to simulate
immune dysregulation that can occur during hyper- and hypo-inflammation in sepsis.
This in silico experiment revealed that an altered monocyte migration does not affect
the infection outcome during C. albicans infection, which shows again the minor role
of macrophages for C. albicans infections. In contrast, a reduced neutrophil migration
led to a decrease in killed C. albicans cells and, thus, an increase in immune evasive
C. albicans cells, which increases the risk for dissemination. Interestingly, we observed
that neutrophil paralysis resembled the condition of neutropenia.
Enhanced risk for fungal dissemination in virtual neutropenic patients
with Candida infection
As described before, we developed a bottom-up modelling approach and predicted
immune reaction rates and immune cell migration parameters on the basis of infection
assays performed with whole-blood from healthy donors. However, patients with an
underlying disease, associated with a compromised immune system, are often at high risk
for infections. Thus, the goal in systems biology of infection is not only to understand
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the infection process in health but also in disease, in order to develop new diagnostic and
therapeutic approaches. Especially, the condition of neutropenia – a neutrophil deficiency
– constitutes a major risk factor for candidiasis [72]. Thus, we addressed this important
issue in the third publication within the context of whole-blood infections. Based on the
afore-described observation that neutrophil paralysis resembles the infection outcome in
neutropenic patients, we hypothesize that an improved neutrophil activation, in terms of
phagocytosis and migration, is able to recover the infection outcome in these patients.
A great advantage of virtual infection modelling is that once a sound model has been
developed and calibrated to experimental data, model parameters or mechanisms can be
changed in a targeted manner and tested for their impact on the simulation outcome.
Thus, we simulated virtual neutropenic patients (VNP) with various severity degrees of
neutropenia by gradually decreasing the absolute number of neutrophils in the ABM. We
then simulated the infection with C. albicans and C. glabrata in these VNP and compared
the infection outcome four hours post-infection. The infection outcome in VNP with
both pathogens was significantly impaired in severe neutropenia, since the number of
killed fungal cells decreased from 90% to 50% and 10% for C. glabrata and C. albicans,
respectively. This shows that the impact of neutropenia on the infection outcome is
much stronger in C. albicans infection, since neutrophils have a higher importance
against this fungus. In contrast, in C. glabrata infections monocytes are more involved
in the immune response. For this reason, they can counteract the loss of neutrophils
to some extent and phagocytose up to 50% of the fungal cells in severe neutropenia
and nearly no fungal cells remain extracellular and alive. However, this still poses the
possibility of dissemination, since C. glabrata has the ability to survive and replicate
within monocytes [146]. In C. albicans monocytes can hardly counteract neutropenic
conditions, which is why a fraction of 30% is still alive and extracellular four hours
post-infection. This subpopulation of C. albicans cells might disseminate in real patients.
The fractions of fungal subpopulations present four hours post-infection in the different
VNP allowed to calculate severity-degree specific patterns of the infection outcome.
In silico cytokine treatment recovers infection outcome in virtual
neutropenic patients
The bottom-up modelling approach also allows testing of hypothetical treatments in
VNP. Based on our hypothesis that neutrophil activation in terms of phagocytosis and
migration may recover the infection outcome in VNP, we performed simulations in the
ABM. We here systematically increased the phagocytosis rate and diffusion coefficient
of neutrophils in all VNP. The previously determined severity-degree specific patterns
allowed for classification of the infection outcome. This analysis revealed that the in silico
treatment indeed improves the infection outcome in VNP. Depending on the severity
degree of neutropenia different treatment strength was required. We could show that a
combined treatment of both parameters is most efficient in infection treatment in VNP
to reach infection outcomes comparable to individuals with normal neutrophil counts.
For C. glabrata lower activation was required to recover the infection outcome in VNP,
i.e. the treatment was more efficient compared to C. albicans.
In the clinical situation the treatment as simulated in the ABM could be realized by
a cytokine treatment. Inflammatory cytokines such as IFNγ and TNFα were shown to
enhance the neutrophil response against Candida spp. [147] and other fungal pathogens,
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such as Aspergillus spp. [148] and Cryptococcus spp. [149]. Besides cytokine treatments,
common methods to treat neutropenia are medication of patients with granulocyte
colony-stimulating factor (G-CSF), which leads to internal stimulation of neutrophil
maturation and release from the bone marrow, as well as the transfusion of G-CSF/steroid
mobilized neutrophils from a donor. Internal stimulation with G-CSF leads to a vast
increase of neutrophils in blood and is mainly applied in congenital neutropenia [150,
151]. Thereby, G-CSF provides an inflammatory signal, which initiates the emergency
mobilization of neutrophils leading to their migration into blood vessels [152]. However,
some patients are low- or no-responders of the G-CSF treatment [74, 150]. Furthermore,
the transfusion therapy of mobilized neutrophils from donors is very effective against
bacterial infections. However, Gazendam et al. [153] showed that in particular G-
CSF/dexamethasone stimulation of donor neutrophils changes the granular content of
neutrophils leading to an impaired fungal killing capacity of C. albicans. This is in line
with the clinical observation that the transfusion therapy improves survival in case of
bacterial infections, which could not consistently be observed for fungal infections [154–
156]. This highlights the need for alternative treatment strategies, which improve survival
also during fungal infections in neutropenic patients.
Perspectives on experimental validation and clinical relevance
Several predictions and new hypotheses could be generated within this thesis, which
might be addressed in future wet-lab studies. Hence, this section outlines perspectives on
future experimental studies as well as possible applications of the bottom-up modelling
approach in the clinical context.
As new microscopy technologies will be available in the future, experimental validation
of our predictions regarding diffusion coefficients can be performed. Such an experimental
testing of predicted migration parameters and immune reaction rates might either confirm
our model or raise the need for model improvement. Once these parameters can be
experimentally determined, our model can be used to address further questions regarding
the infection process and immune response in human blood against C. albicans and
C. glabrata.
In our study on Candida immune evasion in whole-blood infection assays, we performed
hypotheses testing of two mechanisms using the SBM. We predict differences in the
effect of anti-microbial killing for both mechanisms and the two pathogens. Therefore, in
experiment the fungicidal effect of antimicrobial effector proteins inducing extracellular
killing, like lactoferrin, elastase 2 and myeloperoxidase [146], could be measured in the
time-window of 10 to 50 minutes, where the difference was predicted to be largest. A
subsequent comparison of the effect against both pathogens could provide indication for
the underlying mechanism. Furthermore, under neutropenic conditions, large relative
differences in the infection outcome between the two fungal pathogens and the two
immune evasion mechanisms could be observed. Thus, blood from neutropenic patients
or blood with depleted neutrophil numbers could be used in whole-blood infection assays.
These experimental tests could verify or reject our hypotheses and might contribute to
the clarification of the underlying mechanism that causes fungal immune evasion. If
both mechanisms would be falsified, other hypotheses for the immune evasion mechanism
can be tested in silico and in vitro. Conceivable immune evasion mechanisms might
involve other immune components, such as the complement system, monocytes or parts
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of the adaptive immune system. Another possibility is that the subpopulation of immune-
evasive cells exists from the beginning and is a special phenotype within the population
of Candida cells that does not arise due to specific mechanisms in blood. Therefore, the
research on the immune evasion mechanism will initiate further experiment-theory cycles.
Furthermore, we simulated the infection with C. albicans and C. glabrata under
neutropenic conditions, since these patient are at high risk for fungal infections. Since
traditional treatment strategies during neutropenia either do not work properly for some
patients or impair anti-fungal killing capacities of immune cells alternative treatment
strategies need to be investigated. Therefore, we applied an in silico treatment of
the virtual neutropenic patients, where we determined the required treatment strength
that is needed to recover the infection outcome to that of an immunocompetent host.
Experimentally, different cytokines, like IFNγ and TNFα, can be tested for their ability
to increase phagocytic and migratory activity of neutrophils. If the activation effect
appears to be as strong as the predicted required treatment strength, the molecule under
investigation might be appropriate for further testing as a potential therapeutic drug in
neutropenia.
Besides using the bottom-up modelling approach for simulating virtual patients and
treatment testing, it could be also used to stratify the immune-state of sepsis patients in
the clinical setting. Sepsis appears to be a multi-faceted syndrome with hypo- and hyper-
inflammatory phases that often occur simultaneously [157]. Due to the heterogeneous
phenotype of sepsis, there exists no established treatment to date. Classification of sepsis
patients according to their current immune status is, however, not straightforward and
appropriate treatment of these patients strongly depends on the correct assessment of
their immune status. In the future, the bottom-up modelling approach could be of help
in the immuno-profiling of sepsis patients. This could be realized by using blood samples
from sepsis patients for whole-blood infection assays with pathogens, such as Candida spp.
or Staphylococcus aureus. Fitting the SBM to results from whole-blood infection assays
and estimation of immune reaction rates would allow to identify patterns of immune
dysregulation. Furthermore, estimation of immune cell migration parameters would
further support pattern identification. These patterns would allow to build functional
classifiers that can be used in the future for patient stratification.
Perspectives on model developments
The bottom-up modelling approach is a modular and generalized framework that can be
extended in various ways. Currently, it comprises an SBM and an ABM connected by
a self-consistent parameter conversion. In the future, the bottom-up approach can be
extended by a hybrid agent-based model (hABM), which allows simulation of molecule
secretion and diffusion and thereby adds another level of complexity. Simulation of
molecule diffusion, such as anti-microbial peptides or chemokines, could be realized
by adding a molecule layer within the ABM. However, solving the diffusion equation
analytically is not possible in the ABM due to the large amount of sources and sinks in
the system, which are represented by migrating cells that secrete and consume molecules
in the environment. Therefore, molecule diffusion needs to be solved numerically, which
can be realized for example using the forward-Euler approach. However, this method
restricts the simulation time-step to a certain value due to the Courant-limit [158, 159],
which determines the stability of the solution, and thereby increases simulation runtime.
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Another numerical method that can be used to solve the diffusion equation is the Trotter-
Suzuki-Matrix-Exponential approach, which has the advantage that it is unconditionally
stable. Furthermore, besides the parameter estimation methods simulated annealing
based on the Metropolis Monte Carlo scheme and adaptive regular grid search other
parameter estimation methods could be implemented within the bottom-up modelling
approach for comparison and faster convergence to the optimum. Parameter validation
methods such as parameter sensitivity analysis and parameter identifiability analysis
methods can be used to identify key parameters of the virtual infection model and might
improve the modelling and simulation process of the bottom-up approach.
To date, only temporal dynamics are used as input for the bottom-up approach. This
input data pool could be extended in the future to other types of experimental data, such
as image data, which would provide spatial information and would be especially valuable
for spatial simulations using the ABM. Furthermore, large amounts of gene-expression
data exist that could on the one hand provide additional information to the virtual
infection model. On the other hand, the bottom-up model might help in assigning new
gene functions by fitting the model to data of various experimental conditions.
Currently, the spatial environment within the ABM is represented by a cube, which is
reasonable, since whole-blood infection assays are performed in a slowly rotating tube,
where blood flow is neglected. However, in order to bring these studies closer to the
clinical situation a more sophisticated environment could be implemented. For example,
a torus or a more complex branched system with periodic boundaries can be used to
represent blood vessels. The implementation of such a vascular system can be realized
by implementing the respective spatial structures and blood flow. Furthermore, the
simulation of blood flow within such a vessel system would require the implementation
of physical forces, such as flow and shear forces. This could be realized by adding a
mechanical flow field layer to the ABM, where the Navier-Stokes equation, which accounts
for flow and shear forces, is solved using numerical approaches from computational fluid
dynamics [160–163]. Since flow forces act on cell movement and molecule diffusion the
implementation of appropriate mechanisms that can handle these forces within the ABM
would be required. Moreover, this vascular system could be embedded within a tissue
environment, which would allow for simulation of tissue invasion by fungal cells and
immune cell recruitment and migration within the tissue. Here, a well-conceived handling
of boundary conditions between tissue and blood vessels that allows for molecule diffusion
and blood flow needs to be developed.
Furthermore, the bottom-up modelling approach that was developed within my PhD
project can be applied to various other research questions. For example, it provides the
possibility to investigate infection and immune processes in whole blood regarding various
pathogens, such as the gram-positive coccal bacterium Staphylococcus aureus, which is a
human commensal and resides predominantly on the human skin and mucosal surfaces [17,
164]. It is a major human pathogen and the leading cause for bacteremia. In industrial
countries, per year 10 to 30 people out of 100 000 suffer from S. aureus bacteremia [164].
Moreover, neutropenia correlates not only with a higher risk for Candida infections but
also for Staphylocoocus and Streptococcus infections [165–167].
Besides simulating whole-blood infections with other pathogens the bottom-up approach
provides also the possibility to model and simulate completely different biological systems
such as the formation of biofilms on surfaces of medical devices, like catheters, but also
on epithelial cells. It could also be applied in the context of intraspecies interaction as is
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the case in the human microbiota, which highly interacts with the human immune system
and contributes to health and disease to a major extent. Both systems – biofilms and
microbiota – are also very important in the context of fungal colonization and infection,
since Candida spp. colonize large fractions of the world population [16–18] and cause
severe bloodstream infections by entering blood vessels through catheters. Modelling
these biological systems will also rely on extensions of the ABM with regard to molecule
diffusion and blood flow and will further require the implementation of specific biological
structures.

11. Aspergillus fumigatus lung infection
Every human individual inhales several hundreds up to thousands airborne conidia
of A. fumigatus every day [43]. Unnoticed, the immune system is able to clear the
lung from the conidia in healthy individuals, while this fails in immunocompromised
individuals, causing life-threatening infections. Research on the infection dynamics in the
lung under physiological conditions poses a great challenge, since appropriate microscopy
techniques that capture infection dynamics in vivo are not available to date. Even in
vitro experiments cannot easily be conducted, since alveolar epithelial cells of type I,
which make up approximately 95% of the alveolar surface, are challenging to cultivate.
Furthermore, natural daily inhalation and experimentally administered infection doses
differ by several orders of magnitude and, typically, experiments are conducted using
mice, which exhibit a different lung physiology and different cellular composition. In
order to assess the impact of various infection doses as well as morphological differences
in the murine and human lung during the infection process with A. fumigatus we applied
virtual infection modelling.
First, we established a model using evolutionary game theory (EGT) on graphs that
incorporates several immune mechanisms, such as the complement system, AM and
neutrophils, and simulates the immune response in a broader context. Secondly, we
extended a previously established hABM of a realistic to-scale representation of the
human alveolus by Pollmächer and Figge [139, 140]. We simulated the infection process
in a very detailed fashion in human and mice and focused on the immune response by
alveolar macrophages (AM) as well as chemokine secretion and diffusion.
Evolutionary game theory deciphers key immune processes against
A. fumigatus for various infection doses and immune conditions
The infection-inflammation process during A. fumigatus lung infections involves various
immune effector mechanisms and cell types. Each of these processes relies on several
rates that are often neither known from literature nor accessible in experiment, leading
to the generation of unreliable predictions during modelling and simulation. Nevertheless,
in EGT model parameters can be elegantly condensed, which still allows capturing
characteristic features of the infection-inflammation process.
In the first study within the topic of A. fumigatus lung infections (see Figure 6 lower
panel), we developed an EGT model, where fungal cells are simulated as individual
entities that are able to adapt different morphologies, such as resting and swollen conidia
as well as hyphae. These morphologies resemble strategies in the context of game theory
and are assigned with certain abilities of the fungal cells. For example swollen conidia and
hyphae can obtain more nutrients than resting conidia, which increases its reproductive
fitness, while they are also better recognized by the immune system and, thus, face
a stronger immune response. Hence, individual fungal cells choose their strategy in
order to increase their payoff, which represents the utility they gain from higher nutrient
availability and loose by stronger immune attacks. For each of the considered immune
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components we created a game, where fungal cells play against each other under the
pressure of the immune system. We modelled the interaction with the complement system
in Game I, with alveolar macrophages in Game II and with neutrophils in Game III.
During the simulation of these games the strategies of fungal cells evolve over iterative
evolutionary steps. Thereby, fungal cells choose their strategy in order to optimize their
reproductive fitness. However, strategies are also influenced by random mutation and
adaptation events.
This approach allowed incorporation of several aspects of the immune response by
simultaneously keeping the number of unknown parameters in the model feasible and
simulation run times low. We used this model to simulate the counterplay of human
immune processes against A. fumigatus under various infection doses and immune
conditions. Each game was simulated for several parameters, such as the strength of the
immune mechanisms. Furthermore, the infection outcome was quantified by calculation
of an infection score, which considers the fractions of fungal morphologies when the
steady state is reached.
First, we simulated the interaction with the complement system in Game I, which is
at a time scale of the first seconds and minutes after entry of the condidia in the human
lung. Therefore, fungal cell can only be resting or swollen, where the latter ones have
a higher nutrient acquisition ability and a higher virulence but also attract stronger
immune responses. As expected, weaker complement responses and higher nutrient
availability led to increased fractions of swollen conidia. Next, in Game II we simulated
the interaction of fungal cells under the immune response of AM, where we distinguished
cases of low, moderate and high AM activity. Here, fungal cells could not only be resting
and swollen, but also in a hyphal state. We found that for low infection doses AM were
able to clear the infection, if AM activity was sufficiently high, which was not the case in
high infection doses due to the inability of AM to phagocytose hyphae. Finally, in Game
III fungal strategies evolved under the immune response by neutrophils, which could for
most parameters clear the infection in low infection doses, given a minimum neutrophil
recruitment. For high infection doses sufficiently high neutrophil activity and recruitment
were crucial for fungal clearance. Interestingly, reduced neutrophil activity could be, to
some extend, compensated by an increased recruitment. However, it is known that higher
neutrophil recruitment contributes also to increased host cell damage [168]. Furthermore,
AM regulate the immune response also during later stages by shutting down inflammation
and by the initiation of tissue recovery at sites of damage [169–171].
In silico inflammatory cascade reconciles contradictory view on alveolar
macrophages in the literature
Immune effector mechanisms against infectious agents establish an inflammatory milieu
that activates signalling cascades and leads to recruitment and activation of other players
along the cascade of the immune system. In order to account for this inflammatory
cascade we aligned the afore described games in a temporal sequence. Thereby, each game
relied on the inflammation strength caused by the previous game, which is determined by
the fractions of fungal cells with a certain morphology and the strength of the immune
system against these morphologies.
The inflammation caused by the complement system in Game I determined directly
the activity of AM in Game II. As expected, high AM activities led to an improved
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fungal clearance in both, low and high infection dose scenarios. However, only in low
infection doses AM with high activity were able to clear the infection completely, while
this failed under high infection doses. Furthermore, AM with weak activity induced
higher inflammatory signals, leading to increased neutrophil recruitment. As already the
single-game simulation showed, neutrophils are able to clear the infection in almost all
cases of low infection scenarios and lower neutrophils activation was compensated by
higher recruitment. In high infection doses a minimum neutrophil activity was required
for infection clearance. The regulatory role of AM during high infection doses was
pronounced by the fact that AM with low activity caused higher inflammation and, thus,
more neutrophil recruitment, which turned out to be beneficial for the infection clearance.
These results reconciled an existing contradictory view in the literature on the role of
AM during the immune response against A. fumigatus in the lung. As AM are resident
immune cells in the lung [172] they are the first immune cells to encounter inhaled
conidia. Furthermore, it is well known that an impaired AM function is associated with
an increased risk for invasive infections [173]. On the contrary, Mircescu et al. [174]
performed experimental aspergillosis studies in mice and came to the conclusion that
AM are not important, while neutrophils are the major players during fungal clearance.
Surprisingly, these contradictory observations are both in line with our results. We
found that under low infection doses AM where able to clear the lung from the inhaled
conidia by themselves, while under high infection doses their role switches towards a
regulatory function. This regulatory function involves formation of an inflammatory
milieu to recruit neutrophils from the blood stream to the site of infection, since they
feature a broader spectrum of defence mechanisms than AM, especially, in response to
hyphae. Mircescu et al. [174] administered infection doses in mice experiments that
exceeded daily inhalation by several orders of magnitude. In line with our results, they
observed that under high infection doses mainly neutrophils contribute to phagocytosis of
A. fumigatus. Furthermore, our results indicate that during the normal daily inhalation,
AM clear the lung from the inhaled conidia, which is in line with the observation that AM
impairment increases the risk for invasive mycoses. Therefore, the EGT model predicts
that the different views on the role of AM are not in conflict with each other, but rather
describe the infection scenario under different infection doses.
Realistic to-scale hybrid agent-based modelling predicts chemokine
properties in human and mice
Mice are the most commonly used model organism to investigate pulmonary aspergillosis.
Besides differences in the lung morphometry also infection doses of natural inhalation in
humans and experimentally administered doses in mice differ by several orders of magni-
tude. However, little is known to date concerning the comparability and transferability
of experimental aspergillosis models in mice to the human system. We addressed this
issue in the second publication within the topic of A. fumigatus infection (see Figure 6
lower panel).
Therefore, we adapted a previously established hABM of a realistic to-scale representa-
tion of the human alveolus by Pollmächer and Figge [139, 140] to the murine system. This
model incorporates various cellular structures of the alveoli and the immune response by
AM as well as chemokine secretion and diffusion, which we screened for physiological
relevant parameter ranges. This allowed comparative analyses with respect to the different
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lung physiology and infection doses. In our studies, we accounted for the actual fungal
burden that reaches the alveoli given a certain infection dose.
First, we addressed the case of low fungal burden, where only one conidium is present in
the alveolus. Here, we predict that optimal chemokine parameters, i.e. diffusion coefficient
D and chemokine secretion by AEC sAEC are are slightly higher in mice, compared to
human. However, the ratio of chemokine parameters for both organisms are in agreement
with the observation by Pollmächer and Figge [140] that a low ratio between diffusion
coefficient and secretion rate leads to more efficient infection clearance. Furthermore,
we found that this also holds true for mice, since this ratio allows maintenance of a
pronounced chemokine gradient in the alveolus, while faster chemokine diffusion or lower
secretion would result in a weaker gradient.
A. fumigatus infection is more efficiently cleared in mice for natural and
experimental infection doses
Typically, in experiment much higher infection doses compared to daily inhalation
doses are administered, which leads to higher fungal burdens and, thus, higher alveolar
occupation numbers in the alveoli. Therefore, in this second study within the topic of
A. fumigatus lung infections (see Figure 6 lower panel), we further simulated the infection
in human and mouse alveoi with more than one conidium per alveolus. Here, we observed
in general higher infection scores compared to the case of low fungal burden. Similarly,
low chemokine diffusion and high secretion led to more efficient fungal clearance, while
higher chemokine diffusion and lower chemokine secretion led to deteriorated infection
scores.
Similarly to low fungal burdens, a low ratio of chemokine diffusion and secretion
contributed to more efficient fungal clearance. Interestingly, we found that in very high
alveolar occupation numbers of more than four conidia per alveolus, which can arise
due to non-uniform distributions of conidia during intranasal administration in liquid
solution, the human system was more efficient in infection clearance. Contrary to the
previous observation that the higher efficiency in mice is due to the shorter migration
distances, in the limit of high fungal burdens we observed a more important role of the
chemokine profile. For four and more conidia in the relatively small murine alveolus,
chemokine is secreted by all AEC leading to a uniform chemokine distribution in the
alveolus and, thus, inefficient random walk migration of AM.
The number of alveoli in the human lung outnumbers the number of alveoli in the murine
lung by two order of magnitude and the surface area of human alveoli is approximately 20
times larger compared to murine alveoli. This is why the alveolar occupation number is
not directly related to the fungal burden. Thus, we performed a statistical analysis that
relates the alveolar occupation number to the fungal burden, which allows to compare
the infection outcome for the same fungal burden in human and mice. We found that
over a broad range of fungal burdens, including natural and experimental infection doses,
the infection clearance was in most cases more efficient in mice.
Higher alveolar occupation numbers and non-optimal chemokine parameters increased
the infection score values higher than 0.05, i.e. in more than 5% of all simulations
the alveolus could not be cleared from the conidia. These undetected conidia pose
the risk of germination and invasion in real patients, highlighting the importance of a
well-established chemokine gradient and functional sensing by AM.
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To conclude, we can state that conidia clearance seems to be more efficient in mice
in relevant regimes of natural and experimental doses. Of note, results from mice
experiments on the infection dynamics or treatment efficacies cannot be transferred 1:1 to
the human system. It can be expected, that infection prognosis under a specific infection
dose is impaired in humans and may require stronger treatments.
Perspectives on experimental validation and clinical relevance
In this theses several hypotheses could be generated by virtual infection modelling on the
infection-inflammation process during A. fumigatus lung infections that may build the
basis for future experimental studies. Both, the EGT model and the hABM rely on a
spectrum of parameters that were screened in large ranges, since values from the literature
were not available. Determining values or ratios of model parameters experimentally
would open up new opportunities for model extensions to investigate additional aspects
of the infection-inflammation process and to still generate reliable predictions.
The current EGT model comprises immune effector mechanisms of the complement
system, AM as well as neutrophils and would benefit from experimental assessment of the
strength of these effector mechanisms against different fungal morphologies. For example,
the opsonization efficiency of different A. fumigatus morphologies by the complement
molecules C3b and C5b could be measured and relative differences could be incorporated
into Game I of the EGT model. Similarly, immune effector mechanisms of the fungal
killing by alveolar macrophages and neutrophils could be experimentally assessed and
incorporated in Game II and III, respectively.
Furthermore, in the EGT model we predict that the role of AM switches in an infection-
dose dependent manner. However, validation of this observation remains an open issue.
Therefore, confrontation assays could be performed, where AM are confronted with
various infection doses and quantification of phagyocytosis and cytokine profiles could
be measured. Confrontation assays of murine AM and A. fumigatus condia have been
performend previously and phagocytosis was quantified by automated image analysis
by Kraibooj et al. [175] and Cseresnyes et al. [176]. However, they did neither consider
different infection doses nor cytokine secretion by AM, which could be addressed in
future studies. The resulting quantities on AM dynamics could form the basis for model
refinements, which is in the scope of image-based systems biology.
Furthermore, new experimental approaches, like lab-on-a-chip systems could be used to
investigate chemokine parameters, surfactant properties, migration speed and directional
persistence of AM and uptake of fungal cells by AEC [177–179]. Light-sheet microscopy of
murine lungs could give further insights into the distribution of conidia, and neutrophils
after administration of various infection doses in mice experiments.
Perspectives on model developments
Besides experimental validation of already generated predictions as outlined in the
previous section, the developed virtual infection models provide also the basis for further
dry-lab studies and model extensions. The current EGT model comprises the most
important innate effector mechanisms against A. fumigatus. However, it is known that
also dendritic cells initiate the activation of a T cell-mediated defence against A. fumigatus
and Th1/Th2 dysregulation is associated with an increased risk for invasive aspergillosis
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[41, 44, 173]. Therefore, the model can be extended by including various aspects of the
adaptive immune response and their regulation through, for example, dendritic cells.
This could be realized by incorporation of additional games that could be arranged
in a network structure instead of a linear process, since innate and adaptive immune
mechanisms are highly interwoven and regulate each other.
The hABM could be extended by simulating morphological changes of the fungus
over time. Until now, only resting spores are considered within the model. However,
especially in scenarios where AM fail to detect the conidia, time limits before the start of
germination are exceeded. Therefore, swelling and hyphae formation should be considered,
since virulence properties and the detection by immune cells and their effector mechanisms
are very morphology specific.
Furthermore, the model can be extended by including neutrophil recruitment as well as
an explicit phagocytosis model for AM, neutrophils and AEC [180], since until now only
the time for first contact with the fungal cells is determined. However, this first contact
does not necessarily lead to phagocytosis in reality. Thus, implementing a phagocytosis
model would be essential to simulate infection dynamics. Neutrophil recruitment would
rely on the simulation of chemokine secretion by AM, which could be realized by adding
further molecules to the existing close-to-equidistant discretization of the three-quarter
alveolus. Sensing of these molecules by the neutrophils would be implemented similar to
the receptor-ligand model modeled with PDEs in AM.
Furthermore, the current hABM represents the most commonly observed alveolar
morphometry, which is approximated as a three-quarter sphere. However, it is known
that alveolar surfaces can adapt to various polyhedral shapes [83]. Therefore, in the
future the model could be extended to other representations such as one-quarter spheres,
as they make up about 44% of all alveoli in the human lung [181].
Additionally, the hABM provides also the possibility to scale up the environment
to for example a whole alveolar sac to investigate the infection dynamics on tissue
or even whole organ level. Since an alveolar sac comprises about 21 densely packed
alveoli [83], they typically do not exhibit the rigid three-quarter shape, as currently
implemented in the hABM, but rather involve several other morphometries of alveoli,
which continuously change due to dynamic forces and breathing. Pollmächer and Figge
[139] already simulated breathing within a single alveolus and found that this does
not impact on the infection outcome with A. fumigatus. If this holds also true on the
tissue scale could be tested in future in silico experiments. Simulating the infection
process within these irregular alveolar shapes would require to develop an elaborate
approach to calculate a close-to-equidistant grid representation for molecule diffusion
along several alveoli. Furthermore, within the alveolar sac AM would be able to migrate
through the Pores of Kohn and the alveolar entrance rings [182]. To sum up, these
model developments would enormously increase the realism of the simulations. However,
this detailed representation of alveolar morphometry as well as all consequences on the
calculation of the grid-based molecule layer, numerical solution of the diffusion equation
as well as AM migration along an irregular shape would also increase computational
costs.
In addition, studies on lung infections using the developed virtual infection models
could also be extended to other pathogens that are known to cause pulmonary infections,
such as Mycobacterium tuberculosis, Legionella spp. and Streptococcus pneumoniae [183].
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